# Witt_2021_Psychosocial interventions for self-harm in adults._1

Cochrane
Library

Cochrane Database of Systematic Reviews

Psychosocial interventions for self-harm in adults (Review)

Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K

Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. 
Psychosocial interventions for self-harm in adults. 
Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No.: CD013668. 
DOI: 10.1002/14651858.CD013668.pub2.

www.cochranelibrary.com

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

T A B L E   O F   C O N T E N T S

ABSTRACT.....................................................................................................................................................................................................
PLAIN LANGUAGE SUMMARY.......................................................................................................................................................................
SUMMARY OF FINDINGS..............................................................................................................................................................................
BACKGROUND..............................................................................................................................................................................................
OBJECTIVES..................................................................................................................................................................................................
METHODS.....................................................................................................................................................................................................
RESULTS........................................................................................................................................................................................................
Figure 1..................................................................................................................................................................................................
Figure 2..................................................................................................................................................................................................
Figure 3..................................................................................................................................................................................................
DISCUSSION..................................................................................................................................................................................................
Figure 4..................................................................................................................................................................................................
Figure 5..................................................................................................................................................................................................
Figure 6..................................................................................................................................................................................................
AUTHORS' CONCLUSIONS...........................................................................................................................................................................
ACKNOWLEDGEMENTS................................................................................................................................................................................
REFERENCES................................................................................................................................................................................................
CHARACTERISTICS OF STUDIES..................................................................................................................................................................
RISK OF BIAS................................................................................................................................................................................................
DATA AND ANALYSES....................................................................................................................................................................................
Analysis 1.1. Comparison 1: CBT-based psychotherapy, Outcome 1: Repetition of SH at post-intervention..................................
Analysis 1.2. Comparison 1: CBT-based psychotherapy, Outcome 2: Repetition of SH at six months.............................................
Analysis 1.3. Comparison 1: CBT-based psychotherapy, Outcome 3: Repetition of SH at 12 months..............................................
Analysis 1.4. Comparison 1: CBT-based psychotherapy, Outcome 4: Repetition of SH at 24 months..............................................
Analysis 1.5. Comparison 1: CBT-based psychotherapy, Outcome 5: Frequency of SH at post-intervention..................................
Analysis 1.6. Comparison 1: CBT-based psychotherapy, Outcome 6: Frequency of SH at six months.............................................
Analysis 1.7. Comparison 1: CBT-based psychotherapy, Outcome 7: Time to SH repetition............................................................
Analysis 1.8. Comparison 1: CBT-based psychotherapy, Outcome 8: Depression scores at post-intervention................................
Analysis 1.9. Comparison 1: CBT-based psychotherapy, Outcome 9: Depression scores at six months..........................................
Analysis 1.10. Comparison 1: CBT-based psychotherapy, Outcome 10: Depression scores at 12 months.......................................
Analysis 1.11. Comparison 1: CBT-based psychotherapy, Outcome 11: Depression scores at 24 months.......................................
Analysis 1.12. Comparison 1: CBT-based psychotherapy, Outcome 12: Hopelessness scores at post-intervention........................
Analysis 1.13. Comparison 1: CBT-based psychotherapy, Outcome 13: Hopelessness scores at six months..................................
Analysis 1.14. Comparison 1: CBT-based psychotherapy, Outcome 14: Hopelessness scores at 12 months...................................
Analysis 1.15. Comparison 1: CBT-based psychotherapy, Outcome 15: Suicidal ideation scores at post-intervention..................
Analysis 1.16. Comparison 1: CBT-based psychotherapy, Outcome 16: Suicidal ideation scores at six months.............................
Analysis 1.17. Comparison 1: CBT-based psychotherapy, Outcome 17: Proportion reporting suicidal ideation.............................
Analysis 1.18. Comparison 1: CBT-based psychotherapy, Outcome 18: Suicide deaths by final follow-up.....................................
Analysis 1.19. Comparison 1: CBT-based psychotherapy, Outcome 19: Repetition of SH at 12 months (by repeater status).........
Analysis 2.1. Comparison 2: DBT, Outcome 1: Repetition of SH by post-intervention......................................................................
Analysis 2.2. Comparison 2: DBT, Outcome 2: Repetition of SH by 12 months.................................................................................
Analysis 2.3. Comparison 2: DBT, Outcome 3: Frequency of SH by post-intervention......................................................................
Analysis 2.4. Comparison 2: DBT, Outcome 4: Treatment adherence: Proportion completing treatment.......................................
Analysis 2.5. Comparison 2: DBT, Outcome 5: Depression scores by post-intervention...................................................................
Analysis 2.6. Comparison 2: DBT, Outcome 6: Suicidal ideation scores by post-intervention..........................................................
Analysis 2.7. Comparison 2: DBT, Outcome 7: Suicide deaths by post-intervention........................................................................
Analysis 2.8. Comparison 2: DBT, Outcome 8: Suicide deaths by 12 months....................................................................................
Analysis 2.9. Comparison 2: DBT, Outcome 9: Suicide deaths by 24 months....................................................................................
Analysis  3.1.  Comparison  3:  Group-based  emotion-regulation  psychotherapy,  Outcome  1:  Repetition  of  SH  at  post-
intervention...........................................................................................................................................................................................

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1
2
4
22
24
24
29
30
34
35
62
67
68
69
71
72
74
96
193
196
198
199
199
199
200
200
200
200
201
201
201
202
202
202
202
203
203
204
204
207
207
208
208
209
209
210
210
211
212

i

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.2. Comparison 3: Group-based emotion-regulation psychotherapy, Outcome 2: Frequency of repetition of SH at post-
intervention...........................................................................................................................................................................................
Analysis  3.3.  Comparison  3:  Group-based  emotion-regulation  psychotherapy,  Outcome  3:  Depression  scores  at  post-
intervention...........................................................................................................................................................................................
Analysis 4.1. Comparison 4: Case management, Outcome 1: Repetition of SH at post-intervention..............................................
Analysis 4.2. Comparison 4: Case management, Outcome 2: Suicide deaths at post-intervention.................................................
Analysis  5.1.  Comparison  5:  Remote  contact  interventions:  Emergency  cards,  Outcome  1:  Repetition  of  SH  at  post-
intervention...........................................................................................................................................................................................
Analysis 5.2. Comparison 5: Remote contact interventions: Emergency cards, Outcome 2: Repetition of SH at 12 months..........
Analysis 6.1. Comparison 6: Remote contact interventions: Postcards, Outcome 1: Repetition of SH at post-intervention...........
Analysis 6.2. Comparison 6: Remote contact interventions: Postcards, Outcome 2: Repetition of SH at 12 months......................
Analysis 6.3. Comparison 6: Remote contact interventions: Postcards, Outcome 3: Frequency of SH at post-intervention..........
Analysis 6.4. Comparison 6: Remote contact interventions: Postcards, Outcome 4: Frequency of SH at 12 months......................
Analysis 6.5. Comparison 6: Remote contact interventions: Postcards, Outcome 5: Frequency of SH at 24 months......................
Analysis 6.6. Comparison 6: Remote contact interventions: Postcards, Outcome 6: Suicide deaths at post-intervention.............
Analysis 7.1. Comparison 7: Remote contact interventions: Telephone-based psychotherapy, Outcome 1: Repetition of SH at
post-intervention...................................................................................................................................................................................
Analysis 7.2. Comparison 7: Remote contact interventions: Telephone-based psychotherapy, Outcome 2: Depression scores at
post-intervention...................................................................................................................................................................................
Analysis  7.3.  Comparison  7:  Remote  contact  interventions:  Telephone-based  psychotherapy,  Outcome  3:  Suicide  deaths  at
post-intervention...................................................................................................................................................................................
Analysis 8.1. Comparison 8: Provision of information and support, Outcome 1: Repetition of SH at post-intervention................
Analysis 8.2. Comparison 8: Provision of information and support, Outcome 2: Suicide deaths at post-intervention...................
Analysis 9.1. Comparison 9: Other multimodal interventions, Outcome 1: Repetition of SH at post-intervention.........................
Analysis 9.2. Comparison 9: Other multimodal interventions, Outcome 2: Time to SH repetition..................................................
Analysis 9.3. Comparison 9: Other multimodal interventions, Outcome 3: Depression scores at post-intervention......................
Analysis 9.4. Comparison 9: Other multimodal interventions, Outcome 4: Hopelessness scores at post-intervention..................
Analysis 9.5. Comparison 9: Other multimodal interventions, Outcome 5: Suicide deaths at post-intervention...........................
ADDITIONAL TABLES....................................................................................................................................................................................
APPENDICES.................................................................................................................................................................................................
WHAT'S NEW.................................................................................................................................................................................................
HISTORY........................................................................................................................................................................................................
CONTRIBUTIONS OF AUTHORS...................................................................................................................................................................
DECLARATIONS OF INTEREST.....................................................................................................................................................................
SOURCES OF SUPPORT...............................................................................................................................................................................
DIFFERENCES BETWEEN PROTOCOL AND REVIEW....................................................................................................................................
INDEX TERMS...............................................................................................................................................................................................

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

212

212

213
214
215

215
218
219
220
221
222
222
223

223

224

224
225
226
226
227
227
227
227
230
233
233
233
234
234
234
234

ii

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

[Intervention Review]

Psychosocial interventions for self-harm in adults

Katrina G Witt1,2, Sarah E Hetrick3, Gowri Rajaram1,2, Philip Hazell4, Tatiana L Taylor Salisbury5, Ellen Townsend6, Keith Hawton7

1Orygen, Parkville, Melbourne, Australia. 2Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
3Department of Psychological Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
4Speciality of Psychiatry, University of Sydney School of Medicine, Sydney, Australia. 5Health Service and Population Research
Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. 6Self-Harm Research Group,
School of Psychology, University of Nottingham, Nottingham, UK. 7Centre for Suicide Research, Department of Psychiatry, University of
Oxford, Oxford, UK

Contact: Katrina G Witt, katrina.witt@orygen.org.au.

Editorial group: Cochrane Common Mental Disorders Group.
Publication status and date: New, published in Issue 4, 2021.

Citation: Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm
in adults. Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No.: CD013668. DOI: 10.1002/14651858.CD013668.pub2.

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Background

A B S T R A C T

Self-harm (SH; intentional self-poisoning or self-injury regardless of degree of suicidal intent or other types of motivation) is a growing
problem in most counties, often repeated, and associated with suicide. There has been a substantial increase in both the number of trials
and therapeutic approaches of psychosocial interventions for SH in adults. This review therefore updates a previous Cochrane Review (last
published in 2016) on the role of psychosocial interventions in the treatment of SH in adults.

Objectives

To  assess  the  effects  of  psychosocial  interventions  for  self-harm  (SH)  compared  to  comparison  types  of  care  (e.g.  treatment-as-usual,
routine psychiatric care, enhanced usual care, active comparator) for adults (aged 18 years or older) who engage in SH.

Search methods

We searched the Cochrane Common Mental Disorders Specialised Register, the Cochrane Library (Central Register of Controlled Trials
[CENTRAL] and Cochrane Database of Systematic reviews [CDSR]), together with MEDLINE, Ovid Embase, and PsycINFO (to 4 July 2020).

Selection criteria

We included all randomised controlled trials (RCTs) comparing interventions of specific psychosocial treatments versus treatment-as-
usual (TAU), routine psychiatric care, enhanced usual care (EUC), active comparator, or a combination of these, in the treatment of adults
with a recent (within six months of trial entry) episode of SH resulting in presentation to hospital or clinical services. The primary outcome
was the occurrence of a repeated episode of SH over a maximum follow-up period of two years. Secondary outcomes included treatment
adherence, depression, hopelessness, general functioning, social functioning, suicidal ideation, and suicide.

Data collection and analysis

We independently selected trials, extracted data, and appraised trial quality. For binary outcomes, we calculated odds ratio (ORs) and their
95% confidence intervals (CIs). For continuous outcomes, we calculated mean differences (MDs) or standardised mean differences (SMDs)
and 95% CIs. The overall quality of evidence for the primary outcome (i.e. repetition of SH at post-intervention) was appraised for each
intervention using the GRADE approach.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Main results

Cochrane Database of Systematic Reviews

We included data from 76 trials with a total of 21,414 participants. Participants in these trials were predominately female (61.9%) with a
mean age of 31.8 years (standard deviation [SD] 11.7 years). On the basis of data from four trials, individual cognitive behavioural therapy
(CBT)-based psychotherapy may reduce repetition of SH as compared to TAU or another comparator by the end of the intervention (OR 0.35,
95% CI 0.12 to 1.02; N = 238; k = 4; GRADE: low certainty evidence), although there was imprecision in the effect estimate. At longer follow-
up time points (e.g., 6- and 12-months) there was some evidence that individual CBT-based psychotherapy may reduce SH repetition.
Whilst there may be a slightly lower rate of SH repetition for dialectical behaviour therapy (DBT) (66.0%) as compared to TAU or alternative
psychotherapy (68.2%), the evidence remains uncertain as to whether DBT reduces absolute repetition of SH by the post-intervention
assessment. On the basis of data from a single trial, mentalisation-based therapy (MBT) reduces repetition of SH and frequency of SH by
the post-intervention assessment (OR 0.35, 95% CI 0.17 to 0.73; N = 134; k = 1; GRADE: high-certainty evidence). A group-based emotion-
regulation psychotherapy may also reduce repetition of SH by the post-intervention assessment based on evidence from two trials by
the same author group (OR 0.34, 95% CI 0.13 to 0.88; N = 83; k = 2; moderate-certainty evidence). There is probably little to no effect
for different variants of DBT on absolute repetition of SH, including DBT group-based skills training, DBT individual skills training, or an
experimental form of DBT in which participants were given significantly longer cognitive exposure to stressful events. The evidence remains
uncertain as to whether provision of information and support, based on the Suicide Trends in At-Risk Territories (START) and the SUicide-
PREvention Multisite Intervention Study on Suicidal behaviors (SUPRE-MISS) models, have any effect on repetition of SH by the post-
intervention assessment. There was no evidence of a difference for psychodynamic psychotherapy, case management, general practitioner
(GP) management, remote contact interventions, and other multimodal interventions, or a variety of brief emergency department-based
interventions.

Authors' conclusions

Overall, there were significant methodological limitations across the trials included in this review. Given the moderate or very low quality
of the available evidence, there is only uncertain evidence regarding a number of psychosocial interventions for adults who engage in SH.
Psychosocial therapy based on CBT approaches may result in fewer individuals repeating SH at longer follow-up time points, although no
such effect was found at the post-intervention assessment and the quality of evidence, according to the GRADE criteria, was low. Given
findings in single trials, or trials by the same author group, both MBT and group-based emotion regulation therapy should be further
developed and evaluated in adults. DBT may also lead to a reduction in frequency of SH. Other interventions were mostly evaluated in
single trials of moderate to very low quality such that the evidence relating to the use of these interventions is inconclusive at present.

P L A I N   L A N G U A G E   S U M M A R Y

Psychosocial interventions for adults who self-harm

We have reviewed the interventional literature regarding psychosocial intervention treatment trials in the field. A total of 76 trials meeting
our inclusion criteria were identified. There may be beneficial effects for psychological therapy based on cognitive behavioural therapy
(CBT) approaches at longer follow-up time points, and for mentalisation-based therapy (MBT), and emotion-regulation psychotherapy
at the post-intervention assessment. There may also be some evidence of effectiveness of standard dialectical behaviour therapy (DBT)
on  frequency  of  SH  repetition.  There  was  no  clear  evidence  of  effect  for  case  management,  information  and  support,  remote  contact
interventions  (e.g.  emergency  cards,  postcards,  telephone-based  psychotherapy),  provision  of  information  and  support,  and  other
multimodal interventions.

Why is this review important?

Self-harm (SH), which includes intentional self-poisoning/overdose and self-injury, is a major problem in many countries and is strongly
linked with suicide. It is therefore important that effective treatments are developed for people who engage in SH. There has been an
increase in both the number of trials and the diversity of therapeutic approaches for SH in adults in recent years. It is therefore important
to assess the evidence for their effectiveness.

Who will be interested in this review?

Hospital administrators (e.g. service providers), health policy officers and third party payers (e.g. health insurers), clinicians working with
people who engage in SH, the people themselves, and their relatives.

What questions does this review aim to answer?

This review is an update of a previous Cochrane review from 2016 which found that CBT-based psychological therapy can result in fewer
individuals repeating SH whilst DBT may lead to a reduction in frequency of repeated SH. This updated review aims to further evaluate the
evidence for effectiveness of psychosocial interventions for people engaging in SH with a broader range of outcomes.

Which studies were included in the review?

To be included in the review, studies had to be randomised controlled trials of psychosocial interventions for adults who had recently
engaged in SH.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

2

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

What does the evidence from the review tell us?

Cochrane Database of Systematic Reviews

Overall,  there  were  a  number  of  methodological  limitations  across  the  trials  included  in  this  review.  We  found  positive  effects  for
psychological  therapy  based  on  CBT  approaches  at  longer  follow-up  assessments,  and  for  mentalisation-based  therapy  (MBT),  and
emotion-regulation  psychotherapy  on  repetition  of  SH  at  post-intervention.  There  may  also  be  some  evidence  of  effects  for  standard
dialectical behaviour therapy (DBT) on frequency of SH repetition. However, remote contact interventions, case management, information
and support, and other multimodal interventions do not appear to have benefits in terms of reducing repetition of SH.

What should happen next?

The promising results for CBT-based psychotherapy at longer follow-up time points, and for MBT, group-based emotion regulation, and
DBT warrant further investigation to understand which people benefit from these types of interventions. Greater use of head-to-head trials
(where treatments are directly compared with each other) may also assist in identifying which component(s) from these often complex
interventions may be most effective.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

3

 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

S U M M A R Y   O F   F I N D I N G S

Summary of findings 1.   Comparison 1.1: Individual-based CBT-based psychotherapy compared to TAU or another comparator for self-harm in adults

Comparison 1.1: Individual-based CBT-based psychotherapy compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: CBT-based psychotherapy
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with CBT-based
psychotherapy

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Repetition of
SH at post-in-
tervention

Study population

200 per 1000

80 per 1000
(29 to 203)

OR 0.35
(0.12 to 1.02)

238
(4 RCTs)

⊕⊕⊝⊝
LOW 1,2

Our confidence in the effect estimate of case man-
agement on repetition of SH at post-intervention is
limited. The true effect may be substantially differ-
ent from the estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CBT: cognitive behavioural therapy; CI: Confidence interval; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; OR: Odds ratio.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 2.   Comparison 1.2: Group-based CBT-based psychotherapy compared to TAU or another comparator for self-harm in adults

Comparison 1.2: Group-based CBT-based psychotherapy compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: CBT-based psychotherapy

4

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with CBT-
based psy-
chotherapy

Repetition of
SH at post-in-
tervention

Study population

190 per 1000

134 per 1000
(78 to 221)

OR 0.66
(0.36 to 1.21)

313
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate
of group-based CBT-based psychotherapy on repeti-
tion of SH at post-intervention. The true effect is likely
to be close to the estimate of the effect, but there is a
possibility that it is substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CBT: cognitive behavioural therapy; CI: Confidence interval; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; OR: Odds ratio.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 3.   Comparison 2.1: DBT compared to TAU or another comparator for self-harm in adults

Comparison 2.1: DBT compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: DBT
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with DBT

5

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Repetition of
SH by post-in-
tervention

Study population

682 per 1000

604 per 1000
(407 to 769)

OR 0.71
(0.32 to 1.55)

502
(6 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

We have very little confidence in the effect estimate of
DBT on repetition of SH at post-intervention. The true
effect is likely to be substantially different from the es-
timate of effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; DBT: Dialectical behaviour therapy; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by two levels as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for two or
more of the studies included in the pooled estimate.
2 We downgraded this domain by one level as the I2 value indicated substantial levels of heterogeneity.
3 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 4.   Comparison 2.2: DBT group-based skills training compared to TAU or another comparator for self-harm in adults

Comparison 2.2: DBT group-based skills training compared to TAU or alternative psychotherapy for self-harm in adults

Patient or population: self-harm in adults
Intervention: DBT group-based skills training
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects*
(95% CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with DBT
group-based
skills training

Repetition of
attempted sui-
cide at post-in-
tervention

Study population

364 per 1000

274 per 1000
(116 to 515)

OR 0.66
(0.23 to 1.86)

66
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate
of DBT group-based skills training on repetition of at-
tempted suicide at post-intervention. The true effect is
likely to be close to the estimate of the effect, but there
is a possibility that it is substantially different.

6

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

Repetition of
NSSI at post-in-
tervention

Study population

576 per 1000

544 per 1000
(309 to 761)

OR 0.88
(0.33 to 2.34)

66
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate of
DBT group-based skills training on repetition of NSSI at
post-intervention. The true effect is likely to be close to
the estimate of the effect, but there is a possibility that
it is substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; DBT: Dialectical behaviour therapy; NSSI: Non-suicidal self-injury; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm;
TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 5.   Comparison 2.3: DBT individual therapy compared to TAU or another comparator for self-harm in adults

Comparison 2.3: DBT individual therapy compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: DBT individual therapy
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects*
(95% CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with DBT
individual
therapy

Repetition of
attempted sui-
cide at post-in-
tervention

Study population

364 per 1000

455 per 1000
(236 to 691)

OR 1.46
(0.54 to 3.91)

66
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate of
DBT individual therapy on repetition of attempted sui-
cide at post-intervention. The true effect is likely to be
close to the estimate of the effect, but there is a possibil-
ity that it is substantially different.

7

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Repetition of
NSSI at post-in-
tervention

Study population

576 per 1000

636 per 1000
(394 to 825)

OR 1.29
(0.48 to 3.47)

66
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate of
DBT individual therapy on repetition of NSSI at post-in-
tervention. The true effect is likely to be close to the es-
timate of the effect, but there is a possibility that it is
substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; DBT: Dialectical behaviour therapy; NSSI: Non-suicidal self-injury; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm;
TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 6.   Comparison 2.4: DBT prolonged exposure protocol compared to TAU or another comparator for self-harm in adults

Comparison 2.4: DBT prolonged exposure protocol compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: DBT prolonged exposure protocol
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with DBT pro-
longed exposure
protocol

Repetition of
SH at post-in-
tervention

Study population

333 per 1000

251 per 1000
(38 to 740)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

OR 0.67
(0.08 to 5.68)

18
(1 RCT)

⊕⊕⊕⊝
MODERATE1

We are moderately confident in the effect estimate
of DBT prolonged exposure protocol on repetition
of SH at post-intervention. The true effect is likely
to be close to the estimate of the effect, but there
is a possibility that it is substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

8

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

CI: Confidence interval; DBT: Dialectical behaviour therapy; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 7.   Comparison 3: MBT compared to TAU or another comparator for self-harm in adults

Comparison 3: MBT compared TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults 
Intervention: MBT
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with MBT

Repetition of
SH at post-in-
tervention

Study population

492 per 1000

253 per 1000
(141 to 414)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

OR 0.35
(0.17 to 0.73)

134
(1 RCT)

⊕⊕⊕⊕
HIGH

We are very confident that the true effect for MBT
on repetition of SH at post-intervention lies close
to that of the estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; MBT: Mentalisation-based therapy; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

9

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Summary of findings 8.   Comparison 4: Emotion-regulation psychotherapy compared to TAU or another comparator for self-harm in adults

Comparison 4: Emotion-regulation psychotherapy compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Group-based emotion-regulation psychotherapy
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with Group-based
emotion-regulation psy-
chotherapy

Repetition of
SH at post-in-
tervention

Study population

775 per 1000

539 per 1000
(309 to 752)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

OR 0.34
(0.13 to 0.88)

83
(2 RCTs)

⊕⊕⊕⊝
MODERATE1

We are moderately confident that the true ef-
fect of group-based emotion-regulation psy-
chotherapy on repetition of SH at post-inter-
vention lies close to that of the estimate of
the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgradedthis domain by one level as one study was suggestive of benefit, whilst the second trial of this intervention was not.

Summary of findings 9.   Comparison 5: Psychodynamic psychotherapy compared to TAU or another comparator for self-harm in adults

Psychodynamic psychotherapy compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Psychodynamic psychotherapy
Comparison: TAU or another comparator

1
0

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with Psy-
chodynamic psy-
chotherapy

Repetition of
SH at post-in-
tervention

Study population

133 per 1000

65 per 1000
(20 to 194)

OR 0.45
(0.13 to 1.56)

170
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate
of psychodynamic psychotherapy on repetition of
SH at post-intervention. The true effect is likely to be
close to the estimate of the effect, but there is a pos-
sibility that it is substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 10.   Comparison 6: Case management compared to TAU or another comparator for self-harm in adults

Case management compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Case management
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with Case
management

Study population

1
1

OR 0.78
(0.47 to 1.30)

1608
(5 RCTs)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of case man-
agement on repetition of SH at post-intervention is

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Repetition of
SH at post-in-
tervention

114 per 1000

91 per 1000
(57 to 143)

limited. The true effect may be substantially differ-
ent from the estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the I2 value indicated substantial levels of heterogeneity.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 11.   Comparison 7: Structured GP follow-up compared to TAU or another comparator for self-harm in adults

Structured general practitioner (GP) follow-up compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Structured general practitioner (GP) follow-up
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with Struc-
tured general
practitioner (GP)
follow-up

Repetition of
SH at post-in-
tervention (hos-
pital records)

Study population

133 per 1000

134 per 1000
(55 to 291)

OR 1.01
(0.38 to 2.68)

143
(1 RCT)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of structured
general practitioner (GP) follow-up on repetition of SH
(according to hospital records) at post-intervention is
limited. The true effect may be substantially different
from the estimate of the effect.

Repetition of
SH at post-

1
2

Study population

OR 2.56
(0.80 to 8.15)

123
(1 RCT)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of structured
general practitioner (GP) follow-up on repetition of SH

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

intervention
(emergency
records)

72 per 1000

167 per 1000
(59 to 389)

(according to emergency records) at post-intervention
is limited. The true effect may be substantially differ-
ent from the estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 12.   Comparison 9.1: Emergency cards compared to TAU or another comparator for self-harm in adults

Comparison 9.1: Emergency cards compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Emergency cards
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with Remote con-
tact interventions:
Emergency cards

Repetition of
SH at post-in-
tervention

Study population

171 per 1000

145 per 1000
(60 to 306)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

OR 0.82
(0.31 to 2.14)

1039
(2 RCTs)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of emer-
gency cards on repetition of SH at post-inter-
vention is limited. The true effect may be sub-
stantially different from the estimate of the ef-
fect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

1
3

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the I2 value indicated substantial levels of heterogeneity.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 13.   Comparison 9.2: Coping cards compared to TAU or another comparator for self-harm in adults

Comparison 9.2: Coping cards compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Coping cards
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with Coping
cards

Repetition of
SH at post-in-
tervention

Study population

156 per 1000

15 per 1000
(0 to 212)

OR 0.08
(0.00 to 1.45)

64
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate of
coping cards on repetition of SH at post-intervention.
The true effect is likely to be close to the estimate of
the effect, but there is a possibility that it is substan-
tially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1
4

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 14.   Comparison 9.4: Postcards compared to TAU or another comparator for self-harm in adults

Comparison 9.4: Postcards compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Postcards
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with Remote con-
tact interventions: Post-
cards

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Repetition of
SH at post-in-
tervention

Study population

132 per 1000

117 per 1000
(86 to 157)

OR 0.87
(0.62 to 1.23)

3277
(4 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

We have very little confidence in the effect es-
timate for postcards on repetition of SH. The
true effect is likely to be substantially differ-
ent from the estimate of effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
2 We downgraded this domain by one level as the I2 value indicated substantial levels of heterogeneity.
3 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 15.   Comparison 9.5: Telephone contact compared to TAU or another comparator for self-harm in adults

Comparison 9.5: Telephone contact compared to TAU or another comparator for self-harm in adults

1
5

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Patient or population: self-harm in adults
Intervention: Telephone contact
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with Tele-
phone contact

Repetition of
SH at post-in-
tervention

Study population

77 per 1000

35 per 1000
(3 to 295)

OR 0.43
(0.04 to 5.02)

55
(1 RCT)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of telephone
contact on repetition of SH at post-intervention is
limited. The true effect may be substantially differ-
ent from the estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 16.   Comparison 9.6: Telephone contact, emergency cards, and letters compared to TAU or another comparator for self-harm in
adults

Comparison 9.6: Telephone contact, emergency cards, and letters compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Telephone contact, emergency cards, and letters
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

1
6

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Risk with com-
parator

Risk with Remote con-
tact interventions:
Telephone contact,
emergency cards, and
letters

Repetition of
SH at post-in-
tervention

Study population

139 per 1000

145 per 1000
(82 to 244)

OR 1.05
(0.55 to 2.00)

303
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect esti-
mate of telephone contact, emergency cards,
and letters on repetition of SH at post-interven-
tion. The true effect is likely to be close to the
estimate of the effect, but there is a possibility
that it is substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 17.   Comparison 9.7: Telephone-based psychotherapy compared to TAU or another comparator for self-harm in adults

Comparison 9.7: Telephone-based psychotherapy compared to TAU or alternative psychotherapy for self-harm in adults

Patient or population: self-harm in adults
Intervention: Telephone-based psychotherapy
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with Remote con-
tact interventions:
Telephone-based psy-
chotherapy

1
7

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

Repetition of
SH at post-in-
tervention

Study population

11 per 1000

4 per 1000
(0 to 87)

OR 0.36
(0.01 to 8.94)

185
(2 RCTs)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of tele-
phone-based psychotherapy on repetition of
SH at post-intervention is limited. The true ef-
fect may be substantially different from the
estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 18.   Comparison 10: Provision of information and support compared to TAU or another comparator for self-harm in adults

Comparison 10: Provision of information and support compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Provision of information and support
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with Provision
of information and
support

Repetition of
SH at post-in-
tervention

Study population

90 per 1000

97 per 1000
(72 to 129)

1
8

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

OR 1.09
(0.79 to 1.50)

1853
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

We have very little confidence in the effect esti-
mate for information and support on repetition of
SH by the post-intervention assessment. The true
effect is likely to be substantially different from the
estimate of effect.

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Publication bias is suspected as data from some centres have not been published.
2 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
3 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 19.   Comparison 11: Other multimodal interventions compared to TAU or another comparator for self-harm in adults

Comparison 11: Other multimodal interventions compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: Other multimodal interventions
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95% CI)

Risk with com-
parator

Risk with Other
multimodal inter-
ventions

Repetition of
SH at post-in-
tervention

Study population

252 per 1000

189 per 1000
(111 to 305)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

OR 0.61
(0.37 to 1.30)

1937
(3 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2

We have very little confidence in the effect esti-
mate for other multimodal interventions on rep-
etition of SH at post-intervention. The true effect
is likely to be substantially different from the esti-
mate of effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence

1
9

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by two levels as the I2 value indicated considerable levels of heterogeneity.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

Summary of findings 20.   Comparison 12.5: General hospital management compared to TAU or another comparator for self-harm in adults

Comparison 12.5: General hospital management compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults
Intervention: General hospital management
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with General
hospital manage-
ment

Repetition of
SH at post-in-
tervention

Study population

51 per 1000

53 per 1000
(8 to 294)

OR 1.03
(0.14 to 7.69)

77
(1 RCT)

⊕⊕⊕⊝
MODERATE 1

We are moderately confident in the effect estimate
of general hospital management on repetition of SH
at post-intervention. The true effect is likely to be
close to the estimate of the effect, but there is a pos-
sibility that it is substantially different.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

2
0

1 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
P
s
y
c
h
o
s
o
c
i
a
l

i

n
t
e
r
v
e
n
t
i
o
n
s
f
o
r
s
e
l
f
-
h
a
r
m

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

C
o
p
y
r
i
g
h
t

©
2
0
2
1
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

2
1

Summary of findings 21.   Comparison 12.8: Long-term therapy compared to TAU or another comparator for self-harm in adults

Comparison 12.8: Long-term therapy compared to TAU or another comparator for self-harm in adults

Patient or population: self-harm in adults

Intervention: Long term therapy
Comparison: TAU or another comparator

Outcomes

Anticipated absolute effects* (95%
CI)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Risk with com-
parator

Risk with Long
term therapy

Repetition of
SH at post-in-
tervention

Study population

225 per 1000

225 per 1000
(92 to 454)

OR 1.00
(0.35 to 2.86)

80
(1 RCT)

⊕⊕⊝⊝
LOW 1 2

Our confidence in the effect estimate of long-term
therapy on repetition of SH at post-intervention is
limited.The true effect may be substantially different
from the estimate of the effect.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

CI: Confidence interval; OR: Odds ratio; RCT: Randomised controlled trial; RR: Risk ratio; SH: Self-harm; TAU: Treatment as usual.

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in Assessment of risk of bias in included studies) at high risk for one of
the studies included in the pooled estimate.
2 We downgraded this domain by one level as the 95% CI for the pooled effect included the null value.

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

B A C K G R O U N D

Description of the condition

Self-harm (SH), which includes all intentional acts of self-poisoning
(such  as  intentional  drug  overdoses)  or  self-injury  (such  as  self-
cutting),  regardless  of  degree  of  suicidal  intent  or  other  types  of
motivation  (Hawton  2003),  has  been  a  growing  problem  in  most
countries. In Australia, for example, it is estimated that there are
now  more  than  26,000  general  hospitalisations  for  SH  each  year,
or  a  rate  of  116.7  per  100,000  persons  (Harrison  2014),  similar
to  rates  observed  in  a  number  of  other  comparable  countries
(Canner  2018;  Griffin  2014;  Morthorst  2016;  Ting  2012;  Wilkinson
2002). However, it is notable that rates of emergency department
presentations for SH are often higher than hospitalisations (Bergen
2010;  Corcoran  2015).  In  the  UK,  for  example,  higher  rates  of
emergency department presentations for SH in both females (442
per  100,000)  and  males  (362  per  100,000)  have  been  reported
(Geulayov  2016).  There  are  also  many  more  episodes  of  SH
occurring  in  the  community  that  do  not  come  to  the  attention
of  clinical  services.  Worldwide,  for  example,  the  World  Health
Organization (WHO) estimates that the rate of SH may be as high as
400 per 100,000, according to self-report data (WHO 2014).

In  contrast  to  suicide  rates,  rates  of  hospital-presenting  SH  are
higher  in  females  than  in  males  in  most  countries  (Canner  2018;
Griffin  2014;  Masiran  2017;  Morthorst  2016;  Ting  2012;  Wilkinson
2002), with rates peaking in younger adults up to 24 years of age
(Perry  2012).  However,  this  difference  decreases  across  the  life
cycle (Hawton 2008). SH is less common in older people, but tends
to  be  associated  with  higher  suicidal  intent  (Hawton  2008),  with
consequent greater risk of suicide (Murphy 2012).

For  those  who  present  to  hospital,  the  most  common  method  of
SH  is  self-poisoning.  Overdoses  of  analgesics  and  psychotropics,
especially  paracetamol  or  acetaminophen,  are  common  in  some
countries,  particularly  high-income  countries.  Self-cutting  is  the
next most frequent method used by those who present to hospital.
However,  in  the  community,  self-cutting  and  other  forms  of  self-
injury are far more frequent than self-poisoning (Müller 2016).

SH  is  often  repeated.  Up  to  one-quarter  of  those  who  present
to  hospital  with  SH  return  to  the  same  hospital  within  a  year
(Carroll 2014; Owens 2002), although some individuals may present
to  another  hospital.  Others  may  not  present  to  hospital  at  all
given that studies identifying SH repetition via self-report suggest
as  many  as  one  in  five  report  further  SH  episodes  following  a
hospital  presentation  (Carroll  2014).  Repetition  is  more  common
in  individuals  who  have  a  history  of  previous  episodes  of  SH,
personality  disorder,  psychiatric  treatment,  and  alcohol  or  drug
misuse  (Larkin  2014).  Risks  of  repeat  SH  may  also  be  associated
with  method.  Rates  of  repetition  are  higher  among  those  who
present to hospital following self-injury alone (Carroll 2014; Lilley
2008),  or  combined  self-injury  and  self-poisoning  (Perry  2012),
compared to those who present for self-poisoning alone.

SH is associated with suicide. The risk of death by suicide within
one  year  among  people  who  present  to  hospital  following  SH
varies across studies from nearly 1% to over 3% (Liu 2020; Carroll
2014;  Owens  2002).  This  variation  reflects  the  characteristics  of
the  population,  and  the  background  national  suicide  rate.  In  the
UK,  for  example,  during  the  first  year  after  an  episode  of  SH,  the
risk  of  suicide  is  around  50  times  that  of  the  general  population,

Cochrane Database of Systematic Reviews

with a particularly high risk in men (Carroll 2014; Geulayov 2019).
One  quarter  of  these  deaths  are  estimated  to  occur  within  one
month  after  discharge,  and  almost  50%  by  three  months  (Forte
2019), although the risk of suicide appears to remain elevated for
a number of years (Geulayov 2019). A history of SH is the strongest
risk  factor  for  suicide  across  a  range  of  psychiatric  disorders.
Repetition of SH further increases the risk of suicide (Zahl 2004).

SH  and  suicide  are  the  result  of  a  complex  interplay  between
genetic, biological, psychiatric, psychosocial, social, cultural, and
other factors. Psychiatric disorders, particularly mood and anxiety
disorders, are associated with the largest contribution to the risk
of  both  SH  (Hawton  2013),  and  suicide  in  adults  (Ferrari  2014).
Personality  disorders,  including  borderline  personality  disorder,
are  also  associated  with  SH,  particularly  frequent  repetition.
Alcohol  use  may  also  play  an  important  role  (Ferrari  2014).  Both
psychological  and  biological  factors  appear  to  further  increase
vulnerability  to  SH.  Psychological  factors  may  include  difficulties
in  problem-solving,  low  self-esteem,  impulsivity,  vulnerability  to
having  pessimistic  thoughts  about  the  future  (i.e.  hopelessness),
and a sense of entrapment. Biological factors include disturbances
in  the  serotonergic  and  stress  response  systems  (Van  Heeringen
2014).

Description of the intervention

Psychological approaches used to treat adults who engage in SH
typically  involve  brief  individual-  or  group-based  psychological
therapy.  Treatment  may  vary  in  terms  of  initial  management,
location  of  treatment,  continuity,  intensity,  and  frequency  of
contact  with  therapists.  There  is  also  considerable  variation
among  countries  in  the  availability  of  services  to  provide  such
interventions.  Consequently,  there  is  no  standard  psychosocial
treatment  of  SH  in  adults.  However,  in  high-income  countries,
treatment  generally  consists  of  a  combination  of  assessment,
support,  and  individual  psychological  therapies.  In  lower  and
middle-income countries, aftercare more usually involves various
forms of support, both face-to-face and via digital means.

How the intervention might work

Psychosocial  interventions  may  address  some  of  the  underlying
psychological  risk  factors  associated  with  SH.  The  mechanisms
of  action  of  these  interventions  might  help  people  improve  their
coping  skills  and  tackle  specific  problems,  manage  psychiatric
disorders, 
increase  a  sense  of  social
connectedness,  and  reduce  impulsivity  and  harmful  reactions
to  distressing  situations.  What  follows  is  a  description  of  the
psychosocial  interventions  that  are  typically  available  for  adults
who engage in SH behaviours.

improve  self-esteem, 

Cognitive behavioural therapy-based psychotherapy

Cognitive  behavioural  therapy  (CBT)-based  psychotherapy  helps
people  identify  and  critically  evaluate  the  ways  in  which  they
interpret  and  evaluate  disturbing  emotional  experiences  and
events, and aims to help them change the ways in which they deal
with  problems  (Westbrook  2008).  This  is  achieved  in  three  steps:
first, people are helped to change the ways in which they interpret
and evaluate distressing emotions; second, they learn strategies to
help them change the way in which they think about the meanings
and  consequences  of  these  emotions;  finally,  with  the  benefit  of
modified interpretation of emotions and events, they are helped to

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

22

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

change their behaviour and develop positive functional behaviour
(Jones 2012).

Problem-solving therapy (PST) is an integral part of CBT, although
it  can  be  delivered  as  a  therapy  in  and  of  itself.  PST  assumes
that ineffective and maladaptive coping behaviours that drive SH
might be overcome by helping the person to learn skills to actively,
constructively, and effectively solve the problems he or she faces
in their daily lives (Nezu 2010). PST typically involves identification
of the problem, generation of a range of solutions, implementation
of  chosen  solutions  based  on  appraisal,  and  the  evaluation  of
these  solutions  (D'Zurilla  2010).  Treatment  goals  include  helping
people  to  develop  a  positive  problem-solving  orientation,  use
rational problem-solving strategies, reduce the tendency to avoid
problem-solving, and reduce the use of impulsive problem-solving
strategies.

Dialectical behaviour therapy

In  contrast  to  CBT  and  PST,  which  focus  on  changing  behaviour
and cognitive patterns, the focus of dialectical behavioural therapy
(DBT) is to provide people with the skills to develop an awareness
and  acceptance  of  thoughts  and  emotions,  including  painful  or
distressing  internal  experiences,  without  judgement  or  attempts
to  alter,  suppress,  avoid,  or  otherwise  change  these  experiences
(Lynch 2006). The primary treatment goals of DBT are three-fold:
to  reduce  SH,  reduce  behaviours  that  interfere  with  the  success
of  treatment,  such  as  treatment  non-adherence,  and  reduce  any
other factors that may adversely affect the person's quality of life
(e.g. frequency or duration of psychiatric hospitalisations) (Linehan
1993).

Mentalisation-based therapy

Mentalisation refers to the ability to understand the behaviour of
both one's self and others in terms of motivational and emotional
states (Allen 2008). Maladaptive and impulsive coping behaviours,
including  SH,  are  presumed  to  arise  from  a  disrupted  ability
to  engage  in  these  processes.  In  mentalisation-based  therapy
(MBT),  the  goal  is  to  help  people  understand  their  emotions  and
behaviours, and develop strategies to regulate them to minimise
the risk that they will engage in SH during times of distress.

Emotion-regulation psychotherapy

includes  psychoeducation, 

Emotion-regulation  psychotherapy  is  based  on  DBT,  Acceptance
and  Commitment  Therapy  (ACT),  and  emotion-focused  therapy.
It 
identification  of  emotions,
distress  tolerance,  emotional  acceptance,  behavioural  activation,
developing  alternative  coping  strategies,  impulse  control,  and
identifying and clarifying valued directions.

Psychodynamic psychotherapy

focus  on  affective  experiences,
Psychodynamic  approaches 
exploring  and  understanding  the  unconscious  meaning  and
resolving  difficulties
function  of  SH,  and  exploring  and 
in 
resulting  emotional
relationships,  and 
difficulties,  within  a  therapeutic  relational  framework  (Yakeley
2018).

interpersonal 

Case management

"In its simplest form...case management is a means of coordinating
services.  Each...person  is  assigned  a  'case  manager'  who  is

Cochrane Database of Systematic Reviews

expected  to  assess  that  person's  needs,  develop  a  care  plan,
arrange for suitable care to be provided, monitor the quality of the
care  provided,  and  maintain  contact  with  the  person"  (Marshall
2000a).  Case  management  might  have  a  significant  role  in  the
aftercare  of  people  who  engage  in  SH  because  many  of  them
demonstrate poor treatment adherence, and because of the varied
nature of the problems these individuals are often facing (Lizardi
2010).

Remote contact interventions

Remote contact interventions, which may include letters, brief text
messages delivered by telephone, telephone calls, and postcards,
are  low-resource  and  non-intrusive  interventions  that  seek  to
maintain  long-term  contact  with  people.  These  interventions
provide  a  sense  of  ongoing  concern,  and  may  mitigate  the  sense
of  social  isolation  reported  by  many  people  who  engage  in  SH.
They may also help to improve their knowledge about triggers and
warning signs for SH, provide them with information on alternative
coping behaviours to SH, and where they can access help (Milner
2016).

These  interventions  may  also  be  combined  with  emergency  card
interventions,  which  encourage  people  to  seek  help  when  they
feel  distressed,  and  offer  on-demand  emergency  contact  with
psychiatric services or inpatient care. The aim is to reduce the risk
of SH by facilitating rapid access to care.

Other multimodal interventions

Any  of  the  above  active  psychosocial  interventions  may  also  be
combined into a multimodal approach (Högberg 2008).

Why it is important to do this review

SH  is  a  major  social  and  healthcare  problem.  It  represents
significant morbidity, is often repeated, and is linked with suicide.
Many countries now have suicide prevention strategies, all of which
include  a  focus  on  improved  management  of  people  presenting
with  SH  (WHO  2014).  SH  also  leads  to  substantial  healthcare
costs  (Sinclair  2011).  In  the  UK,  the  overall  median  cost  per
episode  of  SH  has  been  estimated  to  be  £809,  although  costs
are significantly higher for cases of combined self-injury and self-
poisoning, compared to either self-injury of self-poisoning alone.
These costs are mainly attributable to health-service level contact
(i.e. inpatient stay or admission to intensive care; Tsiachristas 2017).

In  the  UK,  the  National  Collaborating  Centre  for  Mental  Health
(NCCMH)  produced  the  first  guideline  on  the  treatment  of  SH
behaviours  in  2004  (NCCMH  2004).  This  guideline  focused  on  the
short-term  physical  and  psychological  management  of  SH.  This
guidance was updated in 2011, using interim data from a previous
version  of  this  review  as  the  evidence  base,  and  focused  on
the  longer-term  psychological  management  of  SH  (NICE  2011).
Subsequently, similar guidelines have been published by the Royal
College  of  Psychiatrists  (Royal  College  of  Psychiatrists  2014),  the
Royal Australian and New Zealand College of Psychiatrists (Carter
2016), and German Professional Associations and Societies (Plener
2016), amongst others (Courtney 2019).

In 2021, the guidance contained in the 2011 NICE guidelines for the
longer-term management of SH will be due for updating. Therefore,
we  are  updating  our  review  (Hawton  2016),  in  order  to  provide
contemporary evidence to guide clinical policy and practice.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

23

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

O B J E C T I V E S

3. Mentalisation-based  therapy  (MBT)  versus  TAU  or  another

To  assess  the  effects  of  psychosocial  interventions  for  self-harm
(SH) compared to comparison types of care (e.g. treatment as usual,
routine psychiatric care, enhanced usual care, active comparator)
for adults (aged 18 years or older) who engage in SH.

M E T H O D S

comparator;

4. Emotion-regulation  psychotherapy  versus  TAU  or  another

comparator;

5. Psychodynamic  psychotherapy  versus  TAU  or  another

comparator;

6. Case management versus TAU or another comparator;
7. Structured  general  practitioner  (GP)  follow-up  versus  TAU  or

Criteria for considering studies for this review

another comparator;

Types of studies

We  considered  all  randomised  controlled  trials  (RCTs)  of  specific
psychosocial  interventions  versus  treatment  as  usual,  routine
psychiatric  care,  enhanced  usual  care,  active  comparator,  or  a
combination  of  these,  in  the  treatment  of  adults  with  a  recent
(within  six  months  of  trial  entry)  presentation  for  self-harm  (SH).
All RCTs (including cluster-RCTs [cRCTs] and cross-over trials) were
eligible  for  inclusion  regardless  of  publication  type  or  language;
however, we excluded quasi-randomised trials.

8. Brief emergency department-based interventions versus TAU or

another comparator;

9. Remote  contact 

interventions  versus  TAU  or  another

comparator;

10.Provision  of  information  and  support  versus  TAU  or  another

comparator;

11.Other  multimodal 

interventions  versus  TAU  or  another

comparator;

12.Other mixed interventions versus TAU or another comparator.

Types of participants

Comparators

While exact eligibility criteria often differ both within and between
regions and countries (Witt 2020a), we included participants of both
sexes and all ethnicities, who were 18 years and older, with a recent
(i.e.  within  six  months  of  trial  entry)  presentation  to  hospital  or
clinical services for SH.

We  defined  SH  as  all  intentional  acts  of  self-poisoning  (such  as
intentional  drug  overdoses)  or  self-injury  (such  as  self-cutting),
regardless  of  the  degree  of  suicidal  intent  or  other  types  of
motivation (Hawton 2003). This definition includes acts intended to
result in death ('attempted suicide'), those without suicidal intent
(e.g.  to  communicate  distress,  to  temporarily  reduce  unpleasant
feelings;  sometimes  termed  'non-suicidal  self-injury'),  and  those
with mixed motivation. We did not distinguish between attempted
suicide and non-suicidal self-injury in this review, because there is
a high level of co-occurrence between them, and the two cannot
be distinguished in any reliable way, including on levels of suicidal
intent (Klonsky 2011). Lastly, the motivations for SH are complex
and can change, even within a single episode (De Beurs 2018).

We  excluded  trials  in  which  participants  presented  to  clinical
services for suicidal ideation only (i.e. without evidence of SH).

Types of interventions

Categorisation of the interventions in this review was informed by
the trials themselves, and based on consensus discussions among
members of the review team, who have considerable experience in
both research and clinical practice related to SH. However, based on
the previous version of this review (Hawton 2016), we anticipated
the following groupings:

Interventions

These included the following:

1. Cognitive behavioural therapy (CBT)-based psychotherapy (e.g.
CBT,  problem-solving  therapy  [PST])  versus  TAU  or  another
comparator;

2. Dialectical  behaviour  therapy  (DBT)  versus  TAU  or  another

comparator;

Treatment-as-usual (TAU) is likely to vary widely between settings
and between studies conducted over different time periods (Witt
2018). Following previous work, we defined TAU as routine clinical
care  that  the  person  would  receive  had  they  not  been  included
in  the  study  (i.e.  routine  care  or  'standard  disposition';  Hunt
2013).  Other  comparators  could  include  no  specific  treatment,
or  enhanced  usual  care,  which  refers  to  TAU  that  has,  in  some
way, been supplemented, such as by providing psychoeducation,
assertive  outreach,  or  more  regular  contact  with  case  managers,
and standard assessment approaches.

Types of outcome measures

For all outcomes, we were primarily interested in quantifying the
effect  of  treatment  assignment  to  the  intervention  at  baseline,
regardless  of  whether  the  intervention  was  received  as  intended
(i.e. the intention-to-treat effect).

Primary outcomes

The primary outcome measure in this review was the occurrence
of  repeated  SH  over  a  maximum  follow-up  period  of  two  years.
Repetition  of  SH  may  be  identified  through  self-report,  collateral
report,  clinical  records,  or  research  monitoring  systems.  As  we
wished  to  incorporate  the  maximum  data  from  each  trial,  we
included  both  self-reported  and  hospital  records  of  SH,  where
available. Preference was given to clinical records over self-report
where a trial reported both measures. We also reported proportions
of  participants  repeating  SH,  frequency  of  repeat  episodes,  and
time to SH repetition (where available).

Secondary outcomes

Given  increasing  interest  in  the  measurement  of  outcomes  of
importance to those who engage in SH (Owens 2020b), we planned
to  analyse  data  for  the  following  secondary  outcomes  (where
available) over a maximum follow-up period of two years:

Treatment adherence

This  was  assessed  using  a  range  of  measures  of  adherence,
including:  pill  counts,  changes  in  blood  measures,  and  the

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

24

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

proportion  of  participants  that  both  started  and  completed
treatment.

We searched for retraction statements and errata once the included
studies were selected.

Depression

This  was  assessed  as  either  continuous  data,  by  scores  on
psychometric  measures  of  depression  symptoms,  for  example,
total  scores  on  the  Beck  Depression  Inventory  (BDI;  Beck  1961),
or scores on the depression subscale of the Hospital Anxiety and
Depression Scale (HADS; Zigmond 1983), or as dichotomous data as
the proportion of participants who met defined diagnostic criteria
for depression.

Hopelessness

This  was  assessed  as  either  continuous  data,  by  scores  on
psychometric  measures  of  hopelessness,  for  example,  total
scores  on  the  Beck  Hopelessness  Scale  (BHS;  Beck  1974),  or  as
dichotomous  data  as  the  proportion  of  participants  reporting
hopelessness.

General functioning

This  was  assessed  as  either  continuous  data,  by  scores  on
psychometric measures of general functioning, for example, total
scores on the Global Assessment of Functioning (GAF; APA 2000),
or as dichotomous data as the proportion of participants reporting
improved general functioning.

Social functioning

This  was  assessed  as  either  continuous  data,  by  scores  on
psychometric  measures  of  social  functioning,  for  example,  total
scores  on  the  Social  Adjustment  Scale  (SAS;  Weissman  1999),  or
as  dichotomous  data  as  the  proportion  of  participants  reporting
improved social functioning.

Suicidal ideation

This  was  assessed  as  either  continuous  data,  by  scores  on
psychometric  measures  of  suicidal  ideation,  for  example,  total
scores on the Beck Scale for Suicidal Ideation (BSSI; Beck 1988), or
as dichotomous data as the proportion of participants reaching a
defined cut-off for ideation.

Suicide

This included register-recorded deaths, or reports from collateral
informants, such as family members or neighbours.

Search methods for identification of studies

Electronic searches

An 
information  specialist  searched  the  following  databases
(to  4  July  2020),  using  relevant  subject  headings  (controlled
vocabularies)  and  search  syntax  as  appropriate 
for  each
resource: Cochrane Common Mental Disorders Specialised Register
(Appendix  1),  Cochrane  Library  (Central  Register  of  Controlled
Trials;  CENTRAL),  Cochrane  Database  of  Systematic  Reviews
(CDSR), MEDLINE Ovid, Embase Ovid, and PsycINFO Ovid (Appendix
2).

A date restriction was applied to the search as the search was to
update an earlier version of this review (Hawton 2016). However,
we did not apply any further restrictions on language or publication
status to the searches.

We  also  searched  the  World  Health  Organization  International
Clinical Trials Registry Platform, and the US National Institutes of
Health Ongoing Trials Register ClinicalTrials.gov to identify ongoing
trials.

The  search  was  based  on  population  only,  participants  who  self-
harm (all ages). Records were screened to identify trials which were
relevant to this review and two others (Witt 2021a; Witt 2021b).

Searching other resources

Conference abstracts

In addition to conference abstracts retrieved via the main electronic
search, we also screened the proceedings of recent (last five years)
conferences organised by the largest scientific committees in the
field:

1. International  Association  for  Suicide  Prevention  (both  global

congresses and regional conferences);

2. Joint International Academy of Suicide Research and American
Foundation  for  Suicide  Prevention  International  Summits  on
Suicide Research.

Reference lists

We  also  checked  the  reference  lists  of  all  relevant  RCTs,  and
the  reference  lists  of  major  reviews  that  included  a  focus  on
psychosocial  interventions  for  SH  in  adults  (Bornheimer  2020;
Briggs 2019; Calati 2016; D'Anci 2019; DeCou 2019; Ghanbari 2015;
Gøtzsche 2017; Hawton 2016; Hanratty 2019; Hetrick 2016; Inagaki
2019;  Krysinska  2017;  Meerwijk  2016;  Milner  2015;  Milner  2016;
Padmanathan 2020; Riblet 2017; Tighe 2018).

Correspondence

We consulted the corresponding authors of trials, and other experts
in  the  field  to  find  out  if  they  are  aware  of  any  ongoing  or
unpublished  RCTs  on  the  psychosocial  treatment  of  adults  who
engage in SH that were not identified by the electronic searches.

Data collection and analysis

Selection of studies

Review  authors  KW,  KH,  and  one  of  either  SH,  GR,  TTS,  ET,  or
PH, independently assessed the titles of reports identified by the
electronic search for eligibility. We distinguished between:

1. eligible  or  potentially  eligible  trials  for  retrieval,  in  which  any
psychosocial intervention was compared with a comparator (i.e.
TAU, routine psychiatric care, standard disposition, no specific
treatment, enhanced usual care);
ineligible, general treatment trials, not for retrieval (i.e. where
there was no control treatment).

2.

All  trials  identified  as  potentially  eligible  for  inclusion  then
underwent  a  second  screening.  Pairs  of  review  authors,  working
independently from one another, screened the full text of eligible
or  potentially  eligible  trials  to  identify  whether  the  trial  met  our
inclusion criteria. We resolved disagreements in consultation with
the senior review author (KH). Where disagreements could not be
resolved  from  the  information  reported  in  the  trial,  or  where  it

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

25

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

was  unclear  whether  the  trial  satisfied  our  inclusion  criteria,  we
contacted corresponding trial authors for additional clarification.

We identified and excluded duplicate records, and collated multiple
reports  of  the  same  trial,  so  that  each  trial,  rather  than  each
report, represented the unit of interest in the review. We recorded
the  selection  process  in  sufficient  detail  to  complete  a  PRISMA
flow  diagram  (Liberati  2009),  and  completed  a  'Characteristics  of
excluded studies' table.

Data extraction and management

Assessment of risk of bias in included studies

Highly  biased  studies  are  more  likely  to  overestimate  treatment
effectiveness  (Moher  1998).  Review  author  KW  and  one  of  either
SH, or GR independently evaluated the risk of bias for the primary
outcome (i.e. repetition of SH at post-intervention) by using version
2 of the Cochrane Risk of Bias tool, RoB 2 (Sterne 2019). This tool
encourages consideration of the following domains:

1. Bias in the randomisation process;
2. Deviations  from  the  intended  intervention  (assignment  to

Review  author  KW  and  one  of  either  SH,  or  GR  independently
extracted  data  from  the  included  trials,  using  a  standardised
extraction form. Where there were any disagreements, they were
resolved in consensus discussions with KH.

intervention);

3. Missing outcome data;
4. Bias in the measurement of the outcome;
5. Bias in the selection of the reported result.

Data extracted from each eligible trial included the following:

For cluster-RCTs, we also evaluated the following:

1. Participant  information:  number  randomised,  number  lost  to
follow-up  or  withdrawn,  number  analysed,  mean  or  median
age,  sex  composition,  diagnoses,  diagnostic  criteria,  inclusion
criteria, and exclusion criteria;

2. Methods: trial design, total duration of the trial, details of any
'run-in' period (if applicable), number of trial centres and their
location, setting, and date;

3. Intervention(s):  details  of  the  intervention,  including  dose,
duration, whether concomitant treatments were permitted and
details of these treatments, and any excluded treatments;

4. Comparator(s):  details  on  the  comparator,  including  dose,
duration, whether concomitant treatments were permitted and
details of these treatments, and any excluded treatments;

5. Outcomes:  raw  data  for  each  eligible  outcome  (see  Types  of
outcome  measures),  details  of  other  outcomes  specified  and
reported, and time points at which outcome were reported;
6. Notes:  source  of  trial  funding,  and  any  notable  conflicts  of

interest of trial authors.

We  extracted  both  dichotomous  and  continuous  outcomes  data
from  eligible  trials.  As  the  use  of  non-validated  psychometric
scales is associated with bias, we extracted continuous data only
if the psychometric scale used to measure the outcome of interest
had been previously published in a peer-reviewed journal, and was
not  subjected  to  item,  scoring,  or  other  modification  by  the  trial
authors (Marshall 2000b).

We planned the following main comparisons:

1. Cognitive behavioural therapy (CBT)-based psychotherapy (e.g.
CBT,  problem-solving  therapy  [PST])  versus  TAU  or  another
comparator;

2. Dialectical  behaviour  therapy  (DBT)  versus  TAU  or  another

comparator;

3. Mentalisation-based  therapy  (MBT)  versus  TAU  or  another

comparator;

4. Emotion-regulation  psychotherapy  versus  TAU  or  another

comparator;

5. Case management versus TAU or another comparator;
6. Remote  contact 

interventions  versus  TAU  or  another

comparator;

7. Other  multimodal 

interventions  versus  TAU  or  another

comparator.

1. Bias arising from the timing of identification and recruitment of

participants.

Signalling  questions  in  the  RoB  2  tool  provided  the  basis  for  the
tool’s domain-level judgements about the risk of bias. Two review
authors independently judged each source of potential bias as low
risk, high risk, or some concerns. An overall 'Risk of bias' judgement
was then made for each study by combining ratings across these
domains.  Specifically,  if  any  of  the  above  domains  were  rated  at
high risk, the overall 'Risk of bias' judgement was rated at high risk.
We reported this overall judgement, which could be low risk, high
risk, or some concerns, in the text of the review, and in the 'Risk of
bias' tables.

Where inadequate details were provided in the original report, we
contacted corresponding trial authors to provide clarification. We
resolved disagreements through discussions with KH.

We  entered  and  organised  our  RoB  2  assessments  on  an  Excel
spreadsheet  (Microsoft  Excel  RoB2  Macro),  and  made  them
available as electronic supplements.

Measures of treatment effect

Dichotomous outcomes

We  summarised  dichotomous  outcomes,  such  as  the  number
of  participants  engaging  in  a  repeat  SH  episode,  or  number  of
deaths  by  suicide,  using  the  summary  odds  ratio  (OR)  and  the
accompanying  95%  confidence  interval  (CI),  as  the  OR  is  the
most appropriate effect size statistic for summarising associations
between  two  dichotomous  groups  (Fleiss  1994).  Time  to  SH
repetition  was  summarised  using  the  hazard  ratio  (HR)  and  its
accompanying 95% CI.

Continuous outcomes

For  outcomes  measured  on  a  continuous  scale,  we  used  mean
differences  (MDs)  and  accompanying  95%  CI  where  the  same
outcome  measure  was  used.  Where  different  outcome  measures
were used, we used the standardised mean difference (SMD) and its
accompanying 95% CI.

We aggregated trials in a meta-analysis only where treatments were
sufficiently similar. For trials that could not be included in a meta-
analysis, we provided narrative descriptions of the results.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

26

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Hierarchy of outcomes

Where  a  trial  measured  the  same  outcome,  for  example,
depression  in  two  or  more  ways,  we  planned  to  use  the  most
common  measure  across  trials  in  any  meta-analysis.  We  also
planned to report scores from other measures in a supplementary
table.

Timing of outcome assessment

The  primary  end  point  for  this  review  was  post-intervention  (i.e.
at  the  conclusion  of  the  treatment  period).  We  also  reported
outcomes for the following secondary end points (where data were
available):

1. Between  zero  and  six  months  after  the  conclusion  of  the

treatment period;

2. Between six and 12 months after the conclusion of the treatment

period;

3. Between 12 and 24 months after the conclusion of the treatment

period.

Where there was more than one outcome assessment within a time
period, we used data from the last assessment in the time period,
unless different outcomes were assessed at different time points.
For treatment adherence, we also planned to use within-treatment
results.

Unit of analysis issues

Zelen design trials

Trials  in  this  area  are  increasingly  using  Zelen's  method,  in
which  consent  is  obtained  subsequent  to  randomisation  and
treatment allocation (Witt 2020a). This design may lead to bias if,
for  example,  participants  allocated  to  one  particular  arm  of  the
trial disproportionally refuse to provide consent for participation
or,  alternatively,  if  participants  only  provide  consent  if  they  are
allowed to cross over to the other treatment arm (Torgerson 2004).

We identified five trials that used Zelen's design (Carter 2005; Gysin-
Maillart  2016;  Hatcher  2011;  Hatcher  2015;  Hatcher  2016).  Where
possible,  we  therefore  analysed  data  for  these  trials  using  data
for  all  randomised  participants  as  this  is  consistent  with  Zelen’s
original intention (Zelen 1979), and preserves randomisation. This
was typically possible for our primary outcome, repetition of SH,
as  this  was  generally  ascertained  from  clinical,  hospital,  and/or
medical  records  in  these  five  trials.  However,  for  certain  self-
reported  secondary  outcome  measures,  data  were  only  reported
on the basis of those who consented to participation. We therefore
planned to conduct sensitivity analyses to investigate what impact,
if any, the inclusion of these trials may have on the pooled estimate
of treatment effectiveness.

Cluster-randomised trials

Cluster randomisation, for example by clinician or general practice,
can  lead  to  overestimation  of  the  significance  of  a  treatment
effect,  resulting  in  an  inflation  of  the  nominal  type  I  error  rate,
unless appropriate adjustment is made for the effects of clustering
(Donner 2002; Kerry 1998).

One  trial  included  in  this  review  used  cluster  randomisation
(Bennewith 2002). We had planned to follow the guidance outlined
in  Higgins  2019a.  Specifically,  where  possible,  we  planned  to

Cochrane Database of Systematic Reviews

analyse  data  using  measures  that  statistically  accounted  for  the
cluster design. Where this was not possible, we planned to analyse
data  using  the  effective  sample  size.  However,  the  trial  authors
were unable to provide values for either the inter-cluster correlation
coefficient  or  the  design  effect,  and  further,  there  was  no  similar
cluster-RCT of this intervention approach from which these values
could be approximated. We were therefore unable to statistically
account for the effects of clustering in this trial.

In  future  updates  of  this  review,  should  we  be  able  to  obtain
information on either the inter-cluster correlation coefficient or the
design effect, we will follow the guidance outlined in Higgins 2019a.

Cross-over trials

is  the  carry-over
A  primary  concern  with  cross-over  trials 
effect,  in  which  the  effect  of  the  intervention  treatment  (e.g.
pharmacological,  physiological,  psychological) 
influences  the
participant's  response  to  the  subsequent  control  condition
(Elbourne 2002). As a consequence, on entry to the second phase
of the trial, participants may differ systematically from their initial
state,  despite  a  wash-out  phase.  In  turn,  this  may  result  in  a
concomitant underestimation of the effectiveness of the treatment
intervention (Curtin 2002a; Curtin 2002b).

included 

One  trial 
in  the  current  review  used  cross-over
methodology (Marasinghe 2012). To protect against the carry-over
effect, we only extracted data from the first phase of this trial, prior
to cross-over.

Studies with multiple treatment arms

Five trials in the current review included multiple treatment arms
(Andreoli  2015;  Armitage  2016;  Linehan  2015;  Stewart  2009;  Wei
2013. For two of these trials (Andreoli 2015; Stewart 2009), it was
possible  to  combine  data  from  the  two  intervention  arms  given
their  similarity.  For  the  remaining  three,  however,  two  different
psychotherapies were compared (Armitage 2016; Linehan 2015; Wei
2013. Therefore, we included information from these trials in both
categories of intervention using data from the relevant intervention
arm.  As  we  did  not  combine  data  from  the  intervention  arms  in
any meta-analysis, we used the same comparator arm data for both
analyses.

Studies with adjusted effect sizes

Where trials reported both unadjusted and adjusted effect sizes, we
included only observed, unadjusted effect sizes.

Dealing with missing data

We  did  not  impute  missing  data,  as  we  considered  that  the
bias  that  would  be  introduced  by  doing  this  would  outweigh
any  benefit  of  increased  statistical  power  that  may  have  been
gained by including imputed data. However, where authors omitted
standard  deviations  (SD)  for  continuous  measures,  we  contacted
corresponding authors to request missing data. Where missing data
could not be provided, we calculated missing SDs using other data
from the trial, such as CIs, based on methods outlined in Higgins
2019b.

Assessment of heterogeneity

Between-study heterogeneity can be assessed using either the Chi2
or I2 statistics. However, in this review, we used only the I2 statistic
to quantify inconsistency, as this is considered to be more reliable

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

27

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

(Deeks 2019). The I2 statistic indicates the percentage of between-
study variation due to chance, and can take any value from 0% to
100% (Deeks 2019).

We  used  the  following  values  to  denote  relative  importance  of
heterogeneity, as per Deeks 2019:

1. unimportant: 0% to 40%;
2. moderate: 30% to 60%;
3. substantial: 50% to 90%;
4. considerable: 75% to 100%.

We also took the magnitude and direction of effects and strength of
evidence for heterogeneity into account (e.g. the CI for I2).

Where substantial levels of heterogeneity were found, we explored
reasons  for  this  heterogeneity  (see  Subgroup  analysis  and
investigation of heterogeneity for details).

Assessment of reporting biases

Reporting  bias  occurs  when  the  decision  to  publish  a  particular
trial  is  influenced  by  the  direction  and  significance  of  the  results
(Egger  1997).  Research  suggests,  for  example,  that  trials  with
statistically significant findings are more likely to be submitted for
publication and, subsequently, be accepted for publication, leading
to possible overestimation of the true treatment effect (Hopewell
2009).

To  assess  whether  trials  included  in  any  meta-analysis  were
affected by reporting bias, we planned to enter data into a funnel
plot  when  a  meta-analysis  included  results  of  at  least  ten  trials.
Should  evidence  of  any  small  study  effects  be  identified,  we
planned  to  explore  reasons  for  funnel  plot  asymmetry,  including
the presence of possible publication bias (Egger 1997).

Data synthesis

For  the  purposes  of  this  review,  we  calculated  the  pooled  odds
ratio  (OR)  and  accompanying  95%  CI  using  the  random-effects
model,  as  this  is  the  most  appropriate  model  for  incorporating
heterogeneity between studies (Deeks 2019). We used the Mantel-
Haenszel method for dichotomous data, and the inverse variance
method for continuous data. We conducted all analyses in Review
Manager 5.4 (Review Manager 2020).

Subgroup analysis and investigation of heterogeneity

Subgroup analyses

We planned to undertake the following subgroup analyses where
there were sufficient data to do so:

1. sex (males versus females);
2. repeater status (first SH episode versus repeat SH episode).

Given  the  increasing  use  of  enhanced  usual  care  rather  than
TAU  in  trials  in  this  field  (Witt  2020a),  we  also  planned  to
undertake  subgroup  analyses  to  determine  whether  comparator
choice influenced the pattern of results observed.

Formal tests for subgroup differences were undertaken in Review
Manager 5.4 (Review Manager 2020). However, it is only possible to
undertake these subgroup analyses if randomisation was stratified

Cochrane Database of Systematic Reviews

by these factors, otherwise, there is the risk that doing so could lead
to confounding.

Randomisation  was  stratified  by  sex  in  five  trials  (Carter  2005;
Hvid  2011;  McAuliffe  2014;  Walton  2020;  Van  der  Sande  1997).
Six  trials  also  stratified  randomisation  by  repeater  status  (Gratz
2014; Hatcher 2015; Hatcher 2016; McAuliffe 2014; Morthorst 2012;
Mouaffak 2015).

Investigation of heterogeneity

Several  meta-analyses  were  associated  with  substantial  levels  of
between-study heterogeneity (i.e. I2 ≥ 75%). For these analyses, KW
and KH firstly independently triple-checked data to ensure these
were  correctly  entered.  Next,  we  investigated  the  source  of  this
heterogeneity  using  a  formal  statistical  approach  as  outlined  in
Viechtbauer 2020.

Sensitivity analysis

We  planned  to  undertake  the  following  sensitivity  analyses,
where appropriate, to test whether key methodological factors or
decisions may have influenced the main result:

1. Where a trial made use of Zelen's method of randomisation (see

Unit of analysis issues);

2. Where  a  trial  contributed  to  substantial  between-study
heterogeneity  (see  Subgroup  analysis  and  investigation  of
heterogeneity).

Five  trials  used  Zelen's  design  (Carter  2005;  Gysin-Maillart  2016;
Hatcher  2011;  Hatcher  2015;  Hatcher  2016).  We  were  therefore
able  to  undertaken  sensitivity  analyses,  excluding  these  trials,  to
investigate what impact, if any, Zelen's design had on the pooled
estimate of treatment effectiveness. We reported results of these
sensitivity analyses in the text.

Additionally,  several  meta-analyses  were  associated  with
substantial 
levels  of  between-study  heterogeneity.  We  also
reported results of these sensitivity analyses in the text, alongside
discussion of the likely causes of these differences.

Summary of findings and assessment of the certainty of the
evidence

For  each  comparison,  we  planned  to  construct  a  'Summary  of
findings'  table  for  our  primary  outcome  measure,  repetition  of
SH post-intervention, following the recommendations outlined in
Schünemann  2019.  These  tables  provide  information  concerning
the  overall  quality  of  the  evidence  from  all  included  trials  that
measured the outcome. We assessed the quality of evidence across
the following domains:

'Risk of bias' assessment;
1.
2. Indirectness of evidence;
3. Unexplained heterogeneity or inconsistency of results;
4. Imprecision of effect estimates;
5. Potential publication bias.

For  each  of  these  domains,  we  downgraded  the  evidence  from
high certainty by one level (for serious) or by two levels (for very
serious). For risk of bias, we downgraded this domain by one level
when  we  rated  any  of  the  sources  of  risk  of  bias  (as  described
in  Assessment  of  risk  of  bias  in  included  studies)  at  high  risk  for

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

28

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

any  of  the  studies  included  in  the  pooled  estimate,  or  by  two
levels when we rated multiple studies at high risk for any of these
sources. For indirectness of evidence, we considered the extent to
which  trials  included  in  any  meta-analysis  used  proxy  measures
to ascertain repetition of SH; we downgraded this domain by one
level if one study used proxy measures, and by two levels if multiple
studies  used  proxy  measures.  For  unexplained  heterogeneity  or
inconsistency of results, we downgraded this domain by one level
where the I2 value indicated substantial levels of heterogeneity, or
by  two  levels  where  the  I2  value  indicated  considerable  levels  of
heterogeneity. For imprecision, we downgraded this domain by one
level where the 95% CI for the pooled effect included the null value.
Finally,  for  the  potential  publication  bias  domain,  we  considered
any  evidence  of  funnel  plot  asymmetry  (if  available),  as  well  as
other evidence such as suspected selective availability of data, and
downgraded  by  one  or  more  levels  where  publication  bias  was
suspected.

We then used these domains to rate the overall quality of evidence
for the primary outcome according to the following:

1. High  certainty:  further  research  is  very  unlikely  to  change  our

confidence in the estimate of effect;

2. Moderate  certainty:  further  research  is  likely  to  have  an
important  impact  on  our  confidence  in  the  estimate  of  effect,
and may change the estimate;

Cochrane Database of Systematic Reviews

3. Low  certainty:  further  research  is  very  likely  to  have  an
important  impact  on  our  confidence  in  the  estimate  of  effect,
and may change the estimate;

4. Very low certainty: we are very uncertain about the estimate.

We constructed 'Summary of findings' tables using GRADEpro GDT
software (GRADEpro GDT 2015).

Reaching conclusions

We based our conclusions only on findings from the quantitative
or  narrative  synthesis  of  the  studies  included  in  this  review.  Our
recommendations for practice and research suggest priorities for
future research, and outline remaining uncertainties in the area.

R E S U L T S

Description of studies

Results of the search

For this update, a total of 7186 records were found using the search
strategy  as  outlined  in  Appendix  1  and  Appendix  2.  Five  further
records were identified following correspondence and discussion
with researchers in the field. After deduplication, the initial number
was  reduced  to  4678.  Of  these,  4454  were  excluded  following
title/abstract  screening,  whist  a  further  157  were  excluded  after
reviewing the full texts (Figure 1).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

29

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Figure 1.   Study Flow Diagram

Cochrane Database of Systematic Reviews

Included studies

In  the  previous  version  of  this  review  (Hawton  2016),  55  trials
of  psychosocial  interventions  for  self-harm  (SH)  in  adults  were
included. The present update located 21 new trials of psychosocial
interventions  for  SH  in  adults.  The  present  review  therefore
includes  76  non-overlapping  trials  (see  the  Characteristics  of
included studies tables for further information on these trials).

Unpublished  data  were  obtained  from  the  trial  authors  for  42  of
these trials (Bateman 2009; Beautrais 2010; Bennewith 2002; Brown
2005;  Carter  2005;  Cedereke  2002;  Clarke  2002;  Crawford  2010;
Davidson 2014; Dubois 1999; Fleischmann 2008; Gratz 2006; Gratz
2014; Guthrie 2001; Gysin-Maillart 2016; Harned 2014; Hassanian-
Moghaddam  2011;  Hatcher  2011;  Hatcher  2015;  Hatcher  2016;
Husain  2014;  Hvid  2011;  Kapur  2013;  Kawanishi  2014;  Linehan

1991; Linehan 2006; Marasinghe 2012; McAuliffe 2014; McMain 2009;
Owens  2020;  Patsiokas  1985;  Priebe  2012;  Slee  2008;  Sreedaran
2020; Stewart 2009;  Tapolaa 2010; Turner 2000; Tyrer 2003;  Vaiva
2006; Walton 2020; Wei 2013; Weinberg 2006).

Design

Most  trials  (97.4%)  randomised  at  the  individual-level  employing
either simple randomisation (Allard 1992; Armitage 2016; Beautrais
2010;  Brown  2005;  Clarke  2002;  Crawford  2010;  Davidson  2014;
Dubois  1999;  Evans  1999a;  Evans  1999b;  Fleischmann  2008;
Gibbons  1978;  Gratz  2006;  Hawton  1981;  Hawton  1987;  Kapur
2013;  Liberman  1981;  McLeavey  1994;  Morgan  1993;  Mousavi
2015; Mousavi 2017; Naidoo 2014; O'Connor 2015; O'Connor 2020;
Patsiokas  1985;  Sahin  2018;  Salkovskis  1990;  Slee  2008;  Stewart
2009; Tapolaa 2010; Torhorst 1987; Torhorst 1988; Turner 2000; Van

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

30

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Heeringen 1995; Wang 2016; Waterhouse 1990; Wei 2013; Weinberg
2006;  Welu  1977),  or  a  restricted  randomisation  scheme  such
as adaptive minimisation (Linehan 2015), blocked randomisation
(Amadéo  2015;  Andreoli  2015;  Grimholt  2015;  Guthrie  2001;
Hassanian-Moghaddam  2011;  Husain  2014;  Lin  2020;  McMain
2009;  McMain  2017;  Priebe  2012;  Sreedaran  2020;  Vaiva  2018),  or
minimisation procedure (Bateman 2009, Harned 2014, Kawanishi
2014;  Linehan  1991;  Linehan  2006;  O'Connor  2017;  Owens  2020)
procedure. One trial used a matched pair randomisation procedure
(Cedereke  2002).  Nine  trials  used  stratification  (Gratz  2014;  Hvid
2011;  McAuliffe  2014;  Morthorst  2012;  Mouaffak  2015;  Tyrer  2003;
Vaiva  2006;  Van  der  Sande  1997;  Walton  2020).  Five  used  Zelen's
design  (Carter  2005;  Gysin-Maillart  2016;  Hatcher  2011;  Hatcher
2015; Hatcher 2016).

In one trial, cluster randomisation was used (Bennewith 2002). One
trial was a cross-over RCT (Marasinghe 2012).

Setting

Of  the  76  independent  RCTs  included  in  this  review,  one-quarter
(25.0%)  were  from  the  UK  (Bateman  2009;  Bennewith  2002;
Clarke  2002;  Crawford  2010;  Davidson  2014;  Evans  1999a;  Evans
1999b;  Gibbons  1978;  Guthrie  2001;  Hawton  1981;  Hawton  1987;
Kapur  2013;  Morgan  1993;  O'Connor  2017;  Owens  2020;  Priebe
2012;  Salkovskis  1990;  Tyrer  2003;  Waterhouse  1990),  14  were
from  the  USA  (Brown  2005;  Gratz  2006;  Gratz  2014;  Harned
2014; Liberman 1981; Linehan 1991; Linehan 2006; Linehan 2015;
O'Connor  2015;  O'Connor  2020;  Patsiokas  1985;  Turner  2000;
Weinberg  2006;  Welu  1977),  four  from  France  (Dubois  1999;
Mouaffak  2015;  Vaiva  2006;  Vaiva  2018),  four  from  New  Zealand
(Beautrais 2010; Hatcher 2011; Hatcher 2015; Hatcher 2016), three
from Australia (Carter 2005; Stewart 2009; Walton 2020), three from
Canada (Allard 1992; McMain 2009; McMain 2017), three from Iran
(Hassanian-Moghaddam  2011;  Mousavi  2015;  Mousavi  2017),  two
from  Denmark  (Hvid  2011;  Morthorst  2012),  two  from  Germany
(Torhorst  1987;  Torhorst  1988),  two  from  the  Netherlands  (Slee
2008;  Van  der  Sande  1997),  two  from  the  Republic  of  Ireland
(McAuliffe  2014;  McLeavey  1994),  two  from  Switzerland  (Andreoli
2015; Gysin-Maillart 2016), two from Sweden (Cedereke 2002; Sahin
2018), two from Taiwan (Lin 2020; Wang 2016), and one was from
each of Belgium (Van Heeringen 1995), China (Wei 2013), Finland
(Tapolaa 2010), French Polynesia (Amadéo 2015), India (Sreedaran
2020), Japan (Kawanishi 2014), Malaysia (Armitage 2016), Norway
(Grimholt  2015),  Pakistan  (Husain  2014),  South  Africa  (Naidoo
2014), and Sri Lanka (Marasinghe 2012). One was a multicentre trial
conducted in a number of countries (Fleischmann 2008).

In  the  majority  of  trials,  participants  were  identified  following  a
clinical presentation for SH. In 16 trials (21.1%), participants were
identifying  following  referral  to  outpatient  mental  health  and/or
specialist personality disorder treatment services (Bateman 2009;
Gratz  2006;  Gratz  2014;  Harned  2014;  Liberman  1981;  Linehan
1991;  Linehan  2006;  Linehan  2015;  McMain  2009;  McMain  2017;
Priebe 2012; Sahin 2018; Salkovskis 1990; Walton 2020; Wang 2016;
Weinberg  2006).  All  participants  in  these  trials  had  a  history  of
SH resulting in presentation to clinical services within six months
preceding trial entry.

For most trials (85.5%), treatment was delivered in an outpatient
setting  or  in  the  participants'  home  environment.  In  four  trials,
acute-phase  treatment  was  delivered  in  an  inpatient  setting
followed  by  outpatient  follow-up  appointments  (Amadéo  2015;

Cochrane Database of Systematic Reviews

Torhorst  1987;  Torhorst  1988;  Van  der  Sande  1997),  whilst  in
two  older  trials,  treatment  was  delivered  in  an  inpatient  setting
(Liberman  1981;  Waterhouse  1990).  In  the  remaining  five  trials,
the  intervention  was  delivered  while  individuals  were  receiving
treatment in hospital and/or the emergency department (Armitage
2016;  Crawford  2010;  O'Connor  2015;  O'Connor  2017;  O'Connor
2020).

Participants and participant characteristics

The included trials comprised a total of 21,414 participants. All had
engaged in at least one episode of SH prior to trial entry. A history of
SH prior to the index episode (i.e. a history of multiple episodes of
SH) was a requirement for participation in 17 trials (Bateman 2009;
Evans 1999b; Gratz 2006; Gratz 2014; Harned 2014; Liberman 1981;
Linehan 1991; Linehan 2006; McMain 2009; Mousavi 2015; Mousavi
2017; Priebe 2012; Sahin 2018; Salkovskis 1990; Torhorst 1988; Tyrer
2003; Weinberg 2006). In 20 trials, around half of the sample had
a  history  of  multiple  episodes  of  SH  (Allard  1992;  Brown  2005;
Cedereke  2002;  Evans  1999a;  Guthrie  2001;  Gysin-Maillart  2016;
Hatcher 2011; Hatcher 2015; Hatcher 2016; Kapur 2013; Kawanishi
2014;  Lin  2020;  Morthorst  2012;  Mouaffak  2015;  O'Connor  2017;
Owens 2020; Slee 2008; Torhorst 1987; Van der Sande 1997; Welu
1977)  Only  one  trial  excluded  those  with  a  history  of  multiple
episodes of SH prior to trial entry (Morgan 1993).

Information on the methods of SH for the index episode was not
reported in half (k = 38; 50.0%) of the trials (Allard 1992; Amadéo
2015; Andreoli 2015; Armitage 2016; Bateman 2009; Cedereke 2002;
Davidson  2014;  Dubois  1999;  Evans  1999b;  Fleischmann  2008;
Gratz  2006;  Gratz  2014;  Hvid  2011;  Kapur  2013;  Liberman  1981;
Lin  2020;  Linehan  1991;  Linehan  2006;  Linehan  2015;  Marasinghe
2012;  McMain  2009;  Morthorst  2012;  Mousavi  2017;  Naidoo  2014;
O'Connor 2020; Patsiokas 1985; Priebe 2012; Sahin 2018; Salkovskis
1990;  Sreedaran  2020;  Stewart  2009;  Tapolaa  2010;  Turner  2000;
Tyrer 2003; Walton 2020; Wang 2016; Wei 2013; Weinberg 2006). Full
details of the methods used at the index episode for the remaining
trials is provided in Table 1. Whilst the predominance of participants
engaging in self-poisoning in the majority of these trials is reflective
of the typical pattern observed in those who present to hospital,
or in the community, SH more often involves self-cutting and other
forms of self-injury (Müller 2016).

Whilst most trials included both male and female participants, the
majority of participants in the 71 trials that reported information
on  sex  were  female  (61.9%),  reflecting  the  typical  pattern  for  SH
(Hawton 2008). Of the 64 trials that reported information on age,
the weighted mean age of participants at trial entry was 31.8 years
(SD: 11.7 years).

In the 38 trials that reported information on psychiatric diagnoses
(Allard 1992; Amadéo 2015; Andreoli 2015; Bateman 2009; Brown
2005;  Carter  2005;  Cedereke  2002;  Clarke  2002;  Crawford  2010;
Davidson 2014; Dubois 1999; Evans 1999a; Evans 1999b; Gibbons
1978;  Gratz  2006;  Gratz  2014;  Gysin-Maillart  2016;  Harned  2014;
Kawanishi 2014; Lin 2020; Linehan 2006; Linehan 2015; McLeavey
1994;  McMain  2009;  McMain  2017;  Morgan  1993;  Mouaffak  2015;
Priebe 2012; Sahin 2018; Slee 2008; Sreedaran 2020; Turner 2000;
Tyrer  2003;  Vaiva  2018;  Van  der  Sande  1997;  Van  Heeringen
1995;  Walton  2020;  Wei  2013),  participants  were  most  commonly
diagnosed  with  major  depression  (56.7%),  followed  by  any  other
mood  disorder  (37.6%),  any  personality  disorder  (31.6%),  any
anxiety  disorder  (26.7%),  and  substance  use  disorder  (26.7%).  A

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

31

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

total  of  14  trials  focused  specifically  on  participants  diagnosed
with borderline personality disorder (Andreoli 2015; Bateman 2009;
Gratz 2006; Gratz 2014; Harned 2014; Linehan 1991; Linehan 2006;
Linehan 2015; McMain 2009; McMain 2017; Sahin 2018; Turner 2000;
Walton  2020;  Weinberg  2006),  and  three  focused  on  participants
diagnosed  with  any  personality  disorder  (Davidson  2014;  Evans
1999b;  Priebe  2012).  Only  two  trials  reported  information  on  the
proportion  of  participants  without  psychiatric  diagnoses  at  trial
entry  (Evans  1999a;  Sreedaran  2020).  In  these  two  trials,  a  small
proportion  (15.1%)  were  not  diagnosed  with  a  major  psychiatric
disorder.

Information  on  comorbid  diagnoses  was  reported  in  eight  trials
(Andreoli 2015; Bateman 2009; Davidson 2014; Gratz 2014 Harned
2014;  Mouaffak  2015;  Sahin  2018;  Turner  2000).  Under  one-half
(40.9%)  were  diagnosed  with  comorbid  psychiatric  diagnoses,
typically  comorbid  mood  or  anxiety  disorders  and  personality
disorders,  although  the  nature  of  these  comorbidities  was  not
always clearly reported in these trials. In three further trials (Carter
2005; McMain 2009; Slee 2008), the median number of psychiatric
diagnoses was greater than two, indicating that most participants
in these trials were also diagnosed with more than one psychiatric
disorder; however, none of the three reported further information
on specific diagnoses.

Interventions

The trials included in this review investigated the effectiveness of
various forms of psychosocial interventions:

1. Cognitive behavioural therapy (CBT)-based psychotherapy (e.g.
CBT,  problem-solving  therapy  [PST])  versus  TAU  or  another
comparator;

2. Dialectical  behaviour  therapy  (DBT)  versus  TAU  or  another

comparator;

3. Mentalisation-based  therapy  (MBT)  versus  TAU  or  another

comparator;

4. Emotion-regulation  psychotherapy  versus  TAU  or  another

comparator;

5. Psychodynamic  psychotherapy  versus  TAU  or  another

comparator;

6. Case management versus TAU or another comparator;
7. Structured  general  practitioner  (GP)  follow-up  versus  TAU  or

another comparator;

8. Brief emergency department-based interventions versus TAU or

another comparator;

9. Remote  contact 

interventions  versus  TAU  or  another

comparator;

10.Provision  of  information  and  support  versus  TAU  or  another

comparator;

11.Other  multimodal 

interventions  versus  TAU  or  another

comparator;

12.Other mixed interventions versus TAU or another comparator.

Comparators

Of  the  76  RCTs  included  in  this  review,  the  majority  (76.3%)
compared  the  intervention  to  TAU  (Allard  1992;  Amadéo  2015;
Andreoli  2015;  Armitage  2016;  Bateman  2009;  Beautrais  2010;
Bennewith 2002; Brown 2005; Carter 2005; Cedereke 2002; Clarke
2002;  Crawford  2010;  Davidson  2014;  Dubois  1999;  Evans  1999a;

Cochrane Database of Systematic Reviews

Evans 1999b; Fleischmann 2008; Gibbons 1978; Gratz 2006; Gratz
2014; Grimholt 2015; Guthrie 2001; Gysin-Maillart 2016; Hassanian-
Moghaddam  2011;  Hatcher  2011;  Hatcher  2015;  Hatcher  2016;
Hawton  1987;  Husain  2014;  Hvid  2011;  Kapur  2013;  Lin  2020;
Linehan 1991; McAuliffe 2014; McMain 2009; Morgan 1993; Mouaffak
2015;  Mousavi  2017;  O'Connor  2015;  O'Connor  2017;  O'Connor
2020;  Owens  2020;  Patsiokas  1985;  Priebe  2012;  Sahin  2018;
Salkovskis  1990;  Slee  2008;  Stewart  2009;  Tapolaa  2010;  Tyrer
2003; Vaiva 2006; Vaiva 2018; Van der Sande 1997; Van Heeringen
1995; Wang 2016; Weinberg 2006; Welu 1977). The remaining trials
compared the effectiveness of the intervention to alternative forms
of  psychotherapy  (Harned  2014;  Hawton  1981;  Liberman  1981;
Linehan 2006; Linehan 2015; McLeavey 1994; Mousavi 2015; Naidoo
2014; Sreedaran 2020; Torhorst 1987; Torhorst 1988; Turner 2000;
Walton  2020),  waiting  list  (Marasinghe  2012;  McMain  2017),  no
treatment  (Waterhouse  1990;  Wei  2013),  or  enhanced  usual  care
(EUC; Kawanishi 2014; Morthorst 2012).

Outcomes

Primary outcome

Information  on  the  primary  outcome,  repetition  of  SH,  was
available  for  all  but  two  (3.0%)  of  the  included  trials  (Patsiokas
1985; Sreedaran 2020).

In the majority of trials, repetition of SH was ascertained either from
self-reported  information  alone  (Amadéo  2015;  Armitage  2016;
Brown 2005; Davidson 2014; Fleischmann 2008; Gratz 2006; Gratz
2014;  Harned  2014;  Hassanian-Moghaddam  2011;  Husain  2014;
Liberman 1981; Linehan 1991; Linehan 2006; Linehan 2015; McMain
2009;  Mousavi  2015;  Mousavi  2017;  Naidoo  2014;  O'Connor  2015;
O'Connor 2020; Priebe 2012; Sahin 2018; Slee 2008; Tapolaa 2010;
Torhorst 1987; Turner 2000; Walton 2020; Wei 2013; Weinberg 2006),
followed  by  self-reported  information  supplemented  by  clinical,
hospital,  and/or  medical  records  (Bateman  2009;  Cedereke  2002;
Evans 1999b; Grimholt 2015; Guthrie 2001; Gysin-Maillart 2016; Hvid
2011; Lin 2020; Mouaffak 2015; Tyrer 2003; Vaiva 2006; Vaiva 2018),
or self-reported information supplemented with information from
a collateral informant (e.g. a general practitioner [GP]) (McLeavey
1994;  McMain  2017;  Van  Heeringen  1995;  Waterhouse  1990;  Welu
1977).

For  the  remaining  23  trials,  information  on  repetition  of  SH
was  obtained  from  clinical,  hospital,  and/or  medical  records
(Andreoli  2015;  Beautrais  2010;  Bennewith  2002;  Clarke  2002;
Crawford 2010; Evans 1999a; Gibbons 1978; Hatcher 2011; Hatcher
2015;  Hatcher  2016;  Kapur  2013;  Morgan  1993;  Morthorst  2012;
O'Connor 2017; Owens 2020; Salkovskis 1990; Stewart 2009; Van der
Sande 1997), from monitoring systems (Carter 2005; Hawton 1981;
Hawton  1987),  or  from  clinical,  hospital,  and/or  medical  records
supplemented with information from collateral informants (Allard
1992).

In  one  trial  (McAuliffe  2014),  mixed  methods  were  used  to
determine repetition of SH. Specifically, self-reported information
was  used  at  the  post-intervention  and  six-month  follow-up
assessments, whereas data on hospital representations were used
at the 12-month follow-up assessment in this trial.

For five trials, information on the source of the data for repetition
of  SH  was  not  clearly  reported  (Dubois  1999;  Kawanishi  2014;
Marasinghe 2012; Torhorst 1988; Wang 2016).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

32

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Secondary outcomes

Treatment adherence

Of the 28 trials that reported information on treatment adherence,
this  was  assessed  using  a  variety  of  methods.  This  included  the
proportion  of  participants  who  completed  the  full  course  of  the
intervention treatment (Andreoli 2015; Bateman 2009; Bennewith
2002;  Brown  2005;  Crawford  2010;  Evans  1999b;  Grimholt  2015;
Harned  2014;  Husain  2014;  Kawanishi  2014;  Lin  2020;  Linehan
2015; McAuliffe 2014; McLeavey 1994; McMain 2009; McMain 2017;
O'Connor  2017;  Owens  2020;  Priebe  2012;  Slee  2008;  Sreedaran
2020;  Torhorst  1987;  Torhorst  1988;  Turner  2000;  Walton  2020;
Van  Heeringen  1995),  although  for  some  trials,  corresponding
information  on  the  proportion  completing  treatment  in  the
comparator arm was not clearly reported. A smaller number of trials
reported  information  on  the  total  number  of  treatment  sessions
attended (Allard 1992; Brown 2005; McLeavey 1994; Torhorst 1988;
Van der Sande 1997).

Depression

Depression was assessed using the BDI in just under half (47.6%) of
the 42 trials that reported information on this outcome (Armitage
2016;  Bateman  2009;  Brown  2005;  Fleischmann  2008;  Gibbons
1978;  Grimholt  2015;  Guthrie  2001;  Gysin-Maillart  2016;  Hawton
1987;  Husain  2014;  Liberman  1981;  Linehan  1991;  Marasinghe
2012;  McAuliffe  2014;  McMain  2009;  McMain  2017;  Salkovskis
1990;  Slee  2008;  Tapolaa  2010;  Turner  2000),  followed  by  the
depression  subscale  of  the  HADS  in  six  trials  (Davidson  2014;
Evans  1999b;  Hatcher  2011;  Hatcher  2015;  Hatcher  2016;  Tyrer
2003), the Hamilton Rating Scale for Depression (HRSD; Hamilton
1960) in eight trials (Andreoli 2015; Brown 2005; Harned 2014; Lin
2020;  Linehan  2006;  Linehan  2015;  Turner  2000;  Wei  2013),  the
Depression  Anxiety  Stress  Scales  (DASS;  Lovibond  1995)  in  two
trials  (Gratz  2006;  Gratz  2014),  the  Lorr  and  McNair  Mood  Scale
(LMMS; McNair 1964) in one trial (Hawton 1981), the Montgomery-
Åsberg Depression Rating Scale (MADRS; Montgomery 1979) in one
trial  (Van  der  Sande  1997),  and  the  Zung  Self-Rating  Depression
Scale (ZSRDS; Zung 1965) in one trial (Liberman 1981). In two trials,
it was not clear what scale was used to assess depression (Torhorst
1987; Torhorst 1988).

Hopelessness

Hopelessness was assessed using the BHS in the majority (80.9%)
of the 21 trials that reported information on this outcome (Brown
2005;  Grimholt  2015;  Hatcher  2011;  Hatcher  2015;  Hatcher  2016;
Husain  2014;  Kawanishi  2014;  Lin  2020;  Linehan  1991;  McAuliffe
2014;  McLeavey  1994;  Patsiokas  1985;  Salkovskis  1990;  Stewart
2009;  Van  der  Sande  1997;  Waterhouse  1990;  Wang  2016),  by  the
future optimism subscale score on the Reasons for Living Inventory
(RFL; Osman 1992), which was reverse coded in the present review
to indicate a perceived lack of optimism about the future in three
trials  (Linehan  2015;  O'Connor  2015;  O'Connor  2020),  and  by  an
idiosyncratic scale in one trial (Mousavi 2017).

General functioning

General  functioning  was  assessed  using  the  Global  Assessment
Scale (GAS; Endicott 1976) in the majority (66.7%) of the six trials
that reported information on this outcome (Allard 1992; Andreoli
2015;  Bateman  2009;  Tyrer  2003),  followed  by  the  GAF  in  the
remaining two trials (Cedereke 2002; Sahin 2018).

Cochrane Database of Systematic Reviews

Social functioning

Social functioning was assessed using the Social Adjustment Scale
(SAS;  Weissman  1999)  in  just  over  half  (55.6%)  of  the  nine  trials
that reported information on this outcome (Bateman 2009; Hawton
1981;  Hawton  1987;  McMain  2017;  Torhorst  1988),  the  Social
Functioning  Questionnaire  (SFQ;  Tyrer  1990)  in  two  trials  (Evans
1999b;  Tyrer  2003),  and  the  social  performance  subscale  of  the
Social  Behaviour  Assessment  Schedule  (SBAS;  Platt  1983)  in  one
trial (Waterhouse 1990). In one further trial, an idiosyncratic scale
was used (Gibbons 1978).

Suicidal ideation

Eighteen  trials  assessed  suicidal  ideation  using  the  BSSI  (Brown
2005;  Cedereke  2002;  Davidson  2014;  Grimholt  2015;  Guthrie
2001;  Gysin-Maillart  2016;  Hatcher  2011;  Hawton  1981;  Husain
2014;  Lin  2020;  Marasinghe  2012;  McAuliffe  2014;  O'Connor  2015;
O'Connor  2020;  Patsiokas  1985;  Salkovskis  1990;  Stewart  2009;
Turner 2000), three trials used the Suicide Behaviors Questionnaire
(SBQ; Linehan 1981) (Linehan 2006; Linehan 2015; Weinberg 2006),
one  trial  used  the  Scale  for  Suicidal  Ideators  (SSI;  Schotte  1982)
(Linehan 1991), one the suicidal ideation subscale of the Psychiatric
Status  Schedule  (PSS;  Spitzer  1970)  (Waterhouse  1990),  and  one
the  suicidal  ideation  subscale  of  the  Suicide  Risk  Inventory  (SRI;
Hsu  1997)  (Wang  2016).  Six  trials  measured  suicidal  ideation
dichotomously  as  the  proportion  with  self-reported  suicidal
ideation  (Andreoli  2015;  Hassanian-Moghaddam  2011;  Liberman
1981; Mousavi 2015; Mousavi 2017; Wei 2013).

Suicide

In over half of the 60 trials (60.0%) that recorded information on
suicide, the method used to ascertain this outcome was not clearly
reported  (Andreoli  2015;  Bateman  2009;  Beautrais  2010;  Brown
2005; Clarke 2002; Davidson 2014; Dubois 1999; Gratz 2006; Gratz
2014;  Grimholt  2015;  Guthrie  2001;  Gysin-Maillart  2016;  Harned
2014;  Husain  2014;  Kapur  2013;  Lin  2020;  Linehan  1991;  Linehan
2006;  Linehan  2015;  Marasinghe  2012;  McLeavey  1994;  McMain
2009;  McMain  2017;  Mousavi  2015;  Naidoo  2014;  Owens  2020;
Priebe  2012;  Sahin  2018;  Salkovskis  1990;  Slee  2008;  Sreedaran
2020;  Stewart  2009;  Tapolaa  2010;  Torhorst  1987;  Walton  2020;
Weinberg 2006). In the remaining trials, a variety of sources were
used to ascertain suicide, including: Coroner's records (Allard 1992;
Amadéo  2015;  Hatcher  2011;  Hatcher  2015;  Hatcher  2016;  Hvid
2011; Tyrer 2003), mortality registers (Carter 2005; Cedereke 2002;
Hassanian-Moghaddam  2011;  Kawanishi  2014;  Morthorst  2012;
Mouaffak  2015;  O'Connor  2017;  Van  Heeringen  1995),  mortality
statistics  supplemented  by  Coroner’s  records  (Evans  1999a),
hospital records (McAuliffe 2014), medical records (Van der Sande
1997), hospital and/or medical records supplemented by Coroner’s
records (Vaiva 2006; Vaiva 2018), or from collateral informant report
(Crawford 2010; Fleischmann 2008; Hawton 1987; Wei 2013).

Excluded studies

A  total  of  157  studies  were  excluded  from  this  update.  The  most
common reason for exclusion was that not all trial participants had
engaged in SH within six months of trial entry (90 studies). Reasons
for exclusion for the remaining studies are shown in Figure 1.

Details  on  the  reasons  for  exclusion  for  those  trials  related  to
psychosocial interventions for SH in adults identified by this update
are reported in the Characteristics of excluded studies section.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

33

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Ongoing studies

Studies awaiting classification

Of  the  20  ongoing  studies  identified  in  the  previous  version  of
this  review  (Hawton  2016),  seven  were  included  in  this  update
(Brown 2005; Lin 2020; O'Connor 2015; O'Connor 2017; O'Connor
2020; Owens 2020; Vaiva 2018). Ten were excluded: for three, trial
results  were  unavailable,  for  two,  trial  registration  subsequently
lapsed,  two  were  suspended  due  to  feasibility  difficulties,  two
subsequently  included  participants  who  had  not  engaged  in  SH,
and one was subsequently published as a qualitative report.

A  total  of  25  ongoing  studies  were  identified  in  this  update  (see
Characteristics of ongoing studies section for further information).

Two potentially eligible trials could not be included in this review
(NCT00533117; NCT00834834). Whilst results from these trials have
been posted online, we were unable to confirm whether they met
our  inclusion  criteria  with  the  trial  authors.  Further  information
is provided in the Characteristics of studies awaiting classification
section.

Risk of bias in included studies

Risk of bias was evaluated for the primary outcome repetition of SH
at post-intervention. The results of the 'Risk of bias' assessments
can be seen in Figure 2 and Figure 3. Full 'Risk of bias' assessments,
including the evidence we used to justify our ratings, are available
here: doi.org/10.6084/m9.figshare.14159244.

Figure 2.   Summary of 'Risk of bias' assessments 

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

34

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 3.   Results of 'Risk of bias' assessments for each study

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

35

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Figure 3.   (Continued)

Cochrane Database of Systematic Reviews

Bias arising from randomisation process

All  trials  used  random  allocation  to  assign  participants  to  the
intervention and comparator arms. Most trials (98.7%) randomised
at the individual level. In one trial, cluster randomisation was used
(Bennewith 2002). Over half (55.3%) were rated as having a low risk
of bias for this domain. Thirty (39.5%) trials were rated as having
some  concerns  for  this  domain.  For  most  of  these,  insufficient
detail  on  either  generation  of  the  randomisation  sequence  and/
or  allocation  concealment  was  reported  (Allard  1992;  Amadéo
2015; Brown 2005; Cedereke 2002; Dubois 1999; Gratz 2006; Gratz
2014;  Kapur  2013;  Liberman  1981;  Linehan  2006;  Marasinghe
2012; McLeavey 1994; Morgan 1993; Mousavi 2015; O'Connor 2020;
Patsiokas  1985;  Priebe  2012;  Sahin  2018;  Stewart  2009;  Tapolaa
2010; Turner 2000; Van Heeringen 1995; Wang 2016; Wei 2013). For
three further trials, baseline differences between the intervention
and comparator arms suggested there may have been a problem
with the randomisation process (Carter 2005; Guthrie 2001; Hatcher
2011), whilst for two older trials, information on characteristics of
the intervention and comparator arms at baseline was not reported
(Waterhouse  1990;  Welu  1977).  Four  (5.3%)  trials  were  rated  as
having  high  risk  of  bias  for  this  domain  due  to  insufficient  detail
on  generation  of  the  randomisation  sequence  and/or  allocation
concealment  coupled  with  significant  differences  between  the
intervention and control arms at baseline on one or more factors,
suggesting there may have been a problem with the randomisation
process  in  these  trials  (Davidson  2014;  O'Connor  2015;  Torhorst
1987; Torhorst 1988).

Bias due to deviations from intended interventions

Whilst participants and clinical personnel were, typically, not blind
to  allocation  owing  to  likely  differences  in  treatment  intensity
between the intervention and comparator arms, most trials (69.9%)
were  nonetheless  rated  as  being  at  low  risk  of  bias  for  this

domain  as  no  deviations  from  the  intended  intervention  were
apparent  and  analyses  were  conducted  on  an  intention-to-treat
(ITT)  basis,  although  the  statistical  method(s)  used  to  undertake
these  analyses  were  not  always  clearly  reported.  Twenty-one
trials  were  rated  as  having  some  concerns  for  this  domain.  For
the  majority  of  these,  there  was  insufficient  information  on  the
analyses method(s) used (Dubois 1999; Evans 1999b; Fleischmann
2008;  Gibbons  1978;  Gratz  2006;  Hawton  1981;  Liberman  1981;
Linehan  1991;  Linehan  2006;  McAuliffe  2014;  McLeavey  1994;
Mousavi  2015;  Mousavi  2017;  O'Connor  2015;  Patsiokas  1985;
Sreedaran  2020;  Torhorst  1987;  Torhorst  1988;  Waterhouse  1990;
Welu  1977).  For  one,  some  minor  departures  from  the  intended
intervention  occurred  as  a  result  of  the  experimental  context.
Specifically,  some  participants  moved  GP  practices.  However,  as
the proportion of participants who moved practices was small and
relatively balanced between the intervention and comparator arms
in this trial, this was unlikely to have had a substantial impact on the
results observed (Bennewith 2002). Two trials were rated as being
at high risk of bias for this domain (Carter 2005; Naidoo 2014). In the
first, some participants randomised to the control group mistakenly
received the intervention treatment and whilst ITT analyses were
undertaken, the impact was not balanced between the intervention
and comparator arms in this trial (Carter 2005). In the second, the
trial authors claimed the intervention was effective in preventing
repeat SH even though there were major discrepancies in the data
presented  in  the  original  trial  report  that  we,  as  review  authors,
were unable to clarify through correspondence (Naidoo 2014).

Bias due to missing outcome data

The  majority  of  trials  (82.9%)  were  at  low  risk  of  bias  for  this
domain  as  fewer  than  5%  of  the  data  were  missing  at  the  post-
intervention  assessment  or,  the  proportion  of  missing  data  was
balanced between the intervention and comparator arms at post-
intervention.  However,  there  were  some  concerns  with  respect

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

36

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

to  this  domain  for  four  (5.3%)  trials.  For  two  of  these,  no  data
on  repetition  of  SH  were  reported  (Patsiokas  1985;  Sahin  2018).
For  one,  there  was  evidence  of  a  larger  proportion  of  missing
data for the comparator arm as compared to the intervention arm
(McAuliffe  2014),  whilst,  for  one,  the  proportion  of  missing  data
was  greater  for  the  intervention  arm  (O'Connor  2015).  None  of
these trials undertook sensitivity analyses to investigate the impact
that  missing  data  may  have  had  on  the  estimate  of  treatment
effectiveness.

Nine  (11.8%)  trials  were  rated  as  being  at  high  risk  of  bias  for
this domain. For five of these, there was evidence of a difference
in  the  proportion  of  missing  data  between  the  intervention  and
comparator arms, no information on likely causes of missingness
was  reported,  and  sensitivity  analyses  were  not  undertaken  to
investigate  the  impact  of  missing  data  (Davidson  2014;  Evans
1999b;  Grimholt  2015;  McLeavey  1994;  Wei  2013).  For  one  trial,
those with a repeat episode of SH during the follow-up period were
excluded from subsequent analyses (Sreedaran 2020); in another,
data  for  over  one-third  (38.1%)  of  the  randomised  sample  were
not included in follow-up assessments (Linehan 1991). For another
trial,  there  were  major  discrepancies  in  the  data  presented  in
the  original  trial  report  that  we,  as  review  authors,  were  unable
to  clarify  through  correspondence  (Naidoo  2014).  Finally,  for  one
multisite and multi-country trial there was evidence of substantial
regional differences in missingness (Fleischmann 2008).

Bias in measurement of the outcome

There were some concerns regarding bias in the measurement of
the  outcome  for  just  over  one-fifth  (21.1%)  of  the  trials  included
in  this  review.  Typically,  this  was  because  repetition  of  SH  was
ascertained from self-reported information alone and participants
were  either  not  blind  to  treatment  allocation  and/or  participant
blinding  was  unlikely  to  have  been  possible  to  achieve  given
the  differences  in  therapeutic  intensity  between  the  intervention
and  comparator  arms  (Gratz  2014;  Hassanian-Moghaddam  2011;
McAuliffe  2014;  Mousavi  2017;  O'Connor  2020;  Priebe  2012;  Slee
2008; Tapolaa 2010; Torhorst 1987; Torhorst 1988; Van Heeringen
1995;  Walton  2020;  Wei  2013;  Weinberg  2006).  For  one  trial,
repetition of SH was ascertained from clinical personnel who were
not  blind  to  treatment  allocation  (Waterhouse  1990),  whilst  in
another, repetition of SH was ascertained from unblinded clinical
personnel  for  the  majority  of  those  allocated  to  the  intervention
arm (Allard 1992).

Ten  (13.2%)  trials  were  rated  as  being  at  high  risk  of  bias  for
this  domain.  For  most  of  these,  repetition  of  SH  was  ascertained
from  self-reported  information  alone,  participant  blinding  was
unlikely  to  have  been  possible  to  achieve  given  the  differences
in therapeutic intensity between the intervention and comparator
arms, and assessment of the outcome could have been influenced
by knowledge of the intervention received (Lin 2020; Linehan 1991;
O'Connor  2015;  Sahin  2018;  Turner  2000;  Welu  1977).  For  one
trial,  repetition  of  SH  was  obtained  from  self-report.  Given  that
participants  assigned  to  the  intervention  and  comparator  arms
in  this  trial  received  different  treatment  modalities  (i.e.  face-to-
face  versus  telephone)  and  that  previous  work  has  shown  that
participants  may  be  less  willing  to  report  sensitive  information
face-to-face  than  by  telephone  (Pridemore  2005),  ascertainment
of  the  outcome  could  have  differed  between  groups  in  this
trial  (Mousavi  2015).  For  one  further  trial,  there  were  major
discrepancies  for  this  outcome  in  the  original  trial  report  that

Cochrane Database of Systematic Reviews

we  were  unable  to  clarify  through  correspondence  with  the  trial
authors  (Naidoo  2014).  Finally,  for  two  trials,  no  information  on
repetition of SH was reported (Patsiokas 1985; Sreedaran 2020).

Bias in selection of the reported result

Fourteen trials (18.4%) were rated as being at low risk of bias for
this  domain.  Of  these,  only  one  clearly  reported  that  data  had
been analysed in accordance with a prespecified analysis plan that
had been finalised before unblinded outcome data and been made
available for analysis (Tyrer 2003), whilst for 13 further trials there
had been no major departures from the analysis plan as outlined
in either a published trial protocol (Linehan 2015) or clinical trials
register (Bateman 2009; Gysin-Maillart 2016; Harned 2014; Hatcher
2011;  Hatcher  2015;  Hatcher  2016;  Husain  2014;  McMain  2017;
O'Connor 2017; O'Connor 2020; Owens 2020; Vaiva 2018), although
it  should  be  noted  that  one  of  these  trials  was  retrospectively
registered (Bateman 2009).

Most  trials  (80.3%)  were  rated  as  having  some  concerns  for  this
domain.  In  the  majority  of  cases,  this  was  because  trials  were
published prior to the International Committee of Medical Journal
Editors' (ICMJE) requirement in 2015 that all trials be preregistered
in  a  publicly  available  clinical  trials  registry.  It  was,  therefore,
difficult to determine whether data had been analysed according
to a prespecified plan, although there were no apparent departures
from the analyses outlined in the methods section of these trials
(Armitage  2016;  Amadéo  2015;  Andreoli  2015;  Mouaffak  2015;
Mousavi  2015;  Mousavi  2017;  Sahin  2018;  Walton  2020;  Wang
2016).  For  five  trials  that  were  preregistered,  this  domain  was
also rated as having some concerns, as the information provided
within the clinical trials was not sufficiently detailed to determine
whether  there  had  been  departures  from  the  proposed  analysis
plan  (Grimholt  2015;  Kawanishi  2014;  Lin  2020;  McMain  2009;
O'Connor 2015). For two further trials, there were some concerns
for  this  domain  as  data  on  repetition  of  SH  for  one  or  more
eligible time point(s) were not reported (Naidoo 2014; Salkovskis
1990);  however,  in  both  of  these  trials,  it  was  unlikely  results
were  selectively  reported  for  favourability.  Finally,  for  two  trials,
no information on repetition of SH was reported (Patsiokas 1985;
Sreedaran 2020).

One  trial  was  rated  as  being  at  high  risk  of  bias  for  this  domain
as,  although  repetition  of  SH  was  a  prespecified  outcome,  data
at  post-intervention  and  at  the  12-month  follow-up  assessment
were  not  reported  due  to  a  high  proportion  of  missing  outcome
data  for  these  time  points,  although  data  at  longer  time  points
were reported (Sahin 2018). Additionally, we were unable to obtain
unpublished data for these time points despite correspondence.

Overall bias

As a consequence, most trials (84.2%) were rated as either having
some concerns or being at high risk of bias.

Effects of interventions

See:  Summary  of  findings  1  Comparison  1.1:  Individual-based
CBT-based psychotherapy compared to TAU or another comparator
for  self-harm  in  adults;  Summary  of  findings  2  Comparison
1.2:  Group-based  CBT-based  psychotherapy  compared  to  TAU
or  another  comparator  for  self-harm  in  adults;  Summary  of
findings  3  Comparison  2.1:  DBT  compared  to  TAU  or  another
comparator  for  self-harm  in  adults;  Summary  of  findings  4

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

37

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Comparison  2.2:  DBT  group-based  skills  training  compared  to
TAU  or  another  comparator  for  self-harm  in  adults;  Summary
of  findings  5  Comparison  2.3:  DBT  individual  therapy  compared
to  TAU  or  another  comparator  for  self-harm  in  adults;  Summary
of  findings  6  Comparison  2.4:  DBT  prolonged  exposure  protocol
compared  to  TAU  or  another  comparator  for  self-harm  in  adults;
Summary of findings 7 Comparison 3: MBT compared to TAU or
another comparator for self-harm in adults; Summary of findings
8 Comparison 4: Emotion-regulation psychotherapy compared to
TAU  or  another  comparator  for  self-harm  in  adults;  Summary
of  findings  9  Comparison  5:  Psychodynamic  psychotherapy
compared  to  TAU  or  another  comparator  for  self-harm  in  adults;
Summary  of  findings  10  Comparison  6:  Case  management
compared  to  TAU  or  another  comparator  for  self-harm  in  adults;
Summary  of  findings  11  Comparison  7:  Structured  GP  follow-
up  compared  to  TAU  or  another  comparator  for  self-harm  in
adults;  Summary  of  findings  12  Comparison  9.1:  Emergency
cards  compared  to  TAU  or  another  comparator  for  self-harm  in
adults;  Summary  of  findings  13  Comparison  9.2:  Coping  cards
compared  to  TAU  or  another  comparator  for  self-harm  in  adults;
Summary  of  findings  14  Comparison  9.4:  Postcards  compared
to  TAU  or  another  comparator  for  self-harm  in  adults;  Summary
of  findings  15  Comparison  9.5:  Telephone  contact  compared  to
TAU  or  another  comparator  for  self-harm  in  adults;  Summary  of
findings 16 Comparison 9.6: Telephone contact, emergency cards,
and letters compared to TAU or another comparator for self-harm
in  adults;  Summary  of  findings  17  Comparison  9.7:  Telephone-
based  psychotherapy  compared  to  TAU  or  another  comparator
for  self-harm  in  adults;  Summary  of  findings  18  Comparison
10:  Provision  of  information  and  support  compared  to  TAU  or
another comparator for self-harm in adults; Summary of findings
19  Comparison  11:  Other  multimodal  interventions  compared  to
TAU  or  another  comparator  for  self-harm  in  adults;  Summary
of  findings  20  Comparison  12.5:  General  hospital  management
compared  to  TAU  or  another  comparator  for  self-harm  in  adults;
Summary  of  findings  21  Comparison  12.8:  Long-term  therapy
compared to TAU or another comparator for self-harm in adults

Comparison 1: Cognitive behavioural therapy (CBT)-based
psychotherapy versus TAU or another comparator

Twenty-one  trials  assessed  the  effectiveness  of  CBT-based
psychotherapy,  in  which  participants  in  the  intervention  group
were  offered  some  form  of  specific  psychological  therapy  such
as  CBT  or  problem-solving  therapy  (PST),  for  adults  (weighted
mean age: 31.7 ± 12.1 years; 56.7% female) presenting to services
following an episode of SH (Brown 2005, N = 120; Davidson 2014, N
= 20; Dubois 1999, N = 102; Evans 1999b, N = 32; Gibbons 1978, N =
400; Guthrie 2001, N = 119; Hatcher 2011, N = 1094; Hawton 1987,
N = 80; Husain 2014, N = 221; Lin 2020, N = 147; McAuliffe 2014, N
= 433; Mousavi 2017, N = 60; Owens 2020, N = 62; Patsiokas 1985,
N = 15; Salkovskis 1990, N = 20; Slee 2008, N = 82; Stewart 2009, N
= 32; Tapolaa 2010, N = 16; Tyrer 2003, N = 480; Wei 2013, N = 162;
Weinberg 2006, N = 30).

In  most  trials,  therapy  was  typically  very  brief  (i.e.  ≤  10  sessions)
over a relatively brief period (i.e. median: three months; IQR: one
to 3.7 months; range: one to 12 months), and was delivered on an
individual basis in all but one (McAuliffe 2014).

Cochrane Database of Systematic Reviews

Comparison 1.1: Individual cognitive behavioural therapy
(CBT)-based psychotherapy versus TAU or another comparator

For one trial (Stewart 2009), there were separate treatment arms
for  CBT  and  PST.  We  therefore  combined  data  from  these  two
conditions, given their similarity. For one further trial (Wei 2013),
there were two intervention arms: CBT-based psychotherapy and
telephone  contact.  We  therefore  included  only  data  for  the  CBT-
based psychotherapy arm.

Primary outcome

1.1.1 Repetition of SH

Four trials reported data on the proportion with a repeat episode
of SH by the post-intervention assessment (Mousavi 2017; Stewart
2009; Wei 2013; Weinberg 2006). While there was imprecision in the
effect estimate, CBT-based psychotherapy may reduce repetition of
SH by post-intervention (OR 0.35, 95% CI 0.12 to 1.02; participants
=  238;  studies  =  4;  I2  =  0%;  Analysis  1.1).  The  overall  risk  of  bias
was  high  for  one  trial  (Wei  2013)  and  there  were  some  concerns
for the remaining trials. According to GRADE criteria, we judged the
evidence to be of low certainty.

By the six-month follow-up assessment, on the basis of data from 12
trials, there was evidence of an effect for CBT-based psychotherapy
on repetition of SH (OR 0.52, 95% CI 0.38 to 0.70; N = 1260; k = 12; I2 =
2%; Analysis 1.2). For one trial (Owens 2020), data on self-reported
SH were also reported. Using these data did not materially change
this result.

There was also evidence of an effect for CBT-based psychotherapy
by the 12-month follow-up assessment in nine trials (OR 0.81, 95%
CI 0.66 to 0.99; N = 2458; k = 9; I2 = 0%; Analysis 1.3). One trial also
reported data for the consenting sample (i.e. including only those
participants  who,  following  treatment  allocation,  subsequently
consented to participation), rather than all those randomised, as
well  as  data  on  the  proportion  of  participants  self-reporting  an
episode of SH rather than those admitted to hospital following an
episode of SH, as well as data for the consenting sample (Hatcher
2011).  Using  either  source  of  data  for  this  trial,  however,  did  not
materially  affect  the  overall  result.  Two  trials  reported  data  on
repetition of SH by 24 months. An effect for this outcome was found
(OR 0.31, 95% CI 0.14 to 0.69; N = 105; k = 2; I2 = 0%; Analysis 1.4).

With respect to frequency of SH, data from four trials indicated no
effect for CBT-based psychotherapy on frequency of SH repetition
by the post-intervention assessment (MD -0.53, 95% CI -1.67 to 0.61;
participants  =  149;  studies  =  4;  I2  =  62%  ;  Analysis  1.5).  However,
there  was  evidence  of  an  effect  for  CBT-based  psychotherapy  by
the  six-month  assessment  (MD  -0.71,  95%  CI  -1.32  to  -0.11;  N  =
118;  k  =  4;  I2  =  0%;  Analysis  1.6).  One  trial  reported  information
on  median,  rather  than  mean,  number  of  episodes  of  SH  at  six
months.  However,  the  authors  found  that  although  “[t]he  rate  of
self-harm episodes was lower in the [experimental] group...[it was
not] significantly so” (Evans 1999b, pg.22).

There was evidence of an effect for CBT-based psychotherapy by the
12-month assessment in a single trial (mean 1.18, SD 4.22, n = 40
versus mean 4.58; SD 8.37; n = 33; MD -3.40, 95% CI -6.54 to -0.26;
N = 73; k = 1; I2 = not applicable; Slee 2008). A further trial reported
information  on  median  number  of  episodes  of  SH  at  12  months’
follow-up, finding that “[t]he median number of self-harm episodes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

38

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

was two in both [the experimental and TAU] groups” (Tyrer 2003,
pg.972).

Three trials reported numeric data on time to SH repetition. There
was  no  evidence  of  an  effect  for  CBT-based  psychotherapy  on
time  to  SH  repetition  in  these  three  trials  (Analysis  1.7).  Four
trials  reported  narrative  information  on  time  to  SH  repetition.  In
one, authors reported "[t]he time till next parasuicide act...showed
trends  in  favour  of  MACT  compared  with  TAU  although  [it  was
not]  statistically  significant"  (Evans  1999b,  pg.23),  whilst  in  a
second,  trial  authors  reported  "[i]n  the  experimental  (treated)
group, the mean time to repeat was 9.3 months, while the mean
time to repeated attempt for the subjects in the control group was
three  months"  (Salkovskis  1990,  pg.874).  However,  trial  authors
in a third reported "Kaplan-Maier survival analysis indicated that
MACT  effected  no  significant  difference  in  time  to  repetition  of
DSH  (log-rank  chi  square  =  .88,  df  =  15,  n.s.)"  (Weinberg  2006,
pg.487). Finally, in a more recent trial, "time to repetition...showed
a  more  complex  pattern,  with  speedier  initial  repetition  among
participants  randomised  to  problem-solving  therapy"  (Owens
2020, pg.9).

Secondary outcomes

1.1.2 Treatment adherence

Data  on  treatment  adherence  was  reported  for  both  the
intervention  and  comparator  arms  in  one  trial  in  which  an  effect
for  CBT-based  psychotherapy  was  found  for  the  proportion  of
participants who completed all 12 sessions of therapy during the
acute phase in addition to the three booster sessions (40/40 versus
33/42;  OR  22.97,  95%  CI  1.29  to  409.37;  N  =  82;  k  =  1;  I2  =  not
applicable; Slee 2008).

Five  trials  reported  data  on  treatment  adherence  for  the
intervention arm only (Brown 2005; Evans 1999b; Husain 2014; Lin
2020;  Owens  2020).  Brown  2005  found  that  “participants  in  the
cognitive  therapy  (CT)  group  participated  in  a  mean  (SD)  of  8.92
(5.97) CT sessions (range 0-24). Thirty participants (50%) received
ten or more CT sessions” (pg.568). In Evans 1999b, five participants
in the intervention group did not have specific sessions of manual-
assisted cognitive-behaviour therapy (MACT) and received almost
all input from the booklet component of CBT alone. Overall, 17 of
the 18 participants in the experimental group received the booklets.
Husain 2014 found that “more than half of the (intervention) group
attended  all  six  sessions  (n  =  56)”  (pg.466).  Lin  2020  found  that
"only around one fourth participants [sic] completed the scheduled
intervention" (pg.697). Owens 2020 found that almost half (43.3%)
attended all treatment sessions.

1.1.3 Depression

There was evidence of an effect for CBT-based psychotherapy on
depression scores at the post-intervention assessment (SMD -0.28,
95% CI -0.54 to -0.02; N = 953; k = 4; I2 = 71%; Analysis 1.8).

There was no evidence of an effect for CBT-based psychotherapy
on  depression  scores  at  the  six-month  assessment  in  eight  trials
(Analysis 1.9); however, there was evidence of an effect by the 12-
month assessment in seven trials (SMD -0.36, 95% CI -0.64 to -0.07;
N  =  1130;  k  =  7;  I2  =  76%;  Analysis  1.10).  One  trial  reported  data
on median (rather than mean) HDRS scores at six- and 12-months
follow-up (Lin 2020); however, no effect was found for CBT-based
psychotherapy in this trial for this outcome.

Cochrane Database of Systematic Reviews

Only two trials reported depression scores by the 24-month follow-
up assessment; however, there was no evidence of an effect for CBT-
based psychotherapy by this time point (Analysis 1.11).

1.1.4 Hopelessness

There  was  evidence  of  an  effect  for  CBT-based  psychotherapy
on  hopelessness  scores  at  the  post-intervention  assessment  in
five  trials  (MD  -2.99,  95%  CI  -3.91  to  -2.07;  N  =  803;  k  =  5;  I2  =
0%; Analysis 1.12). One further trial also reported information on
hopelessness scores at post-intervention (Mousavi 2017); however,
as an idiosyncratic scale was used in this trial, data could not be
included in this review.

There  was  also  evidence  of  an  effect  on  hopelessness  scores  by
the six-month follow-up assessment in two trials (MD -3.14, 95% CI
-4.78 to -1.49; N = 315; k = 2; I2 = 0%; Analysis 1.13).

Three  trials  reported  data  on  hopelessness  scores  at  12  months,
again showing a evidence of an effect for CBT-based psychological
therapy (MD -1.89, 95% CI -2.97 to -0.81; N = 539; k = 3; I2 = 16%;
Analysis  1.14).  One  further  trial  reported  data  on  median  (rather
than mean) BHS scores at six- and 12-months follow-up (Lin 2020).

One  trial  reported  data  on  hopelessness  scores  at  24  months
(Brown 2005). However, there was no evidence of an effect for CBT-
based psychotherapy on hopelessness scores by this time point in
this trial (mean 6.07, SD 5.28, n = 45 versus mean 7.24, SD 6.35, n =
40; MD -1.17, SD -3.67 to 1.33; N = 85; k = 1; I2 = not applicable).

1.1.5 General functioning

One  trial  reported  data  on  general  functioning  scores  by  the  six-
month  assessment.  However,  whilst  there  was  no  evidence  of
a  difference  in  mean  scores  on  this  measure  between  the  CBT-
based  psychotherapy  and  TAU  arms  in  this  trial  (i.e.  59.4  versus
59.6), insufficient information was reported to enable imputation
of missing SDs (Tyrer 2003).

1.1.6 Social functioning

One  trial  reported  data  on  social  functioning  scores  at  post-
intervention  and,  whilst  there  was  no  evidence  of  a  difference
in  mean  scores  on  this  measure  between  the  CBT-based
psychotherapy  and  TAU  arms  in  this  trial  (i.e.  2.3  versus  2.3),
insufficient  information  was  reported  to  enable  imputation  of
missing SDs (Hawton 1987).

Three trials reported data on social functioning by the six-month
follow-up  assessment  (Evans  1999b;  Hawton  1987;  Tyrer  2003),
however,  for  two  of  these  trials  insufficient  information  was
reported to enable imputation of missing SDs (Hawton 1987; Tyrer
2003). For the remaining trial, there was evidence of an effect for
CBT-based  psychological  therapy  on  social  functioning  scores  by
this time point (mean 9.8, SD 4.9, n = 18 versus mean 13.1, SD 4.0, n
= 12; MD -3.30, 95% CI -6.50 to -0.10; N = 30; k = 1; I2 = not applicable;
Evans 1999b).

One of these trials also reported data on social functioning scores
by the 12-month follow-up period. However, whilst those allocated
to CBT-based psychotherapy had lower mean scores (i.e. 1.7 versus
2.1),  once  again  insufficient  information  was  reported  to  enable
imputation of missing SDs (Hawton 1987).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

39

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

1.1.7 Suicidal ideation

There was evidence of an effect for CBT-based psychotherapy in five
trials at the post-intervention assessment (SMD -0.48, 95% CI -0.68
to -0.28; N = 718; k = 5; I2 = 20%; Analysis 1.15), and by the six-month
follow-up assessment in four trials (SMD -0.38, 95% CI -0.60 to -0.17;
N = 353; k = 4; I2 = 0%; Analysis 1.16).

One  trial  reported  information  on  suicidal  ideation  scores  by  12
months;  however,  CBT-based  psychotherapy  was  not  associated
with an effect by this time point in this trial (mean 3.70, SD 6.70,
n = 187 versus mean 4.80, SD 7.40, n = 231; MD -1.10, 95% CI -2.45
to 0.25; N = 418; k = 1; I2 = not applicable; Hatcher 2011). One trial
reported data on median (rather than mean) BSSI scores at six- and
12-months follow-up (Lin 2020); however, no effect was found for
CBT-based psychotherapy in this trial for this outcome.

Two trials reported information on the proportion of participants
with  suicidal 
ideation  (Mousavi  2017;  Wei  2013).  At  post-
intervention, data from both of these trials indicated no evidence of
an effect for CBT-based psychotherapy. There was also no evidence
of an effect by the six-month or 12-month follow-up assessments in
one of these trials (Analysis 1.17). However, it is notable that for one
of these trials (Wei 2013), results were reported on the basis of those
randomised despite the fact that a self-reported measure was used,
and high levels of dropout were observed by the 12-month follow-
up assessment. As we were unable to confirm these numbers with
trial authors, results much be interpreted with caution.

One  trial  reported  data  on  BSSI  scores,  however,  insufficient
information  was  available  to  enable  imputation  of  missing  SDs
(Salkovskis 1990). One further trial reported data on the proportion
scoring above zero on the BSSI at the post-intervention, 6, 12, and
24-month  follow-up  assessments  (Brown  2005),  however,  as  this
was not based on clinically established cut-points, these data were
unable to be included in this review.

1.1.8 Suicide

Sixteen  trials  reported  data  on  suicide  deaths  during  follow-up.
There was no evidence of an effect for CBT-based psychotherapy on
suicides by final follow-up (i.e. up to 24 months) (Analysis 1.18). In
one trial, there was one death in the intervention arm that medical
staff considered to be a suicide, although the coroner did not record
a suicide verdict in this case (Tyrer 2003). Including this death as a
suicide did not materially change the overall result.

Subgroup analyses

Two  further  trials  reported  data  on  repetition  of  SH  by  repeater
status (Hatcher 2011; Lin 2020). There was no evidence of an effect
for CBT-based psychotherapy on repetition of SH by the six-month
follow-up  assessment  for  either  those  with  a  history  of  repeated
SH (7/39 versus 16/49; OR 0.45, 95% CI 0.16 to 1.24; N = 88; k = 1;
I2  =  not  applicable;  Lin  2020),  or  those  without  this  history  (3/33
versus  7/26;  OR  0.27,  95%  CI  0.06  to  1.18;  N  =  59;  k  =  1;  I2  =  not
applicable; Lin 2020) in one trial. However, by the 12-month follow-
up  assessment,  data  from  these  two  trials  indicated  that  whilst
CBT-based  psychotherapy  was  not  associated  with  an  effect  on
repetition of SH for those without a history of SH prior to trial entry
(Analysis 1.19), there was evidence of an effect on this outcome for
those  with  a  history  of  multiple  episodes  of  SH  (OR  0.56,  95%  CI
0.36  to  0.88;  N  =  508;  k  =  1;  I2  =  0%;  Analysis  1.19).  However,  the

Cochrane Database of Systematic Reviews

test for subgroup differences was not statistically significant for this
outcome at this time point (Chi2 = 1.97, df = 1, p = 0.16).

With regards to time to SH repetition, data from one of these trials
suggested that, whilst there was no evidence of an effect in those
without a history of multiple episodes of SH prior to trial entry (HR
1.55, 95% CI 0.98 to 2.48; N = 135; k = 1; I2 = not applicable), CBT-
based psychotherapy was associated with an effect on time to SH
repetition  in  those  with  a  history  of  multiple  episodes  of  SH  (HR
0.58, 95% CI 0.36 to 0.94; N = 194; k = 1; I2 = not applicable) in this
trial (Hatcher 2011).

Sensitivity analyses

One  trial  used  Zelen's  design  (Hatcher  2011).  Omitting  this  trial
did  not  materially  affect  results  for  CBT-based  psychotherapy  on
repetition  of  SH  by  the  12-month  assessment,  depression  scores
at  the  12-month  assessment,  hopelessness  scores  by  the  post-
intervention or 12-month assessments, or suicidal ideation scores
at  post-intervention.  However,  omitting  this  trial  did  cause  a
reduction in the SMD for CBT-based psychotherapy on depression
scores by the post-intervention assessment and the estimate was
no longer statistically significant (SMD -0.19, 95% CI -0.40 to 0.02; N
= 313; k = 5; I2 = 54%).

Two  analyses  within  this  comparison  were  associated  with
substantial levels of heterogeneity (Analysis 1.10, I2 = 76%; Analysis
1.17.1, I2 = 85%); however, analyses did not indicate any individual
study  was  associated  with  excessive  influence  for  either  of  these
outcomes.

Comparison 1.2: Group-based cognitive behavioural therapy
(CBT)-based psychotherapy versus TAU or another comparator

Primary outcome

1.2.1 Repetition of SH

There was no evidence of an effect for CBT-based psychotherapy,
delivered in a group-based format, as compared to TAU by the post-
intervention  assessment  in  a  single  trial  (23/171  versus  27/142;
OR  0.66,  95%  CI  0.36  to  1.21;  N  =  313;  k  =  1;  I2  =  not  applicable).
According  to  GRADE  criteria,  we  judged  the  evidence  to  be  of
moderate certainty.

There  was  also  no  evidence  of  an  effect  for  group-based  CBT-
based psychotherapy on repetition of SH by the six-month follow-
up assessment (39/128 versus 26/106; OR 1.35, 95% CI 0.75 to 2.41;
N = 234; k = 1; I2 = not applicable), or by the 12-month follow-up
assessment (54/222 versus 50/211; OR 1.03, 95% CI 0.67 to 1.61; N
= 433; k = 1; I2 = not applicable).

There was also no evidence of an effect for group-based CBT-based
psychotherapy  on  frequency  of  SH  repetition  by  the  12-month
follow-up assessment in this trial (mean 0.43, SD 1.23, n = 222 versus
mean 0.49, SD 1.53, n = 211; MD -0.06, 95% CI -0.32 to 0.20; N = 433;
n = 1; I2 = not applicable).

Secondary outcomes

1.2.2 Treatment adherence

Data  on  treatment  adherence  was  reported  for  the  intervention
arm  only.  The  authors  found  that  “almost  half  of  those  assigned
to  [problem-solving  therapy]  (103,  46.4%)  attended  all  6  therapy
sessions” (McAuliffe 2014, pg.4).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

40

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

1.2.3 Depression

There  was  no  evidence  of  an  effect  for  group-based  CBT-based
psychotherapy  on  depression  by  either  the  post-intervention
(mean 18.20, SD 14.80, n = 171 versus mean 20.60, SD 16.00, n = 142;
MD -0.16, 95% CI -0.38 to 0.07; N = 313; k = 1; I2 = not applicable) or
the six-month follow-up assessment (mean 17.30, SD 15.90, n = 128
versus mean 19.40, SD 17.00, n = 106; MD -0.13, 95% CI -0.39 to 0.13;
N = 234; k = 1; I2 = not applicable).

1.2.4 Hopelessness

There was also no evidence of an effect for group-based CBT-based
psychotherapy  on  hopelessness  scores  at  the  post-intervention
(mean 6.50, SD 6.10, n = 171 versus mean 7.30, SD 6.20, n = 142; MD
-0.80, 95% CI -2.17 to 0.57; N = 313; k = 1; I2 = not applicable) or six-
month follow-up assessment (mean 6.80, SD 6.30, n = 128 versus
mean 7.10, SD 6.10, n = 106; MD -0.30, 95% CI -1.89 to 1.29; N = 234;
k = 1; I2 = not applicable).

1.2.5 General functioning

No data available.

1.2.6 Social functioning

No data available.

1.2.7 Suicidal ideation

There  was  no  evidence  of  an  effect  for  group-based  CBT-based
psychotherapy on suicidal ideation by either the post-intervention
(mean 4.30, SD 8.00, n = 171 versus mean 5.80, SD 9.70, n = 142; MD
-1.50, 95% CI -3.50 to 0.50; N = 313; k = 1; I2 = not applicable) or the
six-month follow-up assessment (mean 4.70, SD 8.90, n = 128 versus
mean 4.90, SD 8.90, n = 106; MD -0.20, 95% CI -2.49 to 2.09; N = 234;
k = 1; I2 = not applicable).

1.2.8 Suicide

There  was  no  evidence  of  an  effect  for  group-based  CBT-based
psychotherapy on suicide deaths by the final follow-up assessment
(1/222 versus 2/211; OR 0.47, 95% CI 0.04 to 5.25; N = 433; k = 1; I2
= not applicable).

Subgroup analyses

Randomisation  was  stratified  by  both  sex  and  repeater  status  in
this trial (McAuliffe 2014). However, we were unable to obtain data
disaggregated by either factor from the trial authors.

Sensitivity analyses

Not applicable.

Comparison 2: Dialectical behavioural therapy (DBT) versus
TAU or another comparator

Ten  trials  investigated  the  effectiveness  of  dialectical  behaviour
therapy  (DBT)  as  compared  to  either  TAU  (Linehan  1991,  N  =  63;
McMain 2009, N = 180; McMain 2017, N = 84; Priebe 2012, N = 80;
Sahin  2018,  N  =  50)  or  other  forms  of  alternative  psychotherapy
(Harned 2014, N = 26; Linehan 2006, N = 101; Linehan 2015, N = 99;
Turner 2000, N = 24; Walton 2020, N = 166) in adults (weighted mean
age: 27.5 ± 11.3 years; 89.7% female) diagnosed with a personality
disorder,  typically  borderline  personality  disorder,  and  who  were
receiving treatment from outpatient mental health services due to
recurrent SH.

Cochrane Database of Systematic Reviews

For one of these trials, there were two different intervention arms:
psychodynamic psychotherapy and DBT (Sahin 2018). We therefore
included  only  data  for  the  DBT  arm.  For  a  second  of  these  trials,
comparison  was  made  between  two  different  forms  of  DBT:  DBT
group-based  skills  training  only  (DBT-S;  Linehan  2015a)  and  DBT
individual therapy only (DBT-I; Linehan 2015b).

Comparison 2.1: Standard DBT

Primary outcome

2.1.1 Repetition of SH

Overall,  there  was  no  evidence  of  an  effect  for  standard  DBT
compared to either TAU or alternative psychotherapy in terms of
the  proportion  of  patients  repeating  SH  by  the  post-intervention
assessment (OR 0.71, 95% CI 0.32 to 1.55; participants = 502; studies
=  6;  I2  =  60%;  (Analysis  2.1).  There  was  also  no  difference  by
comparator (i.e. TAU versus alternative psychotherapy). The overall
risk of bias was high for two trials (Linehan 1991; Turner 2000) and
there  were  some  concerns  for  the  remaining  trials.  According  to
GRADE criteria, we judged the evidence to be of very low certainty.

There  was  also  no  evidence  of  an  effect  for  DBT  on  repetition  of
SH by the 12-month (OR 0.65, 95% CI 0.24 to 1.72; participants =
269;  studies  =  3;  I2  =  47%;  Analysis  2.2)  assessment.  Once  again,
there was no difference by comparator (i.e. TAU versus alternative
psychotherapy).

DBT was associated with an effect for frequency of repeated SH by
the post-intervention assessment when compared to either TAU or
alterative psychotherapy (MD -5.00, 95% CI -8.92 to -1.08; N = 659;
k  =  7;  I2  =  49%;  Analysis  2.3).  However,  this  effect  was  no  longer
found  by  the  six-month  follow-up  assessment  in  one  trial  (mean
0.32, SD 1.27, n = 42 versus mean 1.14, SD 3.94, n = 42; MD -0.82,
95% CI -2.07 to 0.43; N = 84; k = 1; I2 = not applicable; McMain 2017).
Following  a  'naturalistic'  follow-up  period,  data  from  one  further
trial indicated that the effectiveness of DBT in terms of frequency of
SH was maintained at 24 months in this trial; however, this outcome
was only investigated for a proportion of the original participants
(61.9%)  who  the  researchers  were  able  to  contact  at  24  months
(Linehan 1991). Results have therefore not been reproduced in this
review.

One  trial  reported  information  on  time  to  repetition  of  SH,
finding  that  those  "receiving  DBT  were  half  as  likely  to  make
a  suicide  attempt  (hazard  ratio,  2.66;  P  =  .005)"  (Linehan  2006,
pg.757). However, insufficient information was reported to enable
calculation of the accompanying CIs for this outcome for this trial.

Secondary outcomes

2.1.2 Treatment adherence

There  was  no  evidence  of  an  effect  for  DBT  compared  with
either  TAU  or  alternative  psychotherapy  for  the  proportion  of
participants  who  completed  treatment  (Analysis  2.4).  There  was
also no evidence of a difference by comparator. Two further trials
did not report information on the proportion completing treatment
in the comparator arm (McMain 2017; Priebe 2012), although the
comparator in the former trial was a waiting-list control condition.
We were, therefore, unable to incorporate these results in a meta-
analysis.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

41

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

2.1.3 Depression

There  was  evidence  of  an  effect  for  DBT  compared  to  both
TAU  or  alternative  psychotherapy  on  depression  scores  at  post-
intervention (SMD -0.37, 95% CI -0.58 to -0.17; N = 557; k = 6; I2 = 23%;
Analysis 2.5). There was no evidence of a difference by comparator.
One  trial  also  measured  depression  scores  at  post-intervention
using the HRSD; however, there was no evidence of an effect for DBT
according to this measure in this trial (mean 7.50, SD 5.96, n = 12
versus mean 12.58, SD 3.90, n = 12; MD -5.08, 95% CI -9.11 to -1.05;
N = 24; k = 1; I2 = not applicable; Turner 2000).

There was no evidence of an effect for DBT on depression scores
by the six-month follow-up assessment in one trial (mean 27.94, SD
16.08, n = 42 versus mean 29.50, SD 15.71, n = 42; MD -1.56, 95% CI
-8.36 to 5.24; N = 84; k = 1; I2 = not applicable; McMain 2017) or by the
12-month follow-up assessment in one further trial (mean 12.60, SD
6.80, n = 46 versus mean 14.40, SD 9.10, n = 35; MD -1.80, 95% CI
-5.40 to 1.80; N = 81; k = 1; I2 = not applicable; Linehan 2006).

2.1.4 Hopelessness

We obtained data on hopelessness by correspondence for one trial
(Linehan 1991); however, there was no evidence of an effect for DBT
as compared to TAU by the 24-month follow-up assessment in this
trial (mean 10.86, SD 6.04, n = 7 versus mean 10.69, SD 6.18, n = 11;
MD 0.17, 95% CI -5.61 to 5.95; N = 18; k = 1; I2 = not applicable).

2.1.5 General functioning

No data available.

2.1.6 Social functioning

One  trial  reported  data  on  social  functioning  scores  at  post-
intervention and by the six-month follow-up assessment (McMain
2017).  Whilst  there  was  evidence  of  an  effect  for  DBT  on  social
functioning scores at post-intervention in this trial (mean 2.50, SD
0.56, n = 42 versus mean 2.88, SD 0.59, n = 42; MD -0.38, 95% CI -0.63
to -0.13; N = 84; k = 1; I2 = not applicable), this effect was no longer
apparent  by  the  six-month  follow-up  assessment  (mean  2.60,  SD
0.70, n = 42 versus mean 2.87, SD 0.65, n = 42; MD -0.27, 95% CI -0.56
to 0.02; N = 84; k = 1; I2 = not applicable).

2.1.7 Suicidal ideation

There was no evidence of an effect for DBT when compared either
to TAU or to alternative psychotherapy on suicidal ideation scores
at the post-intervention assessment in three trials (Analysis 2.6), or
by the 12-month assessment in one of these trials (mean 24.10, SD
19.80, n = 46 versus mean 31.92, SD 26.80, n = 35; MD -7.80, 95% CI
-18.38 to 2.74; N = 81; k = 1; I2 = not applicable; Linehan 2006). There
was also no evidence of a difference by comparator.

2.1.8 Suicide

There was no evidence of an effect for DBT as compared to either
TAU or alternative psychotherapy on suicide deaths at either post-
intervention  (Analysis  2.7),  the  12-month  (Analysis  2.8),  or  24-
month follow-up period (Analysis 2.9).

Subgroup analyses

Randomisation  was  stratified  by  sex  in  one  trial  (Walton  2020).
Whilst  data  obtained  by  correspondence  from  the  trial  authors
indicated that, compared with alternative psychotherapy, DBT was
not  associated  with  an  effect  on  repetition  of  SH  by  the  post-

Cochrane Database of Systematic Reviews

intervention assessment for females (21/38 versus 33/50; OR 0.64,
95% CI 0.27 to 1.52; N = 88; k = 1; I2 = not applicable), DBT may be
associated with a greater proportion of males engaging in a repeat
episode of SH at this time point (12/13 versus 6/13; OR 14.00, 95%
CI 1.39 to 141.49; N = 26; k = 1; I2 = not applicable).

With  regards  to  frequency  of  SH  repetition,  data  obtained  by
correspondence  for  this  trial  indicated  that,  whilst  DBT  was
associated  with  an  effect  at  post-intervention  for  females  (mean
5.08, SD 11.13, n = 38 versus mean 17.66, SD 33.10, n = 50; MD -12.58,
95% CI -22.41 to -2.75; N = 88; k = 1; I2 = not applicable), there was
no evidence of an effect for males (mean 5.77, SD 5.34, n = 13 versus
mean 4.93, SD 7.24, n = 13; MD 0.84, 95% CI -4.05 to 5.73; N = 26; k
= 1; I2 = not applicable).

There  was  no  evidence  of  an  effect  for  DBT  as  compared  to
alternative psychotherapy on the proportion of males (9/19 versus
11/18; OR 0.57, 95% CI 0.15 to 2.12; N = 37; k = 1; I2 = not applicable)
or females (35/62 versus 37/63; OR 0.91, 95% CI 0.45 to 1.85; N = 125;
k = 1; I2 = not applicable) who completed the full course of treatment
on this trial.

Finally,  whilst  DBT  was  associated  with  an  effect  on  depression
scores  as  compared  to  alternative  psychotherapy  at  the  post-
intervention  assessment  for  males  (mean  13.54,  SD  12.82,  n  =  13
versus mean  23.70, SD  12.30, n  =  12; MD -10.16, 95% CI -20.01 to
-0.31; N = 25; k = 1; I2 = not applicable), there was no evidence of an
effect on depression scores for females in this trial (mean 15.34, SD
14.01, n = 37 versus mean 21.88, SD 19.00, n = 48; MD -6.54, 95% CI
-13.56 to 0.48; N = 85; I2 = not applicable).

Sensitivity analyses

Not applicable.

Comparison 2.2: DBT group-based skills training

For  one  trial  (i.e.  Linehan  2015),  there  were  two  different
intervention  arms:  DBT  group-based  skills  training  only  (DBT-S;
Linehan  2015a)  and  DBT  individual  therapy  only  (DBT-I;  Linehan
2015b).  For  a  detailed  description  of  the  therapeutic  content  of
the  two  different  intervention  arms  included  in  this  trial,  see  the
Characteristics of included studies section.

Here we included results for DBT group-based skills training only as
compared with standard DBT in adult women (mean age: 30.4 ± 7.5
years) diagnosed with borderline personality disorder referred for
outpatient treatment for repeated SH (Linehan 2015a, N = 66).

Primary outcome

2.2.1 Repetition of SH

In  this  trial,  data  on  repetition  of  SH  were  reported  separately
for  episodes  of  attempted  suicide  and  NSSI.  As  we  were  unable
to  obtain  data  on  combined  SH  from  the  trial  authors  despite
correspondence,  we  have  reproduced  the  results  for  attempted
suicide and NSSI separately.

There  was  no  evidence  of  an  effect  for  DBT  group-based  skills
training only as compared with standard DBT on suicide reattempts
(9/33 versus 12/33; OR 0.66, 95% CI 0.23 to 1.86; N = 66; k = 1; I2 = not
applicable) or NSSI (18/33 versus 19/33; OR 0.88, 95% CI 0.33 to 2.34;
N = 66; k = 1; I2 = not applicable) at post-intervention. According to
GRADE criteria, we judged the evidence to be of moderate certainty.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

42

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

There was also no evidence of an effect for DBT group-based skills
training only on suicide reattempts (6/33 versus 2/33; OR 3.44, 95%
CI  0.64  to  18.51;  N  =  66;  k  =  1;  I2  =  not  applicable)  or  NSSI  (15/33
versus  15/33;  OR  1.00,  95%  CI  0.38  to  2.64;  N  =  66;  k  =  1;  I2  =  not
applicable) by the 12-month assessment in this trial.

There  was  no  evidence  of  an  effect  for  DBT  group-based  skills
training  only  on  frequency  of  suicide  reattempts  (mean  2.60,  SD
2.90,  n  =  33  versus  mean  3.40,  SD  4.60,  n  =  33;  MD  -0.80,  95%  CI
-2.66 to 1.06; N = 66; k = 1; I2 = not applicable) or episodes of NSSI
(mean 9.90, SD 19.70, n = 33 versus mean 10.20, SD 16.30, n = 33;
MD  -0.30,  95%  CI  -9.02  to  8.42;  N  =  66;  k  =  1;  I2  =  not  applicable)
at  post-intervention.  Nor  was  there  any  evidence  of  an  effect  for
this intervention on frequency of suicide reattempts (mean 1.50, SD
0.60, n = 33 versus mean 2.00, SD 1.40, n = 33; MD -0.50, 95% CI -1.02
to 0.02; N = 66; k = 1; I2 = not applicable) or episodes of NSSI (mean
9.40, SD 20.40, n = 33 versus mean 7.90, SD 8.50, n = 33; MD 1.50, 95%
CI -6.04 to 9.04; N = 66; k = 1; I2 = not applicable) by the 12-month
follow-up assessment in this trial.

Finally,  with  regards  to  time  to  SH  repetition,  "[s]urvival
analysis...indicated no difference between groups in the time to the
first suicide attempt (χ2 = 1.4 [P = .50])" (Linehan 2015, pg.4).

Secondary outcomes

2.2.2 Treatment adherence

There  was  no  evidence  of  an  effect  for  DBT  group-based  skills
training,  as  compared  with  standard  DBT,  on  the  proportion  of
participants  who  completed  treatment  by  the  post-intervention
assessment in this trial (20/33 versus 25/33; OR 0.49, 95% CI 0.17 to
1.42; N = 66; k = 1; I2 = not applicable; Linehan 2015a).

There was also no evidence of an effect for DBT group-based skills
training, as compared with standard DBT, on the number of group
therapy sessions attended (mean 4.20, SD 0.11, n = 33 versus mean
4.20,  SD  0.12,  n  =  33;  MD  0.00,  95%  CI  -0.06  to  0.06;  N  =  66;  k  =
1; I2 = not applicable; Linehan 2015a). Information on the number
of individual therapy sessions attended could not be estimated as
individuals assigned to the group-based skills training arm in this
trial did not receive any individual therapy sessions.

2.2.3 Depression

There  was  no  evidence  of  a  significant  treatment  effect  for  DBT
group-based  skills  training,  as  compared  with  standard  DBT,  on
depression scores at either the post-intervention (mean 10.40, SD
6.40, n = 33 versus mean 12.30, SD 8.00, n = 33; MD -1.90, 95% CI -5.40
to 1.60; N = 66; k = 1; I2 = not applicable), or 12-month assessment
(mean 11.90, SD 8.80, n = 33 versus mean 15.20, 8.60, n = 33; MD
-3.30, 95% CI -7.50 to 0.90; N = 66; k = 1; I2 = not applicable; Linehan
2015a).

2.2.4 Hopelessness

There was also no evidence of an effect for DBT group-based skills
training, as compared with standard DBT, on hopelessness at either
the post-intervention (mean -155.30, SD 41.40, n = 33 versus mean
-168.70, SD 45.3, n = 33; MD 13.40, 95% CI -7.54 to 34.34; N = 66; k
= 1; I2 = not applicable) or 12-month follow-up assessment (mean
-152.20, SD 43.20, n = 33 versus mean -159.90, SD 40.20, n = 33; MD
7.40, 95% CI -12.73 to 27.53; N = 66; k = 1; I2 = not applicable; Linehan
2015a) in this trial.

2.2.5 General functioning

No data available.

2.2.6 Social functioning

No data available.

2.2.7 Suicidal ideation

There  was  no  evidence  of  an  effect  for  DBT  group-based  skills
training,  as  compared  with  standard  DBT,  on  suicidal  ideation
scores at either the post-intervention (mean 27.50, SD 19.10, n = 33
versus mean 32.00, SD 21.60, n = 33; MD -4.50, 95% CI -14.34 to 5.34;
N = 66; k = 1; I2 = not applicable) or 12-month follow-up assessment
(mean 21.20, SD 19.20, n = 33 versus mean 28.90, SD 16.60, n = 33;
MD -7.80, 95% CI -16.46 to 0.86; N = 66; k = 1; I2 = not applicable).

2.2.8 Suicide

There  was  one  suicide  death  in  the  standard  DBT  arm  by  the
24-month  follow  up  assessment  in  this  trial;  however,  there  was
no  evidence  of  an  effect  for  DBT  group-based  skills  training,  as
compared with standard DBT, on this outcome by this time point
(0/33 versus 1/33; OR 0.32, 95% CI 0.01 to 8.23; N = 66; k = 1; I2 = not
applicable).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 2.3: DBT individual therapy

For  one  trial  (i.e.  Linehan  2015),  there  were  two  different
intervention  arms:  DBT  group-based  skills  training  only  (DBT-S;
Linehan  2015a)  and  DBT  individual  therapy  only  (DBT-I;  Linehan
2015b).  For  a  detailed  description  of  the  therapeutic  content  of
the  two  different  intervention  arms  included  in  this  trial,  see  the
Characteristics of included studies section.

Here  we  included  results  for  DBT  individual  therapy  only  as
compared with standard DBT in adult women (mean age: 30.6 ± 7.9
years) diagnosed with borderline personality disorder referred for
outpatient treatment for repeated SH (Linehan 2015b, N = 66).

Primary outcome

2.3.1 Repetition of SH

As  before,  in  this  trial,  data  on  repetition  of  SH  were  reported
separately  for  episodes  of  attempted  suicide  and  NSSI.  As  we
were  unable  to  obtain  data  on  combined  SH  from  the  trial
authors despite correspondence, we have reproduced the results
for attempted suicide and NSSI separately.

There  was  no  evidence  of  an  effect  for  DBT  individual  therapy
only as compared with standard DBT on suicide reattempts (15/33
versus  12/33;  OR  1.46,  95%  CI  0.54  to  3.91;  N  =  66;  k  =  1;  I2  =  not
applicable) or NSSI (21/33 versus 19/33; OR 1.29, 95% CI 0.48 to 3.47;
N  =  66;  k  =  1;  I2  =  not  applicable)  at  post-intervention.  According
to the GRADE criteria, we judged the evidence to be of moderate
certainty.

There was also no evidence of an effect for DBT individual therapy
only on suicide reattempts (7/33 versus 2/33; OR 4.17, 95% CI 0.80 to

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

43

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

21.85; N = 66; k = 1; I2 = not applicable) or NSSI (13/33 versus 15/33;
OR 0.78, 95% CI 0.29 to 2.07; N = 66; k = 1; I2 = not applicable) by the
12-month assessment in this trial.

There was no evidence of an effect for DBT individual therapy only
on  frequency  of  suicide  reattempts  (mean  2.90,  SD  3.00,  n  =  33
versus mean 3.40, SD 4.60, n = 33; MD -0.50, 95% CI -2.37 to 1.37; N
= 66; k = 1; I2 = not applicable) or episodes of NSSI (mean 20.60, SD
33.10, n = 33 versus mean 10.20, SD 16.30, n = 33; MD 10.40, 95% CI
-2.19 to 22.99; N = 66; k = 1; I2 = not applicable) at post-intervention.
Nor  was  there  any  evidence  of  an  effect  for  this  intervention  on
frequency of suicide reattempts (mean 3.60, SD 3.20, n = 33 versus
mean 2.00, SD 1.40, n = 33; MD 1.60, 95% CI 0.41 to 2.79; N = 66; k
= 1; I2 = not applicable) or episodes of NSSI (mean 16.00, SD 32.60,
n = 33 versus mean 7.90, SD 8.50, n = 33; MD 8.10, 95% CI -3.39 to
19.59; N = 66; k = 1; I2 = not applicable) by the 12-month follow-up
assessment in this trial.

Finally,  with  regards  to  time  to  SH  repetition,  "[s]urvival
analysis...indicated no difference between groups in the time to the
first suicide attempt (χ2 = 1.4 [P = .50])" (Linehan 2015, pg.4).

Secondary outcomes

2.3.2 Treatment adherence

There  was  evidence  of  an  effect  for  DBT  individual  therapy,  as
compared with standard DBT, on the proportion of participants who
completed treatment by the post-intervention assessment in this
trial (17/33 versus 25/33; OR 0.34, 95% CI 0.12 to 0.97; N = 66; k = 1;
I2 = not applicable; Linehan 2015b).

There was no evidence of an effect for DBT individual therapy, as
compared with standard DBT, on the number of individual therapy
sessions attended (mean 4.16, SD 0.18, n = 33 versus mean 4.20, SD
0.18, n = 33; MD -0.04, 95% CI -0.13 to 0.05; N = 33; k = 1; I2 = not
applicable; Linehan 2015b). Information on the number of group
therapy sessions attended could not be estimated as participants
assigned to the individual therapy arm in this trial did not receive
any group-based therapy sessions.

2.3.3 Depression

There  was  evidence  of  an  increase  in  depression  scores  at  post-
intervention  for  those  receiving  DBT  individual  therapy  (mean
18.20,  SD  7.90,  n  =  33  versus  mean  12.30,  SD  8.00,  n  =  33;  MD
5.90,  95%  CI  2.06  to  9.74;  N  =  66;  k  =  1;  I2  =  not  applicable).
By  the  12-month  follow-up  assessment,  however,  there  was  no
longer evidence of an effect on depression scores for DBT individual
therapy, as compared with standard DBT in this trial (mean 13.90,
SD 9.60, n = 33 versus mean 15.20, 8.60, n = 33; MD -1.30, 95% CI
-5.70 to 3.10; N = 66; k = 1; I2 = not applicable).

2.3.4 Hopelessness

There was no evidence of an effect for DBT individual therapy, as
compared with standard DBT, on hopelessness at either the post-
intervention (mean -177.90, SD 53.10, n = 33 versus mean -168.70,
SD 45.30, n = 33; MD -9.20, 95% CI -33.01 to 14.61; N = 66; k = 1; I2 =
not applicable), or 12-month follow-up assessment (mean -178.40,
SD 53.70, n = 33 versus mean -159.90, SD 40.20, n = 33; MD -18.50,
95% CI -41.39 to 4.39; N = 66; k = 1; I2 = not applicable) in this trial.

2.3.5 General functioning

No data available.

2.3.6 Social functioning

No data available.

2.3.7 Suicidal ideation

There was also no evidence of an effect for DBT individual therapy,
as  compared  with  standard  DBT,  on  suicidal  ideation  scores  at
either the post-intervention (mean 30.30, SD 27.50, n = 33 versus
mean 32.00, SD 21.60, n = 33; MD -1.70, 95% CI -13.63 to 10.23; N
= 66; k = 1; I2 = not applicable) or 12-month follow-up assessment
(mean 25.50, SD 20.80, n = 33 versus mean 28.90, SD 16.60, n = 33;
MD -3.40, 95% CI -12.48 to 5.68; N = 66; k = 1; I2 = not applicable).

2.3.8 Suicide

There  was  one  suicide  death  in  the  standard  DBT  arm  by  the
24-month  follow-up  assessment  in  this  trial;  however,  there  was
no  evidence  of  an  effect  for  DBT  individual  therapy  only  on  this
outcome by this time point (0/33 versus 1/33; OR 0.32, 95% CI 0.01
to 8.23; N = 66; k = 1; I2 = not applicable).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 2.4: DBT prolonged-exposure protocol

The effectiveness of two forms of DBT were compared over a three-
month  period  in  one  small  trial  of  adult  (mean  age:  32.6  ±  12.0
years)  women  diagnosed  with  comorbid  borderline  personality
disorder and post-traumatic stress disorder and who were referred
to  outpatient  clinical  services  due  to  recurrent  SH  (Harned  2014,
N  =  26).  In  this  trial,  participants  assigned  to  the  intervention
arm received, in addition to the standard DBT protocol, additional
weekly  therapy  sessions  involving  in  vivo  and  imaginal  exposure
to previously traumatic experiences (i.e. DBT prolonged-exposure
protocol).

Primary outcome

2.4.1 Repetition of SH

Data obtained by correspondence indicated there was no evidence
of an effect for the DBT prolonged-exposure protocol on repetition
of  SH  by  the  post-intervention  assessment  (3/12  versus  2/6;  OR
0.67, 95% CI 0.08 to 5.68; N = 18; k = 1; I2 = not applicable). According
to  GRADE  criteria,  we  judged  the  evidence  to  be  of  moderate
certainty.

There  was  also  no  evidence  of  an  effect  for  the  DBT  prolonged-
exposure protocol on repetition of SH by the six-month follow-up
assessment (3/12 versus 2/6; OR 0.67, 95% CI 0.08 to 5.68; N = 18; k
= 1; I2 = not applicable).

Data on frequency of SH, obtained following correspondence with
trial  authors,  also  suggested  no  effect  for  the  DBT  prolonged-
exposure protocol by either the post-intervention (mean 0.92, SD
1.97, n = 12 versus mean 1.17, SD 2.40, n = 6; MD -0.25, 95% CI -2.47
to  1.97;  N  =  18;  k  =  1;  I2  =  not  applicable)  or  six-month  follow-up
assessments (mean 0.67, SD 1.50, n = 12 versus mean 0.33, SD 0.52,
n = 6; MD 0.34, 95% CI -0.61 to 1.29;  N = 18; k = 1; I2 = not applicable).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

44

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Secondary outcomes

2.4.2 Treatment adherence

There was no evidence of an effect for the DBT prolonged-exposure
protocol on the proportion of participants who completed the full
one-year  course  of  treatment  (10/17  versus  5/9;  OR  1.14,  95%  CI
0.22 to 5.84; N = 26; k = 1; I2 = not applicable). According to the trial
authors, however, "...one therapist...was not adherent to DBT and
had a 100% dropout rate" (Harned 2014, p.12). Excluding the four
participants treated by this therapist did not, however, materially
affect this result.

2.4.3 Depression

There was no evidence of an effect for the DBT prolonged-exposure
protocol  for  depression  scores  at  either  the  post-intervention
(mean 11.80, SD 8.00, n = 12 versus mean 15.50, SD 6.50, n = 6; MD
-3.70, 95% CI -10.59 to 3.19; N = 18; k = 1; I2 = not applicable) or six-
month follow-up (mean 12.50, SD 8.20, n = 12 versus mean 16.80,
SD 3.40, n = 6; MD -4.30, 95% CI -9.68 to 1.08; N = 18; k = 1; I2 = not
applicable) assessments.

2.4.4 Hopelessness

No data available.

2.4.5 General functioning

No data available.

2.4.6 Social functioning

No data available.

2.4.7 Suicidal ideation

No data available.

2.4.8 Suicide

There was no evidence of an effect for the DBT prolonged-exposure
protocol on death by suicide by the follow-up assessment in this
trial (0/17 versus 1/9; OR 0.16, 95% CI 0.01 to 4.41, N = 26; k = 1; I2
= not applicable).

Subgroup analyses

Cochrane Database of Systematic Reviews

I2  =  not  applicable).  According  to  GRADE  criteria,  we  judged  the
evidence to be of high certainty.

There was also evidence of an effect for MBT on frequency of SH
episodes  by  the  post-intervention  assessment  according  to  data
obtained  by  correspondence  (mean  0.38,  SD  0.38,  n  =  71  versus
mean 1.66, SD 2.87, n = 63; MD -1.28, 95% CI -2.01 to -0.55; N = 134;
k = 1; I2 = not applicable).

Secondary outcomes

3.2 Treatment adherence

There  was  no  evidence  of  an  effect  for  MBT  on  the  proportion  of
participants  who  completed  the  full  course  of  treatment  (52/71
versus 47/63; OR 0.93, 95% CI 0.43 to 2.02; N = 134; k = 1; I2 = not
applicable).

3.3 Depression

MBT  was  associated  with  an  effect  for  depression  at  the  post-
intervention assessment (mean 14.80, SD 8.55, n = 71 versus mean
18.68, SD 8.76, n = 63, MD -3.88, 95% CI -6.82 to -0.94; N = 134; k =
1; I2 = not applicable).

3.4 Hopelessness

No data available.

3.5 General functioning

There was evidence of an effect for MBT on general functioning at
the post-intervention assessment (mean 60.9, SD 15.8, n = 71 versus
mean 53.2, SD 11.7, n = 63; MD 7.70, 95% CI 3.03 to 12.37; N = 134;
k = 1; I2 = not applicable).

3.6 Social functioning

There was also evidence of an effect for MBT on social functioning at
the post-intervention assessment in this trial (mean 1.76, SD 0.50,
n = 71 versus mean 2.17, SD 0.64, n = 63; MD -0.41, 95% CI -0.61 to
-0.21; N = 134; k = 1; I2 = not applicable).

3.7 Suicidal ideation

No data available.

No included trial stratified randomisation by sex or repeater status.

3.8 Suicide

Sensitivity analyses

Not applicable.

Comparison 3: Mentalisation-based therapy (MBT) versus TAU
or another comparator

A single trial investigated the effectiveness of mentalisation-based
therapy (MBT) in adults (mean age: 31.1 ± 7.7 years; 79.9% female)
diagnosed  with  BPD  referred  to  a  specialist  personality  disorder
treatment  service  following  a  suicide  attempt  or  episode  of  life-
threatening SH (Bateman 2009, N = 134).

Primary outcome

3.1 Repetition of SH

MBT may reduce repetition of SH by the conclusion of the 18-month
treatment  period  based  on  data  obtained  by  correspondence
(18/71  versus  31/63;  OR  0.35,  95%  CI  0.17  to  0.73;  N  =  134;  k  =  1;

There were no suicides in either treatment arm by the time of the
post-intervention assessment.

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 4: Emotion-regulation psychotherapy versus TAU
or another comparator

Two  trials  investigated  the  effectiveness  of  emotion-regulation
psychotherapy, delivered in a group-based format, in adult women
(weighted mean age: 33.2 ± 11.2 years) diagnosed with BPD referred
for outpatient treatment as a result of recurrent SH (Gratz 2006, N
= 22; Gratz 2014, N = 61).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

45

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Primary outcome

4.1 Repetition of SH

Group-based  emotion-regulation  psychotherapy  may  reduce
repetition  of  SH  by  the  post-intervention  assessment  based  on
evidence from two trials (OR 0.34, 95% CI 0.13 to 0.88; N = 83; k =
2; I2 = 0%; Analysis 3.1). According to GRADE criteria, we judged the
evidence to be of moderate certainty.

There  was  no  evidence  of  an  effect  for  group-based  emotion-
regulation psychotherapy on frequency of repetition of SH by the
post-intervention assessment (Analysis 3.2).

Secondary outcomes

4.2 Treatment adherence

No data available.

4.3 Depression

There  was  evidence  of  an  effect  for  group-based  emotion-
regulation  therapy  on  depression  scores  at  the  post-intervention
assessment (MD -9.59, 95% CI -13.43 to -5.75; N = 83; k = 2; I2 = 0%;
Analysis 3.3).

4.4 Hopelessness

No data available.

4.5 General functioning

No data available.

4.6 Social functioning

No data available.

4.7 Suicidal ideation

No data available.

4.8 Suicide

There  were  no  suicides  in  either  the  intervention  or  comparator
arms in either trial by the post-intervention assessment.

Subgroup analyses

Randomisation was stratified by repeater status in one trial (Gratz
2014). However, we were unable to obtain disaggregated data from
the trial authors despite correspondence.

Sensitivity analyses

Not applicable.

Comparison 5: Psychodynamic psychotherapy versus TAU or
another comparator

trials 

Two 
investigated  psychodynamic  psychotherapeutic
approaches as compared to TAU in adults (weighted mean age: 31.7
± 9.8 years; 88.9% female) who either presented to EDs following
an episode of SH or who were receiving outpatient treatment for
frequent repetition of SH (Andreoli 2015, N = 170; Sahin 2018, N =
71).

For  the  first  trial  (Andreoli  2015),  there  were  two  separate
intervention arms: psychodynamic psychotherapy delivered either
by  certified  psychotherapists  or  trained  nurses.  We  therefore

Cochrane Database of Systematic Reviews

combined  data  from  these  two  conditions  given  their  similarity.
For the second trial, however, there were two different intervention
arms:  psychodynamic  psychotherapy  and  DBT  (Sahin  2018).
We  therefore  included  here  only  data  for  the  psychodynamic
psychotherapy arm.

Primary outcome

5.1 Repetition of SH

for  psychodynamic
There  was  no  evidence  of  an  effect 
psychotherapy by the post-intervention assessment in one of these
trials (9/140 versus 4/30; OR 0.45, 95% CI 0.13 to 1.56; N = 170; k = 1;
I2 = not applicable; Andreoli 2015). According to GRADE criteria, we
judged the evidence to be of moderate certainty.

This  trial  also  reported  information  on  time  to  repetition  of  SH,
finding  that  "participants  who  received  either  form  of  AP...had
increased  survival  to  suicidal  crisis  relapse  compared  to  patients
assigned to TAU (AP-P vs. TAU log-rank test: Mantel χ2 = 7.63, df =
1, p = .006; AP-N vs. TAU log-rank test: Mantel χ2 = 9.87, df = 1, p
= .002)" (Andreoli 2015, pg.11).

Secondary outcomes

5.2 Treatment adherence

There was evidence of an effect for psychodynamic psychotherapy
on the proportion of participants who completed treatment by the
post-intervention assessment in one trial (131/140 versus 19/30; OR
8.43, 95% CI 3.09 to 22.99; N = 170; k = 1; I2 = not applicable; Andreoli
2015).

5.3 Depression

There was evidence of an effect for psychodynamic psychotherapy
on depression scores at post-intervention in one trial (mean 9.90,
SD 5.70, n = 140 versus mean 13.40, SD 6.40, n = 30; MD -3.50, 95%
CI -5.98 to -1.02; N = 170; k = 1; I2 = not applicable; Andreoli 2015).

5.4 Hopelessness

No data available.

5.5 General functioning

There  was  also  evidence  of  an  effect  for  psychodynamic
psychotherapy  on  general  functioning  scores  by  the  post-
intervention assessment in one trial (mean 62.90, SD 6.20, n = 140
versus mean 57.6, SD 7.60, n = 30; MD 5.30, 95% CI 2.39 to 8.21; N =
170; k = 1; I2 = not applicable; Andreoli 2015).

5.6 Social functioning

No data available.

5.7 Suicidal ideation

One trial assessed suicidal ideation as the frequency of episodes
necessitating additional intensive psychiatric care (Andreoli 2015).
There was evidence of an effect for this intervention on frequency
of episodes of suicidal ideation scores at post-intervention in this
trial (mean 0.30, SD 0.60, n = 140 versus mean 1.00, SD 1.10, n = 30;
MD -0.70, 95% CI -1.11 to -0.29; N = 170; k = 1; I2 = not applicable;
Andreoli 2015).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

46

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

5.8 Suicide

One participant died by suicide in the TAU arm in one trial by the
post-intervention assessment (0/140 versus 1/30; OR 0.07, 95% CI
0.00 to 1.76; N = 170; k = 1; I2 = not applicable; Andreoli 2015).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 6: Case management versus TAU or another
comparator

Five trials investigated the provision of case management for the
prevention of SH compared either to TAU (Clarke 2002, N = 467; Hvid
2011, N = 133; Van Heeringen 1995, N = 516) or enhanced usual care
(EUC; Kawanishi 2014, N = 914; Morthorst 2012, N = 243) in adults
(weighted  mean  age  37.9  ±  13.7  years;  56.2%  female)  admitted
to hospital following an episode of SH. Although the intervention
in  three  of  these  trials  included  aspects  of  PST,  this  was  not  the
primary  or  only  element  of  the  case  management  strategy  (Hvid
2011; Kawanishi 2014; Morthorst 2012). We therefore thought these
trials were sufficiently similar to the others to justify pooling within
a meta-analysis.

Primary outcome

6.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  case  management  on
repetition  of  SH  by  the  post-intervention  assessment  in  four
of  these  trials,  nor  was  there  any  evidence  of  a  difference
by  comparator  (i.e.  TAU  versus  EUC)  (OR  0.78,  95%  CI  0.47
to  1.30;  participants  =  1608;  studies  =  4;  I2  =  54%;  Analysis
4.1).  Supplementing  hospital-recorded  episodes  of  SH  with  self-
reported  data  for  Morthorst  2012  did  not  materially  affect  this
result.  Multiple  readmissions  for  SH  were,  however,  significantly
more  common  in  the  case  management  group  than  in  the  TAU
group in one trial (9/220 versus 2/247; OR 5.23, 95% CI 1.12 to 24.45;
N = 467; k = 1; I2 = not applicable; Clarke 2002). According to GRADE
criteria, we judged the evidence to be of low certainty.

There was also no evidence of an effect for case management as
compared with TAU on repetition of SH by the 12-month follow-up
assessment in one further trial (21/196 versus 34/195; OR 0.57, 95%
CI 0.32 to 1.02; N = 391; k = 1; I2 = not applicable; Van Heeringen
1995).

Two trials provided information on time to SH repetition. In one,
trial authors reported that "[t]he log-rank test shows a significant
difference  in  favour  of  fewer  events  in  the  intervention  arm,  log-
rank  test  4.16  (P  =  0.0414)"  (Hvid  2011,  pg.295).  However,  in  the
second, trial authors reported "the survival curve for the assertive
case management group was not significantly different from that
for  the  control  group  (log-rank  P  =  0.258,  Wilcoxon  P  =  0·103)"
Kawanishi 2014, pg.197).

Secondary outcomes

6.2 Treatment adherence

Cochrane Database of Systematic Reviews

intervention" (Kawanishi 2014, pg.197). However, as corresponding
numbers  for  the  EUC  group  were  not  reported,  we  were  unable
to analyse the effect of assertive case management on treatment
adherence for this trial.

Case management was associated with an effect on the proportion
of participants who completed treatment as compared with TAU by
the 12-month assessment in one trial (129/252 versus 102/256; OR
1.58,  95%  CI  1.11  to  2.25;  N  =  508;  k  =  1;  I2  =  not  applicable;  Van
Heeringen 1995).

6.3 Depression

No data available.

6.4 Hopelessness

Although  the  BHS  was  administered  to  participants  in  one
trial  (Kawanishi  2014),  no  data  on  this  outcome  was  reported.
Correspondence with trial authors for the previous version of this
review  indicated  they  were  analysing  these  data  to  present  in  a
future report. However, data on this outcome has not been reported
in any of the secondary publications of this trial identified by this
update of the review.

6.5 General functioning

No data available.

6.6 Social functioning

No data available.

6.7 Suicidal ideation

No data available.

6.8 Suicide

There was no evidence of an effect for case management on suicide
by the post-intervention assessment, nor was there any evidence
of a significant difference by comparator for this outcome (Analysis
4.2). There was also no evidence of an effect for case management
on  suicide  by  the  12-month  follow-up  assessment  in  one  further
trial (6/196 versus 7/195; OR 0.85, 95% CI 0.28 to 2.57; N = 391; k = 1;
I2 = not applicable; Van Heeringen 1995).

Subgroup analyses

One  trial  stratified  randomisation  by  sex  (Hvid  2011).  Although
there was no evidence of an effect in males in this trial (4/20 versus
4/18; OR 0.88, 95% CI 0.18 to 4.17; N = 38; k = 1; I2 = not applicable),
case management was associated with an effect on repetition of SH
in females (2/49 versus 10/46; OR 0.15, 95% CI 0.03 to 0.74; N = 95;
k = 1; I2 = not applicable).

A  second  trial  stratified  randomisation  by  repeater  status
(Morthorst  2012).  However,  we  were  unable 
to  obtain
disaggregated data from the trial authors despite correspondence.

Sensitivity analyses

Not applicable.

Comparison 7: Structured general practitioner (GP) follow-up
versus TAU or another comparator

The  authors  of  one  trial  reported  that  "11  participants  in
the  assertive  case  management  group  did  not  receive  the

A single trial investigated the effectiveness of structured follow-up
by the participants' general practitioner (GP) compared with TAU

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

47

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

over  a  six-month  period  in  adults  (mean  age:  38.2  years,  SD  not
reported; 74.5% female) admitted to the acute ward of a general
hospital following an episode of self-poisoning (Grimholt 2015, N =
202).

Primary outcome

7.1 Repetition of SH

There was no evidence of an effect for structured GP follow-up on
the proportion repeating SH by the post-intervention assessment
according  either  to  hospital  records  (8/60  versus  11/83;  OR  1.01,
95% CI 0.38 to 2.68; N = 143; k = 1; I2 = not applicable) or emergency
medical records (9/54 versus 5/69; OR 2.56, 95% CI 0.80 to 8.15; N
= 123; k = 1; I2 = not applicable). According to GRADE criteria, we
judged the evidence to be of low certainty.

The  trial  authors  also  reported  data  on  self-reported  repeat
episodes of self-poisoning, self-cutting, and other methods of SH.
Whilst  a  greater  proportion  of  those  assigned  to  structured  GP
follow-up reported repeat episodes of self-poisoning by the post-
intervention assessment (15/38 versus 9/57; OR 3.48, 95% CI 1.33 to
9.12; N = 95; k = 1; I2 = not applicable), there was no evidence of an
effect for this intervention on self-reported episodes of self-cutting
(10/40 versus 9/58; OR 1.81, 95% CI 0.66 to 4.98; N = 98; k = 1; I2 = not
applicable) or other methods of SH (5/18 versus 9/17; OR 0.34, 95%
CI 0.08 to 1.39; N = 35; k = 1; I2 = not applicable) by this time point.

Secondary outcomes

7.2 Treatment adherence

There was no evidence of an effect for structured GP follow-up on
the  proportion  of  participants  who  completed  treatment  by  the
post-intervention assessment in this trial (47/62 versus 64/87; OR
1.13, 95% CI 0.53 to 2.39; N = 149; k = 1; I2 = not applicable).

7.3 Depression

Although  those  allocated  to  the  intervention  arm  in  this  trial
had  slightly  higher  depression  scores  by  the  post-intervention
assessment,  there  was  no  evidence  of  an  effect  (mean  24.90,  SD
10.10, n = 18 versus mean 18.80, SD 12.10, n = 22; MD 6.10, 95% CI
-0.78 to 12.98; N = 40; k = 1; I2 = not applicable); however, there were
substantial missing data for this outcome (109/149; 73.2%).

7.4 Hopelessness

There was also no evidence of an effect for structured GP follow-up
on hopelessness scores by the post-intervention assessment in this
trial (mean 11.70; SD 5.60, n = 18 versus mean 8.70, SD 6.70, n = 26;
MD 3.00, 95% CI -0.65 to 6.65, N = 44; k = 1; I2 = not applicable). There
were, however, substantial missing data for this outcome (105/149;
70.5%).

7.5 General functioning

No data available.

7.6 Social functioning

No data available.

7.7 Suicidal ideation

There was no evidence of an effect for structured GP follow-up on
suicidal ideation scores by the post-intervention assessment (mean
19.80, SD 5.30, n = 6 versus mean 17.10, SD 7.20, n = 7; MD 2.70, 95%

Cochrane Database of Systematic Reviews

CI -4.11 to 9.51; N = 13; k = 1; I2 = not applicable). Again, there were
substantial missing data for this outcome (136/149; 91.3%).

7.8 Suicide

There  was  one  suicide  death  in  each  trial  arm  by  the  post-
intervention  assessment.  However,  there  was  no  evidence  of
an  effect  for  structured  GP  follow-up  by  the  post-intervention
assessment for this outcome (1/62 versus 1/87; OR 1.41, 95% CI 0.09
to 22.98; N = 149; k = 1; I2 = not applicable).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 8: Brief emergency department-based
interventions versus TAU or another comparator

Five  trials 
investigated  the  effectiveness  of  a  one-off  brief
(i.e. between 30 to 57 minutes' duration) intervention conducted in
the emergency department (ED) in adults (weighted mean age 35.4
± 13.5 years; 61.2% female) presenting to EDs following an episode
of  SH  (Armitage  2016,  N  =  226;  O'Connor  2015,  N  =  30;  O'Connor
2017, N = 518; O'Connor 2020, N = 48).

Comparison 8.1: Brief Collaborative Assessment and
Management of Suicidality (CAMS)-based intervention

Two  trials  investigated  the  effectiveness  of  a  brief  intervention
informed  by  therapeutic  principles  of  both  the  Collaborative
Assessment and Management of Suicidality (CAMS) model, in which
a collaborative rapport is developed together with the participant,
and  the  functional  analysis  model  of  DBT  in  which  validation
and  guided  discovery  is  used  to  understand  the  participant's
motivations for SH, in adults (weighted mean age: 42.1 ± 8.7 years;
43.6%  female)  presenting  to  the  ED  following  an  episode  of  SH
(O'Connor 2015, N = 30; O'Connor 2020, N = 48).

Primary outcome

8.1.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  brief  CAMS  and  DBT-
based interventions on repetition of SH by the 12-month follow-up
assessment in one of these trials (1/13 versus 2/10; OR 0.33, 95% CI
0.03 to 4.32; N = 23; k = 1; I2 = not applicable; O'Connor 2020).

One trial also reported data on frequency of repeat SH by the 12-
month  follow-up  assessment  which  could  be  estimated  from  the
data reported. Once again, however, there was no evidence of an
effect for a brief ED-based intervention on frequency of repeat SH
in this trial (mean 0.08, SD 0.28, n = 13 versus mean 1.30, SD 3.47, n
= 10; MD -1.22, 95% CI -3.38 to 0.94; N = 23; k = 1; I2 = not applicable;
O'Connor 2020).

Secondary outcomes

8.1.2 Treatment adherence

No data available.

8.1.3 Depression

No data available.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

48

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

8.1.4 Hopelessness

Data  on  hopelessness  were  available  for  both  of  these  trials;
however,  the  trial  authors  did  not  report  information  on  SDs  or
other information to enable imputation of SDs.

By  the  six-month  follow-up  assessment,  authors  of  one  of  these
trials reported "[s]ignificant improvements across time on Reasons
for Living improvements were also observed for the [intervention]
group  compared  to  the  usual  care  group..."  (O'Connor  2015,
pg.431). However, data estimated from graphics presented in the
trial report suggested any such difference was likely to be modest
(estimated mean -138.00, n = 11 versus estimated mean -136.50, n
= 13).

By  the  12-month  follow-up  assessment,  authors  of  the  second
of  these  trials  reported  there  were  "no  statistically  significant
differences between groups on reported reasons for living...at any
time point" (O'Connor 2020, pg.116).

8.1.5 General functioning

No data available.

8.1.6 Social functioning

No data available.

8.1.7 Suicidal ideation

Data  on  suicidal  ideation  scores  were  available  for  both  of  these
trials; however, the trial authors did not report information on SDs
or other information to enable imputation of SDs.

By  the  six-month  assessment,  authors  of  the  first  trial  reported
"[a]lthough  a  trend  was  observed  for  greater  improvement  of
suicidal  ideation  for  the  TAU  group..."  (O'Connor  2015,  pg.431),
this  was  not  significant.  Indeed,  data  estimated  from  graphics
presented in the trial report suggested that suicidal ideation scores
were  similar  between  the  intervention  and  control  arms  by  this
time  point  (estimated  mean  7.00,  n  =  11  versus  estimated  mean
6.00, n = 13).

For the second trial (O'Connor 2020), data estimated from graphics
presented  in  the  trial  report  indicated  there  was  no  meaningful
difference  in  suicidal  ideation  scores  by  the  12-month  follow-
up  assessment  in  this  trial  (estimated  mean  5.50,  n  =  13  versus
estimated mean 5.30, n = 10).

8.1.8 Suicide

No data available.

Subgroup analyses

Cochrane Database of Systematic Reviews

responses that may help them to avoid SH (Armitage 2016, N = 151;
O'Connor 2017, N = 518).

For  one  of  these  trials  (Armitage  2016),  there  were  two  separate
intervention arms: a guided implementation-focused intervention
based  on  the  volitional  help-sheet  model  (Armitage  2016a),  and
a  self-directed  implementation  intention-focused  intervention
(Armitage 2016b). Given that the model used in Armitage 2016a was
based  in  a  large  part  on  O'Connor  2017,  and  involved  authors  of
this latter trial in the design of the intervention, we grouped these
two trials within a single analysis. For a detailed description of the
therapeutic content of the two different intervention arms included
in this trial, see the Characteristics of included studies section.

Primary outcome

8.2.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  this  intervention  on
repetition of SH by the six-month follow-up assessment in one of
these trials (72/259 versus 72/259; OR 1.00, 95% CI 0.68 to 1.47; N =
518; k = 1; I2 = not applicable; O'Connor 2017).

One trial reported data on frequency of repeat SH episodes by the
six-month follow-up assessment; however, there was no evidence
of  an  effect  for  this  intervention  in  this  trial  (mean  0.68,  SD  2.53,
n = 259 versus mean 0.85, SD 2.78, n = 259; MD -0.17, 95% CI -0.63
to  0.29;  N  =  518;  k  =  1;  I2  =  not  applicable;  O'Connor  2017).  For
the second of these trials (Armitage 2016a), data on frequency of
SH could not be disaggregated from data on frequency of suicidal
ideation and therefore could not be included in the review.

There was also no evidence of an effect for this intervention on time
to SH repetition in one of these trials (HR 0.80, 95% CI 0.55 to 1.18,
N = 518; k = 1; I2 = not applicable; O'Connor 2017).

Secondary outcomes

8.2.2 Treatment adherence

Data  from  one  trial  indicated  that  almost  all  (95.7%)  of  those
assigned to the intervention arm completed the intervention in the
hospital.  However,  as  corresponding  numbers  were  not  reported
for  the  comparator  arm  in  this  trial,  we  could  not  calculate
treatment effect sizes for this outcome (O'Connor 2017).

8.2.3 Depression

One  trial  reported  data  on  depression  scores  by  the  six-month
follow-up  assessment  (Armitage  2016a);  however,  there  was  no
evidence of an effect for this intervention (mean 16.65, SD 5.92, n =
75 versus mean 17.78, SD 6.51, n = 73; MD -1.13, 95% CI -3.14 to 0.88;
N = 148; k = 1; I2 = not applicable).

No included trial stratified randomisation by sex or repeater status.

8.2.4 Hopelessness

Sensitivity analyses

Not applicable.

Comparison 8.2: Brief guided Integrated Motivational-
Volitional-focused intervention

Two  trials  investigated  a  guided  intervention,  based  on  the
Integrated  Motivational-Volitional  help-sheet  model,  in  which
participants  are  encouraged  to  identify  situations  in  which  they
may be triggered to engage in SH and link these with alternative

No data available.

8.2.5 General functioning

No data available.

8.2.6 Social functioning

No data available.

8.2.7 Suicidal ideation

No data available.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

49

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

8.2.8 Suicide

There was no evidence of an effect for this intervention on suicide
deaths by the six-month follow-up in one trial (1/259 versus 2/259;
OR  0.50,  95%  CI  0.04  to  5.53;  N  =  518;  k  =  1;  I2  =  not  applicable;
O'Connor 2017).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 8.3: Brief self-guided Integrated Motivational-
Volitional-focused intervention

The  second  intervention  arm  in  Armitage  2016  investigated  the
effectiveness of a self-guided intervention, based in the Integrated
Motivational-Volitional  help-sheet  model,  as  compared  to  TAU  in
adults  (mean  age:  29.3  ±  11.9  years;  69.9%  female)  presenting  to
the emergency department following an episode of SH (Armitage
2016b, N = 151).

Primary outcome

8.3.1 Repetition of SH

For this trial, data on frequency of SH could not be disaggregated
from data on frequency of suicidal ideation and therefore could not
be included in the review.

Sensitivity analyses

Not applicable.

Comparison 8.4: Brief alcohol-focused intervention

One  trial  investigated  the  effectiveness  of  a  brief  ED-based
intervention for alcohol misuse on repetition of SH over a six-month
follow-up  period  in  adults  (mean  age:  37.2  ±  12.0  years;  50.0%
female) who were misusing alcohol and were admitted to the ED
following an episode of SH (Crawford 2010, N = 103).

Primary outcome

8.4.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  brief  alcohol-focused  ED-
based interventions on repetition of SH by the six-month follow-up
assessment in this trial (7/52 versus 11/51; OR 0.57, 95% CI 0.20 to
1.60; k = 1; I2 = not applicable; Crawford 2010).

Secondary outcomes

8.4.2 Treatment adherence

The  trial  authors  reported  that  only  around  half  (47.1%)  of
those  randomised  to  the  intervention  arm  attended  the  brief
alcohol  treatment  session  (Crawford  2010,  pg.1826).  However,  as
corresponding numbers were not available for those allocated to
the control arm, who did not receive an invitation to brief alcohol
treatment sessions, we could not calculate treatment effect sizes
for this outcome.

Secondary outcomes

8.3.2 Treatment adherence

No data available.

8.3.3 Depression

No effect for this intervention approach was found for depression
scores  by  the  six-month  follow-up  assessment  in  this  trial  (mean
16.20, SD 6.56, n = 78 versus mean 17.78, SD 6.51, n = 73; MD -1.58,
95% CI -3.67 to 0.51; N = 151; k = 1; I2 = not applicable; Armitage
2016b).

8.3.4 Hopelessness

No data available.

8.3.5 General functioning

No data available.

8.3.6 Social functioning

No data available.

8.3.7 Suicidal ideation

No data available.

8.3.8 Suicide

No data available.

Subgroup analyses

8.4.3 Depression

No data available.

8.4.4 Hopelessness

No data available.

8.4.5 General functioning

No data available.

8.4.6 Social functioning

No data available.

8.4.7 Suicidal ideation

No data available.

8.4.8 Suicide

Correspondence with trial authors confirmed that no participants
died  by  suicide  in  either  arm  over  the  course  of  the  six-month
follow-up period. However, the authors warned that, as they were
unable to track participants via their National Health Service (NHS)
identity numbers, they were unable to confirm numbers of suicides
from  national  mortality  data.  Thus,  there  may  have  been  suicide
deaths amongst those participants whom the authors were unable
to contact by the six-month follow-up assessment in this trial.

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

50

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 9: Remote contact interventions versus TAU or
another comparator

A  number  of  trials  investigated  the  effectiveness  of  a  variety
of  remote  contact  interventions,  including:  emergency  cards
(Evans  1999a;  Morgan  1993),  coping  cards  (Wang  2016),  general
practitioners'  (GP)  letters  (Bennewith  2002),  postcards  (Beautrais
2010;  Carter  2005;  Hassanian-Moghaddam  2011;  Kapur  2013),
telephone  contact  (Cedereke  2002;  Mousavi  2015;  Vaiva  2006),
telephone  contact  combined  with  emergency  cards  and  letters
(Mouaffak 2015; Vaiva 2018), and telephone-based psychotherapy
(Marasinghe 2012; Sreedaran 2020; Wei 2013).

Comparison 9.1: Emergency cards

Two trials investigated the effectiveness of providing an emergency
contact card ('green card') providing 24-hour access to emergency
advice  from  a  psychiatrist  in  addition  to  TAU  in  adults  (weighted
mean  age:  32.6  ±  11.7  years;  55.4%  female)  admitted  to  general
hospitals  following  an  episode  of  SH,  most  commonly  self-
poisoning  (Evans  1999a,  N  =  827;  Morgan  1993,  N  =  212).  Note,
repetition of SH data for Evans 1999a was reported in a secondary
publication (Evans 2005).

Primary outcome

9.1.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  emergency  cards  on
repetition of SH by the post-intervention assessment in these two
trials (OR 0.82, 95% CI 0.31 to 2.14; participants = 1039; studies = 2;
I2 = 68%; Analysis 5.1). According to GRADE criteria, we judged the
evidence to be of low certainty.

There was also no evidence of an effect for emergency cards by the
12-month follow-up assessment in the one trial for which data were
available (Analysis 5.2).

One  trial  reported  data  on  frequency  of  repetition  of  SH  as  the
proportion of participants who had no episodes at follow-up, the
proportion with a single episode at follow-up, and the proportion
with two or more repeat episodes of SH by the 12-month follow-
up  assessment  (Evans  1999a).  There  was  no  difference  between
groups in the number of participants who had none (347/417 versus
351/410;  OR  0.83,  95%  CI  0.57  to  1.21;  N  =  827;  k  =  1;  I2  =  not
applicable),  one  (46/417  versus  32/410;  OR  1.46,  95%  CI  0.91  to
2.35;  N  =  827;  k  =  1;  I2  =  not  applicable),  or  two  or  more  (24/417
versus 27/410; OR 0.87, 95% CI 0.49 to 1.53; N = 827; k = 1; I2 = not
applicable) further episodes of SH.

One trial also reported information on time to SH repetition. The
authors found that whilst "[t]he median time to first repeat among
those given a green card was 33 days (range 1-180); in the control
group it was 40 days (range 2-156). This difference is not significant
(log rank test: chi-square 0.82, P = 0.36" (Evans 1999a, pg.25).

Secondary outcomes

9.1.2 Treatment adherence

No data available.

9.1.3 Depression

No data available.

9.1.4 Hopelessness

No data available.

9.1.5 General functioning

No data available.

9.1.6 Social functioning

No data available.

9.1.7 Suicidal ideation

No data available.

9.1.8 Suicide

Data  on  suicides  were  reported  in  only  one  trial  (Evans  1999a).
There was no evidence of an effect for emergency cards on suicide
by  the  post-intervention  assessment  in  this  trial  (2/417  versus
1/410;  OR  1.97,  95%  CI  0.18  to  21.82;  N  =  827;  k  =  1;  I2  =  not
applicable).

Subgroup analyses

Data on repetition of SH was available by repeater status (i.e. those
without  a  history  of  multiple  episodes  of  SH  versus  those  with  a
history of multiple episodes of SH) in one trial (Evans 1999a). There
was  no  evidence  of  an  effect  for  emergency  cards  on  repetition
of  SH  in  those  without  a  history  of  multiple  episodes  of  SH;
however, emergency cards were associated with an increased risk
of repetition of SH in those with a history of multiple episodes of SH
by the 12-month follow-up assessment in this trial (Analysis 5.2).

For those without a history of multiple episodes of SH, there was no
difference between groups in the number of participants who had
none (203/221 versus 181/206; OR 1.56, 95% CI 0.82 to 2.95; N = 427;
k = 1; I2 = not applicable), one (13/221 versus 16/206; OR 0.74, 95%
CI 0.35 to 1.58; N = 427; k = 1; I2 = not applicable), or two or more
(5/221 versus 9/206; OR 0.51, 95% CI 0.17 to 1.54; N = 427; k = 1; I2 =
not applicable) repeat episodes of SH (Evans 1999a).

For  those  with  a  history  of  multiple  episodes  of  SH,  however,
receipt  of  an  emergency  card  was  associated  with  a  reduction  in
the number of participants with no further episodes of SH (142/194
versus 167/200; OR 0.54, 95%CI 0.33 to 0.88; N = 394; k = 1; I2 = not
applicable) coupled with an increase in the number of participants
with  one  repeat  episode  of  SH  (33/194  versus  15/200;  OR  2.53,
95%  CI  1.33  to  4.82;  N  =  394;  k  =  1;  I2  =  not  applicable).  There
was no difference between the intervention and comparator groups
with  respect  to  the  number  of  participants  with  or  two  or  more
subsequent  episodes  of  SH  for  those  with  a  history  of  multiple
episodes  of  SH,  however  (19/194  versus  18/200;  OR  1.10,  95%  CI
0.56 to 2.16; N = 394; k = 1; I2 = not applicable) (Evans 1999a).

Sensitivity analyses

Not applicable.

Comparison 9.2: Coping cards

A single, small trial investigated the effectiveness of coping cards,
in  which  participants  were  encouraged  to  note  down  alternative
activities they could engage in when feeling suicidal, resources they
found helpful when seeking help, as well as the numbers of a 24-
hour  crisis  line  and  local  medical  services,  in  addition  to  TAU  as
compared to TAU alone in adults (mean age: 37.9±11.1 years; 73.4%

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

51

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

female) referred to a specialist suicide prevention service following
a suicide attempt (Wang 2016, N = 64).

Primary outcome

9.2.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  coping  cards  on  the
proportion  of  participants  re-attempting  suicide  by  the  post-
intervention assessment (0/32 versus 5/32; OR 0.08, 95% CI 0.00 to
1.45;  N  =  64;  k  =  1;  I2  =  not  applicable;  Wang  2016).  According  to
GRADE criteria, we judged the evidence to be of moderate certainty.

Regarding  time  to  repetition,  whilst  numeric  data  were  not
provided the authors report "[r]esults indicated that participants
in  the  coping  card  group  had  a  significantly  longer  time  to  re-
attempt than those in the TAU group...[at the] 3-month" (i.e., post-
intervention) period (Wang 2016, p.112).

Secondary outcomes

9.2.2 Treatment adherence

No data available.

9.2.3 Depression

The authors indicate they measured depression; however, no data
on this outcome were reported in the trial report.

9.2.4 Hopelessness

There was no evidence of an effect for coping cards on hopelessness
scores at post-intervention (mean 6.81, SD 2.98, n = 32 versus mean
8.38, SD 3.96, n = 32; MD -1.57, 95% CI -3.29 to 0.15; N = 64; k = 1; I2
= not applicable; Wang 2016).

9.2.5 General functioning

No data available.

9.2.6 Social functioning

No data available.

9.2.7 Suicidal ideation

ideation  was  assessed 

Suicidal 
in  this  trial;  however,  an
idiosyncratic six-point scale was used. Data on this outcome were
therefore unable to be included in this review.

9.2.8 Suicide

No data available.

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 9.3: GP letters

A  single  cRCT  compared  the  effectiveness  of  a  letter  from
participants'  general  practitioners  following  discharge  from
hospital  offering  an  appointment  and  advice  compared  to  TAU
over  a  12-month  period  in  adults  (mean  age:  32.5  ±  13.2  years;
59.0%  female)  presenting  to  hospital  following  an  episode  of  SH
(Bennewith 2002, clusters = 98, N = 1932).

Cochrane Database of Systematic Reviews

As  the  trial  authors  were  unable  to  provide  values  for  either  the
inter-cluster correlation coefficient or the design effect, and further,
there was no similar cluster RCT of this intervention approach from
which  these  values  could  be  approximated,  we  were  unable  to
statistically account for the effects of clustering. Results presented
in this section may therefore overestimate the effectiveness of this
intervention.

Primary outcome

9.3.1 Repetition of SH

There was no evidence of an effect for a letter from participants' GPs
on repetition of SH by the 12-month follow-up assessment in this
trial (211/964 versus 189/968; OR 1.15, 95% CI 0.93 to 1.44; N = 1932;
k = 1; I2 = not applicable).

There was also no evidence of an effect for GP letters on time to SH
repetition in this trial (HR, 1.15, 95% CI 0.94 to 1.42; N = 1932; k = 1;
I2 = not applicable).

Secondary outcomes

9.3.2 Treatment adherence

There  was  no  effect  for  the  number  of  participants  with  a  least
one  contact  with  treatment  services  by  the  12-month  follow-up
assessment (351/599 versus 387/681; OR 1.08, 95% CI 0.86 to 1.34;
N = 1280; k = 1; I2 = not applicable).

9.3.3 Depression

No data available.

9.3.4 Hopelessness

No data available.

9.3.5 General functioning

No data available.

9.3.6 Social functioning

No data available.

9.3.7 Suicidal ideation

No data available.

9.3.8 Suicide

No data available.

Subgroup analyses

Data on repetition of SH was available by sex and repeater status
(i.e. those without a history of multiple episodes of SH versus those
with a history of multiple episodes of SH). A post hoc analysis by
sex  suggested  that  whilst  there  was  no  effect  for  males  (82/383
versus 84/413; OR 1.07, 95% CI 0.76 to 1.50; N = 796; k = 1; I2 = not
applicable), a GP letter was associated with an effect on repetition
of SH for females (30/581 versus 105/555; OR 0.23, 95% CI 0.15 to
0.36; N = 1136; k = 1; I2 = not applicable).

The trial authors also reported data on repetition of SH by repeater
status  at  trial  entry  and  concluded  that  "[t]he  odds  ratio  for
the  effect  of  the  intervention  in  patients  with  a  history  of  self-
harm was 0.57 (0.33 to 0.98), indicating a beneficial effect, and in
those with no history was 1.32 (1.02 to 1.70), indicating a harmful

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

52

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

effect"  (Bennewith  2002,  pg.1258).  However,  as  the  raw  data  on
which  these  subgroup  results  were  based  were  not  reported,  we
were unable to reproduce these results in this review.

Sensitivity analyses

Not applicable.

Comparison 9.4: Postcards

Four  trials  assessed  the  effectiveness  of  sending  postcards  on  a
regular  basis  over  a  12-month  period  to  adults  (weighted  mean
age: 27.1 ± 8.9 years; 63.0% female) presenting to hospital following
an episode of SH (Beautrais 2010, N = 327; Hassanian-Moghaddam
2011, N = 2113; Kapur 2013, N = 66), including one that used Zelen's
design and reported data only for the randomised sample (Carter
2005, N = 772).

Primary outcome

9.4.1 Repetition of SH

Overall,  there  was  no  evidence  of  an  effect  for  postcards  on
the  proportion  of  patients  repeating  SH  by  the  post-intervention
assessment  (OR  0.87,  95%  CI  0.62  to  1.23;  participants  =  3277;
studies = 4; I2 = 51%; Analysis 6.1). According to GRADE criteria, we
judged the evidence to be of very low certainty.

There was also no evidence of an effect for postcards on repetition
of SH by the 12-month follow-up assessment in two of these trials
(Analysis 6.2).

With  respect  to  frequency  of  SH,  we  obtained  data  on  the  mean
number  of  repeat  SH  episodes  by  correspondence  for  three  of
the  four  trials  of  postcards  (Carter  2005;  Hassanian-Moghaddam
2011; Kapur 2013). Overall, there was no evidence of an effect for
postcards  on  frequency  of  repeated  SH  by  the  post-intervention
assessment  in  these  three  trials  (Analysis  6.3).  For  the  one
remaining  trial  (Beautrais  2010),  the  available  data  indicated  a
reduced mean number of SH episodes for the intervention group
at  post-intervention  (0.57  versus  0.78);  however,  SDs  were  not
presented  and  insufficient  information  was  reported  to  enable
imputation  of  SDs.  There  was  similarly  no  evidence  of  an  effect
for postcards either by the 12-month follow-up assessment in two
trials  (Analysis  6.4),  or  by  the  24-month  follow-up  assessment  in
one trial (Analysis 6.5).

Secondary outcomes

9.4.2 Treatment adherence

No data available.

9.4.3 Depression

No data available.

9.4.4 Hopelessness

No data available.

9.4.5 General functioning

No data available.

9.4.6 Social functioning

No data available.

Cochrane Database of Systematic Reviews

9.4.7 Suicidal ideation

One  trial  reported  information  on  suicidal  ideation  at  both  the
post-intervention  assessment  and  12-  to  24-months'  follow-up
(Hassanian-Moghaddam  2011).  There  was  an  effect  for  postcards
on  the  proportion  of  participants  reporting  suicidal  ideation  at
the  post-intervention  assessment  (302/1043  versus  446/1070;  OR
0.57,  95%  CI  0.48  to  0.68;  N  =  2113;  k  =  1;  I2  =  not  applicable).
Data reported by the same trial authors in a subsequent follow-up
publication suggested that this effect was maintained by the 12- to
24-month follow-up assessment (465/997 versus 588/1004; OR 0.62,
95% CI 0.52 to 0.74; N = 2001; k = 1; I2 = not applicable; Hassanian-
Moghaddam 2017).

9.4.8 Suicide

There was no evidence of an effect for postcards on suicide by the
post-intervention assessment in these four trials (Analysis 6.6).

Data  on  suicides  by  the  12-month  follow-up  assessment  were
reported  in  one  trial;  however,  no  effect  was  found  by  this  time
point either (2/378 versus 5/394; OR 0.41, 95% CI 0.08 to 2.15; N =
772; k = 1; I2 = not applicable; Carter 2005).

Subgroup analyses

Randomisation was stratified by sex in one of these trials (Carter
2005); however, there was no evidence of an effect for postcards in
either sex at either the post-intervention (Analysis 6.1) or the the 12-
month follow-up assessment (Analysis 6.2).

Through  correspondence,  we  were  also  able  to  obtain  data  on
frequency  of  SH  repetition  by  the  post-intervention  assessment
by  both  sex  and  repeater  status  for  three  trials  (Carter  2005;
Hassanian-Moghaddam 2011; Kapur 2013). There was no evidence
of  an  effect  for  postcards  either  by  sex  (test  for  subgroup
differences: Chi2 = 0.07, df = 1, P = 0.79; Analysis 6.3) or by repeater
status  (i.e.  first  SH  episode  versus  repeat  SH  episode)  (test  for
subgroup differences: Chi2 = 0.59, df = 1, P = 0.44; Analysis 6.3) in
these trials. There was also no evidence of an effect for postcards
either  by  sex  (test  for  subgroup  differences:  Chi2  =  1.25,  df  =  1,
P  =  0.26;  Analysis  6.4)  or  by  repeater  status  (test  for  subgroup
differences: Chi2 = 0.60, df = 1, P = 0.44; Analysis 6.4) by the 12-month
follow-up assessment in two trials, or by the 24-month follow-up
period in one trial (sex: test for subgroup differences: Chi2 = 0.57, df
= 1, P = 0.45; repeater status: test for subgroup differences: Chi2 =
0.35, df = 1, P = 0.55; Analysis 6.5).

Sensitivity analyses

One  trial  used  Zelen's  design  (Carter  2005).  Omitting  this  trial
did not materially affect results for postcards on repetition of SH
by  the  post-intervention  assessment.  However,  by  the  12-month
assessment, excluding this trial caused the result for repetition of
SH to become statistically significant (OR 0.67, 95% CI 0.52 to 0.86;
N = 2113; k = 1; I2 = not applicable). Additionally, excluding this trial
suggested a potentially harmful effect of postcards on suicides by
the post-intervention assessment (OR 3.74, 95% CI 1.04 to 13.51; N
= 2692; k = 3; I2 = 0%).

Four  analyses  within  this  comparison  were  associated  with
substantial levels of heterogeneity (Analysis 6.4.1, I2 = 84%; Analysis
6.4.1,  I2  =  84%;  Analysis  6.4.3,  I2  =  76%;  Analysis  6.4.4,  I2  =
81%); however, analyses did not indicate any individual study was
associated with excessive influence for either of these outcomes.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

53

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 9.5: Telephone contact

9.5.7 Suicidal ideation

Three  trials  investigated  the  effectiveness  of  telephone  contact
in  adults  (weighted  mean  age:  36.5  ±  13.5  years;  72.1%  female)
presenting to emergency departments following a suicide attempt
(Cedereke 2002, N = 216; Mousavi 2015, N = 55; Vaiva 2006, N = 605).

Telephone  contact  was  not  associated  with  an  effect  on  suicidal
ideation scores by the 12-month follow-up assessment in one trial
(mean 5.80, SD 7.80, N = 5 versus mean 4.00, SD 6.20, N = 8; MD 1.80,
95% CI -6.27 to 9.87; N = 13; k = 1; I2 = not applicable; Cedereke 2002).

Primary outcome

9.5.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  telephone  contact  on
repetition of SH by the post-intervention in one trial (1/29 versus
2/26; OR 0.43, 95% CI 0.04 to 5.02; N = 55; k = 1; I2 = not applicable;
Mousavi 2015). According to GRADE criteria, we judged the evidence
to be of low certainty.

There was also no evidence of an effect for telephone contact on
repetition  of  SH  by  the  12-month  assessment  in  a  second  trial
(14/83  versus  15/89;  OR  1.00,  95%  CI  0.45  to  2.23;  N  =  172;  k  =  1;
I2 = not applicable; Cedereke 2002), or by the 24-month follow-up
assessment in a third trial (44/293 versus 59/312; OR 0.76, 95% CI
0.49 to 1.16; N = 605; k = 1; I2 = not applicable; Vaiva 2006).

With  respect  to  frequency  of  repetition  of  SH,  there  was  no
evidence of an effect for telephone contact by the post-intervention
assessment  in  one  trial  (mean  0.04,  SD  0.20,  n  =  25  versus  mean
0.18, SD 0.66, n = 22; MD -0.14, 95% CI -0.43 to 0.15; N = 47; k = 1;
I2 = not applicable; Mousavi 2015). The mean number of episodes
of SH was similar between arms in both Cedereke 2002 by the 12-
month assessment (0.31 versus 0.30) and in Vaiva 2006 by the 24-
month  assessment  (0.15  versus  0.19).  However,  as  trial  authors
provided insufficient information to enable imputation of SDs, we
were  unable  to  calculate  the  mean  difference  in  the  number  of
repeat episodes of SH between arms in these two trials.

Secondary outcomes

9.5.2 Treatment adherence

No data available.

9.5.3 Depression

No data available.

9.5.4 Hopelessness

No data available.

9.5.5 General functioning

Whilst data on general functioning were available for one of these
trials by the 12-month follow-up assessment (mean 61.4, SD 20.4
versus  mean  58.6,  20.2),  it  was  unclear  how  many  of  the  163
participants with data on this outcome had been allocated to the
intervention and control arms (Cedereke 2002). We were therefore
unable  to  include  these  data  in  our  review.  The  trial  authors,
however, reported that "[a]t 12 months there had been significant
improvements within both the intervention and control groups in
global functioning (GAF)..." (Cedereke 2002, pg.87).

9.5.6 Social functioning

No data available.

One  further  trial  reported  information  on  the  proportion  of
participants  reporting  suicidal  ideation;  however,  once  again
telephone contact was not associated with an effect by the post-
intervention assessment in this trial (2/25 versus 1/22; OR 1.83, 95%
CI 0.15 to 21.64; N = 47; k = 1; I2 = not applicable; Mousavi 2015).

9.5.8 Suicide

There  was  no  evidence  of  an  effect  for  telephone  contact  on
suicides either by the post-intervention (0/25 versus 1/22; OR 0.28,
95% CI 0.01 to 7.26; N = 47; k = 1; I2 = not applicable; Mousavi 2015),
12-month (1/107 versus 1/109; OR 1.02, 95% CI 0.06 to 16.50; N =
216; k = 1; Cedereke 2002) or 24-month (1/293 versus 2/312; OR 0.52,
95% CI 0.05 to 5.89; N = 605; Vaiva 2006) follow-up assessments.

Subgroup analyses

Whilst one trial stratified randomisation, this trial compared those
who  engaged  in  three  or  fewer  suicide  attempts  over  the  three
years prior to trial entry to those who had engaged in four or more
episodes over this time frame, rather than those engaging in a first
episode  versus  a  repeat  episode  (Vaiva  2006).  We  were  therefore
unable to include these data in our review.

Sensitivity analyses

Not applicable.

Comparison 9.6: Telephone contact combined with emergency
cards and letters

Two relatively large trials assessed the effectiveness of telephone
contact  combined  with  emergency  cards  and  letters  (for  those
unable to be contacted via telephone) compared to TAU in adults
(weighted mean age: 38.4 ± 13.2 years; 64.5% female) presenting to
the emergency department following a suicide attempt (Mouaffak
2015, N = 302; Vaiva 2018, N = 987).

Primary outcome

9.6.1 Repetition of SH

There was no evidence of an effect for telephone contact combined
with  emergency  cards  and  letters  on  repetition  of  SH  by  the
post-intervention assessment in one of these trials (22/152 versus
21/151;  OR  1.05,  95%  CI  0.55  to  2.00;  N  =  303;  k  =  1;  I2  =  not
applicable; Mouaffak 2015). According to GRADE criteria, we judged
the evidence to be of moderate certainty.

For  the  second  of  these  trials,  information  on  SH  repetition
was  combined  with  that  for  suicide  deaths  (Vaiva  2018).  Despite
correspondence, we were unable to obtain disaggregated data for
these outcomes. We were therefore unable to include these data in
our analyses.

There  was  also  no  evidence  of  an  effect  for  this  intervention  on
frequency of repeated SH by the post-intervention assessment in
one of these trials (mean 0.20, SD 0.58, n = 152 versus mean 0.23,
SD 0.84, n = 150; MD -0.03, 95% CI -0.19 to 0.13; N = 302; k = 1; I2 =
not applicable; Mouaffak 2015).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

54

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Although neither trial provided numeric data, both reported there
was  no  effect  for  telephone  contact  combined  with  emergency
cards  and  letters  on  time  to  SH  repetition:  "[t]he  intervention
had  no  significant  impact  on...the  duration  of  the  period  that
patients were free of attempts (Vaiva 2018, pg.5), and, there was no
"significant differences between the two groups" (Mouaffak 2015,
pg.916).

As this latter trial used a cross-over design, we reported only data
from the post-intervention assessment (i.e. prior to cross-over) in
this  review.  Additionally,  for  one  of  these  trials  (i.e.  Wei  2013),
there were two intervention arms: CBT-based psychotherapy and
telephone-based psychotherapy. We therefore included here only
data for the telephone contact arm, and have split the comparator
arm data following the advice in Higgins 2011.

Secondary outcomes

9.6.2 Treatment adherence

No data available.

9.6.3 Depression

No data available.

9.6.4 Hopelessness

No data available.

9.6.5 General functioning

No data available.

9.6.6 Social functioning

No data available.

9.6.7 Suicidal ideation

No data available.

9.6.8 Suicide

There was no evidence of an effect for telephone contact combined
with  emergency  cards  and  letters  by  the  post-intervention
assessment in one trial (1/152 versus 0/150; OR 2.98, 95% CI 0.12 to
73.74; N = 302; k = 1; I2 = not applicable; Mouaffak 2015), or by the
13-month follow-up assessment in the second trial (3/493 versus
8/494; OR 0.37, 95% CI 0.10 to 1.41; N = 987; k = 1; I2 = not applicable;
Vaiva 2018).

Subgroup analyses

Randomisation was stratified by history of SH prior to trial entry in
one of these trials (Mouaffak 2015); however, there was no evidence
of an effect for telephone contact combined with emergency cards
and letters on repetition of SH by the post-intervention assessment
either in those with a history of SH (18/79 versus 17/72; OR 0.95,
95% CI 0.45 to 2.03; N = 151; k = 1; I2 = not applicable) or in those
without this history at trial entry (4/77 versus 4/74; OR 0.96, 95% CI
0.23 to 3.98; N = 151; k = 1; I2 = not applicable).

Sensitivity analyses

Not applicable.

Primary outcome

9.7.1 Repetition of SH

For  one  trial,  correspondence  with  trial  authors  indicated  there
were "no suicide attempts in both groups in those who did not drop
out [at post-intervention]...We were unable to obtain information
from  those  who  dropped  out  with  respect  to  suicide  attempts.
We  did  have  one  suicide  attempt  in  the  [intervention]  group,
but  this  was  before  all  interventions  were  completed  and  so
this  was  excluded  from  final  analysis"  (Sreedaran  2020,  personal
communication).

For the remaining two trials, there was no evidence of an effect for
telephone-based  psychotherapy  on  repetition  of  SH  by  the  post-
intervention  in  two  of  these  trials  (OR  0.36,  95%  CI  0.01  to  8.94;
participants = 185; studies = 2; I2 = 0%; Analysis 7.1). According to
GRADE criteria, we judged the evidence to be of low certainty.

There  was  also  no  evidence  of  an  effect  for  telephone-based
psychotherapy  on  repetition  of  SH  by  the  six-month  (1/41  versus
4/40; OR 0.23, 95% CI 0.02 to 2.11; N = 81; k = 1; I2 = not applicable;
Wei 2013), or 12-month follow-up assessments in one of these trials
(1/36 versus 5/27; OR 0.13, 95% CI 0.01 to 1.15; N = 63; k = 1; I2 = not
applicable; Wei 2013).

Secondary outcomes

9.7.2 Treatment adherence

There was no effect for mobile telephone-based psychotherapy on
the  proportion  of  participants  who  completed  treatment  by  the
post-intervention  assessment  in  one  of  these  trials  (8/13  versus
7/12; OR 1.14, 95% CI 0.23 to 5.67; N = 25; k = 1; I2 = not applicable;
Sreedaran 2020).

9.7.3 Depression

There was also no evidence of an effect for mobile telephone-based
psychotherapy  on  depression  scores  by  the  post-intervention
assessment in two of these trials (Analysis 7.2), or by the six-month
(mean 6.01, SD 8.87, n = 41 versus mean 5.85, SD 8.16, n = 40; MD
0.16, 95% CI -3.55 to 3.87; N = 81; k = 1; I2 = not applicable) or 12-
month (mean 5.73, SD 8.71, n = 36 versus mean 5.84, SD 8.23, n =
27; MD -0.11, 95% CI -4.32 to 4.10; N = 63; k = 1; I2 = not applicable)
follow-up assessments in one of these trials (Wei 2013).

Comparison 9.7: Telephone-based psychotherapy

Three  trials  from  developing  countries  (i.e.  China,  India,  and  Sri
Lanka) assessed the effectiveness of psychotherapy, incorporating
principles from CBT-based psychotherapy, third-wave techniques,
and social support delivered by telephone over either a one-month
(Sreedaran 2020, N = 28), three-month (Wei 2013, N = 157), or six-
month (Marasinghe 2012, N = 68) period in adults (weighted mean
age: 32.6 ± 14.0; 69.6% female) presenting to services following an
episode of SH.

9.7.4 Hopelessness

No data available.

9.7.5 General functioning

No data available.

9.7.6 Social functioning

No data available.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

55

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

9.7.7 Suicidal ideation

There  was  evidence  of  an  effect  for  mobile  telephone-based
psychotherapy for suicidal ideation scores at the post-intervention
assessment in one trial (mean 3.60, SD 1.60, n = 34 versus mean 7.30,
SD 5.50, n = 34; MD -3.70, 95% CI -5.63 to -1.77; N = 68; k = 1; I2 = not
applicable; Marasinghe 2012).

One  trial  reported  information  on  the  proportion  of  participants
reporting  suicidal  ideation  (Wei  2013);  however,  there  was  no
evidence  of  an  effect  for  telephone-based  psychotherapy  on
the  proportion  reporting  suicidal  ideation  at  either  the  post-
intervention  (37/80  versus  32/77;  OR  1.21,  95%  CI  0.64  to  2.27;  N
=  157;  k  =  1;  I2  =  not  applicable),  six-month  (26/80  versus  24/77;
OR  1.06,  95%  CI  0.54  to  2.08;  N  =  157;  k  =  1;  I2  =  not  applicable),
or 12-month (24/80 versus 25/77; OR 0.89, 95% CI 0.45 to 1.75; N =
157; k = 1; I2 = not applicable) follow-up assessments in this trial.
However, it is notable that, for this trial, results were reported on
the basis of those randomised despite the fact that a self-reported
measure was used, and high levels of dropouts were observed by
the 12-month follow-up assessment. As we were unable to confirm
these numbers with trial authors, results much be interpreted with
caution.

9.7.8 Suicide

Data  obtained  by  correspondence  indicated  that  there  was  no
evidence of an effect for telephone-based psychotherapy on suicide
by the post-intervention assessment (Analysis 7.3).

Subgroup analyses

Telephone-based psychotherapy was associated with an effect for
depression  scores  at  the  post-intervention  assessment  in  males
(mean 5.90, SD 2.40, n = 17 versus mean 13.30, SD 6.10, n = 17; MD
-7.40, 95% CI -10.52 to -4.28; N = 34; k = 1; I2 = not applicable), but not
in females (mean 8.10, SD 6.30, n = 17 versus mean 11.60, SD 6.50, n
= 17; MD -3.50, 95% CI -7.80 to 0.80; N = 34; k = 1; I2 = not applicable)
in one trial (Marasinghe 2012).

However, for suicidal ideation scores, whilst there was no evidence
of  an  effect  for  telephone-based  psychotherapy  at  the  post-
intervention assessment in males in this trial (mean 3.50, SD 1.80,
n = 17 versus mean 6.20, SD 5.50, n = 17; MD -2.70, 95% CI -5.45 to
0.05; N = 34; k = 1; I2 = not applicable), there was, however, an effect
for females (mean 3.80, SD 1.40, n = 17 versus mean 8.90, SD 6.20, n
= 17; MD -5.10, 95% CI -8.12 to -2.08; N = 34; k = 1; I2 = not applicable)
(Marasinghe 2012).

Sensitivity analyses

One  analysis  within  this  comparison  was  associated  with
substantial levels of heterogeneity (Analysis 7.2, I2 = 90%); however,
analyses did not indicate any individual study was associated with
excessive influence for this outcome.

Comparison 10: Provision of information and support versus
TAU or another comparator

Two  multicentre  and  multi-country  studies  investigated  the
effectiveness  of  providing  a  one-off  hospital-based  information
session  combined  with  regular  home  visits  and/or  telephone
contact  in  addition  to  TAU  over  an  18-month  period  in  adults
(weighted  mean  age:  26.7  years,  SD  not  reported;  62.6%  female)
presenting to the emergency department following an episode of
SH:  the  START  Study  (Amadéo  2015,  N  =  190)  and  the  SUPRE-

Cochrane Database of Systematic Reviews

MISS  Study  (Fleischmann  2008,  N  =  1699).  In  one  further  trial,
participants nominated a support person in addition to receiving
information  and  support  using  the  original  SUPRE-MISS  model
(Naidoo 2014, N = 688).

Primary outcome

10.1 Repetition of SH

There was no evidence of an effect for information and support on
repetition of SH by the 18-month post-intervention assessment in
two trials (OR 1.09, 95% CI 0.79 to 1.50; participants = 1853; studies =
2; I2 = 0%; Analysis 8.1). Whilst a third trial also reported information
on repetition of SH by the post-intervention assessment, there were
major discrepancies for this outcome that we were unable to clarify
with trial authors (Naidoo 2014). According to GRADE criteria, we
judged the evidence to be of very low certainty.

As randomisation was conducted locally for each country included
in  the  SUPRE-MISS  study,  we  were  also  able  to  include  results
for  each  of  the  five  countries  separately.  Although  there  was  no
difference  between  groups  for  the  individual  sites  in  Campinas,
Brazil (21/71 versus 10/64; OR 2.27, 95% CI 0.97 to 5.28; N = 135; k =
1; I2 = not applicable), Colombo, Sri Lanka (3/130 versus 5/121; OR
0.55, 95% CI 0.13 to 2.34; N = 251; k = 1; I2 = not applicable), Karaj,
Iran (33/303 versus 28/298; OR 1.18, 95% CI 0.69 to 2.00; N = 601; k
= 1; I2 = not applicable), and Yuncheng, China (1/58 versus 0/38; OR
2.01, 95% CI 0.08 to 50.60; N = 96; k = 1; I2 = not applicable), fewer
participants in the intervention group had repeated SH by the 18-
month period at the Chennai, India site (8/301 versus 17/260; OR
0.39, 95% CI 0.17 to 0.92; N = 561; k = 1; I2 = not applicable).

One secondary publication for the SUPRE-MISS study also reported
data  on  frequency  of  SH  for  one  site  (i.e.  Karaj,  Iran)  by  the  six-
month follow-up assessment (Hassanzadeh 2010). At this site, there
was  evidence  of  a  increase  in  frequency  of  SH  repetition  in  the
intervention and support arm relative to the TAU arm (mean 1.63,
SD 1.19, n = 319 versus mean 1.17, SD 0.38, n = 310; MD 0.46, 95% CI
0.32 to 0.60; N = 629; k = 1; I2 = not applicable).

Secondary outcomes

10.2 Treatment adherence

No data available.

10.3 Depression

Correspondence  with  trial  authors  revealed  that  information  on
depression  was  recorded  at  one  site  only:  Yuncheng,  China  (Xu
2012).  There  was  evidence  of  an  effect  for  information  and
support on depression scores at this site by the post-intervention
assessment (mean 0.64, SD 0.29, n = 57 versus mean 0.52, SD 0.30, n
= 54; MD 0.12, 95% CI 0.01 to 0.23; N = 111; k = 1; I2 = not applicable).

10.4 Hopelessness

No data available.

10.5 General functioning

No data available.

10.6 Social functioning

No data available.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

56

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

10.7 Suicidal ideation

No data available.

10.8 Suicide

There  was  evidence  of  an  effect  for  information  and  support  on
suicide deaths by the 18-month post-intervention assessment (OR
0.12, 95% CI 0.03 to 0.44; N = 1889; k = 2; I2 = 0%; Analysis 8.2).

For  the  SUPRE-MISS  study,  data  on  suicide  deaths  were  also
available for three sites in related publications (i.e. Chennai, India
[Vijayakumar 2011], Karaj, Iran [Hassanzadeh 2010], and Yuncheng,
China [Xu 2012]). There was evidence of an effect for information
and support on suicide deaths by the 18-month assessment at the
Chennai,  India  site  (1/302  versus  9/320;  OR  0.11,  95%  CI  0.01  to
0.91; N = 622; k = 1; I2 = not applicable), but not at the Karaj, Iran
(2/319  versus  2/310;  OR  0.97,  95%  CI  0.14  to  6.94;  N  =  629;  k  =
1;  I2  =  not  applicable),  or  the  Yuncheng,  China  (0/57  versus  2/54;
OR  0.18,  95%  CI  0.01  to  3.89;  N  =  111;  k  =  1;  I2  =  not  applicable)
sites. Notably, the number of completed suicides in the intervention
group  reported  for  these  three  subsamples  was  greater  than  the
number reported for the overall SUPRE-MISS cohort in the primary
trial (i.e. Fleischmann 2008). We were unable to confirm the correct
number of completed suicides in the intervention group with the
authors. Including the one additional suicide for the intervention
group  identified  from  the  three  subsample  publications  with  the
data  reported  in  the  primary  study  reference,  however,  did  not
materially  affect  the  result  obtained  for  the  overall  SUPRE-MISS
cohort.

Subgroup analyses

For  the  SUPRE-MISS  study,  data  on  repetition  of  SH  were  also
available  for  males  and  females  separately  (Fleischmann  2008).
Overall, across all five sites in this trial, there was no evidence of an
effect on repetition of SH by the post-intervention assessment in
either males (30/349 versus 27/340; OR 1.09, 95% CI 0.63 to 1.88; N =
689; k = 1; I2 = not applicable) or females (36/514 versus 33/460; OR
0.97, 95% CI 0.60 to 1.59; N = 974; k = 1; I2 = not applicable). Breaking
these  results  down  by  sex  for  the  individual  sites  involved  in  the
SUPRE-MISS study revealed no effect for information and support
on repetition of SH by the 18-month assessment for either sex at
any  of  the  five  study  sites:  Campinas,  Brazil  (males:  4/21  versus
3/25; OR 1.73, 95% CI 0.34 to 8.76; N = 46; k = 1; I2 = not applicable;
females: 17/50 versus 7/39; OR 2.35, 95% CI 0.86 to 6.44; N = 89; k
= 1; I2 = not applicable), Chennai, India (males: 5/148 versus 7/125;
OR 0.59, 95% CI 0.18 to 1.91; N = 273; ; k = 1; I2 = not applicable;
females: 3/153 versus 10/153; OR 0.29, 95% CI 0.08 to 1.06; N = 306;
k = 1; I2 = not applicable), Colombo, Sri Lanka (males: 1/54 versus
3/53; OR 0.31, 95% CI 0.03 to 3.12; N = 107; k = 1; I2 = not applicable;
females: 2/76 versus 2/68; OR 0.89, 95% CI 0.12 to 6.51; N = 144; k =
1; I2 = not applicable), Karaj, Iran (males 19/109 versus 14/118; OR
1.57, 95% CI 0.74 to 3.31; N = 227; k = 1; I2 = not applicable; females:
14/194 versus 14/180; OR 0.92, 95% CI 0.43 to 1.99; N = 374; k = 1;
I2 = not applicable), Yuncheng, China (males: 1/17 versus 0/19; OR
3.55, 95% CI 0.14 to 93.01; N = 36; k = 1; I2 = not applicable; females
0/41 versus 0/38; OR not estimable, 95% CI not estimable; N = 79; k
= 1; I2 = not applicable).

For  the  START  study,  data  on  repetition  of  SH  were  reported
separately  for  those  with  a  history  of  SH  prior  to  trial  entry;
however,  there  was  no  evidence  of  an  effect  for  information  and
support on repetition of SH by the post-intervention assessment in

Cochrane Database of Systematic Reviews

this group (7/14 versus 9/17; OR 0.89, 95% CI 0.22 to 3.66; N = 31; k
= 1; I2 = not applicable; Amadéo 2015).

Sensitivity analyses

Not applicable.

Comparison 11: Other multimodal interventions versus TAU or
another comparator

Three  Zelen  RCTs  investigated  the  effectiveness  of  a  package  of
interventions, including CBT-based psychotherapy, remote contact
interventions  (e.g.  telephone  contact,  letters,  and/or  postcards),
and GP vouchers in adults (weighted mean age: 35.5 ± 12.5; 54.7%
female) admitted to emergency departments following an episode
of SH (Gysin-Maillart 2016, N = 120; Hatcher 2015, N = 1474; Hatcher
2016, N = 365). For one of these trials, the treatment package was
culturally  adapted  for  those  who  identified  as  of  Māori  ethnicity
(Hatcher 2016).

Primary outcome

11.1 Repetition of SH

There was no evidence of an effect for this package of interventions
at  post-intervention  in  terms  of  repetition  of  SH  (Analysis  9.1).
Using  data  for  the  consenting  sample  (i.e.  including  only  those
participants  who,  following  treatment  allocation,  subsequently
consented to participation), rather than all those randomised, for
Hatcher  2015  and  Hatcher  2016,  did  not  materially  affect  these
results. According to GRADE criteria, we judged the evidence to be
of very low certainty.

One  trial  reported  data  on  frequency  of  SH  at  post-intervention.
There  was  evidence  of  an  effect  for  a  multimodel  package  of
interventions on frequency of SH in this trial (mean 0.08, SD 0.28,
n = 60 versus mean 0.82, SD 1.89, n = 50; MD -0.74, 95% CI -1.27 to
-0.21; N = 110; k = 1; I2 = not applicable; Gysin-Maillart 2016).

With  regard  to  time  to  SH  repetition,  there  was  no  evidence  of  a
significant treatment effect for this package of interventions in two
trials  (Analysis  9.2).  Information  on  time  to  first  SH  presentation
was  also  reported  in  Hatcher  2015;  however,  "...there  was  no
significant  difference  between  the  two  groups  in  time  to  first  re-
presentation  (log-rank  test  P  =  0.6564)"  (Hatcher  2015,  pg.232).
As hazard ratios (HRs) and their accompanying 95% CIs were not
reported in this trial, we were unable to include this result in our
review.

Secondary outcomes

11.2 Treatment adherence

No data available.

11.3 Depression

There was no effect for this package of interventions on depression
scores at the post-intervention assessment (Analysis 9.3).

11.4 Hopelessness

There was also no apparent effect for this package of interventions
on  hopelessness  scores  at  the  post-intervention  assessment
(Analysis 9.4).

However,  the  trial  authors  for  one  of  these  trials  noted  that
"whilst there was a greater change in hopelessness scores at...12

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

57

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

months [i.e. the post-intervention assessment] in the intervention
group,  the  control  group  had  a  significantly  lower  baseline  score
[;]...because  of  the  significant  differences  in  baseline  scores  and
missing follow up data we...used a mixed linear model to estimate
the  differences  in  scores  at  [the  post-intervention  assessment]".
Using  this  model,  the  trial  authors  found  "there  was  a  decrease
in [h]opelessness scores in the treatment group compared to the
usual care group but this was statistically non-significant" (Hatcher
2016, pg.889).

11.5 General functioning

No data available.

11.6 Social functioning

No data available.

11.7 Suicidal ideation

One trial reported information on suicidal ideation scores (Gysin-
Maillart 2016); however, there was no evidence of an effect for this
package  of  interventions  on  suicidal  ideation  scores  by  the  post-
intervention  assessment  in  this  trial  (mean  4.80,  SD  7.88,  n  =  35
versus mean 4.62, SD 6.48, n = 34; MD 0.18, 95% CI -3.22 to 3.58; N
= 69; k = 1; I2 = not applicable).

11.8 Suicide

There was no effect for this intervention package on suicides by the
post-intervention assessment in any trial (Analysis 9.5). For one of
these trials (i.e. Hatcher 2015), one death in the intervention arm
and one in the control arm were due to uncertain causes and had
yet  to  be  investigated  by  the  Coroner.  However,  assuming  these
deaths  to  be  attributable  to  suicide  did  not  materially  affect  this
result.

Subgroup analyses

Randomisation was stratified by history of SH ( i.e. first SH episode
versus  repeat  SH  episode)  in  two  of  these  trials  (Hatcher  2015;
Hatcher 2016); however, there was no difference in repetition of SH
at post-intervention in either trial for either those without a history
of multiple episodes of SH prior to the index episode (i.e. first SH
episode)  or  for  those  with  a  history  of  multiple  episodes  of  SH
(i.e. repeat SH episode) (Analysis 9.1).

Sensitivity analyses

As  all  trials  included  in  this  comparison  used  Zelen's  design,  we
were  unable  to  undertake  sensitivity  analyses  to  investigate  the
impact use of this design may have had on the results observed.

Two  analyses  within  this  comparison  were  associated  with
substantial levels of heterogeneity (Analysis 9.1.1, I2 = 81%; Analysis
9.2,  I2  =  89%);  however,  analyses  did  not  indicate  any  individual
study  was  associated  with  excessive  influence  for  any  of  these
outcomes.

Comparison 12: Other mixed interventions versus TAU or
another comparator

A  number  of  single  trials  investigated  the  effectiveness  of  other
mixed  types  of  interventions  compared  with  TAU  or  another
comparator,  including:  continuity  of  care  by  the  same  therapist
(Torhorst 1987), interpersonal problem-solving therapy (McLeavey
1994),  behaviour  therapy  (Liberman  1981),  intensive  in-  and  out-

Cochrane Database of Systematic Reviews

patient treatment (Van der Sande 1997), general hospital admission
(Waterhouse  1990),  intensive  outpatient  treatment  (Allard  1992;
Welu  1977),  home-based  psychotherapy  and  telephone  contact
(Hawton 1981), and long-term therapy (Torhorst 1988).

Comparison 12.1: Continuity of care by the same therapist

One  trial  investigated  the  effectiveness  of  continuing  aftercare
with the same therapist (defined as continued therapeutic contact
with the original hospital therapist in an outpatient setting) versus
changing  to  a  different  therapist  (defined  as  receiving  therapy  in
a  specialised  suicide  prevention  centre  which  involved  changing
both  therapist  and  institution)  over  a  12-month  follow-up  period
in adults (mean ± SD age not reported; 69.5% female) admitted to
hospital following an episode of self-poisoning (Torhorst 1987, N =
141).

Primary outcome

12.1.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  this  intervention  on
repetition of SH by the 12-month follow-up assessment in this trial
(3/70 versus 9/66; OR 0.28, 95% CI 0.07 to 1.10; N = 136; k = 1; I2 = not
applicable; Torhorst 1987).

Secondary outcomes

12.1.2 Treatment adherence

There  was  evidence  of  an  effect  for  this  intervention  on  the
proportion of participants who completed treatment compared to
alternative psychotherapy (49/68 versus 36/73; OR 2.65, 95% CI 1.32
to 5.34; N = 141; k = 1; I2 = not applicable; Torhorst 1987).

12.1.3 Depression

Depression scores did not differ between groups at the 12-month
follow-up assessment in this trial (mean 6.20, SD 6.90, n = 65 versus
mean 7.60, SD 9.20, n = 62; MD -1.40, 95% CI -4.24 to 1.44; N = 127;
k = 1; I2 = not applicable; Torhorst 1987).

12.1.4 Hopelessness

No data available.

12.1.5 General functioning

No data available.

12.1.6 Social functioning

No data available.

12.1.7 Suicidal ideation

No data available.

12.1.8 Suicide

There  was  no  evidence  of  an  effect  for  this  intervention  on  the
number of participants who died by suicide by the 12-month follow-
up period (2/70 versus 3/66; OR 0.62, 95% CI 0.10 to 3.82; N = 136; k
= 1; I2 = not applicable; Torhorst 1987).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

58

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Sensitivity analyses

Not applicable.

Comparison 12.2: Interpersonal problem-solving therapy

skills 

One  small  trial  compared  the  effectiveness  of  interpersonal
problem-solving 
(IPSST)  with  alternative
psychotherapy  (i.e.  brief  problem-oriented  therapy)  in  adults
(mean  age:  23.9  ±  7.2  years;  74.3%  female)  admitted  to  accident
and  emergency  facilities  following  an  episode  of  self-poisoning
(McLeavey 1994, N = 39).

training 

Primary outcome

12.2.1 Repetition of SH

There was no evidence of an effect for repetition of SH, defined as a
'self-poisoning act', by the 12-month follow-up period (2/17 versus
4/16; OR 0.40, 95% CI 0.06 to 2.57; N = 33; k = 1; I2 = not applicable)
in this trial.

Secondary outcomes

12.2.2 Treatment adherence

There was no evidence of an effect on the proportion of participants
who completed the full course of treatment in this trial (2/19 versus
3/20; OR = 0.67, 95% CI 0.10 to 4.51; N = 39; k = 1; I2 = not applicable).

There  was,  however,  evidence  of  an  effect  for  interpersonal
problem-solving  therapy  in  terms  of  the  number  of  treatment
sessions  attended  (mean  5.30,  SD  0.48,  n  =  17  versus  mean  4.20,
SD 1.32, n = 16; MD 1.10, 95% CI 0.41 to 1.79; N = 33; k = 1; I2 = not
applicable).

12.2.3 Depression

No data available.

12.2.4 Hopelessness

There  was  no  evidence  of  an  effect  for  hopelessness  by  the  six-
month follow-up assessment in this trial (mean 6.12, SD 4.61, n = 19
versus mean 4.35, SD 4.39, n = 20; MD 1.77, 95% CI -1.06 to 4.60; N
= 39; k = 1; I2 = not applicable).

12.2.5 General functioning

No data available.

12.2.6 Social functioning

No data available.

12.2.7 Suicidal ideation

No data available.

12.2.8 Suicide

There  were  no  suicide  deaths  in  either  the  intervention  or
comparator arm by the 12-month follow-up period.

Subgroup analyses

Cochrane Database of Systematic Reviews

Comparison 12.3: Behaviour therapy

One  small  trial  compared  the  effectiveness  of  behaviour  therapy
versus alternative psychotherapy (i.e. insight-oriented therapy) in
adults  (mean  age:  29.7  ±  8.8  years;  66.6%  female)  referred  for
inpatient treatment following a suicide attempt (Liberman 1981, N
= 24).

Primary outcome

12.3.1 Repetition of SH

There was no evidence of an effect with regards to the proportion of
participants repeating SH by the 24-month follow-up period (2/12
versus  3/12;  OR  0.60,  95%  CI  0.08  to  4.45;  N  =  24;  k  =  1;  I2  =  not
applicable).

Secondary outcomes

12.3.2 Treatment adherence

No data available.

12.3.3 Depression

Depression  was  measured  using  both  the  BDI  and  ZSRDS  in
one trial. There was evidence of an effect for behaviour therapy at
the post-intervention assessment according to both measures (BDI:
mean  4.00,  SD  4.00,  n  =  12  versus  mean  14.00,  SD  12.00,  n  =  12;
MD -10.00, 95% CI -17.16 to -2.84; N = 24; k = 1; I2 = not applicable;
ZSRDS: mean 32.00, SD 8.00, n = 12 versus mean 43.00, SD 14.00,
n  =  12;  MD  -11.00,  95%  CI  -20.12  to  -1.88;  N  =  24;  k  =  1;  I2  =  not
applicable).

By  the  six-month  follow-up  assessment,  although  there  was  no
effect for behaviour therapy on depression according to the ZSRDS
(mean 34.00, SD 8.00, n = 12 versus mean 41.00, SD 13.00, n = 12; MD
-7.00, 95% CI -15.64 to 1.64; N = 24; k = 1; I2 = not applicable), BDI
scores did show an effect (mean 4.00, SD 6.00, n = 12 versus mean
13.00, SD 11.00, n = 12; MD -9.00, 95% CI -16.09 to -1.91; N = 24; k =
1; I2 = not applicable).

12.3.4 Hopelessness

No data available.

12.3.5 General functioning

No data available.

12.3.6 Social functioning

No data available.

12.3.7 Suicidal ideation

There  was  no  evidence  of  an  effect  for  behaviour  therapy  on  the
proportion  of  participants  reporting  suicidal  ideation  by  the  24-
month follow-up assessment (5/12 versus 9/12; OR 0.24, 95% CI 0.04
to 1.36; N = 24; k = 1; I2 = not applicable).

12.3.8 Suicide

No data available.

No included trial stratified randomisation by sex or repeater status.

Subgroup analyses

Sensitivity analyses

Not applicable.

No included trial stratified randomisation by sex or repeater status.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

59

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Sensitivity analyses

Not applicable.

Comparison 12.4: Intensive in- and outpatient treatment

One trial compared the effectiveness of brief psychiatric inpatient
admission  followed  by  regular  outpatient  appointments  and  24-
hour access to the psychiatric unit with TAU over a 12-month follow-
up  period  in  adults  (mean  age:  36.3  ±  15.1  years;  57.7%  female)
admitted to a general hospital following a suicide attempt (Van der
Sande 1997, N = 274).

Primary outcome

12.4.1 Repetition of SH

There was no evidence of an effect for intensive in- and outpatient
treatment  on  repetition  of  SH  by  the  12-month  follow-up  period
(24/140 versus 20/134; OR 1.18, 95% CI 0.62 to 2.25; N = 274; k = 1;
I2 = not applicable).

There was no evidence of an effect for intensive in- and outpatient
treatment on frequency of repetition of SH (mean 0.23, SD 0.57, n
= 140 versus mean 0.23, SD 0.81, n = 134; MD 0.00, 95% CI -0.17 to
0.17, N = 274; k = 1; I2 = not applicable).

There  was  also  no  evidence  of  an  effect  for  intensive  in-  and
outpatient treatment on time to SH repetition in this trial (HR 1.24,
95% CI 0.68 to 2.27; N = 274; k = 1; I2 = not applicable).

Secondary outcomes

12.4.2 Treatment adherence

There was no effect for intensive in- and outpatient treatment in
the total number of treatment sessions attended (mean 14.30, SD
24.20, n = 140 versus mean 11.40, SD 27.70, n = 134; MD 2.90, 95% CI
-3.27 to 9.07; N = 274; k = 1; I2 = not applicable).

12.4.3 Depression

There was also no effect for intensive in- and outpatient treatment
on depression scores by the 12-month follow-up assessment (mean
30.80, SD 15.90, n = 94 versus mean 35.80, SD 16.20, n = 50; MD -5.00,
95% CI -10.52 to 0.52; N = 144; k = 1; I2 = not applicable).

12.4.4 Hopelessness

There was no effect for intensive in- and outpatient treatment on
hopelessness scores by the 12-month follow-up assessment in this
trial (mean 6.10, SD 5.00, n = 94 versus mean 7.50, SD 5.90, n = 50;
MD -1.40, 95% CI -3.32 to 0.52; N = 144; k = 1; I2 = not applicable).

12.4.5 General functioning

No data available.

12.4.6 Social functioning

No data available.

12.4.7 Suicidal ideation

No data available.

12.4.8 Suicide

Cochrane Database of Systematic Reviews

Subgroup analyses

Whilst  randomisation  was  stratified,  data  disaggregated  by  sex
were not reported.

Sensitivity analyses

Not applicable.

Comparison 12.5: General hospital admission

One trial investigated the effectiveness of admission to a general
hospital versus non-admission over a four-month follow-up period
in  adults  (mean  age:  30.0  years,  SD  not  reported;  62.3%  female)
presenting  to  an  emergency  room  following  an  episode  of  self-
poisoning  and  who  had  no  immediate  medical  or  psychiatric
treatment needs (Waterhouse 1990, N = 77). In this trial, admission
was  described  as  consisting  of  little  more  than  admission  to  an
inpatient bed. The trial authors did not attempt to influence referral
to  psychiatric  or  other  treatment  services.  The  median  length  of
admission  for  those  allocated  to  the  experimental  group  was  17
hours.

Primary outcome

12.5.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  hospital  admission  on
repetition of SH at the post-intervention assessment (2/38 versus
2/39; OR 1.03, 95% CI 0.14 to 7.69; N = 77; k = 1; I2 = not applicable).
According to the GRADE criteria, we judged the evidence to be of
moderate certainty.

There  was  also  no  evidence  of  an  effect  for  general  hospital
management  on  repetition  of  SH  by  the  four-month  follow-up
assessment (3/38 versus 4/39; OR 0.75, 95%CI 0.16 to 3.60; N = 77; k
= 1; I2 = not applicable) in this trial.

Secondary outcomes

12.5.2 Treatment adherence

No data available.

12.5.3 Depression

No data available.

12.5.4 Hopelessness

The  authors  reported  there  was  no  difference  in  hopelessness
scores  at  the  post-intervention  assessment  (mean  10.29,  SD  5.68
versus mean 10.21, SD 4.97); however, as they did not provide the
numbers of patients in each group, we were unable to calculate the
MD and its associated 95% CI. No data on hopelessness scores by
the follow-up assessment were reported.

12.5.5 General functioning

No data available.

12.5.6 Social functioning

There was no evidence of an effect for hospital admission on social
functioning by the four-month assessment in this trial (mean 0.41,
SD 0.44, n = 16 versus mean 0.51, SD 0.40, n = 20; MD -0.10, 95% CI
-0.38 to 0.18; N = 36; k = 1; I2 = not applicable).

There was also no evidence of an effect for suicide by the 12-month
follow-up assessment in this trial (1/140 versus 2/134; OR 0.47, 95%
CI 0.04 to 5.30; N = 274; k = 1; I2 = not applicable).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

60

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

12.5.7 Suicidal ideation

There  was  no  evidence  of  an  effect  for  hospital  admission  on
suicidal  ideation  scores  by  the  four-month  follow-up  assessment
(mean 0.22, SD 0.85, n = 27 versus mean 0.04, SD 0.20, n = 25; MD
0.18, 95% CI -0.15 to 0.51; N = 52; k = 1; I2 = not applicable).

12.5.8 Suicide

No data available.

Subgroup analyses

12.6.4 Hopelessness

No data available.

12.6.5 General functioning

For  one  of  these  trials,  the  authors  found  "[t]here  was  no
difference...in scores on the...GAS" (Allard 1992, pg.311) by the 24-
month follow-up period. However, numerical data for this outcome
were not reported.

12.6.6 Social functioning

No included trial stratified randomisation by sex or repeater status.

No data available.

Sensitivity analyses

Not applicable.

Comparison 12.6: Intensive outpatient treatment

Two  trials  compared  the  effectiveness  of  intensive  outreach
interventions  with  standard  outpatient  care  in  adults  (weighted
mean age: 29.0 years, SD not reported; 55.3% female) admitted to
emergency departments following a suicide attempt (Allard 1992,
N  =  150;  Welu  1977,  N  =  119).  The  first  compared  an  intensive
intervention, involving psychiatrists and a social worker, a schedule
of visits including at least one home visit, therapy provided where
needed,  reminders  (telephone  or  written),  and  home  visits  with
treatment  by  regular  personnel  in  the  same  hospital  over  a  12-
month  period  (Allard  1992).  In  the  second,  a  specialist,  intensive
outreach  programme  in  which  a  community  mental  health  team
contacted participants immediately after discharge and arranged
home  visits  and  weekly  or  bi-weekly  contact  with  therapists
alongside routine psychiatric consultation was compared with TAU.

Primary outcome

12.6.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  intensive  outpatient
treatment on repetition of SH by either the four-month (3/62 versus
9/57; OR 0.27, 95% CI 0.07 to 1.06; N = 119; k = 1; I2 = not applicable;
Welu 1977) or 24-month follow-up assessment (22/63 versus 19/63;
OR 1.24, 95% CI 0.59 to 2.62; N = 126; k = 1; I2 = not applicable; Allard
1992).

In the one trial that included information on frequency of repeated
SH  by  the  24-month  follow-up  assessment,  the  authors  reported
that "the experimental subjects did not make fewer attempts than
the comparison subjects" (Allard 1992, pg.310).

Secondary outcomes

12.6.2 Treatment adherence

Data  on  treatment  adherence  were  only  available  for  one  of
these trials (Allard 1992); however, as insufficient information was
reported to enable imputation of missing SDs in this trial, we were
unable to calculate the mean difference in the number of treatment
sessions  attended.  Nevertheless,  the  trial  authors  reported  that
"[t]he mean numbers of encounters with psychiatrists were 12.35
versus  1.54  (P  <  0.001)  in  the  first  year  and  2.11  versus  0.64  (P  =
0.071) in the second year" (Allard 1992, pg.311).

12.6.3 Depression

No data available.

12.6.7 Suicidal ideation

No data available.

12.6.8 Suicide

One trial reported data on suicide deaths (Allard 1992). There was
no evidence of an effect for the intensive outpatient intervention
on suicides by the 24-month follow-up assessment in this trial (3/76
versus 1/74; OR 3.00, 95% CI 0.30 to 29.52; N = 150; k = 1; I2 = not
applicable).

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 12.7: Home-based psychotherapy and telephone
contact

One  trial  investigated  the  effectiveness  of  problem-oriented
counselling  delivered  in  two  different  ways,  namely  as  a  flexibly-
timed  home-based  therapy,  combined  with  open  access  via
telephone  services  to  the  general  psychiatric  service,  versus
treatment  in  weekly  outpatient  clinics,  in  adults  (mean  age:  25.2
± 8.2 years; 69.8% female) referred to the psychiatric department
of  a  general  hospital  following  admission  for  self-poisoning
(irrespective of suicidal intent) (Hawton 1981, N = 96).

Primary outcome

12.7.1 Repetition of SH

There was no evidence of an effect for home-based psychotherapy
and telephone contact on repetition of SH by the 12-month follow-
up assessment in this trial (5/48 versus 7/48; OR 0.68, 95% CI 0.20
to 2.32; N = 96; k = 1; I2 = not applicable).

Secondary outcomes

12.7.2 Treatment adherence

There  was,  however,  evidence  of  an  effect  for  home-based
psychotherapy  and  telephone  contact  on  the  proportion  of
participants who completed treatment over the course of the 12-
month follow-up period (40/48 versus 20/48; OR 7.00, 95% CI 2.70
to 18.13; N = 96; k = 1; I2 = not applicable).

12.7.3 Depression

Although  this  trial  included  data  on  depression,  the  trial  authors
modified the scale used. We were therefore unable to include data
on this outcome in this review.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

61

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

12.7.4 Hopelessness

No data available.

12.7.5 General functioning

No data available.

12.7.6 Social functioning

Although  this  trial  included  data  on  social  functioning,  the  trial
authors  modified  the  scale  used.  We  were  therefore  unable  to
include data on this outcome in this review.

12.7.7 Suicidal ideation

Data obtained by correspondence suggested there was no effect for
suicidal ideation at either the post-treatment assessment (Mann-
Whitney  U  =  984,  P  =  0.29)  or  six-month  follow-up  assessment
(Mann-Whitney  U  =  726,  P  =  0.14).  As  only  median,  rather  than
mean, scores were available for this outcome, we were unable to
reproduce the mean difference in suicidal ideation scores between
the experimental and control groups in this review.

12.7.8 Suicide

No data available.

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

Comparison 12.8: Long-term therapy

One trial investigated the effectiveness of long-term (one session
per  month  over  12  months)  versus  short-term  (one  session  per
week  over  12  weeks)  outpatient  psychotherapy  on  repetition  of
SH  over  a  12-month  follow-up  period  in  adults  (mean  age:  not
reported,  SD  not  reported;  100%  female)  admitted  to  hospital
following repeated episodes of self-poisoning (Torhorst 1988, N =
80). The content of therapy was not specified.

Primary outcome

12.8.1 Repetition of SH

There  was  no  evidence  of  an  effect  for  long-term  therapy  on
repetition  of  SH  by  the  post-intervention  assessment  in  this  trial
(9/40 versus 9/40; OR 1.00, 95% CI 0.35 to 2.86; N = 80; k = 1; I2 = not
applicable). According to GRADE criteria, we judged the evidence to
be of low certainty.

Secondary outcomes

12.8.2 Treatment adherence

The  trial  authors  did  not  provide  numerical  data  on  treatment
adherence, although they stated, "[a]ttendance at the first session
was  about  equal  for  both  groups  (about  60%)"  (Torhorst  1988,
pg.420).  However,  they  further  stated  that  "participation  of  the
12-month  (long-term  therapy)  group  dropped  drastically  by  the
second session to under 40%, while the participation of the patients
in the 3-month (intensive short-term therapy) program remained
higher" (Torhorst 1988, pg.420). However, it was unclear whether
this difference was statistically significant.

Cochrane Database of Systematic Reviews

Overall, treatment adherence also appears to have been very low
in  both  groups  as  the  "average  number  of  sessions  was  3.9  (out
of  a  possible  12  sessions)  in  the  three-month  group  and  2.6  (out
of a possible 12 sessions) for the 12 month group" (Torhorst 1988,
pg.420). Again, however, it was unclear whether this difference was
statistically significant as insufficient information was reported to
enable imputation of missing SDs in this trial.

12.8.3 Depression

Although numerical data on depression scores was not reported,
means estimated by the review authors from a graph in the original
report  suggested  there  was  little  difference  in  depression  scores
between those allocated to long-term therapy and those allocated
to  short-term  therapy  by  the  12-month  follow-up  assessment
(estimated means 9.3 versus 6.7). However, insufficient information
was reported to enable imputation of missing SDs for this outcome.

trial  authors,  however, 

The 
"self-evaluated
depressivity...improved  considerably  more  for  the  patients  of
the  three-month  program  than  for  those  of  the  12-month
program" (Torhorst 1988, pg.421). This improvement was described
by the trial authors as statistically significant.

stated 

that 

12.8.4 Hopelessness

No data provided.

12.8.5 General functioning

No data provided.

12.8.6 Social functioning

Whilst  "[p]atients  in  the  3-month  group  evaluated  themselves
according to the Social Adjustment Scale (SAS) significantly more
positively...than did the patients of the 12-month group" (Torhorst
1988, pg.421), numerical data for this outcome were not reported.

12.8.7 Suicidal ideation

No data provided.

12.8.8 Suicide

No data provided.

Subgroup analyses

No included trial stratified randomisation by sex or repeater status.

Sensitivity analyses

Not applicable.

D I S C U S S I O N

This  review  included  76  trials,  21  (27.6%)  of  which  have  been
completed  since  the  previous  version  of  this  review  (Hawton
2016).  Previously,  we  commented  that  the  promising  results
for  CBT-based  psychological  therapy  and  DBT  warranted  further
investigation  of  these  approaches  to  understand  which  patients
benefit from these types of interventions. There were only a few,
generally small, trials of most other forms of psychosocial therapy,
providing little evidence of beneficial effects; however, these could
not be ruled out.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

62

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Summary of main results

The trials included in this review investigated the effectiveness of
various forms of psychosocial interventions for SH in adults.

to  obtain  data  on  combined  SH  from  the  trial  authors  despite
correspondence. There was also no apparent effect for DBT group-
based  skills  training  only  on  any  of  the  secondary  outcomes
investigated in this trial.

CBT-based psychotherapy

Individual-based CBT-based psychotherapy

Whilst  20  trials  investigated  the  effectiveness  of  individual-based
cognitive-behavioural  therapy  (CBT)-based  psychotherapy,  only
four (20.0%) reported data on the primary outcome of this review
(i.e.,  repetition  of  SH  at  post-intervention).  Although  there  was
imprecision  in  the  effect  estimate,  on  the  basis  of  data  from
four  of  these  trials,  individual-based  CBT-based  psychotherapy
may  reduce  repetition  of  SH  as  compared  to  TAU  or  another
comparator  by  the  end  of  the  intervention.  At  longer  follow-up
time  points,  there  was  more  robust  evidence  of  effect  for  this
intervention. However, there was no apparent effect for CBT-based
psychotherapy on the frequency of SH, or time to SH repetition.

Few  trials  reported  information  on  secondary  outcomes.  CBT-
based  psychotherapy  was  associated  with  a  relatively  consistent
but  small  beneficial  effect  on  depression,  hopelessness,  and
suicidal  ideation  scores  as  compared  with  TAU  or  another
comparator  over  time.  There  was  no  apparent  effect  for  this
intervention on suicide, however.

Group-based CBT-based psychotherapy

in  which  CBT-
On  the  basis  of  data  from  a  single  trial 
based  psychotherapy  was  delivered  in  a  group-based  format,
there  is  probably  little  to  no  effect  of  group-based  CBT-based
psychotherapy on repetition of SH as compared to TAU by the end
of  the  intervention.  There  was  also  no  evidence  of  effect  for  this
intervention approach at longer follow-up assessment points.

There was also no apparent effect of this intervention approach on
any of the secondary outcome measures assessed by this review.

Dialectical behaviour therapy (DBT)

Standard DBT

On the basis of data from six trials, the evidence remains uncertain
as to whether standard DBT has any effect on absolute repetition
of  SH  by  the  post-intervention  assessment  compared  to  either
TAU  or  alternative  psychotherapy  in  terms  of  the  proportion  of
participants  engaging  in  repeat  SH  by  the  post-intervention  or
12-month follow-up assessments. However, standard DBT may be
associated with an effect for frequency of repeated SH by the post-
intervention assessment.

Whilst there was an apparent effect for standard DBT on depression
and  suicidal  ideation  scores  compared  with  TAU  or  another
comparator  at  post-intervention,  these  effects  were  generally  no
longer apparent at longer follow-up time points; however, few trials
investigated  these  secondary  outcomes.  There  was  no  apparent
effect for standard DBT on suicide.

DBT group-based skills training

Based  on  one  trial  in  which  two  variants  of  DBT  were  compared
to  standard  DBT,  there  is  probably  little  to  no  effect  of  DBT
group-based  skills  training  on  absolute  or  frequency  of  suicide
reattempts or NSSI (Linehan 2015a). For this trial, we were unable

DBT individual therapy

There  is  also  probably  little  to  no  effect  for  DBT  individual
skills training only on absolute repetition or frequency of suicide
reattempts or NSSI as compared to standard DBT, based on findings
of the single trial which included this comparison (Linehan 2015b).
Again,  however,  we  were  unable  to  obtain  data  on  combined  SH
from the trial authors despite correspondence. There was also no
apparent effect for DBT individual skills training only on any of the
secondary outcomes investigated in this trial.

DBT prolonged-exposure protocol

On the basis of data from a single trial, there is probably little to no
effect of an experimental form of DBT in which participants were
given  significantly  longer  cognitive  exposure  to  stressful  events
coupled with the standard DBT protocol on repetition of SH (Harned
2014).  There  was  also  no  apparent  effect  for  the  DBT  prolonged
exposure  intervention  on  frequency  of  SH  repetition,  treatment
adherence, depression scores, or suicide.

Mentalisation-based therapy (MBT)

On  the  basis  of  data  from  a  single  trial,  mentalisation-based
therapy (MBT) for adults referred to a specialist personality disorder
treatment  service  reduces  both  absolute  repetition  of  SH  and
frequency of SH by the post-intervention assessment as compared
with TAU (Bateman 2009).

There was also an apparent effect for MBT on depression scores,
general  functioning  scores,  and  social  functioning  scores  by  this
time  point.  However,  there  was  no  apparent  effect  for  this
intervention  on  treatment  adherence.  No  participants  died  by
suicide in either trial arm by the post-intervention assessment.

Emotion regulation psychotherapy

On  the  basis  of  data  from  two  trials  conducted  by  the  same
research  group,  emotion-regulation  psychotherapy  for  women
diagnosed  with  borderline  personality  disorder  provided  in  a
group-based setting probably reduces absolute repetition of SH by
the  post-intervention  assessment  (Gratz  2006;  Gratz  2014).  There
was  no  apparent  effect  for  this  intervention  on  frequency  of  SH
repetition. However, correspondence with authors suggested that
this  treatment  did  not  require  participants  to  abstain  from  SH.
Instead, participants were encouraged to work on resisting urges to
engage in SH and, when SH occurred, to learn responses to it.

There  was  also  evidence  of  an  apparent  effect  for  group-based
emotion  regulation  psychotherapy  on  depression  scores  by  the
post-intervention  assessment.  No  participants  died  by  suicide  in
either trial arm by the post-intervention assessment.

Psychodynamic psychotherapy

Whilst two trials investigated the effectiveness of psychodynamic
psychotherapeutic approaches as compared to TAU (Andreoli 2015;
Sahin  2018),  we  were  only  able  to  include  data  from  the  first  of
these trials despite attempts to obtain data for the second trial by
correspondence. Therefore, based on data from one trial, there is
probably  little  to  no  effect  of  psychodynamic  psychotherapy  on

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

63

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

repetition  of  SH  by  the  post-intervention  assessment.  However,
there  was  an  apparent  effect  of  this  intervention  on  time  to  SH
repetition.

There was also evidence of an apparent effect for this intervention
on  treatment  adherence,  depression  scores,  general  functioning
scores, and frequency of suicidal ideation episodes necessitating
additional  intensive  psychiatric  care  by  the  post-intervention
assessment.  There  was  no  apparent  effect  on  suicide  deaths.
However, these results were all based on a single trial.

Case management

Five  trials  investigated  the  effectiveness  of  case  management  as
compared  to  either  TAU  (Clarke  2002;  Hvid  2011;  Van  Heeringen
1995) or enhanced usual care (Kawanishi 2014; Morthorst 2012). On
the basis of data from four of these trials, case management may
have little to no effect on repetition of SH by the post-intervention
assessment.  The  impact  of  this  intervention  over  longer  term
follow-up  is  uncertain  as  only  one  of  these  trials  investigated
outcomes  beyond  the  post-intervention  assessment  time  point.
There were inconsistent findings for case management on time to
SH repetition in two trials.

Findings from a single trial indicated that case management may
be  associated  with  an  effect  on  the  proportion  of  participants
who  completed  treatment,  which  was  based  on  attendance
for  outpatient  clinic  appointments,  the  patient  sample  having
been  identified  before  the  trial  as  having  failed  to  attend
such  appointments  (Van  Heeringen  1995).  However,  few  studies
reported data on other secondary outcomes. For one trial, although
data  on  hopelessness  scores  at  post-intervention  were  collected,
data  on  this  outcome  have  not  been  reported  in  any  secondary
publications of this trial to date (Kawanishi 2014), indicating that
publication  bias  may  have  been  present  for  this  outcome.  There
was no apparent effect for case management on suicide.

Structured general practitioner (GP) follow-up

Based  on  results  of  a  single  trial  of  structured  follow-up  by  the
participants' general practitioner (GP) compared with TAU in adults
admitted  to  the  acute  ward  of  a  general  hospital  following  an
episode  of  self-poisoning  (Grimholt  2015),  this  intervention  may
have little to no effect on repetition of SH by the post-intervention
assessment.

There was also no apparent effect for structured GP follow-up on
treatment adherence, depression scores, hopelessness scores, and
suicidal ideation scores, although missing data for these secondary
outcomes  was  substantial  (i.e.  70.5%  to  91.3%).  Therefore,  the
evidence for these secondary outcomes is uncertain. There was also
no apparent effect for this intervention on suicide.

Brief emergency department-based interventions

Five  trials  investigated  one-off  brief  interventions  delivered  in
the  emergency  department.  Two  were  based,  in  a  large  part,
on  the  Collaborative  Assessment  and  Management  of  Suicidality
(CAMS) approach (Jobes 2012), two were based on the Integrated
Motivational-Volitional  theoretical  model  of  suicidal  behaviour
(O'Connor 2011), and one focused on addressing alcohol misuse.

Cochrane Database of Systematic Reviews

Brief Collaborative Assessment and Management of Suicidality
(CAMS)-based intervention

On the basis of data from a single trial, there is likely no effect of a
CAMS-based approach on repetition of SH by the 12-month follow-
up assessment (O'Connor 2020). There was also no apparent effect
for this intervention on frequency of SH repetition by this time point
based on data estimated from graphics presented in the report of
this trial.

Limited  data  were  available  on  any  of  the  secondary  outcomes
assessed  in  this  review.  Although  trial  authors  reported  that
there  were  improvements  in  hopelessness  and  suicidal  ideation
scores  by  the  six-month  assessment  in  the  original  trial  of  this
intervention  (O'Connor  2015),  this  effect  was  no  longer  apparent
by the 12-month follow-up assessment in a subsequent trial of this
intervention (O'Connor 2020).

Brief guided Integrated Motivational-Volitional-focused
intervention

On the basis of data from a single trial, there is likely no effect of the
Integrated Motivational-Volitional model either on the proportion
of  participants  who  engaged  in  a  repeat  episode  of  SH,  the
frequency of SH repetition, or in the proportion dying by suicide, as
compared with TAU (O'Connor 2017).

There  was  some  evidence  of  an  effect  for  this  intervention  on
treatment  adherence  in  this  trial,  however,  there  was  also  no
indication  that  this  approach  led  to  a  reduction  in  depression
scores  in  a  second  trial  (Armitage  2016a).  There  was  also  no
evidence  of  an  apparent  effect  for  this  intervention  on  suicide
deaths.

Brief self-guided Integrated Motivational-Volitional-focused
intervention

The  second  intervention  arm  in  Armitage  2016  investigated
the  effectiveness  of  a  self-guided  version  of  the  Integrated
Motivational-Volitional  model  as  compared  to  TAU  (i.e.  Armitage
2016b).  However, 
in  this  trial,  data  on  repetition  of  non-
fatal  SH  could  not  be  disaggregated  from  data  on  suicidal
ideation,  despite  correspondence.  Therefore,  the  evidence  for
these  secondary  outcomes  is  uncertain.  There  was  no  apparent
effect for this intervention approach on depression scores by the
post-intervention assessment, however.

Brief alcohol-focused intervention

Based  on  a  single  trial  of  a  brief  intervention  for  alcohol  misuse
in  SH  patients,  there  is  likely  no  effect  of  this  intervention  on
repetition of SH by the six-month follow-up assessment (Crawford
2010).  However,  only  around  half  (47.1%)  of  those  randomised
to  the  brief  alcohol-focused  intervention  attended  the  treatment
session.

No suicide deaths were observed amongst the group of participants
for  whom  information  was  available  at  the  six-month  follow-up.
However,  the  trial  authors  warned  that,  as  they  were  unable
to  track  participants  via  their  National  Health  Service  (NHS)
identity numbers, they were unable to confirm numbers of suicides
from  national  mortality  data.  Thus,  there  may  have  been  suicide
deaths amongst those participants whom the authors were unable
to  contact  by  the  six-month  follow-up  assessment  in  this  trial.
The  original  report  did,  however,  identify  a  non-significant  trend

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

64

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

towards  reduced  alcohol  consumption  per  drinking  day  in  those
allocated to the intervention arm.

Remote contact interventions

A  number  of  trials  investigated  the  effectiveness  of  a  variety
of  remote  contact  interventions,  including:  emergency  cards
(Evans  1999a;  Morgan  1993),  coping  cards  (Wang  2016),  general
practitioners'  (GP)  letters  (Bennewith  2002),  postcards  (Beautrais
2010;  Carter  2005;  Hassanian-Moghaddam  2011;  Kapur  2013),
telephone  contact  (Cedereke  2002;  Mousavi  2015;  Vaiva  2006),
telephone  contact  combined  with  emergency  cards  and  letters
(Mouaffak 2015; Vaiva 2018), and telephone-based psychotherapy
(Marasinghe 2012; Sreedaran 2020; Wei 2013).

Emergency cards

On  the  basis  of  data  from  two  trials,  emergency  cards  may  have
little  to  no  effect  on  repetition  of  SH  by  the  post-intervention
assessment (Evans 1999a; Morgan 1993). In the original report for
one of these trials, however, a post hoc subgroup analysis indicated
that  receipt  of  the  emergency  card  may  be  associated  with  an
increased risk of repetition of SH in those with a history of multiple
episodes of SH prior to the index episode (Evans 1999a).

There was also no apparent effect for this intervention on suicide
deaths on the basis of data reported in one of these trials (Evans
1999a).  No  data  on  other  secondary  outcomes  were  reported  in
either of these two trials.

Coping cards

A  single  trial  investigated  the  effectiveness  of  a  coping  card
intervention, in which participants were encouraged to note down
alternative  activities  they  could  engage  in  when  feeling  suicidal,
resources  they  found  helpful  when  seeking  help,  as  well  as  the
numbers of a 24-hour crisis line and local medical services (Wang
2016). On the basis of data from this trial, there is probably little
to  no  effect  of  coping  cards  on  repetition  of  SH  by  the  post-
intervention assessment. There may be an apparent effect for this
intervention on time to SH repetition.

There  was  no  apparent  effect  of  coping  cards  on  hopelessness
scores at post-intervention. However, whilst the authors measured
depression  and  suicidal  ideation  scores  at  post-intervention,
we  were  unable  to  obtain  data  on  these  outcomes  despite
correspondence.  Therefore,  the  evidence  for  these  secondary
outcomes is uncertain.

General practitioner (GP) letters

There  is  likely  no  effect  of  general  practitioners  (GP)  letters  sent
to participants following their discharge from hospital after SH on
repetition of SH by the six-month follow-up assessment in a single
cluster-RCT  (Bennewith  2002).  There  was  also  no  apparent  effect
for this intervention on time to SH repetition. These results were
based on a single cluster-RCT, which may have overestimated the
effectiveness of this intervention. No data on any of the secondary
outcomes were reported, however.

Postcards

Four  trials  investigated  the  effectiveness  of  postcards  sent  on
a  regular  basis  over  a  12-month  period  as  compared  to  TAU
(Beautrais 2010; Carter 2005; Hassanian-Moghaddam 2011; Kapur
2013).  On  the  basis  of  data  from  these  four  trials,  the  evidence

Cochrane Database of Systematic Reviews

remains  uncertain  as  to  whether  postcards  have  any  effect
on  repetition  of  SH  by  the  post-intervention  assessment.  The
single  largest  trial  of  this  intervention,  however,  did  find  fewer
participants  repeating  SH  in  the  experimental  group  (Hassanian-
Moghaddam 2011). This result is notable because the comparator
used in this trial would have consisted of little more than discharge
because of the paucity of psychiatric services in Iran as compared
to  Australia,  New  Zealand,  and  the  UK,  where  these  trials  were
conducted and which have well-developed services. This raises the
possibility that this type of intervention may be more effective in
such settings. Additionally, the postcards used in this trial included
religious  and  philosophical  messages  in  addition  to  providing
general support, which may also explain their apparent efficacy in
reducing SH and suicidal behaviour in this setting.

There  was  no  apparent  effect  of  postcards  on  frequency  of  SH
repetition by this time point. It should be noted that the positive
effect on frequency of repetition of SH as reported in one of these
trials was, according to the trial's author, largely accounted for by
difference in repetition in a small subsample (fewer than 3% of the
total sample) of women with a history of three or more episodes
of SH prior to trial entry (Carter 2005). There was also no apparent
effect of this intervention on suicide deaths.

Telephone contact

On the basis of data from one trial at each time point, telephone
contact  may  have  little  to  no  effect  on  repetition  of  SH  by  either
the post-intervention (Mousavi 2015), 12-month (Cedereke 2002),
or  24-month  (Vaiva  2006)  follow-up  assessments.  There  was  also
no  evidence  of  an  effect  for  this  intervention  on  frequency  of  SH
repetition. There was also no apparent effect for telephone contact
on suicide, or on any of the other secondary outcomes.

Telephone contact combined with emergency cards and letters

Two trials investigated the effect of combining telephone contact
with emergency cards and letters for those unable to be contacted
by  telephone  (Mouaffak  2015;  Vaiva  2006).  On  the  basis  of  data
from  the  first  of  these  trials,  telephone  contact  combined  with
emergency  cards  and  letters  probably  has  little  to  no  effect  on
repetition  of  SH  by  the  post-intervention  assessment.  However,
data  from  the  second  trial  of  this  intervention  approach  was
excluded as information on non-fatal SH repetition was combined
with  that  for  suicide  deaths  and  we  were  unable  to  obtain
disaggregated data from the trial authors in time for publication.
There was also no apparent effect for this intervention on frequency
of  SH  repetition,  time  to  SH  repetition,  or  on  suicide.  Neither
trial investigated other secondary outcomes, including depression,
general or social functioning, or suicidal ideation.

Telephone-based psychotherapy

Three  trials  investigated  the  effectiveness  of  psychotherapy
delivered  via  telephone  (Marasinghe  2012;  Sreedaran  2020;  Wei
2013).  In  all  three,  the  intervention  approach  incorporated
principles  of  CBT-based  psychotherapy,  third-wave  techniques,
and  social  support.  On  the  basis  of  data  from  two  of  these
trials, telephone-based psychotherapy may have little to no effect
on  repetition  of  SH  by  the  post-intervention  assessment,  or  by
the  six-  or  12-month  follow-up  assessments  based  on  results  in
one  of  these  trials.  There  was  no  apparent  effect  for  telephone-
based psychotherapy on treatment adherence, depression, suicidal
ideation, or suicide.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

65

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Provision of information and support

On  the  basis  of  data  from  two  multicentre  and  multi-country
trials,  one  of  the  START  model  (Amadéo  2015)  and  a  second  of
the SUPRE-MISS model (Fleischmann 2008), in which participants
received  a  hospital-based  information  service  combined  with
regular  home  support,  telephone  support  or  both,  the  evidence
remains  uncertain  as  to  whether  this  intervention  has  any  effect
on repetition of SH by the post-intervention assessment. We had
to exclude one further trial of this approach from our analyses as
there were major discrepancies in the data reported which we were
unable  to  clarify  with  the  trial  authors  despite  correspondence
(Naidoo 2014).

There  was  an  apparent  effect  for  this  intervention  approach  on
suicide deaths. However, we have noted that there is a discrepancy
between  findings  for  the  overall  cohort  for  one  of  these  trials
(i.e.  Fleischmann  2008)  and  those  reported  for  the  individual
sites  (i.e.  Hassanzadeh  2010;  Vijayakumar  2011;  Xu  2012),  in  that
the  number  of  suicides  reported  for  the  overall  cohort  for  the
intervention  arm  was  fewer  than  that  reported  in  the  three  local
site reports (i.e. two versus three respectively). Data on secondary
outcomes  were  only  reported  for  the  individual  trial  sites,  rather
than for the overall cohort for these trials.

Other multimodal interventions

Three  Zelen  RCTs  investigated  the  effectiveness  of  a  package  of
interventions, including CBT-based psychotherapy, remote contact
interventions  (e.g.  telephone  contact,  letters,  and/or  postcards),
and  GP  vouchers  in  adults  admitted  to  emergency  departments
following  an  episode  of  SH  (Gysin-Maillart  2016;  Hatcher  2015;
Hatcher  2016).  For  one  of  these  trials,  the  treatment  package
was culturally adapted for those who identified as being of Māori
ethnicity  (Hatcher  2016).  The  evidence  remains  uncertain  as  to
whether this package of interventions has any effect on repetition
of  SH  by  the  post-intervention  assessment,  or  on  time  to  SH
repetition.  There  was  an  apparent  effect  on  frequency  of  SH
repetition in one of these trials (Gysin-Maillart 2016).

There  was  no  evidence  of  an  apparent  effect  for  this  package  of
interventions  on  depression,  hopelessness,  or  suicidal  ideation
scores  by  the  post-intervention  assessment.  There  was  also  no
evidence of an apparent effect for this package of interventions on
suicide by the post-intervention assessment.

Other mixed interventions

Continuity of care by the same therapist

Based on a single trial, there is likely no effect of continuity of care
by the same therapist compared to receiving therapeutic contact
from  a  different  therapist  on  repetition  of  SH  by  the  12-month
assessment (Torhorst 1987). There was an apparent effect for this
intervention on treatment adherence, but no such effect on either
depression scores or suicide.

Interpersonal problem-solving therapy

Based  on  a  single  trial,  there  is  likely  no  effect  of  interpersonal
problem-solving  skills  training  (IPSST)  compared  to  alternative
psychotherapy  (i.e.  brief  problem-oriented  psychotherapy)  on
repetition of SH, hopelessness scores, and suicide by the 12-month
follow-up assessment (McLeavey 1994). There was also no overall
effect for this intervention on treatment adherence, although those

Cochrane Database of Systematic Reviews

assigned  to  the  IPSST  group  did  attend  a  greater  number  of
treatment sessions.

Behaviour therapy

Based  on  a  single  trial,  there  is  likely  no  effect  of  behaviour
therapy  compared  to  alternative  psychotherapy  (i.e.  insight-
oriented  therapy)  on  repetition  of  SH  by  the  24-month  follow-
up  assessment,  although  there  was  an  apparent  effect  for
behaviour therapy on depression scores as compared to alternative
psychotherapy,  at  least  in  the  short  term  (i.e.  post-intervention
assessment)  (Liberman  1981).  Behaviour  therapy  was  also
associated  with  mixed  findings  with  respect  to  suicidal  ideation
scores in this trial.

Intensive in- and outpatient treatment

Based  on  a  single  trial,  there 
is  likely  no  effect  of  brief
inpatient  psychiatric  admission  admission  followed  by  regular
outpatient  appointments  plus  24-hour  access  to  a  treatment
service  (i.e.  intensive  in-  and  outpatient  treatment)  compared  to
TAU on repetition of SH, frequency of SH repetition, or on time to SH
repetition by the 12-month follow-up assessment (Van der Sande
1997).  There  was  also  no  apparent  effect  for  this  intervention  on
treatment adherence, depression scores, hopelessness scores, or
suicide.

General hospital admission

Based on a single trial involving patients who would normally have
been admitted to a general hospital following SH, there is probably
little  to  no  effect  of  general  hospital  admission  compared  with
discharge from the hospital on repetition of SH by either the post-
intervention or the four-month follow-up assessment (Waterhouse
1990).  There  was  also  no  apparent  effect  for  this  intervention  on
social functioning or suicidal ideation scores by either time point.
However,  as  trial  entry  was  limited  to  low-risk  participants,  only
around 15% of presenting patients were eligible for inclusion in this
trial.

Intensive outpatient treatment

Based  on  two  trials  that  compared  a  combination  of  intensive
therapies, including psychotherapy, behaviour therapy, and family
therapy  versus  standard  outpatient  care,  there  is  likely  no  effect
of  intensive  outpatient  treatment  on  repetition  of  SH  by  either
the  four-month  (Welu  1977)  or  24-month  (Allard  1992)  follow-
up  assessments.  There  is  likely  no  effect  of  this  intervention
on  treatment  adherence,  general  functioning,  or  suicide  deaths;
although  secondary  outcomes  were  only  investigated  in  one  of
these two trials (Allard 1992).

Home-based psychotherapy and telephone contact

Based  on  a  single  trial,  there  is  likely  no  effect  of  home-based
psychotherapy  on  repetition  of  SH  by  the  12-month  follow-up
assessment  (Hawton  1981).  Whilst  there  was  an  apparent  effect
for  this  intervention  on  treatment  adherence,  there  was  no  such
effect on suicidal ideation scores. As modified scales were used to
assess depression and social functioning, however, we were unable
to include data for these secondary outcomes in our review.

Long-term therapy

Based  on  a  single  trial,  long-term  therapy  (the  therapeutic
content  and  focus  of  this  approach  was  not  specified)  may  have

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

66

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

little  to  no  effect  on  repetition  of  SH  by  the  post-intervention
assessment compared with short-term intensive therapy (Torhorst
1988). Overall treatment adherence was fairly low in both groups,
however. Estimates of scores from graphs also suggests there was
no apparent effect for long-term therapy on depression scores.

Overall completeness and applicability of evidence

Completeness of evidence

Where it was unclear whether a trial satisfied our inclusion criteria,
we  contacted  corresponding  trial  authors  for  clarification.  We
also contacted corresponding authors where data were either not
clearly reported, or where we required data reported in a different
format  to  allow  for  their  inclusion  in  a  meta-analysis.  However,
despite  engaging  in  over  200  emails  with  corresponding  authors
we were not always able to obtain all relevant data. This was due
to a combination of non-response to our enquiries and to authors
being  unable  to  access  relevant  data,  often  due  to  moving  on  to
later positions or as a result of working from home due to COVID-19
pandemic quarantine orders. This is a common problem in meta-
analyses (Selph 2014).

There are some concerns with regards to completeness of evidence
for  two  large  multicentre  and  multi-country  trials  of  information

Cochrane Database of Systematic Reviews

and support. For the START Study, although the trial was originally
scheduled to be conducted in 13 countries (De Leo 2013), data from
only  one  of  these  sites  (i.e.  French  Polynesia;  Amadéo  2015)  has
been  published  to  date.  Additionally,  while  the  SUPRE-MISS  trial
was  scheduled  to  be  conducted  in  18  sites  (Fleischmann  2002),
data  from  only  five  of  these  were  reported  in  Fleischmann  2008
and  a  related  publication  (Bertolote  2010).  Secondary  data  from
three sites (i.e. China [Xu 2012], Iran [Hassanzadeh 2010], and India
[Vijayakumar 2011]) have also been published. However, data for
the remaining sites involved in this trial have not been published to
date.

Presence of publication bias could only be formally evaluated for
three meta-analyses for CBT-based psychotherapy with respect to
repetition of SH at six months (Figure 4) and 12 months (Figure 5),
and for suicide deaths at final follow-up (Figure 6). In all cases, some
funnel plot asymmetry was apparent and seemed to affect the right
side  of  the  plot  suggesting  that  there  may  be  unpublished  trials
in which the intervention was found to be ineffective. However, as
the  remaining  meta-analyses  in  this  review  included  fewer  than
10 trials, we were unable to investigate publication bias for these
analyses.

Figure 4.   Funnel plot: CBT-based psychotherapy on repetition of SH at six-months.

0

SE(log[OR])

0.5

1

1.5

2
0.1

0.2

0.5

1

2

5

OR

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

67

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 5.   Funnel plot: CBT-based psychotherapy on repetition of SH at 12-months.

0

SE(log[OR])

0.5

1

1.5

2
0.1

0.2

0.5

1

2

5

OR

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

68

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 6.   Funnel plot: CBT-based psychotherapy on suicide deaths by final follow-up.

0

SE(log[OR])

0.5

1

1.5

2
0.01

0.1

1

10

OR

100

Whilst  all  but  two  of  the  included  trials  reported  information  on
repetition of SH, publication bias may have been more common for
the secondary outcomes assessed by this review. However, formal
testing  of  publication  bias  was  not  possible  due  to  the  small
number of trials. Therefore, we cannot rule out the possibility that
publication bias may have affected the results of the other analyses
in this review. This is a problem that commonly affects clinical data
(Easterbrook 1991).

Applicability of evidence

The majority of participants in these trials were female, reflecting
the  typical  pattern  in  hospital-presenting  populations  (Hawton
2008). Only four trials stratified randomisation by sex (Hvid 2011;
McAuliffe  2014;  Van  der  Sande  1997;  Walton  2020)  whilst  data
were  analysed  separately  by  sex  in  six  further  trials  (Bennewith
2002;  Carter  2005;  Fleischmann  2008;  Hassanian-Moghaddam
2011; Kapur 2013; Marasinghe 2012). Trials where sex was reported
largely indicated benefits for females, but not males, in line with a
previous review (Krysinska 2016). However, as these trials generally
included  fewer  males,  it  may  be  that  subgroup  results  for  males
were underpowered. Given that there are some differences in the
motives  for  SH  in  males  as  compared  to  females  (Claes  2007),
further work on the treatment needs and preferences of males who
engage in SH, as well as their experiences of clinical services, and
how these may differ from females who engage in SH, is warranted.
Further, a binary approach to gender was evident in the majority
of  trials.  There  was  therefore  poor  attention  to,  and  reporting
of, outcomes for those with a non-binary gender identity. There is

good evidence that there are higher risks of self-harm in those who
are gender diverse (Newcomb 2020).

The majority of trials included either patients who have all engaged
in intentional drug overdoses or self-poisoning, or samples where
the majority had, again reflecting the typical pattern observed in
patients  who  present  to  general  hospitals  following  SH  (Hawton
2007).  However,  there  are  other  important  patient  subgroups,
such as those who engage in self-cutting, who may have different
treatment needs (Hawton 2004). None of the trials included in this
review specifically focused on these patients; although it should be
noted that method switching is common in those who engage in
repeat episodes of SH (Witt 2019). In some trials there was a lack
of  information  relating  to  the  method  of  SH.  Seventeen  (22.4%)
trials  focused  on  those  with  a  history  of  repeated  SH,  which  is  a
particular issue in this clinical population, given the association of
individuals with a history of repeat episodes having a greater risk
of  suicide  (Zahl  2004).  However,  only  14  investigated  impacts  of
psychosocial interventions for those with an initial episode of SH
versus  those  engaging  in  repeated  SH  (Amadéo  2015;  Bennewith
2002; Carter 2005; Evans 1999a; Gratz 2014; Hatcher 2011; Hatcher
2015; Hatcher 2016; Hassanian-Moghaddam 2011; Kapur 2013; Lin
2020;  McAuliffe  2014;  Morthorst  2012;  Mouaffak  2015).  Outcomes
were generally not stratified by recruitment setting (e.g. emergency
department,  community,  and/or  GP-based  referrals).  This  could
be a focus of future trials and reviews. Secondary outcomes were
also infrequently assessed which limits interpretation of possible
mechanisms of effect.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

69

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Compared  to  previous  versions  of  this  review  (Hawton  2016),
there  is  now  greater  representation  of  trials  from  low-to-middle-
income  countries,  including:  Iran  (Hassanian-Moghaddam  2011;
Mousavi 2015; Mousavi 2017), Taiwan (Lin 2020; Wang 2016), China
(Wei  2013),  India  (Sreedaran  2020),  Malaysia  (Armitage  2016),
Pakistan (Husain 2014), South Africa (Naidoo 2014), and Sri Lanka
(Marasinghe 2012). Additionally, two multicentre and multi-country
trials were conducted in a number of countries, including several
low-to-middle-income  countries  (e.g.  Brazil,  China,  India,  and
Iran (Fleischmann 2008), and French Polynesia (Amadéo 2015)).

This  review  focused  exclusively  on  those  who  engaged  in  SH.
As  a  result,  we  have  excluded  trials  in  which  participants
were  diagnosed  with  conditions  such  as  borderline  personality
disorder  but  where  SH  was  not  required  for  trial  entry.  We  also
excluded  trials  in  which  participants  engaged  in  repetitive  self-
injurious  behaviour  in  the  context  of  an  intellectual  disability
or  developmental  disorder  (e.g.  an  autism  spectrum  disorder).
Readers  interested  in  the  use  of  psychosocial  interventions  for
these  patient  groups  are  instead  referred  to  the  relevant  reviews
(Cristea 2017; Oliver 2010).

Quality of the evidence

Certainty of evidence, as assessed using the GRADE approach, was
generally  moderate  to  very  low  suggesting  that  further  research
is  likely  to  have  an  important  impact  on  our  confidence  in  the
estimates of treatment effectiveness, and may in fact change the
estimates.  This  is  particularly  likely  to  affect  results  for  those
interventions that so far have only been assessed in single trials.

Additionally,  using  the  Cochrane  'Risk  of  bias'  tool  version  2.0
(Sterne 2019), for almost all (85.5%) trials included in this review
there  were  some  concerns  or  a  high  risk  of  bias  in  relation  to  at
least one aspect of trial design, with weaknesses most commonly
observed  with  respect  to  selection  of  the  reported  result  and
measurement of the outcome.

For most trials, insufficient information was reported to determine
whether data were analysed in accordance with a prespecified plan.
In  2015,  the  International  Committee  of  Medical  Journal  Editors
(ICMJE) recommended all clinical trials should be preregistered in
a public trials registry (Witt 2020a). Whilst around half (54.5%) of
the 22 trials published subsequent to this recommendation were
preregistered, in some cases there was insufficient detail provided
within the clinical trial register to determine how key outcome(s)
were  defined.  This  made  it  difficult  to  determine  whether  there
had  been  any  substantive  changes  to  the  proposed  analysis
plan and, if so, the reasons for any such departures. Future trials
should provide sufficient detail within the clinical trial register to
determine how key outcome(s) are defined and measured to aid in
the  determination  as  to  whether  there  has  been  any  substantive
changes to the proposed analysis plan, and if so, the reasons for any
such departures.

Cochrane Database of Systematic Reviews

based  on  self-reported  information  with  those  obtained  from
objective sources to investigate what impact, if any, this bias may
have had on the estimate of treatment effectiveness.

Additionally, participants and clinical personnel were, typically, not
blind to allocation owing to likely differences in treatment intensity
between  the  intervention  and  control  arms  (Witt  2020a).  Indeed,
due  to  safety  considerations,  unblinding  may  be  unavoidable  in
these types of trials. However, given that repetition of SH was based
on  self-report  in  a  number  of  the  included  trials  (Amadéo  2015;
Armitage  2016;  Brown  2005;  Davidson  2014;  Fleischmann  2008;
Gratz 2006; Gratz 2014; Harned 2014; Hassanian-Moghaddam 2011;
Husain 2014; Liberman 1981; Linehan 1991; Linehan 2006; Linehan
2015;  McMain  2009;  Mousavi  2015;  Mousavi  2017;  Naidoo  2014;
O'Connor 2015; O'Connor 2020; Priebe 2012; Sahin 2018; Slee 2008;
Tapolaa 2010; Torhorst 1987; Turner 2000; Walton 2020; Wei 2013;
Weinberg 2006), this may introduce potential bias.

Lastly, the trials included in this review were, in general, relatively
small to detect differences in proportions of patients who engage
in a repeat episode of SH, although it is acknowledged that some
of the trials were feasibility studies (Davidson 2014; Evans 1999b;
Gibbons 1978; Harned 2014; Kapur 2013; O'Connor 2015; O'Connor
2020;  Owens  2020;  Sreedaran  2020).  Whilst  sample  sizes  have
increased over time, most trials in this field are still underpowered.
We have previously calculated that trials in this field may need to
recruit up to a minimum of 1862 participants per arm to detect an
effect for repetition of SH with 80% power at the conventional alpha
level  (Witt  2020a).  Future  trials  should  therefore  supply  a  priori
power calculations to justify their sample size.

Potential biases in the review process

We are confident that we have identified all relevant psychosocial
interventions  for  SH  in  adults.  However,  we  cannot  rule  out  the
possibility that some relevant outcome data may be missing from
this  review.  Although  data  on  repetition  of  SH  were  available  for
all  but  two  of  the  included  trials,  limited  data  were  available  on
secondary  outcomes.  Nevertheless,  by  using  the  random-effects
model in all analyses, our results possess greater generalisability
than if we had used the fixed-effect model (Erez 1996).

It  is  worth  noting  that  the  categorisation  and  grouping  of
interventions in this review may, in some cases, obscure the nature
of  the  discrete  interventions  within  a  particular  comparison.  For
example,  a  decision  was  made  to  group  brief  problem  solving
therapy (PST) with CBT into a single comparison we have referred
to as 'CBT-based psychotherapy'. As PST is usually a component of
CBT,  we have included trials where PST was the key therapeutic
modality.  It  is  important  that  those  making  decisions  about  the
interventions  examined  in  this  review  attend  to  the  particular
therapeutic  components  used  in  each  trial  included  in  any
particular comparison (as we have detailed in the Characteristics of
included studies table).

There were also some concerns relating to bias in the measurement
of  the  outcome.  This  was  typically  because  repetition  of  SH  was
based on self-reported information. Given that around two-thirds
of  SH  recorded  in  medical  and  clinical  records  are  not  reported
by  participants,  prevalence  estimates  derived  from  self-reported
information alone may underestimate the true rate of SH (Mitchell
2016). By supplementing data on self-reported SH with information
from clinical or medical records, future trials could compare results

Agreements and disagreements with other studies or
reviews

This  review  is  an  update  of  the  2016  Cochrane  Review  on
psychosocial  interventions  for  SH  in  adults  (Hawton  2016).  The
previous  review  included  55  trials  of  seven  different  approaches,
finding that CBT-based psychological therapy may result in fewer
individuals  repeating  SH  whilst  DBT  may  lead  to  a  reduction  in

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

70

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

frequency  of  repeated  SH.  This  update  concurs  with  its  previous
iteration. There appears to be a probable beneficial effect for CBT-
based  psychotherapy  on  repetition  of  SH  as  compared  to  TAU  or
another comparator immediately after the end of therapy, and this
effect appears to be maintained over time. There also appears to
be limited positive findings for DBT in terms of reduced frequency
of SH.

We  identified  18  further  reviews  that  included  a  focus  on
psychosocial  interventions  for  SH  in  adults  that  have  been
completed since the previous version of this review was published.
Six  were  systematic  reviews  (D'Anci  2019;  Hanratty  2019;  Inagaki
2019;  Krysinska  2017;  Milner  2015;  Tighe  2018),  10  included
meta-analysis (Bornheimer 2020; Briggs 2019; Calati 2016; DeCou
2019;  Gøtzsche  2017;  Hetrick  2016;  Meerwijk  2016;  Milner  2015;
Padmanathan 2020; Riblet 2017), and two were narrative reviews
(Ghanbari 2015; Pirkis 2020). The majority of these reviews included
studies  where  participants  had  mixed  clinical  presentations
(i.e. clinically significant levels of suicidal ideation and/or SH), and
not all were limited to RCTs.

Of these reviews, those that have focused on specific intervention
approaches, 
including  acceptance  and  commitment  therapy
(ACT)-based approaches (Tighe 2018), brief contact interventions
(Ghanbari 2015; Milner 2015; Milner 2016), CBT (Gøtzsche 2017), the
Collaborative Assessment and Management of Suicidality (CAMS)
model  (Hanratty  2019),  DBT  (DeCou  2019),  psychoanalytic  and
psychodynamically-oriented therapy (Briggs 2019), and provision
of information and support (Pirkis 2020), have generally reported
evidence  of  benefit  for  the  approach  examined;  although  two
reviews  of  brief  contact  interventions  (Milner  2015;  Milner  2016)
and one each of the ACT (Tighe 2018) and CAMS model (Hanratty
2019) indicated there was limited evidence for these approaches on
repetition of SH, in line with findings from our review.

Of  these  reviews  that  have  adopted  a  broader  focus,  whilst  they
generally  indicated  that  delivering  some  form  of  psychotherapy
is likely to be more effective than nothing (e.g. Bornheimer 2020;
Calati  2016;  Hetrick  2016;  Inagaki  2019;  Meerwijk  2016;  Riblet
2017), these reviews have tended to statistically pool results from
very different interventions together and so the results are largely
meaningless for clinical practice as they provide little insight into
which  approach  may  be  most  beneficial  for  particular  clinically
relevant subgroups of patients.

Future  reviews  should  undertake  network  meta-analysis  to
investigate  which  component(s)  of 
typically  multi-
component intervention approaches are most effective. Individual
participant  data  meta-analyses  would  also  assist  with  the
identification of clinically relevant subgroups of patients who may
benefit from certain more intensive forms of intervention.

these 

A U T H O R S '   C O N C L U S I O N S

Implications for practice

The number of trials and range of interventions identified in this
version of the review represents a considerable increase compared
with  the  previous  version  (Hawton  2016).  In  this  update,  we
found  76  non-overlapping  trials  of  a  wide  range  of  psychosocial
interventions  for  adults  who  engage  in  SH.  Overall,  there  were
significant  methodological  limitations  across  the  trials  included
in  this  review.  There  may  be  some  positive  effects  for  cognitive

Cochrane Database of Systematic Reviews

behavioural therapy (CBT)-based psychotherapy for individuals in
reducing repetition of SH compared with treatment-as-usual (TAU),
particularly over the longer term. This is perhaps unsurprising as
these trials were generally much briefer in terms of the number of
therapy sessions delivered (e.g., often between 3 to 5 sessions, and
never  more  than  10  sessions)  as  compared  with  traditional  CBT-
based psychotherapy for depression. Services may wish, where this
is feasible, to ensure availability of clinicians to deliver these types
of  intervention.  This  is  in  keeping  with  official  guidance  (Carter
2016; NICE 2011).

There  were  also  some  positive  effects,  particularly  with  regards
to  frequency  of  SH  repetition,  for  several  interventions  for  the
treatment  of  individuals  with  borderline  personality  disorder  (in
which  repetitive  self-harm  is  often  a  feature),  noting  that  the
trial  participants  were  mostly  female  in  these  trials.  Arguably,
where  patients  engage  in  repeated  episodes  of  SH,  reduction
in  the  frequency  of  SH  could  be  viewed  as  a  key  outcome.
Variation  in  the  method  of  provision  of  DBT  does  not  appear
to  differ  in  effectiveness  from  standard  DBT.  The  standard  DBT
approach  is,  however,  lengthy  (typically  one  year;  Linehan  1991)
and  necessitates  considerable  therapist  time.  We  also  found
some  positive  effects  for  both  MBT  and  emotion-regulation
psychotherapy  delivered  in  a  group-based  format  in  individuals
diagnosed  with  borderline  personality  disorder,  although  these
findings were based on a single trial (MBT) or trials conducted by
the same group (emotion-regulation psychotherapy). We therefore
recommend  further  evaluation  of  these  approaches.  Given  the
multi-component  nature  of  these  intervention  approaches  for
treatment  of  individuals  with  borderline  personality  disorder,
greater  use  of  head-to-head  trials,  which  allow  for  dismantling
of  the  effect  size(s)  between  one  or  more  component(s),  should
be  considered,  especially  as  this  might  help  to  identify  effective
components which could be delivered more briefly.

Remote  contact  interventions,  such  as  sending  regular  postcards
to  patients,  have  been  evaluated  in  several  trials.  Whilst  positive
results  compared  to  TAU  with  regard  to  repetition  of  SH  at
both  short-  and  longer-term  follow-up  have  been  reported,  the
main  positive  result  comes  from  a  single  large  trial  conducted
in  a  resource-poor  setting  (Iran)  where  mental  health  services
are  sparse  (e.g.  Iran  has  an  average  of  2.0  psychiatrists  and  9.5
mental  health-trained  nurses  per  100,000  persons;  WHO  2019).
Therefore this relatively low intensity intervention may represent
a considerable improvement over the likelihood of receiving little
to no aftercare. Remote contact interventions may therefore hold
some promise in settings where there are very limited psychiatric
services,  and  should  remain  an  area  for  further  development  in
such settings.

An  argument  for  intervention  following  an  episode  of  SH  is  that
it  may  improve  other  outcomes  even  if  it  does  not  reduce  SH.
Secondary  outcomes  were  examined  variably  in  many  of  the
included trials. There was only limited evidence that experimental
interventions  result  in  better  outcomes  in  these  other  domains.
CBT-based  psychotherapy,  DBT,  MBT,  and  emotion-regulation
psychotherapy may lead to better outcomes in depression severity,
hopelessness,  and  possibly  also  social  functioning  in  the  short
term.  Case  management  may  improve  treatment  adherence.
However, the certainty of evidence was very low to moderate.

Indeed, few specific types of psychosocial interventions appear to
perform  better  than  TAU.  However,  TAU  was  not  well  described

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

71

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

in most clinical trials we examined. TAU also varies greatly across
clinical settings (Witt 2018). For example, in one trial in which the
comparator was 'enhanced usual care' this consisted of little more
than GP management (Kawanishi 2014). Whilst this may represent
enhanced usual care in that setting, it does not compare favourably
with  TAU  in  a  number  of  other  studies  of  this  intervention
approach  (e.g.  Clarke  2002).  A  positive  step  forward  would  be
the operationalisation of TAU to inform both clinical practice and
research.  It  is  possible  that  TAU  has  an  advantage  over  some
of  these  interventions  because  it  offers  more  flexibility  to  tailor
treatment to the specific needs of patients.

Results  of  this  review  would  also  suggest  that,  whilst  case
management  approaches  did  not  appear  to  be  effective
in  reducing  the  proportion  of  participants  who  repeat  SH,
case  management  may  increase  engagement  with  subsequent
treatment  whilst,  additionally,  enabling  the  identification  of
psychosocial  needs  that  should  be  addressed  during  treatment.
A comprehensive therapeutic psychosocial assessment combined
with case management may have a potential role in encouraging
individuals to attend for other types of therapy and therefore might
be  a  useful  part  of  a  clinical  intervention.  This  is  in  keeping  with
official guidance (NICE 2011).

Implications for research

The primary outcome of this review was repetition of SH at post-
intervention to ensure consistency between the reviews in this suite
of  studies  and,  additionally,  as  this  was  the  time  point  for  which
data were reported most consistently between the trials included
in  this  review.  However,  it  is  acknowledged  that,  in  contrast  to
trials  of  pharmacological  interventions  (which  is  the  subject  of  a
related  review)  where  repetition  of  SH  by  post-intervention  may
be  the  most  appropriate  choice,  there  is  no  consensus  presently
as  to  what  time  point(s)  may  be  most  appropriate  for  trials  of
predominately psychosocial interventions. As the aim of many of
these  approaches  is  to  equip  patients  with  new  skills  that  may
take  time  for  them  to  master  and  use  in  dealing  with  future
crises,  it  may  be  unrealistic  to  expect  benefits  to  be  apparent
immediately post-intervention. This may be particularly so for the
many  brief  intervention  approaches  we  identified  in  this  review.
Longer follow-up assessments are therefore advisable. Given that
naturalistic studies of SH patients following discharge from services
would  suggest  that  the  risk  of  SH  repetition  and  suicide  may
be  greatest  in  the  12-months  following  discharge,  peaking  at
one-month post-discharge (Geulayov 2019; Gunnell 2008; Gilbody
1997),  assessments  at  these  time  points  should  be  considered  in
future trials.

Given  that  SH  results  from  a  complex  interplay  between  genetic,
biological,  psychiatric,  psychosocial,  social,  cultural,  and  other
factors,  the  development  of  psychosocial  interventions  for  SH  in
adults could benefit from being based on detailed investigation of
these  factors,  including  those  that  might  enhance  resilience  that
thereby reduces the risk of further SH, as well as having benefits for
other outcomes.

Additionally,  trials  of  psychosocial  interventions  for  adults  who
engage  in  SH  should  include  a  range  of  outcome  measures,  not
just SH and suicide, but also acceptability, adherence, and attitudes
to  treatment  by  patients,  their  caregivers,  and  services  providers
as these may help to identify contributors to any apparent benefit
or  lack  of  impact.  In  particular,  the  inclusion  of  outcomes  that

Cochrane Database of Systematic Reviews

matter  to  those  who  engage  in  SH  is  required  to  further  inform
intervention development (Owens 2020b). It is also important that
adverse effects, both short- and long-term, are carefully evaluated.

Investigation  of  the  mechanisms  through  which  treatments
might  work  is  also  desirable  to  assist  with  the  identification
of  clinically  relevant  subgroups  of  patients  who  may  benefit
from  certain,  more  intensive  forms  of  intervention.  For  example,
whilst CBT-based psychotherapy may have benefit in patients for
whom SH is predominately driven by depressive symptomatology
(Gøtzsche 2017), more intensive forms of psychosocial intervention
(e.g.  standard  DBT,  MBT,  and  possibly  emotion-regulation
psychotherapy) may be more appropriate for those who engage in
frequent and repetitive SH in the context of a personality disorder,
particularly borderline personality disorder.

In trials where sex differences were examined, outcomes generally
favoured females (perhaps partly because mixed-sex trials included
far  more  women  than  men,  with  consequent  power  issues  for
examining outcomes in men). However, given that suicide following
SH is more common in men (Geulayov 2019; Carroll 2014), attention
needs  to  be  paid  to  the  development  of  interventions  that  may
address the particular needs of men who engage in SH.

There is a major need for further development and evaluation of
interventions in lower- and middle-income countries, particularly
where psychiatric services may be limited. Such developments are
likely to include remote contact and support interventions, which
should be evaluated in large-scale trials, particularly as repetition
of  SH  appears  often  to  be  less  frequent  than  in  Western  settings
(Carroll 2014; Knipe 2019).

Heed  should  also  be  paid  to  the  principles  of  development
and  evaluation  of  treatments,  as  laid  out  in  the  UK  Medical
Research  Council  guidance  regarding  complex  interventions.
Additionally,  from  a  service  planning  perspective,  future  trials
should  also  include  economic  evaluations  in  order  to  determine
which interventions may be more feasible to routinely implement
throughout a health service (Bustamante-Madsen 2018).

A C K N O W L E D G E M E N T S

The  authors  thank  the  following  trial  authors  for  providing
us  with  unpublished  data:  Anthony  Bateman,  Ryan  Barnhart,
Kirsten  Barnicot,  Annette  Beautrais,  Ram  Pratap  Beniwal,  Olive
Bennewith,  Greg  Carter,  Marie  Cedereke,  Tom  Clarke,  Mike
Crawford,  Kate  Davidson,  Elspeth  Guthrie,  Tony  Fitzgerald,
Alexandra  Fleischmann,  Peter  Fonagy,  Kim  Gratz,  Anja  Gysin-
Maillart,  Melanie  Harned,  Simon  Hatcher,  Nusrat  Husain,  Nav
Kapur,  Chiaki  Kawanishi,  Marsha  Linehan,  Rohana  Marasinghe,
Shelley McMain, David Owens, Stefan Priebe, Simon Schwab, Nadja
Slee,  Priya  Sreedaran,  Carmen  Stewart,  Vojna  Tapolaa,  Barbara
Tomenson,  Peter  Tyrer,  Guillaume  Vaiva,  Lakshmi  Vijayakumar,
Carla Walton, August Wang, Igor Weinberg, and Dong Xu.

The authors and the CCMD Editorial Team are also grateful to the
following peer reviewers for their time and comments: Kerry Dwan,
Sarah Fortune, Nick Meader and Jean Sellar-Edmunds. They would
also like to thank Cochrane Copy Edit Support for the team's help
and  Phil  Roberts  from  the  University  of  York  for  graphic  design
support in the production of Figure 2 and 3.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

72

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

This  project  was  previously  supported  by  the  National  Co-
ordinating Centre for NHS Service Delivery and Organisation R&D
(NCCSDO). KH is funded by Oxford Health NHS Foundation Trust.
He  is  a  National  Institute  for  Health  Research  (NIHR)  Senior
Investigator, and personal funding from NIHR helped support this
update.

The NIHR is the largest single funder of the CCMD Group.

The views expressed are those of the authors, and not necessarily
those of the NHS, the NIHR, or the Department of Health and Social
Care.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

73

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

R E F E R E N C E S

References to studies included in this review

Allard 1992 {published data only}

Allard R, Marshall M, Plante MC. Intensive follow-up does not
decrease the risk of repeat suicide attempts. Suicide and Life-
Threatening Behavior 1992;22:303-14.

Amadéo 2015 {published data only}

*  Amadéo S, Rereao M, Malogne A, Favro P, Nguyen NL, Milner A,
et al. Testing brief intervention and phone contact among
subjects with suicidal behavior: a randomized controlled
trial in French Polynesia in the frames of the World Health
Organization/Suicide Trends in At-Risk Territories study. Mental
Illness 2015;7:5818.

De Leo D, Milner A. The WHO/START Study: promoting suicide
prevention for a diverse range of cultural contexts. Suicide and
Life-Threatening Behavior 2010;40:99-106.

Andreoli 2015 {published data only}

Andreoli A, Burnand Y, Cochennec M-F, Ohlendorf P, Frambati L,
Gaudry-Maire D. Disapointed love and suicide: a randomized
controlled trial of "abandonment psychotherapy" among
borderline patients. Journal of Personality Disorders
2015;29:1-17.

Armitage 2016 {published data only (unpublished sought but not
used)}

Armitage CJ, Rahim WA, Rowe R, O'Connor RC. An exploratory
randomised trial of a simple, brief psychological intervention to
reduce subsequent suicidal ideation and behaviour in patients
admitted to hospital for self-harm. British Journal of Psychiatry
2016;208:470-6.

Armitage 2016a {published data only (unpublished sought but not
used)}

Armitage CJ, Rahim WA, Rowe R, O'Connor RC. An exploratory
randomised trial of a simple, brief psychological intervention to
reduce subsequent suicidal ideation and behaviour in patients
admitted to hospital for self-harm. British Journal of Psychiatry
2016;208:470-6.

Armitage 2016b {published data only (unpublished sought but not
used)}

Armitage CJ, Rahim WA, Rowe R, O'Connor RC. An exploratory
randomised trial of a simple, brief psychological intervention to
reduce subsequent suicidal ideation and behaviour in patients
admitted to hospital for self-harm. British Journal of Psychiatry
2016;208:470-6.

Bateman 2009 {published and unpublished
data}ISRCTN27660668

*  Bateman A, Fonagy P. Randomized controlled trial of
outpatient mentalization-based treatment versus structured
clinical management for borderline personality disorder.
American Journal of Psychiatry 2009;166:1355-64.

Bateman A, O'Connell J, Lorenzini N, Gardner T, Fonagy P. A
randomised controlled trial of mentalization-based treatment
versus structured clinical management for patients with

comorbid borderline personality disorder and antisocial
personality disorder. BMC Psychiatry 2016;16:304.

Beautrais 2010 {published and unpublished data}

Beautrais AL, Gibb SJ, Faulkner A, Fergusson DM, Mulder RT.
Postcard intervention for repeat self-harm: randomised
controlled trial. British Journal of Psychiatry 2010;197:55-60.

Bennewith 2002 {published data only}

Bennewith O, Stocks N, Gunnell D, Peters TJ, Evans MO,
Sharp DJ. General practice based intervention to prevent repeat
episodes of deliberate self-harm: cluster randomised controlled
trial. British Medical Journal 2002;324:1254-7.

Brown 2005 {published data only}

*  Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE,
Beck AT. Cognitive therapy for the prevention of suicide
attempts: a randomized controlled trial. Journal of the American
Medical Association 2005;294:563-70.

Ghahramanlou-Holloway M, Bhar SS, Brown GK, Olsen C,
Beck AT. Changes in problem-solving appraisal after cognitive
therapy for the prevention of suicide. Psychological Medicine
2012;42:1185-93.

Stirman SW, Brown GK, Ghahramanlou-Holloway M, Fox AJ,
Chohan MZ, Beck AT. Participation bias among suicidal adults
in a randomized controlled trial. Suicide and Life-Threatening
Behavior 2011;41:203-9.

Carter 2005 {published and unpublished data}

Carter GL, Clover K, Whyte IM, Dawson AH, D’este C. Postcards
from the EDge: 24-month outcomes of a randomised controlled
trial for hospital-treatment self-poisoning. British Journal of
Psychiatry 2007;191:548-53.

*  Carter GL, Clover K, Whyte IM, Dawson AH, D’este C. Postcards
from the EDge project: randomised controlled trial of an
intervention using postcards to reduce repetition of hospital
treated deliberate self-poisoning. British Medical Journal
2005;331:805-9.

Cedereke 2002 {published data only}

Cedereke M, Monti K, Ojehagen A. Telephone contact with
patients in the year after a suicide attempt: does it affect
treatment attendance and outcome? A randomised controlled
study. European Psychiatry 2002;17:82-91.

Clarke 2002 {published data only}

Clarke T, Baker P, Watts CJ, Williams K, Feldman RA, Sherr L.
Self-harm in adults: a randomised controlled trial of nurse-led
case management versus routine care only. Journal of Mental
Health 2002;11:167-76.

Crawford 2010 {published and unpublished data}

Crawford MJ, Csipke E, Brown A, Reid S, Nilsen K, Redhead J,
et al. The effect of referral for brief intervention for alcohol
misuse on repetition of deliberate self-harm: an exploratory
randomized controlled trial. Psychological Medicine
2010;40:1821-8.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

74

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Davidson 2014 {published and unpublished data}

Davidson KM, Brown TM, James V, Kirk J, Richardson J. Manual-
assisted cognitive therapy for self-harm in personality disorder
and substance misuse: a feasibility trial. Psychiatric Bulletin
2014;38:108-11.

Stefanello S, Filinto da Silva Cais C, Mauro MLF, Scavacini de
Freitas GV, Botega NJ. Gender differences in suicide attempts:
preliminary results of the multisite intervention study on
suicidal behavior (SUPRE-MISS) from Campinas, Brazil. Brazilian
Journal of Psychiatry 2008;30:139-43.

Dubois 1999 {published data only}

Dubois L, Walter M, Bleton L, Genest P, Lemonnier E, Lachevre G.
Evaluation of a comparative and prospective protocol for
suicidal youth: analysis of psychiatric diagnosis, therapeutic
compliance and rate of recurrence over one year (preliminary
results) [Evaluation comparative et prospective d’un protocole
de prise en charge specifique de jeunes suicidants: analyse du
diagnostic psychiatrique initial, de l’observance therapeutique
et du taux de recidive a un an (resultats preliminaires)]. Annales
Médico-Psychologiques 1999;157:557-61.

Evans 1999a {published data only}

Evans J, Evans M, Morgan HG, Hayward A, Gunnell, D. Crisis
card following self-harm: 12-month follow-up of a randomised
controlled trial. British Journal of Psychiatry 2005;187:186-7.

*  Evans MO, Morgan HG, Hayward A, Gunnell DJ. Crisis
telephone consultation for deliberate self-harm patients: effects
on repetition. British Journal of Psychiatry 1999;175:23-7.

Evans 1999b {published data only}

Evans K, Tyrer P, Catalan J, Schmidt U, Davidson K, Dent J,
et al. Manual-assisted cognitive-behaviour therapy (MACT):
a randomized controlled trial of a brief intervention with
bibliotherapy in the treatment of recurrent deliberate self-harm.
Psychological Medicine 1999;29:19-25.

Fleischmann 2008 {published and unpublished data}

Bertolote JM, Fleischmann A, De Leo D, Phillips MR, Botega NJ,
Vijayakumar L, et al. Repetition of suicide attempts: data
from five culturally different low- and middle-income country
emergency care settings participating in the WHO SUPRE-MISS
study. Crisis 2010;31:194-201.

Da Silva Cais CF, Stefanello S, Fabricio M, Marisa L, Vaz Scavacini
de Freitas G, Botega NJ. Factors associated with repeated
suicide attempts: preliminary results of the WHO Multisite
Intervention Study on Suicidal Behavior (SUPRE-MISS) from
Capinas, Brazil. Crisis 2009;30:73-8.

*  Fleischmann A, Bertolote JM, Wasserman D, De Leo D,
Bolhari J, Botega NJ, et al. Effectiveness of brief intervention
and contact for suicide attempters: a randomized controlled
trial in five countries. Bulletin of the World Health Organisation
2008;86:703-9.

Fleischmann A, Bertolote JM. Multisite Intervention
Study on Suicidal Behaviours - SUPRE-MISS: protocol of
SUPRE-MISS. citeseerx.ist.psu.edu/viewdoc/download?
doi=10.1.1.174.5140&rep=rep1&type=pdf (accessed 31 October
2020).

Hassanzadeh M, Khajeddin N, Nojomi M, Fleischmann A,
Eshrati T. Brief intervention and contact after deliberate self-
harm: an Iranian randomised controlled trial. Iranian Journal of
Psychiatry and Behavioral Sciences 2010;4:5-12.

Vijayakumar L, Umamaheswari C, Shujaath Ali ZS, Devaraj P,
Kesavan K. Intervention for suicide attempters: a randomized
controlled study. Indian Journal of Psychiatry 2011;53:244-8.

Xu D, Zhang X-L, Li X-Y, Niu Y-J, Zhang Y-P, Wang S-L, et al.
Effectiveness of 18-month psychosocial intervention for suicide
attempters. Zhongguo Xinli Weisheng Zazhi [Chinese Mental
Health Journal] 2012;26:24-9.

Gibbons 1978 {published data only}

Gibbons JS, Butler J, Urwin P, Gibbons JL. Evaluation of a social
work service for self-poisoning patients. British Journal of
Psychiatry 1978;133:111-8.

Gratz 2006 {published and unpublished data}

Gratz KL, Gunderson JG. Preliminary data on an acceptance-
based emotion regulation group intervention for deliberate
self-harm among women with borderline personality disorder.
Behavior Therapy 2006;37:25-35.

Gratz 2014 {published and unpublished data}

Gratz KL, Bardeen JR, Levy R, Dixon-Gordon KL, Tull MT.
Mechanisms of change in an emotion regulation group therapy
for deliberate self-harm among women with borderline
personality disorder. Behaviour Research and Therapy
2015;65:29-35.

Gratz KL, Dixon-Gordon KL, Tull MT. Predictors of treatment
response to an adjunctive emotion regulation group therapy for
deliberate self-harm among women with borderline personality
disorder. Personality disorders: Theory, Research, and Treatment
2014;5:97-107.

*  Gratz KL, Tull MT, Levy R. Randomized controlled trial and
uncontrolled 9-month follow-up of an adjunctive emotion
regulation group therapy for deliberate self-harm among
women with borderline personality disorder. Psychological
Medicine 2013;44:2099-122.

Grimholt 2015 {published data only}

Grimholt TK, Jacobsen D, Haavet OR, Sandvik L, Jorgensen T,
Norheim AB, et al. Structured follow-up by general practitioners
after deliberate self-poisoning: A randomised controlled trial.
BMC Psychiatry 2015;15:245.

*  Grimholt TK, Jacobsen D, Haavet OR, Sandvik L, Jorgensen T,
Norheim AB. Effect of systematic follow-up by general
practitioners after deliberate self-poisoning: a randomised
controlled trial. PLOS One 2015;10:e0143934.

Guthrie 2001 {published data only}

Guthrie E, Kapur N, Kway-Jones K, Chew-Graham C,
Moorey J, Mendel E, et al. Randomised controlled trial of brief
psychological intervention after deliberate self-poisoning.
British Medical Journal 2001;323:135-8.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

75

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Gysin-Maillart 2016 {published data only}

Hatcher 2015 {published and unpublished data}

*  Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K.
A novel brief therapy for patients who attempt suicide: a
24-months follow-up randomized controlled study of the
Attempted Suicide Short Intervention Program (ASSIP). PLOS
One 2016;13:e1001968.

Gysin-Maillart A, Soravia L, Schwab S. Attempted suicide short
intervention program influences coping among patients with
a history of attempted suicide. Journal of Affective Disorders
2020;264:393-9.

Michel K, Valach L, Gysin-Maillart A. A novel therapy for people
who attempt suicide and why we need new models of suicide.
International Journal Environmental Research and Public Health
2017;14:243.

Park A-L, Gysin-Maillart A, Müller TJ, Exadaktylos A, Michel K.
Cost-effectiveness of a brief structured intervention program
aimed at preventing repeat suicide attempts among those who
previously attempted suicide: a secondary analysis of the ASSIP
randomized clinical trial. JAMA Open 2018;1:e183680.

Ring M, Gysin-Maillart A. Patients' satisfaction with the
therapeutic relationship and therapeutic outcome is related to
suicidal ideation in the Attempted Suicide Short Intervention
Program (ASSIP). Crisis 2020;41(5):337-43.

Harned 2014 {published and unpublished data}

Harned MS, Fitzpatrick S, Schmidt SC. Identifying change
targets for posttraumatic stress disorder among suicidal and
self-injuring women with borderline personality disorder.
Journal of Traumatic Studies 2020;33(4):610-16. [DOI: 10.1002/
jts.22504]

*  Harned MS, Korslund KE, Linehan MM. A pilot randomized
controlled trial of dialectical behavior therapy with and
without the dialectical behavior therapy prolonged exposure
protocol for suicidal and self-injuring women with borderline
personality disorder and PTSD. Behaviour Research and Therapy
2014;55:7-17.

Hassanian-Moghaddam 2011 {published and unpublished data}

*  Hassanian-Moghaddam H, Sarjami S, Kolahi A-A, Carter GL.
Postcards in Persia: randomised controlled trial to reduce
suicidal behaviours 12 months after hospital-treated self-
poisoning. British Journal of Psychiatry 2011;198:309-16.

Hassanian-Moghaddam H, Sarjami S, Kolahi A-A, Lewin T,
Carter G. Postcards in Persia: a twelve to twenty-four month
follow-up of a randomized controlled trial for hospital-
treated deliberate self-poisoning. Archives of Suicide Research
2017;21:138-54.

Hatcher 2011 {published and unpublished data}

Hatcher S, Sharon C, Parag V, Collins N. Problem-solving
therapy for people who present to hospital with self-harm:
Zelen randomised controlled trial. British Journal of Psychiatry
2011;199:310-6.

Hatcher S, Sharon C, House A, Collins N, Collings S, Pillai A. The
ACCESS study: Zelen randomised controlled after self-harm.
British Journal of Psychiatry 2015;206:229-36.

Hatcher 2016 {published and unpublished data}

Hatcher S, Coupe N, Wikiriwhi K, Durie M, Pillai A. Te Ira Tangata:
a Zelen randomised controlled trial of a culturally informed
treatment compared to treatment as usual in Māori who
present to hospital after self-harm. Social Psychiatry and
Psychiatric Epidemiology 2016;51:885-94.

Hawton 1981 {published and unpublished data}

Hawton K, Bancroft J, Catalan J, Kingston B, Stedeford A.
Domiciliary and out-patient treatment of self-poisoning
patients by medical and non-medical staff. Psychological
Medicine 1981;11:169-77.

Hawton 1987 {published and unpublished data}

Hawton K, McKeown S, Day A, Martin P, O’Connor M, Yule J.
Evaluation of out-patient counselling compared with general
practitioner care following overdoses. Psychological Medicine
1987;17:751-61.

Husain 2014 {published and unpublished data}

Husain N, Afsar S, Ara J, Fayyaz H, Ur Rahman R, Tomenson B, et
al. Brief psychological intervention after self-harm: randomised
controlled trial from Pakistan. British Journal of Psychiatry
2014;204:462-70.

Hvid 2011 {published and unpublished data}

Hvid M, Vangborg K, Sørensen HJ, Nielsen IK, Stenborg JM,
Wang AG. Preventing repetition of attempted suicide- II: the
Amager Project, a randomized controlled trial. Nordic Journal of
Psychiatry 2011;65:292-8.

Kapur 2013 {published and unpublished data}

Kapur N, Gunnell D, Hawton K, Nadeem S, Khalil S, Longson D,
et al. Messages from Manchester: pilot randomised controlled
trial following self-harm. British Journal of Psychiatry
2013;203:73-4.

Kawanishi 2014 {published and unpublished data}

Furuno T, Nakagawa M, Hinto K, Tamada T, Kawashima Y,
Matsuoka Y, et al. Effectiveness of assertive case management
on repeat self-harm in patients admitted for suicide attempt:
findings from ACTION-J study. Journal of Affective Disorders
2018;225:460-5.

*  Kawanishi C, Aruga T, Ishizuka N, Yonemoto N, Otsuka K,
Kamijo Y, et al. Assertive case management versus enhanced
usual care for people with mental health problems who had
attempted suicide and were admitted to hospital emergency
departments in Japan (ACTIONJ): a multicentre, randomised
controlled trial. Lancet Psychiatry 2014;1:193-201.

Norimoto K, Ikeshita K, Kishimoto T, Okuchi K, Yonemoto N,
Sugimoto T, et al. Effect of assertive case management
intervention on suicide attempters with comorbid Axis I and
II psychiatric diagnoses: secondary analysis of a randomised
controlled trial. BMC Psychiatry 2020;20:311.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

76

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Liberman 1981 {published data only}

Liberman RP, Eckman T. Behavior therapy vs insight-oriented
therapy for repeated suicide attempters. Archives of General
Psychiatry 1981;38:1126-30.

Lin 2020 {published data only (unpublished sought but not used)}

Lin Y-C, Liu S-I, Chen S-C, Sun F-J, Huang H-C, Huang C-R,
et al. Brief cognitive-based psychosocial intervention and
case management for suicide attempters discharged from
the emergency department in Taipei, Taiwan: a randomized
controlled study. Suicide and Life-Threatening Behavior
2020;50:688-705.

Linehan 1991 {published data only}

*  Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL.
Cognitive-behavioral treatment of chronically parasuicidal
borderline patients. Archives of General Psychiatry
1991;48:1060-4.

Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of
a behavioral treatment for chronically parasuicidal borderline
patients. Archives of GeneralPsychiatry 1993;50:971-4.

Linehan 2006 {published and unpublished data}

Bedics JD, Atkins DC, Comtois JA, Linehan MM. Treatment
differences in the therapeutic relationship and introject during
a 2-year randomized controlled trial of dialectical behavior
therapy versus non-behavioral psychotherapy experts for
borderline personality disorder. Journal of Consulting and
Clinical Psychology 2012;80:66-77.

Bedics JD, Atkins DC, Harned MS, Linehan MM. The therapeutic
alliance as a predictor of outcome in dialectical behavior
therapy versus nonbehavioral psychotherapy by experts
for borderline personality disorder. Psychotherapy: Theory,
Research and Practice 2015;52:67-77.

Coyle TN, Shaver JA, Linehan MM. On the potential for
iatrogenic effects of psychiatric crisis services: the example of
dialectical behavior therapy for adult women with borderline
personality disorder. Journal of Consulting and Clinical
Psychology 2018;86:116-24.

Harned MS, Chapman AL, Dexter-Mazza ET, Murray A,
Comtois KA, Linehan MM. Treating co-occurring axis I disorders
in recurrently suicidal women with borderline personality
disorder: a 2-year randomized trial of dialectical behavior
therapy versus community treatment by experts. Journal of
Consulting and Clinical Psychology 2008;76:1068-75.

Harned MS, Chapman AL, Dexter-Mazza ET, Murray A,
Comtois KA, Linehan MM. Treating co-occurring axis I disorders
in recurrently suicidal women with borderline personality
disorder: a 2-year randomized trial of dialectical behavior
therapy versus community treatment by experts. Personality
Disorders: Theory, Research and Treatment 2009;5:35-45.

*  Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ,
Heard HL, et al. Two-year randomized controlled trial and
follow-up of dialectical behavior therapy vs therapy by experts
for suicidal behaviors and borderline personality disorder.
Archives of General Psychiatry 2006;63:757-66.

Neacsiu AD, Lungu A, Harned MS, Rizvi SL, Linehan MM. Impact
of dialectical behavior therapy versus community treatment by
experts on emotional experience, expression,and acceptance
in borderline personality disorder. Behaviour Research and
Therapy 2014;53:47-54.

Secrist CD. The Role of Executive Functioning in the Treatment
of Borderline Personality Disorder. Seattle, WA: Department of
Clinical Psychology, University of Washington, 2014.

Linehan 2015 {published data only}

Kuehn KS, King KM, Linehan MM, Harned MS. Modeling the
suicidal behavior cycle: understanding repeated suicide
attempts among individuals with borderline personality
disorder and a history of attempting suicide. Journal of
Consulting and Clinical Psychology 2020;88:570-81.

Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A,
Neacsiu AD, et al. Dialectical behavior therapy for high suicide
risk in individuals with borderline personality disorder: a
randomized clinical trial and component analysis. JAMA
Psychiatry 2015;72:475-82.

Wilks CR, Korslund KE, Harned M, Linehan MM. Dialectical
behavior therapy and domains of functioning over two years.
Behaviour Research and Therapy 2016;77:162-9.

Linehan 2015a {published data only}

Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A,
Neacsiu AD, et al. Dialectical behavior therapy for high suicide
risk in individuals with borderline personality disorder: a
randomized clinical trial and component analysis. JAMA
Psychiatry 2015;72:475-82.

Kuehn KS, King KM, Linehan MM, Harned MS. Modeling the
suicidal behavior cycle: understanding repeated suicide
attempts among individuals with borderline personality
disorder and a history of attempting suicide. Journal of
Consulting and Clinical Psychology 2020;88:570-81.

Wilks CR, Korslund KE, Harned M, Linehan MM. Dialectical
behavior therapy and domains of functioning over two years.
Behaviour Research and Therapy 2016;77:162-9.

Linehan 2015b {published data only}

Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A,
Neacsiu AD, et al. Dialectical behavior therapy for high suicide
risk in individuals with borderline personality disorder: a
randomized clinical trial and component analysis. JAMA
Psychiatry 2015;72:475-82.

Kuehn KS, King KM, Linehan MM, Harned MS. Modeling the
suicidal behavior cycle: understanding repeated suicide
attempts among individuals with borderline personality
disorder and a history of attempting suicide. Journal of
Consulting and Clinical Psychology 2020;88:570-81.

Wilks CR, Korslund KE, Harned M, Linehan MM. Dialectical
behavior therapy and domains of functioning over two years.
Behaviour Research and Therapy 2016;77:162-9.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

77

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Marasinghe 2012 {published and unpublished data}

*  Marasinghe RB, Edirippulige S, Kavanagh D, Smith A,
Jiffry MTM. Effect of mobile phone-based psychotherapy in
suicide prevention: a randomized controlled trial in Sri Lanka.
Journal of Telemedicine and Telecare 2012;18:151-5.

Stratton N, Mendoza Alvarez M, Labrish C, Barnhart R,
McMain S. Predictors of dropout from a 20-week dialectical
behavior therapy skills group for suicidal behaviors and
borderline personality disorder. Journal of Personality Disorders
2018;32:391-406.

Marasinghe RB. Evaluation of a Brief Inpatient and Community
Intervention to Address Suicide Risk in Sri Lanka Using
Mobile Phones [PhD thesis]. Brisbane, QLD: The University of
Queensland, School of Medicine, 2012.

Morgan 1993 {published data only}

Morgan HG, Jones EM, Owen JH. Secondary prevention of non-
fatal deliberate self-harm. The green card study. British Journal
of Psychiatry 1993;163:111-2.

McAuliffe 2014 {published and unpublished data}

Morthorst 2012 {published data only}

McAuliffe C, McLeavey BC, Fitzgerald T, Corcoran P, Carroll B,
Ryan L, et al. Group problem-solving skills training for self-
harm: randomised controlled trial. British Journal of Psychiatry
2014;204:383-90.

McLeavey 1994 {published data only}

McLeavey B, Daly R, Ludgate J, Murray C. Interpersonal
problem-solving skills training in the treatment of self-
poisoning patients. Suicide and Life-Threatening Behavior
1994;24:382-94.

Morthorst B, Krogh J, Erlangsen A, Alberdi F, Nordentoft M.
Effect of assertive outreach after suicide attempt in the
AID (Assertive Intervention for Deliberate self-harm)
trial: randomised controlled trial. British Medical Journal
2012;345:e4972.

Mouaffak 2015 {published data only}

Mouaffak F, Marchand A, Castaigne E, Arnoux A, Hardy P. OSTA
program: a French follow up intervention program for suicide
prevention. Psychiatry Research 2015;230:913-8.

McMain 2009 {published and unpublished data}

Mousavi 2015 {published data only}

Boritz T, Barnhart R, McMain SF. The influence of posttraumatic
stress disorder on treatment outcomes of patients with
borderline personality disorder. Journal of Personality Disorders
2016;30:395-407.

Mousavi SG, Amini M, Mahaki B, Bagherian-Sarariudi R. Effect
of phone call versus face-to-face follow-up on recurrent suicide
prevention in individuals with a history of multiple suicide
attempts. Advanced Biomedical Research 2016;5:184.

Case BG. Dialectical behavior therapy versus general psychiatric
management in the treatment of borderline personality
disorder. American Journal of Psychiatry 2010;167:475.

McMain SF, Fitzpatrick S, Boritz T, Barnhart R, Links P,
Streiner DL. Outcome trajectories and prognostic factors
for suicide and self-harm behaviors in patients with
borderline personality disorder following one year of
outpatient psychotherapy. Journal of Personality Disorders
2018;32:497-512.

McMain SF, Guimond T, Streiner DL, Cardish RJ, Links PS.
Dialectical behavior therapy compared with general psychiatric
management for borderline personality disorder: clinical
outcomes and functioning over a 2-year follow-up. American
Journal of Psychiatry 2012;169:650-61.

*  McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ,
Korman L, et al. A randomized trial of dialectical behavior
therapy versus general psychiatric management for borderline
personality disorder. American Journal of Psychiatry
2009;166:1365-74.

McMain 2017 {published data only}

Krantz LH, McMain S, Kuo JR. The unique contribution of
acceptance without judgment in predicting nonsuicidal self-
injury after 20-weeks of dialectical behaviour therapy group
skills training. Behaviour Research and Therapy 2018;104:44-50.

*  McMain SF, Guimond T, Barnhart R, Habinski L, Streiner DL.
A randomized trial of brief dialectical behaviour therapy skills
training in suicide patients suffering from borderline disorder.
Acta Psychiatrica Scandinavica 2017;135:138-48.

Mousavi 2017 {published data only}

Mousavi SG, Tehrani MN, Maracy M. The effect of active
treatment and visit compared to conventional treatment,
on preventing recurrent suicidal attempts: a randomized
controlled clinical trial. Advanced Biomedical Research
2017;6:38.

Naidoo 2014 {published data only}

Naidoo SS, Gathiram P, Schlebusch L. Effectiveness of a buddy
intervention support programme for suicidal behaviour
in a primary care setting. South African Family Practice
2014;56:263-70.

O'Connor 2015 {published data only}

O'Connor SS, Comtois KA, Wang J, Russo J, Peterson R, Lapping-
Carr L, et al. The development and implementation of a brief
intervention for medically admitted suicide attempt survivors.
General Hospital Psychiatry 2015;37:427-33.

O'Connor 2017 {published data only}ISRCTN99488269

O'Connor RC, Ferguson E, Scott F, Smyth R, McDaid D, Park A-
L. A brief psychological intervention to reduce repetition of
self-harm in patient admitted to hospital following a suicide
attempt: a randomised controlled trial. Lancet Psychiatry
2017;4:451-60.

O'Connor 2020 {published data only}

O'Connor SS, McClay MM, Choudhry S, Shields AD, Carlson R,
Alonso Y. Pilot randomized clinical trial of the teachable
moment brief intervention for hospitalized suicide attempt
survivors. General Hospital Psychiatry 2020;63:111-8.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

78

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Owens 2020 {published data only}ISRCTN54036115

Torhorst 1987 {published data only}

Collinson M, Owens D, Blenkiron P, Burton K, Graham L,
Hatcher S, et al. MIDSHIPS: Multicentre Intervention Designed
for Self-Harm using Interpersonal Problem-Solving: protocol for
a randomised controlled feasibility study. Trials 2014;15:163.

*  Owens D, Wright-Hughes A, Graham L, Blenkiron P, Burton K,
Collinson M, et al. Problem-solving therapy rather than
treatment as usual for adults after self-harm: a pragmatic,
feasibility, randomised controlled trial (the MIDSHIPS trial). Pilot
and Feasibility Studies 2020;6:119.

Patsiokas 1985 {published data only}

Patsiokas AT, Clum GA. Effects of psychotherapeutic strategies
in the treatment of suicide attempters. Psychotherapy: Theory,
Research and Practice 1985;22:281-90.

Möller HJ. Efficacy of different strategies of aftercare for patients
who have attempted suicide. Journal of the Royal Society of
Medicine 1989;82:643-7.

*  Torhorst A, Möller HJ, Bürk F, Kurz A, Wächtler C, Lauter H. The
psychiatric management of parasuicide patients: a controlled
clinical study comparing different strategies of outpatient
treatment. Crisis 1987;8:53-61.

Torhorst 1988 {published data only}

Torhorst A, Möller HJ, Kurz A, Schmid-Bode W, Lauter H.
Comparing a 3-month and a 12-month-outpatient aftercare
program for parasuicide repeaters. In: Möller HJ, Schmidtke
A, Welz R, editors(s). Current Issues of Suicidology. Berlin,
Germany: Springer-Verlag, 1988:419–24.

Priebe 2012 {published and unpublished data}

Turner 2000 {published data only}

Priebe S, Bhatti N, Barnicot K, Bremner S, Gaglia A,
Katsakou C, et al. Effectiveness and cost-effectiveness of
dialectical behaviour therapy for self-harming patients with
personality disorder: a pragmatic randomised controlled trial.
Psychotherapy and Psychosomatic 2012;81:356-65.

Sahin 2018 {published data only}

Sahin Z, Vinnars B, Gorman BS, Wilczek A, Åsberg M, Barber JP.
Clinical severity as a moderator of outcome in psychodynamic
and dialectical behavior therapies for borderline personality
disorder. Personality Disorders 2018;9:437-46.

Turner RM. Naturalistic evaluation of dialectical behavior
therapy-oriented treatment for borderline personality disorder.
Cognitive and Behavioral Practice 2000;7:413-9.

Tyrer 2003 {published data only}

Tyrer P, Thompson S, Schmidt U, Jones V, Knapp M, Davidson K,
et al. Randomized controlled trial of brief cognitive behaviour
therapy versus treatment as usual in recurrent deliberate
self-harm: the POPMACT study. Psychological Medicine
2003;33:969-76.

Vaiva 2006 {published data only}

Salkovskis 1990 {published data only}

Salkovskis PM, Atha C, Storer D. Cognitive-behavioural
problem solving in the treatment of patients who repeatedly
attempt suicide. A controlled trial. British Journal of Psychiatry
1990;157:871–6.

Vaiva G, Ducrocq F, Meyer P, Mathieu D, Philippe A, Libersa C,
et al. Effect of telephone contact on further suicide attempts
in patients discharged from an emergency department:
randomised controlled study. British Medical Journal
2006;332:1241-5.

Slee 2008 {published and unpublished data}

Vaiva 2018 {published data only}

Slee N, Garnefski N, Van der Leeden R, Arensman E,
Spinhoven P. Cognitive-behavioural intervention for self-
harm: randomised controlled trial. British Journal of Psychiatry
2008;192:202-11.

Sreedaran 2020 {published data only}

Sreedaran P, Beniwal RP, Chari U, Smitha TS, Vidhya SSV,
Gupta V, et al. A randomized controlled trial to assess
feasibility and acceptability of telephone-based psychosocial
interventions in individuals who attempted suicide. Indian
Journal of Psychological Medicine 2020;42:1-6.

Stewart 2009 {published and unpublished data}

Stewart CD, Quinn A, Plever S, Emmerson B. Comparing
cognitive behavior therapy, problem solving therapy, and
treatment as usual in a high risk population. Suicide and Life-
Threatening Behavior 2009;39:538-47.

Tapolaa 2010 {published and unpublished data}

Tapolaa V, Lappalainen R, Wahlström J. Brief intervention for
deliberate self-harm: an exploratory study. Suicidology Online
2010;1:95-108.

Demesmaeker A, Benard V, Leroy A, Vaiva G. Impacts of a brief
contact intervention in suicide prevention on medical care
consumptions [Impacts d'un système de veille en prévention
du suicide sur les consommations de soins]. L'Encéphale
2019;45:S27-31.

Messiah A, Notredame C-E, Demarty A-L, Duhem S, Vaiva G.
Combining green cards, telephone calls and postcards into an
intervention algorithm to reduce suicide reattempt (AlgoS): p-
hoc analyses of an inconclusive randomized controlled trial.
PLOS One 2019;14:e0210778.

*  Vaiva G, Berrouiguet S, Walter M, Courtet P, Ducrocq F,
Jardon V, et al. Combining postcards, crisis cards, and
telephone contact into a decision-making algorithm to reduce
suicide reattempt: a randomized clinical trial of a personalized
brief contact intervention. Journal of Clinical Psychiatry
2018;79:17m11631.

Van der Sande 1997 {published data only}

Van der Sande R, Buskens E, Van der Graaf Y, Van Rooijen E,
Allart E, Van Engeland H. No measurable effect from general
socio-psychiatric care for those attempting suicide: a
randomized experiment [Geen meetbaar effect van algemene
sociaal–psychiatrische nazorg voor suicidepogers; een

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

79

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

gerandomiseerd experiment]. Nederlands Tijdschriftvoor de
Geneeskunde 1998;142:2356.

management - protocol for a three-armed partial randomised
controlled trial. European Psychiatry 2016;33S:S440.

*  Van der Sande R, Van Rooijen L, Buskens E, Allart E, Hawton K,
Van der Graaf Y, et al. Intensive in-patient and community
intervention versus routine care after attempted suicide. A
randomised controlled intervention study. British Journal of
Psychiatry 1997;171:35-41.

Van Heeringen 1995 {published data only}

Van Heeringen C, Jannes S, Buylaert W, Hendrick H,
De Bacquer D, Van Remoortel J. The management of
noncompliance with referral to out-patient after-care among
attempted suicide patients: a controlled intervention study.
Psychological Medicine 1995;25:963-70.

Walton 2020 {published and unpublished data}

Walton CJ, Bendit N, Baker AL, Carter GL, Lewin TJ. A
randomised trial of dialectical behaviour therapy and
the conversational model for the treatment of borderline
personality disorder with recent suicidal and/or non-suicidal
self-injury: an effectiveness study in an Australian public mental
health service. Australian and New Zealand Journal of Psychiatry
2020;54:1020-34.

Wang 2016 {published data only}

Wang Y-C, Hsieh L-Y, Wang M-Y, Chou C-H, Huang M-W,
Ko H-C. Coping card usage can further reduce suicide
reattempt in suicide attempter case management within 3-
month intervention. Suicide and Life-Threatening Behavior
2016;46:106-20.

Waterhouse 1990 {published data only}

Waterhouse J, Platt S. General hospital admission in the
management of parasuicide. A randomised controlled trial.
British Journal of Psychiatry 1990;156:236–42.

Wei 2013 {published data only}

Wei S, Liu L, Bi B, Li H, Hou J, Tan S, et al. An intervention and
follow-up study following a suicide attempt in the emergency
departments of four general hospitals in Shenyang, China. Crisis
2013;34:107-15.

Weinberg 2006 {published data only}

Weinberg I, Gunderson JG, Hennen J, Cutter CJ. Manual assisted
cognitive treatment for deliberate self-harm in borderline
personality disorder patients. Journal of Personality Disorders
2006;20:482-92.

Welu 1977 {published data only}

Welu T. A follow-up program for suicide attempters: evaluation
of effectiveness. Suicide and Life-Threatening Behavior
1977;7:17-30.

References to studies excluded from this review

Agyapong 2016 {published data only}

Agyapong V, Behre T, Juhas M, Greenshaw A. Preventing self-
harm and reducing suicidal ideation through an expediated
regular supportive psychotherapy and assertive case

Ahmed 2016 {published data only}ISRCTN76914248

Ahmed N, John A, Islam S, Jones R, Anderson P, Davies C,
et al. Investigating the feasibility of an enhanced contact
intervention in self-harm and suicidal behaviour: a protocol for
a randomised controlled trial delivering a Social support and
Wellbeing Intervention following Self-Harm (SWISH). British
Medical Journal Open 2016;6:e012043.

Albuixech-García 2020 {published data only}

Albuixech-García R, Juliá-Sanchis R, Molina MAF, Escribano S.
Impact of the mental health care continuity-chain among
individuals expressing suicidal behaviour in a Spanish sample.
Issues in Mental Health Nursing 2020;41:602-7.

Andover 2015 {published data only}

Andover MS, Schatten HT, Morris BW, Miller IW. Development
of an intervention for nonsuicidal self-injury in young
adults: an open pilot trial. Cognitive and Behavioral Practice
2015;22:491-503.

Andover 2017 {published data only}

Andover MS, Schatten HT, Morris BW, Holman CS, Miller IW. An
intervention for non-suicidal self-injury in young adults: a pilot
randomized controlled trial. Journal of Consulting and Clinical
Psychology 2017;85:620-31.

Andreasson 2016 {published data only}

Andreasson K, Krough J, Rosenbaum B, Gluud C, Jobes DA,
Nordentoft M. The DiaS trial: Dialectical behavior therapy versus
collaborative assessment and management of Suicidality
on self-harm in patients with a recent suicide attempt and
borderline personality disorder traits - study protocol for a
randomized controlled trial. Trials 2014;15:194.

*  Andreasson K, Krough J, Wenneberg C, Jessen HKL,
Krakauer K, Gluud C, et al. Effectiveness of dialectical behavior
therapy versus collaborative assessment and management
of suicidality treatment for reduction of self-harm in adults
with borderline personality traits and disorder - randomized
observer-blinded clinical trial. Depression and Anxiety
2016;33:520-30.

Andreoli 2019 {published data only}

Andreoli A, Burnand Y, Frambati L, Manning D, Frances A.
Abandonment psychotherapy and psychosocial functioning
among suicidal patients with borderline personality disorder:
a 3-year naturalistic follow-up. Journal of Personality Disorders
2019;33:423-36.

Barnes 2018 {published data only}

Barnes MC, Haase AM, Bard AM, Donovan JL, Davies R,
Dursley S, et al. HOPE: Help fOr PEople with money,
employment, benefit or housing problems: study protocol
for a randomised controlled trial. Pilot and Feasibility Studies
2017;3:44.

*  Barnes MC, Haase AM, Scott LJ, Linton M-J, Bard AM,
Donovan JL, et al. The Help fOr PEople with money,
employment, benefit or housing problems (HOPE) intervention:

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

80

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

pilot randomised trial with mixed methods feasibility research.
Pilot and Feasibility Studies 2018;4:172.

Barnhofer 2015 {published data only}ISRCTN97185214

*  Barnhofer T, Crane C, Brennan K, Duggan DS, Crane RS,
Eames C, et al. Mindfulness-based cognitive therapy (MBCT)
reduces the association between depressive symptoms
and suicidal cognitions in patients with a history of suicidal
depression. Journal of Consulting and Clinical Psychology
2015;83:1013-20.

Crane C, Barnhofer T, Duggan DS, Eames C, Hepburn S, Shah D,
et al. Comfort from suicidal cognition in recurrently depressed
patients. Journal of Affective Disorders 2014;155:241-6.

Radford S, Eames C, Brennan K, Lambert G, Crane C,
Williams JMG, et al. Trait mindfulness as a limiting factor for
residual depressive symptoms: an explorative study using
quantile regression. PLOS One 2014;9:e100022.

Williams JMG, Russell IT, Crane C, Russell D, Whitaker CJ,
Duggan DS. Staying well after depression: trial design and
protocol. BMC Psychiatry 2010;10:23.

Bateman 2020 {published data only}

Bateman A, Constantinou MP, Fonagy P, Holzer S. Eight-year
prospective follow-up of mentalization-based treatment versus
structured clinical management for people with borderline
personality disorder. Personality Disorders: Theory, Research,
and Treatment 2020 Jun 25 [EPub ahead of print]. [DOI:
10.1037/per0000422]

Bentley 2017 {published data only}

Bentley KH, Sauer-Zavala S, Cassiello-Robbins CF, Conklin LR,
Vento S, Homer D. Treating suicidal thoughts and behaviors
within an emotional disorders framework: acceptability and
feasibility of the unified protocol in an inpatient setting.
Behavior Modification 2017;41:529-57.

Berrouiguet 2019 {published data only}

Berrouiguet S, Barrigón ML, Castroman JL, Courtet P, Artés-
Rodríguez A, Baca-García E. Combining mobile-health
(mHealth) and artificial intelligence (AI) methods to avoid
suicide attempts: the Smartcrises study protocol. BMC
Psychiatry 2019;19:277.

Betz 2020 {published and unpublished data}

Betz ME, Knoepke CE, Simpson S, Siry BJ, Clement A,
Saunders T, et al. An interactive web-based lethal means
safety decision aid for suicidal adults (Lock to Live): pilot
randomized controlled trial. Journal of Medical Internet
Research 2020;22:e16253.

Bryan 2017a {published data only (unpublished sought but not
used)}

Bryan CJ, May AM, Rozek DC, Williams SR, Clemans TA, Mintz J,
et al. Use of crisis management interventions among suicidal
patients: results of a randomized controlled trial. Depression
and Anxiety 2018;35:619-28.

Cochrane Database of Systematic Reviews

Bryan 2017b {published data only}

Bryan CJ, Mintz J, Clemans TA, Leeson B, Burch S, Williams SR,
et al. Effect of crisis response planning vs. contracts for safety
on suicide risk in U.S. army soldiers: a randomized clinical trial.
Journal of Affective Disorders 2017;212:64-72.

Cebria 2015 {published data only}

*  Cebrià AI, Pérez-Bonaventura I, Cuijpers P, Kerkhof A, Parra I,
Escayola A, et al. Telephone management program for patients
discharged from an emergency department after a suicide
attempt: a 5-year follow-up study in a Spanish population. Crisis
2015;36(5):345-52.

Cebrià AI, Parra I, Pàmias M, Escayola A, García-Parés G, Puntí J,
et al. Effectiveness of a telephone management programme
for patients discharged from an emergency department after
a suicide attempt: controlled study in a Spanish population.
Journal of Affective Disorders 2013;147:269-76.

Celano 2017 {published and unpublished data}

Celano CM, Beale EE, Mastromauro CA, Stewart JG, Millstein RA,
Auerbach RP, et al. Psychological interventions to reduce
suicidality in high-risk patients with major depression:
a randomized controlled trial. Psychological Medicine
2017;47(5):810-21.

Currier 2015 {published data only}

Currier GW, Brown GK, Brenner LA, Chesin M, Knox KL,
Ghahramanlou-Holloway M, et al. Rationale and study protocol
for a two-part intervention: safety planning and structured
follow-up among veterans at risk for suicide and discharged
from the emergency department. Contemporary Clinical Trials
2015;43:179-84.

Dassa 2018 {published data only (unpublished sought but not
used)}

Dassa D, Olie E, Courtet P, Ducasse D. Positive psychology for
management of suicidal patients: a controlled trial. European
Psychiatry 2018;48S:S446.

Davidson 2006 {published and unpublished data}

*  Davidson K, Norrie J, Tyrer P, Gumley A, Tata P, Murray H, et al.
The effectiveness of cognitive behavior therapy for borderline
personality disorder: results from the borderline personality
disorder study of cognitive therapy (BOSCOT) trial. Journal of
Personality Disorders 2006;20:450-65.

Davidson K, Tyrer P, Gumley A, Tata P, Norrie J, Palmer S, et al.
A randomized controlled trial of cognitive behavior therapy
for borderline personality disorder: rationale for trial, method,
and description of sample. Journal of Personality Disorders
2006;20:431-49.

Davidson KM, Tyrer P, Norrie J, Palmer SJ, Tyrer H. Cognitive
therapy v. usual treatment for borderline personality disorder:
prospective 6-year follow-up. British Journal of Psychiatry
2010;197:456-62.

Norrie J, Davidson K, Tata P, Gumley A. Influence of therapist
competence and quantity of cognitive behavioural therapy
on suicidal behaviour and inpatient hospitalisation in a
randomised controlled trial in borderline personality disorder:

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

81

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

further analyses of treatment effects in the BOSCOT study.
Psychology and Psychotherapy: Theory, Research and Practice
2013;86:280-93.

Palmer S, Davidson K, Tyrer P, Gumley A, Tata P, Norrie J, et
al. The cost-effectiveness of cognitive behavior therapy for
borderline personality disorder: results from the BOSCOT trial.
Journal of Personality Disorders 2006;20:466-81.

Dimeff 2020 {published data only}

Dimeff LA, Jobes DA, Chalker SA, Piehl BM, Duvivier LL,
Lok BC, et al. A novel engagement of suicidality in the
emergency department: Virtual Collaborative Assessment
and Management of Suicidality. General Hospital Psychiatry
2020;63:119-26.

Di Simplicio 2020 {published data only}

Di Simplicio M, Appiah-Kusi E, Wilkinson P, Watson P, Meiser-
Stedman C, Kavanagh DJ, et al. Imaginator: a proof-of-
concept feasibility trial of a brief imagery-based psychological
intervention for young people who self-harm. Suicide and Life-
Threatening Behavior 2020;50:724-40.

Dixon-Gordon 2015 {published data only}

Dixon KL, Chapman AL, Turner BJ. A preliminary pilot study
comparing dialectical behavior therapy emotion regulation
skills with interpersonal effectiveness skills and a control
group treatment. Journal of Experimental Psychopathology
2015;6:369-88.

Doering 2010 {published data only}

Buchheim A, Hörz-Sagstetter S, Doering S, Rentrop M,
Schuster P, Buchheim P, et al. Change of unresolved attachment
in borderline personality disorder: RCT study of transference-
focused psychotherapy. Psychotherapy and Psychosomatics
2017;86:314-6.

*  Doering S, Hörz S, Rentrop M, Fischer-Kern M, Schuster P,
Benecke C, et al. Transference-focused psychotherapy v.
treatment by community psychotherapists for borderline
personality disorder: randomised controlled trial. British
Journal of Psychiatry 2010;196:389-95.

Ducasse 2018 {published data only (unpublished sought but not
used)}

Ducasse D, Jaussent I, Arpon-Brand V, Vienot M, Laglaoui C,
Béziat S, et al. Acceptance and commitment therapy for the
management of suicidal patients: a randomized controlled trial.
Psychotherapy and Psychosomatics 2018;87:1-12.

Exbrayat 2017 {published data only}

Exbrayat S, Coudrot C, Gourdon X, Gay A, Sevos J, Pellet J, et al.
Effect of telephone follow-up on repeated suicide attempt in
patients discharged from an emergency psychiatry department:
a controlled study. BMC Psychiatry 2017;17:96.

Franklin 2016 {published data only}

Franklin JC, Fox KR, Franklin CR, Kleiman EM, Ribeiro JD,
Jaroszewski AC, et al. A brief mobile app reduces nonsuicidal
and suicidal self-injury: evidence from three randomized
controlled trials. Journal of Consulting and Clinical Psychology
2016;84:544-57.

Cochrane Database of Systematic Reviews

Gabilondo 2020 {published data only}

Gabilondo A, Aristegi E, Gonzalez-Pinto A, Zurimendi JM, Mateos
del Pinto M, Roca R, et al. Prevention of suicidal behaviour with
telemedicine in patients with a recent suicide attempt: is a 6-
month intervention long enough? Suicide and Life-Threatening
Behavior 2020;50:211-9.

Galfalvy 2017 {published data only (unpublished sought but not
used)}

Galfalvy H, Brodsky B, Oquendo M, Stanley B. Childhood
maltreatment moderates antidepressant treatment response
for self-injury in borderline personality disorder. Biological
Psychiatry 2017;81:S74.

Gooding 2020 {published data only}ISRCTN17776666

Gooding PA, Pratt D, Awenat Y, Drake R, Elliott R, Emsley R, et
al. A psychological intervention for suicide applied to non-
affective psychosis: the CARMS (Cognitive AppRoaches to
coMbatting Suicidality) randomised controlled trial protocol.
BMC Psychiatry 2020;20:306.

Goodman 2016 {published data only (unpublished sought but not
used)}

Goodman M, Banthin D, Blair NJ, Mascitelli KA, Wilsnack J,
Chen J, et al. A randomized trial of dialectical behavior therapy
in high-risk suicidal veterans. Journal of Clinical Psychiatry
2016;77:e1591-600.

Goodman 2020 {published data only}

Goodman M, Brown GK, Galfalvy HC, Page Spears A, Sullivan SR,
Kapil-Pair KN, et al. Group ("Project Life Force") versus
individual suicide safety planning: a randomized clinical trial.
Contemporary Clinical Trials Communications 2020;17:100520.

Haddock 2019 {published data only (unpublished sought but not
used)}ISRCTN17890126

Awenat YF, Peters S, Gooding PA, Pratt D, Shaw-Núñez E,
Harris K, et al. A qualitative analysis of suicidal psychiatric
inpatients views and expectations of psychological therapy
to counter suicidal thoughts, acts and deaths. BMC Psychiatry
2018;18:334.

Haddock G, Davies L, Evans E, Emsley R, Gooding P, Heaney L, et
al. Investigating the feasibility and acceptability of a cognitive
behavioural suicide prevention therapy for people in acute
psychiatric wards (the 'INSITE' trial): study protocol for a
randomised controlled trial. Trials 2016;17:79.

*  Haddock G, Pratt D, Gooding PA, Peters S, Emsley R, Evans E,
et al. Feasibility and acceptability of suicide prevention therapy
on acute psychiatric wards: randomised controlled trial. British
Journal of Psychiatry Open 2019;5:e14.

Hashemi-Aliabadi 2020 {published data only}

Hashemi-Aliabadi S, Jalali A, Rahmati M, Salari N. Group
reminiscence for hope and resilience in care-seekers who have
attempted suicide. Annals of General Psychiatry 2020;19:4.

Hooley 2014 {published data only}

Hooley JM, St Germain SA. Nonsuicidal self-injury, pain, and
self-criticism: does changing self-worth change pain endurance

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

82

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

in people who engage in self-injury. Clinical Psychological
Science 2014;2:297-305.

Hooley 2018 {published data only}ISRCTN12276176

Hooley JM, Fox KR, Wang SB, Kwashie AND. Novel online daily
diary interventions for nonsuicidal self-injury: a randomized
controlled trial. BMC Psychiatry 2018;18:264.

Hurtado-Santiago 2018 {published data only}

Hurtado-Santiago S, Guzmán-Parra J, Bersabé RM, Mayoral F.
Effectiveness of iconic therapy for the reduction of borderline
personality disorder symptoms among suicidal youth: study
protocol for a randomised controlled trial. BMC Psychiatry
2018;18:277.

Inder 2015 {published data only}

Inder ML, Crowe MT, Luty SE, Carter JD, Moor S, Frampton CM,
et al. Randomized, controlled trial of interpersonal and social
rhythm therapy for young people with bipolar disorder. Bipolar
Disorder 2015;17:128-38.

*  Inder ML, Crowe MT, Luty SE, Carter JD, Moor S, Frampton CM.
Prospective rates of suicide attempts and nonsuicidal self-
injury by young people with bipolar disorder participating in
a psychotherapy study. Australian and New Zealand Journal of
Psychiatry 2015;50:167-73.

ISRCTN10115835 {unpublished data only}10115835

ISRCTN10115835. Is a talking therapy, called psychodynamic
interpersonal therapy, clinically and cost effective for women
who self-harm in prison? [Women Offenders Repeat Self-Harm
Intervention Pragmatic Trial (WORSHIP III)]. doi.org/10.1186/
ISRCTN10115835 (first received 11 February 2019). [DOI:
10.1186/ISRCTN10115835]

ISRCTN16003313 {unpublished data only}16003313

ISRCTN16003313. A brief psychological intervention for
self-harm in emergency departments [ASsuRED: Improving
outcomes in patients who self-harm. Adapting and evaluating a
brief pSychological inteRvention in Emergency Departments].
doi.org/10.1186/ISRCTN16003313 (first received 27 January
2020).

ISRCTN16049211 {unpublished data only}16049211

ISRCTN16049211. FReSH START feasibility study [Function
REplacement in repeated Self-Harm: Standardising Therapeutic
Assessment and the Related Therapy (FRESH START): feasibility
study]. doi.org/10.1186/ISRCTN16049211 (first received 9
December 2019).

ISRCTN16862589 {unpublished data only}16862589

ISRCTN16862589. Brief education supported treatment for
adolescent borderline personality disorder [Brief Education
Supported Treatment (BEST) for adolescent borderline
personality disorder: a feasibility study of delivery of specialised
early intervention for borderline personality disorder through
collaboration with education providers, incorporating a
feasibility randomised controlled trial]. doi.org/10.1186/
ISRCTN16862589 (first received 28 January 2019).

Cochrane Database of Systematic Reviews

ISRCTN18761534 {unpublished data only}18761534

ISRCTN18761534. Women Offenders Repeat Self-Harm
Intervention Pilot II (WORSHIP II). doi.org/10.1186/
ISRCTN18761534 (first received 19 December 2012).

Jardon 2019 {published data only}

Jardon V, Debien C, Duhem S, Morgiève M, Ducrocq F,
Vaiva G. An example of post-discharge monitoring after a
suicide attempt: VigilanS [Un example de système de veille
post-hospitalière des suicidants: VigilanS]. L'Éncéphale
2019;45:S13-21.

Jobes 2017 {published data only}

Huh D, Jobes DA, Comtois KA, Kerbrat AH, Chalker SA,
Gutierrez PM, et al. The Collaborative Assessment and
Management of Suicidality (CAMS) versus Enhanced Care
As Usual (E-CAU) with suicidal soldiers: moderator analyses
from a randomized controlled trial. Military Psychology
2018;30:495-506.

*  Jobes DA, Comtois KA, Gutierrez PM, Brenner LA, Huh D,
Chalker SA, et al. A randomized controlled trial of the
Collaborative Assessment and Management of Suicidality
versus Enhanced Care As Usual with suicidal soldiers. Psychiatry
2017;80:339-56.

Johnson 2018 {published data only}

Johnson SB, Goodnight BL, Zhang H, Daboin I, Patterson B,
Kaslow NJ. Compassion-based mediation in African Americans:
self-criticism mediates changes in depression. Suicide and Life-
Threatening Behavior 2018;48:160-8.

Kawanishi 2018 {published data only}

Kawanishi C, Ishii T, Yonemoto N, Yamada M, Tachikawa H,
Kishimoto T, et al. Protocol for a prospective multicentre
registry cohort study on suicide attempters given the assertive
case management intervention after admission to an
emergency department in Japan: Post-ACtion-J Study (PACS).
British Medical Journal Open 2018;8:e020517.

Kennedy 2018 {published data only}

Kennedy GA, Forney KJ, Pinner D, Martinez KM, Buchman-
Schmitt JM, Keel PK. Reducing anticipated non-suicidal self-
injury by improving body esteem in individuals with weight
suppression: a proof of concept study. International Journal of
Eating Disorders 2018;52:206-10.

Kholodkov 2015 {published data only}

Kholodkov T. Mindfulness-Based Relapse Prevention for Non-
Suicidal Self-Injury [Doctor of Philosophy thesis]. Laramie, WY:
University of Wyoming, 2015.

Kim 2020 {published data only}

Kim M-H, Lee J, Noh H, Hong J-P, Kim P, Cha YS, et al.
Effectiveness of a flexible and continuous case management
program for suicide attempters. International Journal of
Environmental Research and Public Health 2020;17:2599.

Kline 2016 {published data only}

Kline A, Chesin M, Latorre M, Miller R, St Hill L, Shcherbakov A,
et al. Rationale and study design of a trial of mindfulness-based

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

83

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

cognitive therapy for preventing suicidal behavior (MBCT-S) in
military veterans. Contemporary Clinical Trials 2016;50:245-52.

Korczak 2020 {published data only}

Korczak DJ, Finkelstein Y, Barwick M, Chaim G, Cleverley K,
Henderson J, et al. A suicide prevention strategy for youth
presenting to the emergency department with suicide related
behaviour: protocol for a randomized controlled trial. BMC
Psychiatry 2020;20:20.

LaCroix 2018 {published and unpublished data}

Ghahramanlou-Holloway M, LaCroix JM, Perera KU, Neely L,
Grammer G, Weaver J, et al. Inpatient psychiatric care
following a suicide-related hospitalization: a pilot trial of post-
admission cognitive therapy in a military medical center.
General Hospital Psychiatry 2020;63:46-53.

*  LaCroix JM, Perera KU, Neely LL, Grammer G, Weaver J,
Ghahramanlou-Holloway M. Pilot trial of post-admission
cognitive therapy: inpatient program for suicide prevention.
Psychological Services 2018;15:279-88.

Neely L, Irwin K, Carreno Ponce JT, Perera K, Grammer G,
Ghahramanlou-Holloway M. Post Admission Cognitive Therapy
(PACT) for the prevention of suicide in military personnel with
histories of trauma: treatment development and case example.
Clinical Case Studies 2013;12:457-73.

Lahoz 2016 {published data only}

Lahoz T, Hvid M, Wang AG. Preventing repetition of attempted
suicide - III. The Amager Project, 5-year follow-up of a
randomized controlled trial. Nordic Journal of Psychiatry
2017;70:547-53.

Lin 2019 {published data only}

Lin T-J, Ko H-C, Wu KY-W, Oei TP, Lane H-Y, Chen C-H. The
effectiveness of dialectical behavior therapy skills training
group vs. cognitive therapy group on reducing depression and
suicide attempts for borderline personality disorder in Taiwan.
Archives of Suicide Research 2019;23:82-99.

Luxton 2014 {published data only}

Luxton DD, Thomas EK, Chipps J, Relova RM, Brown D, McLay R,
et al. Caring letters for suicide prevention: implementation of
a multi-site randomized clinical trial in the U.S. military and
veteran affairs healthcare systems. Contemporary Clinical Trials
2014;37:252-60.

Mackie 2017 {published data only}

Mackie C, Dunn N, MacLean S, Testa V, Heisel M, Hatcher S. A
qualitative study of a blended therapy using problem solving
therapy with a customised smartphone app in men who present
to hospital with intentional self-harm. Evidence Based Mental
Health 2017;20:118-22.

Marriott 2016 {published data only}

Marriott BP, Hibbeln JR, Killeen TK, Magruder KM, Holes-
Lewis K, Tolliver BK, et al. Design and methods for the Better
Resiliency Among Veterans and non-Veterans with Omega-3's
(BRAVO) study: A double-blind, placebo-controlled trial of
omega-3 fatty acid supplementation among adult individuals at
risk of suicide. Contemporary Clinical Trials 2016;47:325-33.

Cochrane Database of Systematic Reviews

Matsubara 2019 {published data only}

Matsubara T, Matsuo K, Matsuda A, Ogino Y, Hobara T,
Wakabayashi Y, et al. Combining phone and postcard brief
contact interventions for preventing suicide reattempts:
a quasi-randomized controlled trial. Psychiatry Research
2019;279:395-6.

McCall 2019 {published data only}

McCall WV, Ahn E, Benca R, Krystal A, Rosenquist PB,
Rumble M, et al. 0960. A preliminary report from the "REST-
IT" study: insomnia severity and hypersomnia severity each
independently predict the intensity of suicidal ideation. Sleep
2015;38:A339.

*  McCall WV, Benca RM, Rosenquist PB, Youssef NA, McCloud L,
Newman JC, et al. REducing Suicidal ideation Through
Insomnia Treatment (REST-IT): a randomized clinical trial.
American Journal of Psychiatry 2019;176:957-65.

McManama O'Brien 2018 {published data only}

McManama O'Brien KH, Sellers CM, Battalen AW, Ryan CA,
Maneta EK, Aguinaldo LD, et al. Feasibility, acceptability, and
preliminary effects of a brief alcohol intervention for suicidal
adolescents in inpatient psychiatric treatment. Journal of
Substance Abuse Treatment 2018;94:105-12.

Miller 2016 {published data only}

Miller IW, Gaudiano BA, Weinstock LM. The Coping Long Term
with Active Suicide Program: description and pilot data. Suicide
and Life-Threatening Behavior 2016;46:752-61.

Morley 2014 {published data only}

Morley KC, Sitharthan G, Haber PS, Tucker P, Sitharthan T. The
efficacy of an Opportunistic Cognitive Behavioral intervention
package (OCB) on substance use and comorbid suicide risk: a
multisite randomized controlled trial. Journal of Consulting and
Clinical Psychology 2014;82:130-40.

Navarro-Haro 2018 {published and unpublished data}

Navarro-Haro MV, Botella C, Guillen V, Moliner R, Marco H,
Jorquera M, et al. Dialectical behavior therapy in the treatment
of borderline personality disorder and eating disorders
comorbidity: a pilot study in a naturalistic setting. Cognitive
Therapy and Research 2018;42:636-49.

NCT00218725 {unpublished data only}

NCT00218725. Cognitive therapy for suicide attempters
with drug dependence disorder. clinicaltrials.gov/ct2/show/
NCT00218725 (first received 22 September 2005).

NCT00601939 {unpublished data only}

NCT00601939. Group interventions for abused, suicidal black
women. clinicaltrials.gov/ct2/show/NCT00601939 (first received
28 January 2008).

NCT00603421 {unpublished data only}

NCT00603421. Effectiveness of a 24 hour phone line on the rate
of suicide attempts in borderline patients. clinicaltrials.gov/ct2/
show/NCT00603421 (first received 29 January 2008).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

84

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT00641498 {unpublished data only}

NCT03376113 {unpublished data only}

NCT00641498. Effectiveness of standard emergency department
psychiatric treatment compared with effectiveness of standard
emergency department psychiatric treatment associated
with treatment delivery by a suicide prevention center.
clinicaltrials.gov/ct2/show/NCT00641498 (first received 24
March 2008).

NCT00980824 {published data only (unpublished sought but not
used)}

NCT00980824. ENGAGE - Meeting mental health needs of
complex comorbid patients. clinicaltrials.gov/ct2/show/
NCT00980824 (first received 21 September 2009).

NCT01359761 {unpublished data only}

NCT01359761. Post Admission Cognitive Therapy (PACT)
for the inpatient treatment of military personnel with
suicidal behaviors: a multi-site randomized controlled trial.
clinicaltrials.gov/ct2/show/NCT01359761 (first received 25 May
2011).

NCT01823120 {unpublished data only}

NCT01823120. Text message intervention to reduce repeat self-
harm in patients presenting to the emergency department.
clinicaltrials.gov/ct2/show/NCT01823120 (first received 4 April
2013).

NCT01952405 {unpublished data only}

NCT01952405. Efficacy of dialectical behavior therapy in
patients with borderline personality disorder: a controlled
trial in Taiwan. clinicaltrials.gov/ct2/show/NCT01952405 (first
received 30 September 2013).

NCT02227160 {unpublished data only}

NCT02227160. Group interventions for suicidal African
Americans. clinicaltrials.gov/ct2/show/NCT02227160 (first
received 27 August 2014).

NCT03376113. The effect of a brief psychological intervention
on reducing self-harm repetition: feasibility study.
clinicaltrials.gov/ct2/show/NCT03376113 (first received 18
December 2017).

NCT03489382 {unpublished data only}

NCT03489382. The BEACON Study: protocol for cluster RCT of a
service to deliver smartphone-assisted problem-solving therapy
compared to usual care in men who present with intentional
self-harm to the ED in Ontario (protocol A). clinicaltrials.gov/ct2/
show/NCT03489382 (first received 5 April 2018).

NCT03533075 {unpublished data only}

NCT03533075. A pilot effectiveness trial of the Teachable
Moment Brief Intervention (TMBI) for veterans hospitalized
following a suicide attempt. clinicaltrials.gov/ct2/show/
NCT03533075 (first received 22 May 2018).

NCT03600532 {unpublished data only}

NCT03600532. Testing the efficacy of the Teachable Moment
Brief Intervention for suicide attempt survivors in an inpatient
setting: effects on psychosocial and experimental pain
outcomes. clinicaltrials.gov/ct2/show/NCT03600532 (first
received 26 July 2018).

NCT03943862 {unpublished data only}

NCT03943862. To Share or not to Share (2Share): group
intervention to support disclosure decisions after suicide
attempt. clinicaltrials.gov/ct2/show/NCT03943862 (first
received 9 May 2019).

O'Toole 2019 {published data only}

O'Toole MS, Arendt MB, Pedersen CM. Testing an app-assisted
treatment for suicide prevention in a randomized controlled
trial: effect on suicide risk and depression. Behavior Therapy
2019;50:421-9.

NCT02299440 {unpublished data only}

Pearce 2017 {published data only}

NCT02299440. Effects of ketamine in the acute phase of suicidal
ideation (KETIS). clinicaltrials.gov/ct2/show/NCT02299440 (first
received 24 November 2014).

NCT02522143 {unpublished data only}

NCT02522143. College students who self-harm: an intervention
study. clinicaltrials.gov/ct2/show/NCT02522143 (first received
13 August 2015).

NCT02742922 {unpublished data only}

NCT02742922. Multicenter RCT to evaluate the clinical and
cost-effectiveness of a culturally adapted therapy (C-MAP) in
patients with a history of self-harm. clinicaltrials.gov/ct2/show/
NCT02742922 (first received 19 April 2016).

NCT03300596 {unpublished data only}

NCT03300596. Suicidal adults with alcohol or drug use
problems: a new hospital-based treatment. clinicaltrials.gov/
ct2/show/NCT03300596 (first received 3 October 2017).

Pearce S, Scott L, Attwood G, Saunders K, Dean M, De Ridder R,
et al. Democratic therapeutic community treatment for
personality disorder: randomised controlled trial. British
Journal of Psychiatry 2017;210:149-56.

Pfeiffer 2019 {published data only}

Lapidos A, Abraham KM, Jagusch J, Garlick J, Walters H,
Kim HM, et al. Peer mentorship to reduce suicide attempts
among high-risk adults (PREVAIL): rationale and design of a
randomized controlled effectiveness-implementation trial.
Contemporary Clinical Trials 2019;87:105850.

*  Pfeiffer PN, King C, Ilgen M, Ganoczy D, Clive R, Garlick J,
et al. Development and pilot study of a suicide prevention
intervention delivered by peer support specialists.
Psychological Services 2019;16:360-71.

Philips 2018 {published data only}ISRCTN98982683

Philips B, Wennberg P, Konradsson P, Frank J. Mentalization-
based treatment for concurrent borderline personality disorder
and substance use disorder: a randomized controlled feasibility
study. European Addiction Research 2018;24:1-8.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

85

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Pistorello 2020 {published data only}

Pistorello J, Jobes D, Compton S, Locey NS, Walloch JC,
Gallop R, et al. Developing adaptive treatment strategies to
address suicidal risk in college students: a pilot sequential,
multiple assignment, randomized trial (SMART). Archives of
Suicide Research 2017;22:644-64.

*  Pistorello J, Jobes DA, Gallop R, Compton SN, Locey NS,
Au JS, et al. A randomized controlled trial of the Collaborative
Assessment and Management of Suicidality (CAMS) versus
Treatment As Usual (TAU) for suicidal college students.
Archives of Suicide Research 2020 [ePub ahead of print]. [DOI:
10.1080/13811118.2020.1749742]

Pratt 2015 {published data only}

Pratt D, Tarrier N, Dunn G, Awenat Y, Shaw J, Ulph F, et al.
Cognitive-behavioural suicide prevention for male prisoners:
a pilot randomized controlled trial. Psychological Medicine
2015;45:3441-51.

Rees 2015 {published data only}

Rees CS, Hasking P, Breen LJ, Lipp OV, Marmotte C. Group
mindfulness based cognitive therapy vs group support for self-
injury among young people: study protocol for a randomised
controlled trial. BMC Psychiatry 2015;15:154.

Rompogren 2018 {published data only}

Rompogren JR. Using Resonance Frequency Breathing to
Improve Distress Tolerance in Females who Engage in Non-
Suicidal Self-Injury [Doctor of Philosophy thesis]. San Diego, CA:
Alliant International University, 2018.

Rudd 2015 {published data only}

Bryan CJ, Peterson AL, Rudd MD. Differential effects of brief
CBT versus treatment as usual on posttreatment suicide
attempts among groups of suicidal patients. Psychiatric Services
2018;69:703-9.

Bryan CJ, Rudd MD, Peterson AL, Young-McCaughan S,
Wertenberger EG. The ebb and flow of the wish to live and
the wish to die among suicidal military personnel. Journal of
Affective Disorders 2016;202:58-66.

Bryan CJ, Wood DS, May A, Peterson AL, Wertenberger E,
Rudd MD. 2017. Mechanisms of action contributing to reductions
in suicide attempts following brief cognitive behavioral therapy
for military personnel: a test of the interpersonal-psychological
theory of suicide 2017;22:241-53.

*  Rudd MD, Bryan CJ, Wertenberger EG, Peterson AL, Young-
McCaughan S, Mintz J, et al. Brief cognitive-behavioral therapy
effects on post-treatment suicide attempts in a military sample:
results of a randomized clinical trial with 2-year follow-up.
American Journal of Psychiatry 2015;172:441-9.

Ryberg 2019 {published data only}

Cochrane Database of Systematic Reviews

Ryberg W, Fosse R, Zahl P-H, Brorson I, Moller P, Landrø NI, et
al. Collaborative Assessment and Management of Suicidality
(CAMS) compared to Treatment As Usual (TAU) for suicidal
patients: study protocol for a randomized controlled trial. Trials
2016;17:481.

*  Ryberg W, Zahl P-H, Diep LM, Landrø NI, Fosse R. Managing
suicidality within specialized care: a randomized controlled
trial. Journal of Affective Disorders 2019;249:112-20.

Sáiz 2014 {published and unpublished data}

Sáiz PA, Rodriguez-Revulta J, González-Blanco L, Burón P,
Al-Halabi S, Garrido M, et al. Study protocol of a prevention
of recurrent suicidal behavior program based on case
management (PSyMAC). Revista de Psiquiatría y Salud Mental
2014;7:131-8.

Santel 2020 {published data only}

Santel M, Beblo T, Neuner F, Berg M, Hennig-Fast K, Jobes DA,
et al. Collaborative Assessment and Management of Suicidality
(CAMS) compared to Enhanced Treatment As Usual (E-TAU) for
suicidal patients in an inpatient setting: study protocol for a
randomized controlled trial. BMC Psychiatry 2020;20:183.

Sayal 2019 {published and unpublished data}

Sayal K, Roe J, Atha C, Kaylor-Hughes C, Guo B, Townsend E,
et al. Feasibility of a randomised controlled trial of remotely
delivered problem-solving cognitive behaviour therapy versus
usual care for young people with depression and repeat self-
harm: Lessons learnt (e-DASH). BMC Psychiatry 2019;19:42.

Sequeira 2016 {published data only}

Sequeira E, Field C, Wagler A, Avila A. The moderation effect of
mental health indicators on the efficacy of three brief alcohol
interventions. Alcoholism 2016;40:69A.

Simon 2016 {published data only}

Simon GE, Beck A, Rossom R, Richards J, Kirlin B, King D, et
al. Population-based outreach versus care as usual to prevent
suicide attempt: study protocol for a randomized controlled
trial. Trials 2016;17:452.

Sinnaeve 2018 {published and unpublished data}

Hakkaart-van Roijen L, Sinnaeve R, Bouwmans C, Van
den Bosch L. Cost-effectiveness and cost-utility of short-
term inpatient dialectical behavior therapy for chronically
parasuicidal BPD (young) adults. Journal of Mental Health Policy
and Economics 2015;1:S19.

*  Sinnaeve R, Van den Bosch LMC, Hakkaart-van Roijen L,
Vansteelandt K. Effectiveness of step-down versus outpatient
dialectical behaviour therapy for patients with severe levels
of borderline personality disorder: a pragmatic randomized
controlled trial. Borderline Personality Disorder and Emotion
Dysregulation 2018;5:12.

Ryberg W, Diep LM, Landrø NI, Fosse R. Effects of the
Collaborative Assessment and Management of Suicidality
(CAMS) model: a secondary analysis of moderation and
influencing factors. Archives of Suicide Research 2019 [ePub
ahead of print]. [DOI: 10.1080/13811118.2019.1650143]

Van den Bosch LMC, Sinnaeve R, Hakkaart-van Roijen L, Van
Furth EF. Efficacy and cost-effectiveness of an experimental
short-term inpatient dialectical behavior therapy (DBT)
program: study protocol for a randomized controlled trial. Trials
2014;15:152.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

86

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Slesnick 2020 {published data only}

Slesnick N, Zhang J, Feng X, Wu Q, Walsh L, Granello DH.
Cognitive therapy for suicide prevention: a randomized pilot
with suicidal youth experiencing homelessness. Cognitive
Therapy and Research 2020;44:402-11.

Smits 2020 {published data only}

Laurenssen EMP, Smits ML, Bales DL, Feenstra DJ, Eeren HV,
Noom MJ, et al. Day hospital mentalization-based treatment
versus intensive outpatient mentalization-based treatment for
patients with severe borderline personality disorder: protocol
of a multicentre randomized clinical trial. BMC Psychiatry
2014;14:301.

Laurenssen EMP, Westra D, Kikkert MJ, Noom MJ, Eeren HV,
Van Broekhuyzen AJ, et al. Day hospital mentalization-based
treatment (MBT-DH) versus treatment as usual in the treatment
of severe borderline personality disorder: protocol or a
randomized controlled trial. BMC Psychiatry 2014;14:149.

Smits ML, Feenstra DJ, Bales DL, Blankers M, Dekker JJM,
Lucas Z, et al. Day hospital versus intensive outpatient
mentalization-based treatment: 3-year follow-up of
patients treated for borderline personality disorder in a
multicentre randomized clinical trial. Psychological Medicine
2020;216:79-84.

*  Smits ML, Feenstra DJ, Eeren HV, Bales DL, Laurenssen EMP,
Blankers M, et al. Day hospital versus intensive out-patient
mentalisation-based treatment for borderline personality
disorder: multicentre randomised clinical trial. British Journal of
Psychiatry 2020;216:79-84.

Taha 2015 {published data only}

Taha F, Zhang H, Snead K, Jones AD, Blackmon B, Bryant RJ,
et al. Effects of a culturally informed intervention on abused,
suicidal African American women. Cultural Diversity and Ethnic
Minority Psychology 2015;21:560-70.

Tejedor 2011 {published and unpublished data}

Farré A, Portella MJ, De Angel L, Díaz A, De Diego-Adeliño J,
Vegué J, et al. Benefits of a secondary prevention program in
suicide: a 1-year follow-up experimental study compared with a
treatment-as-usual control group. Crisis 2016;37:281-9.

*  Tejedor C, Díaz A, Faus G, Pérez V, Solà I. Results of the
prevention program of suicidal behavior: eixample district
of Barcelona [Resultados del programa de prevención de
la conducta suicida: Distrito de la Dreta de l’Eixample de
Barcelona]. Actas Españolas de Psiquiatria 2011;39:280-7.

Cochrane Database of Systematic Reviews

sample: randomized controlled trial. Journal of Medical Internet
Research 2018;20:e15.

Ward-Ciesielski 2016 {published data only}

Ward-Ciesielski EF, Jones CB, Wielgus MD, Wilks CR,
Linehan MM. Single-session dialectical behavior therapy skills
training versus relaxation training for non-treatment-engaged
suicidal adults: a randomized controlled trial. BMC Psychology
2016;4:13.

Westling 2019 {published data only}

Liljedahl SI, Helleman M, Daukantaité D, Westrin Å, Westling S.
A standardized crisis management model for self-harming and
suicidal individuals with three or more diagnostic criteria of
borderline personality disorder: the Brief Admission Skåne
Randomized Controlled Trial protocol (BASRCT). BMC Psychiatry
2017;17:220.

*  Westling S, Daukantaitė D, Liljedahl SI, Oh Y, Westrin Å,
Flyckt L, et al. Effect of brief admission to hospital by self-
referral for individuals who self-harm and are at risk of suicide:
a randomized clinical trial. JAMA Network Open 2019;2:e195463.

Wilks 2018 {published data only}

Wilks CR, Lungu A, Ang SY, Matsumiya B, Yin Q, Linehan MM. A
randomized controlled trial of an internet delivered dialectical
behavior therapy skills training for suicidal and heavy episodic
drinkers. Journal of Affective Disorders 2018;232:219-28.

Wittouck 2014 {published data only}

Wittouck C, Van Autreve S, Portzky G, Van Heeringen K. A CBT-
based psychoeducational intervention for suicide survivors: a
cluster randomized controlled study. Crisis 2014;35:193-201.

Yang 2020 {published data only}

Yang X, Liu D, Wang Y, Chen Y, Chen W, Yang C, et al.
Effectiveness of Zhong-Yong thinking based dialectical
behavior therapy group skills training versus supportive group
therapy for lowering suicidal risks in Chinese young adults: a
randomized controlled trial with a 6-month follow-up. Brain and
Behavior 2020;10:e01621.

References to studies awaiting assessment

NCT00533117 {published data only (unpublished sought but not
used)}

NCT00533117. Treating suicidal behavior and self-mutilation in
people with borderline personality disorder. clinicaltrials.gov/
ct2/show/NCT00533117 (first received 21 September 2007).

Vaiva 2016 {published data only}

NCT00834834 {unpublished data only}

Vaiva G, Jardon V, Ducrocq F, Grandgenèvre P, Debien C,
Berrouiguet S, et al. Surveillance is a powerful took to prevent
suicidal acts. In: Courtet P, editors(s). Understanding Suicide:
From Diagnosis to Personalized Treatment. Cham, Switzerland:
Springer International Publishing, 2016:269-79.

Van Spijker 2018 {published data only}

Van Spijker BAJ, Werner-Seidler A, Batterham PJ, Mackinnon A,
Calear AL, Gosling JA, et al. Effectiveness of a web-based self-
help program for suicidal thinking in an Australian community

NCT00834834. Comparing treatments for self-injury and suicidal
behavior in people with borderline personality disorder.
clinicaltrials.gov/ct2/show/NCT00834834 (first received 3
February 2009).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

87

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

References to ongoing studies

ACTRN12617000529347 {unpublished data only}

ACTRN12617000529347. Will prisoners who self-harm reduce
their frequency of self-harming after going through the
Dialectical Behaviour Therapy intervention? www.anzctr.org.au/
Trial/Registration/TrialReview.aspx?id=372437&isReview=true
(first received 27 February 2017).

Berrouiguet 2014 {published and unpublished data}

*  Berrouiguet S, Alavi Z, Vaiva G, Courtet P, Baca-García E,
Vidailhet P, et al. SIAM (Suicide Intervention Assisted by
Messages): the development of a post-acute crisis text
messaging outreach for suicide prevention. BMC Psychiatry
2014;14:294.

Berrouiguet S, Larsen ME, Mesmeur C, Gravey M, Billot R,
Walter M, et al. Toward mHealth brief contact intervention in
suicide prevention: case series from the Suicide Intervention
Assisted by Messages (SIAM) randomized controlled trial.
Journal of Medical Internet Research mHealth and uHealth
2018;6:8.

Chaïb 2020 {published data only (unpublished sought but not
used)}

Chaïb LS, Lopez-Castroman J, Abbar M. Group post-admission
cognitive therapy for suicidality vs individual supportive
therapy for the prevention of repeat suicide attempts: a
randomized controlled trial. Trials 2020;21:889.

McMain 2018 {published and unpublished data}

McMain SF, Chapman AL, Kuo JR, Guimond T, Streiner DL,
Dixon-Gordon KL, et al. The effectiveness of 6 versus 12-months
of dialectical behaviour therapy for borderline personality
disorder: the Feasibility of A Shorter Treatment and Evaluating
Responses (FASTER) trial protocol. BMC Psychiatry 2018;18:230.

NCT02060448 {unpublished data only}

NCT02060448. Exploring two emotion-focused treatment
modules in non-suicidal self-injury. clinicaltrials.gov/ct2/show/
NCT02060448 (first received 12 february 2014).

NCT02354183 {unpublished data only}

NCT02354183. Commitment and motivation in a brief DBT
intervention for self harm. clinicaltrials.gov/ct2/show/
NCT02354183 (first received 3 February 2015).

NCT03081078 {unpublished data only}

NCT03081078. Effects of community-based caring contact on
post-discharge young adults with self-harm. clinicaltrials.gov/
ct2/show/NCT03081078 (first received 15 March 2017).

NCT03185026 {unpublished data only}

NCT03185026. Effectiveness of the first French
psychoeducational program for suicidal
behavior: a randomized controlled trial. clinicaltrials.gov/ct2/
show/NCT03185026 (first received 14 June 2017).

NCT03427190 {unpublished data only}

NCT03427190. Assessment of preventive efficacy of an
algorithm taking place after suicide attempts among attempters
admitted to hospital in the French Overseas Territories.

Cochrane Database of Systematic Reviews

clinicaltrials.gov/ct2/show/NCT03427190 (first received 9
February 2018).

NCT03463980 {unpublished data only}

NCT03463980. Compassion meditation and ReliefLink app for
suicidal, low-income, African Americans. clinicaltrials.gov/ct2/
show/NCT03463980 (first received 13 March 2018).

NCT03541824 {unpublished data only}

NCT03541824. Reducing suicide risk associated with weight
loss. clinicaltrials.gov/ct2/show/NCT03541824 (first received 31
May 2018).

NCT03732300 {unpublished data only}

NCT03732300. Evaluation of ASSIP - Attempted Suicide
Short Intervention Program: a randomized controlled trial.
clinicaltrials.gov/ct2/show/NCT03732300 (first received 6
November 2018).

NCT03853382 {unpublished data only}

NCT03853382. Cognitive Analytic Therapy-informed
Containment for self-Harm (CATCH). clinicaltrials.gov/ct2/show/
NCT03853382 (first received 25 February 2019).

NCT03894462 {unpublished data only}

NCT03894462. Effectiveness of a targeted brief intervention for
recent suicide attempt survivors. clinicaltrials.gov/ct2/show/
NCT03894462 (first received 28 March 2019).

NCT04072666 {unpublished data only}

NCT04072666. Investigations of psychological interventions in
suicide prevention: a comparison of brief cognitive behavioural
therapy and the attempted suicide short intervention program.
clinicaltrials.gov/ct2/show/NCT04072666 (first received 28
August 2019).

NCT04168645 {unpublished data only}

NCT04168645. Inpatient cognitive-behavioral therapy to
reduce suicide risk post-discharge. clinicaltrials.gov/ct2/show/
NCT04168645 (first received 19 November 2019).

NCT04191122 {unpublished data only}

NCT04191122. Community Outpatient Psychotherapy
Engagement Service for Self-harm (COPESS): a feasibility study.
clinicaltrials.gov/ct2/show/NCT04191122 (first received 9
December 2019).

NCT04244786 {unpublished data only}

NCT04244786. Treating self injurious behavior: a novel brain
stimulation approach. clinicaltrials.gov/ct2/show/NCT04244786
(first received 28 January 2020).

NCT04284085 {unpublished data only}

NCT04284085. Evaluation of a psychoeducational intervention
for people with suicidal behaviour in the penitentiary
environment: N'VIU project. clinicaltrials.gov/ct2/show/
NCT04284085 (first received 25 February 2020).

NCT04343703 {unpublished data only}

NCT04343703. Suicide prevention and intervention (SURVIVE):
cohort study and nested randomized controlled trials

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

88

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

of secondary prevention programs for suicide attempts.
clinicaltrials.gov/ct2/show/NCT04343703 (first received 13 April
2020).

NCT04366466 {published data only (unpublished sought but not
used)}

NCT04366466. Program to Promote Engagement in care for the
Prevention of Suicide recidivism (PEPS). clinicaltrials.gov/ct2/
show/NCT04366466 (first received 29 April 2020).

NCT04420546 {unpublished data only}

NCT04420546. Using implementation intentions to reduce self-
harm. clinicaltrials.gov/ct2/show/NCT04420546 (first received 9
June 2020).

O'Connor 2019 {published data only}ISRCTN62181241

O'Connor RC, Lundy J-M, Stewart C, Smillie S, McClelland H,
Syrett S, et al. SAFETEL randomised controlled feasibility trial
of a safety planning intervention with follow-up telephone
contact to reduce suicidal behaviour: study protocol. BMJ Open
2019;9:e025591.

SLCTR/2017/008 {unpublished data only}

SLCTR/2017/008. A brief intervention for prevention of
repetition of self-harm, among those who have recently
attempted self-poisoning: a randomized controlled trial. slctr.lk/
trials/slctr-2017-008 (first received 23 March 2017).

Stevens 2019 {published and unpublished data}

Stevens GJ, Hammond TE, Brownhill S, Anand M, De la Riva A,
Hawkins J, et al. SMS SOS: a randomized controlled trial
to reduce self-harm and suicide attempts using SMS text
messaging. BMC Psychiatry 2019;19:117.

Additional references

Allen 2008

Allen JG, Fonagy P, Bateman AW. Mentalizing in Clinical
Practice. Washington DC, USA: American Psychiatric Publishing,
2008.

APA 2000

American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-
IV-TR). Washington, DC: American Psychiatric Association, 2000.

Beck 1961

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An
inventory for measuring depression. Archives of General
Psychiatry 1961;4:561.

Beck 1974

Beck AT, Weissman A, Lester D, Trexler L. The measurement of
pessimism: the Hopelessness Scale. Journal of Consulting and
Clinical Psychology 1974;42:861-5.

Beck 1976

Beck AT. Cognitive Therapy and Emotional Disorders. New York,
NY: International Universities Press, 1976.

Beck 1988

Beck AT, Steer RA, Ranieri WF. Scale for Suicide Ideation:
psychometric properties of a self-report version. Journal of
Clinical Psychology 1988;44:499-505.

Bergen 2010

Bergen H, Hawton K, Waters K, Cooper J, Kapur N.
Epidemiology and trends in non-fatal self-harm in three
centres in England, 2000-2007. British Journal of Psychiatry
2010;197:493-8.

Bertolote 2010

Bertolote JM, Fleischmann A, De Leo D, Phillips MR, Botega NJ,
Vijayakumar L, et al. Repetition of suicide attempts: data
from five culturally different low- and middle-income country
emergency care settings participating in the WHO SUPRE-MISS
study. Crisis 2010;31:194-201.

Bornheimer 2020

Bornheimer LA, Zhang A, Li J, Hiller M, Tarrier N. Effectiveness
of suicide-focused psychosocial interventions in psychosis:
a systematic review and meta-analysis. Psychiatric Services
2020;71:829-38.

Briggs 2019

Briggs S, Netuveli G, Gould N, Gkaravella A, Gluckman NS,
Kangogyere P, et al. The effectiveness of psychoanalytic/
psychodynamic psychotherapy for reducing suicide attempts
and self-harm: systematic review and meta-analysis. British
Journal of Psychiatry 2019;214:320-8.

Bustamante-Madsen 2018

Bustamante-Madsen L, Eddleston M, Schultz-Hansen K,
Konradsen F. Quality assessment of economic evaluations of
suicide and self-harm interventions. Crisis 2018;39:82-95.

Calati 2016

Calati R, Courtet P. Is psychotherapy effective for reducing
suicide attempt and non-suicidal self-injury rates? Meta-
analysis and meta-regression of literature data. Journal of
Psychiatric Research 2016;79:8-20.

Canner 2018

Canner JK, Giuliano K, Selvaraiah S, Hammond ER,
Schneider EB. Emergency department visits for attempted
suicide and self harm in the USA, 2006-2013. Epidemiology and
Psychiatric Sciences 2018;27:94-102.

Carkhuff 1969

Carkhuff RR. Helping and Human Relations. New York, NY: Holt,
Rinehart, & Winston, 1969.

Carroll 2014

Carroll R, Metcalfe C, Gunnell D. Hospital presenting self-harm
and risk of fatal and non-fatal repetition: systematic review and
meta-analysis. PL0S One 2014;9:e89944.

Carter 2016

Carter G, Page A, Large M, Hetrick S, Milner AJ, Bendit N, et
al. Royal Australian and New Zealand College of Psychiatrists
clinical practice guideline for the management of deliberate

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

89

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

self-harm. Australian and New Zealand Journal of Psychiatry
2006;50:939-1000.

Claes 2007

Claes L, Wandereycken W, Vertommen H. Self-injury in
female versus male psychiatric patients: a comparison of
characteristics, psychopathology and aggression regulation.
Personality and Individual Differences 2007;42:611-21.

Clarkin 1999

Clarkin JF, Yeomans FE, Kernberg OF. Psychotherapy for
Borderline Personality. New York, NY: Wiley, 1999.

DeCou 2019

DeCou CR, Comtois KA, Landes SJ. Dialectical behavior therapy
is effective for the treatment of suicidal behavior: a meta-
analysis. Behavior Therapy 2019;50:60-72.

Deeks 2019

Deeks JJ, Higgins JPT, Altman DG, editor(s). Chapter 10:
Analysing data and undertaking meta-analyses. In: Higgins
JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et
al, editor(s). Cochrane Handbook for Systematic Reviews of
Interventions version 6.0 (updated July 2019). Cochrane, 2019.
Available from www.training.cochrane.org/handbook.

Corcoran 2015

De Leo 2013

Corcoran P, Griffin E, O'Carroll A, Cassidy L, Bonner B. Hospital-
treated deliberate self-harm in the western area of Northern
Ireland. Crisis 2015;36:83-90.

De Leo D, Milner A, Fleischmann A, Bertolote J, Collings S,
Amadeo S, et al. The WHO START Study: suicidal behaviours
across different areas of the world. Crisis 2013;34:156-63.

Courtney 2019

Dhingra 2015

Courtney DB, Duda S, Szatmari P, Henderson J, Bennett K.
Systematic review and quality appraisal of practice guidelines
for self-harm in children and adolescents. Suicide & Life-
threatening Behavior 2019;49:707-23.

Dhingra K, Boduszek D, O'Connor RC. Differentiating suicide
attempters from suicide ideators using the Integrated
Motivational-Volitional Model of Suicidal Behaviour. Journal of
Affective Disorders 2015;186:211-8.

Cristea 2017

Donner 2002

Cristea IA, Gentili C, Cotét CD, Palomba D, Barbui C, Cuijpers P.
Efficacy of psychotherapies for borderline personality disorder:
a systematic review and meta-analysis. JAMA Psychiatry
2017;74:319-28.

Curtin 2002a

Curtin F, Elbourne D, Altman DG. Meta-analysis combining
parallel and cross-over clinical trials. III: the issue of carry-over.
Statistics in Medicine 2002;21:2161-73.

Curtin 2002b

Curtin F, Altman DG, Elbourne D. Meta-analysis combining
parallel and cross-over trials. I. Continuous outcomes. Statistics
in Medicine 2002;21:2131-44.

D'Anci 2019

D'Anci KE, Uhl S, Giradi G, Martin C. Treatments for the
prevention and management of suicide: a systematic review.
Annals of Internal Medicine 2019;171:334-42.

D'Zurilla 1971

D’Zurilla TJ, Goldfried MR. Problem solving and behaviour
modification. Journal of Abnormal Psychology 1971;78:107-26.

D'Zurilla 2010

D'Zurilla TJ, Nezu AM. Problem-solving therapy. In: Dobson KS,
editors(s). Handbook of Cognitive-Behavioral Therapies. New
York, NY: Guilford Press, 2010.

De Beurs 2018

De Beurs D, Vancayseele N, Van Borkulo C, Portzky G, Van
Heeringen K. The association between motives, perceived
problems and current thoughts of self-harm following an
episode of self-harm: a network analysis. Journal of Affective
Disorders 2018;240:262-70.

Donner A, Klar N. Issues in the meta-analysis of cluster
randomized trials. Statistics in Medicine 2002;21:2971-80.

Easterbrook 1991

Easterbrook PJ, Gopalan R, Berlin JA, Matthews DR. Publication
bias in clinical research. Lancet 1991;337:867-72.

Egger 1997

Egger M, Smith GD, Schneider M, Christoph M. Bias in meta-
analysis detected by a simple, graphical test. BMJ 1997;315:629.
[DOI: 10.1136/bmj.315.7109.629]

Elbourne 2002

Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV,
Vail A. Meta-analyses involving cross-over trials: methodological
issues. International Journal of Epidemiology 2002;31:140-9.

Ellis 1986

Ellis A, Grieger R. Handbook of Rational-Emotive Therapy. New
York, NY: Springer, 1986.

Endicott 1976

Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global
Assessment Scale. A procedure for measuring overall severity
of psychiatric disturbance. Archives of General Psychiatry
1976;33:766-71.

Erez 1996

Erez A, Bloom MC, Wells MT. Using random rather than fixed
effects models in meta-analysis: implications for situation
specificity and validity generalization. Personnel Psychology
1996;49:275-306.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

90

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Evans 2005

Gilbody 1997

Evans J, Evans M, Morgan HG, Hayward A, Gunnell D. Crisis
card following self-harm: 12-month follow-up of a randomised
controlled trial. British Journal of Psychiatry 2005;187:186-7.

Gillbody S, House A, Owens D. The early repetition of deliberate
self-harm. Journal of the Royal College of Physicians in London
1997;31:171-2.

Ferrari 2014

GRADEpro GDT 2015 [Computer program]

Ferrari AJ, Norman RE, Freedman G, Baxter AJ, Pirkis JE,
Harris MG, et al. The burden attributable to mental and
substance use disorders as risk factors for suicide: findings
from the Global Burden of Disease Study 2010. PL0S One
2014;9:e91936.

Fleischmann 2002

Fleischmann A, Bertolote JM. Multisite intervention
study on suicidal behaviours - SUPRE-MISS: protocol of
SUPRE-MISS. citeseerx.ist.psu.edu/viewdoc/download?
doi=10.1.1.174.5140&rep=rep1&type=pdf (accessed 31 October
2020).

Fleiss 1994

Fleiss JL. Measures of effect size for categorical data. In: Cooper
H, Hedges LV, editors(s). The Handbook of Research Synthesis.
New York, NY: Russell Sage Foundation, 1994.

Forte 2019

Forte A, Buscaioni A, Fiorillo A, Pompii A, Baldessarini R. Suicidal
risk following hospital discharge: a review. Harvard Review of
Psychiatry 2019;27:209-16.

Furuno 2018

Furuno T, Nakagawa M, Hinto K, Yamada T, Kawashima Y,
Matsuoka Y, et al. Effectiveness of assertive case management
on repeat self-harm in patients admitted for suicide attempt:
findings from ACTION-J study. Journal of Affective Disorders
2018;225:460-5.

GRADEpro GDT. Version accessed 26 June 2020. Hamilton (ON):
McMaster University (developed by Evidence Prime), 2015.
Available at gradepro.org.

Griffin 2014

Griffin E, Arensman E, Corcoran P, Wall A, Williamson E, Perry I.
National Register of Deliberate Self Harm Annual Report. Cork,
Ireland: National Suicide Research Foundation, 2014.

Gunnell 2008

Gunnell D, Hawton K, Ho D, Evans J, O'Connor S, Potokar J,
et al. Hospital admissions for self harm after discharge from
psychiatric inpatient care: cohort study. British Medical Journal
2008;337:a2278.

Guy 1976

Guy W. ECDEU Assessment Manual for Psychopharmacology.
Rockville, MD, USA: US Department of Heath, Education, and
Welfare Public Health Service Alcohol, Drug Abuse, and Mental
Health Administration, 1976.

Gøtzsche 2017

Gøtzsche PC, Gøtzsche PK. Cognitive behavioural therapy
halves the risk of repeated suicide attempts: systematic review.
Journal of the Royal Society of Medicine 2017;110:404-10.

Hamilton 1960

Hamilton M. A rating scale for depression. Journal of Neurology,
Neurosurgery and Psychiatry 1960;32:56-62.

Geulayov 2016

Hanratty 2019

Geulayov G, Kapur N, Turnbull P, Clements C, Waters K, Ness J,
et al. Epidemiology and trends in non-fatal self-harm in three
centres in England, 2000-2012: findings from the Multicentre
Study of Self-harm in England. BMJ Open 2016;6:e010538.

Geulayov 2019

Geulayov G, Casey D, Bale L, Brand F, Clements C, Farooq B, et
al. Suicide following presentation to hospital for non-fatal self-
harm in the Multicentre Study of Self-Harm: a long-term follow-
up study. Lancet Psychiatry 2019;6:1021-30.

Ghahramanlou-Holloway 2012

Ghahramanlou-Holloway M, Cox DW, Greene FN. Post-
Admission Cognitive Therapy: a brief intervention for
psychiatric inpatients admitted after a suicide attempt.
Cognitive and Behavioral Practice 2012;19:233-44.

Ghanbari 2015

Ghanbari B, Malakouti SK, Nojomi M, Alavi K, Khaleghparast S.
Suicide prevention and follow-up services: a narrative review.
Global Journal of Health Sciences 2015;8:145-53.

Hanratty D, Kilicaslan J, Wilding H, Castle D. A systematic review
of efficacy of Collaborative Assessment and Management of
Suicidality (CAMS) in managing suicide risk and deliberate
self-harm in adult populations. Australasian Psychiatry
2019;27:559-64.

Harrison 2014

Harrison JE, Henley G, AIHW. Suicide and hospitalised
self-harm in Australia: trends and analysis. 2014. Injury
research and statistics series no. 93. Cat. no. INJCAT 169.
Canberra: AIHW. Available at www.aihw.gov.au/getmedia/
b70c6e73-40dd-41ce-9aa4-b72b2a3dd152/18303.pdf.aspx?
inline=true.

Hassanian-Moghaddam 2017

Hassanian-Moghaddam H, Sarjami S, Kolahi A-A, Lewin T,
Carter G. Postcards in Persia: a twelve to twenty-four month
follow-up of a randomized controlled trial for hospital-
treated deliberate self-poisoning. Archives of Suicide Research
2017;21:138-54.

Hassanzadeh 2010

Hassanzadeh M, Khajeddin N, Nojomi M, Fleischmann A,
Eshrati T. Brief intervention and contact after deliberate self-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

91

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

harm: an Iranian randomised controlled trial. Iranian Journal of
Psychiatry and Behavioral Sciences 2010;4:5-12.

Interventions version 6.0 (updated July 2019). Cochrane, 2019.
Available from www.training.cochrane.org/handbook.

Hawton 1987b

Högberg 2008

Hawton K, Catalan J. Attempted Suicide: A Practical Guide to its
Nature and Management. Oxford, UK: Oxford University Press,
1987.

Hawton 2003

Hawton K, Hariss L, Hall S, Simkin S, Bale E, Bond A. Deliberate
self-harm in Oxford, 1990-2000: a time of change in patient
characteristics. Psychological Medicine 2003;33:987-96.

Hawton 2004

Hawton K, Harriss L, Simkin S, Bale E, Bond A. Self-cutting:
patient characteristics compared with self-poisoners. Suicide
and Life-Threatening Behavior 2004;34:199-208.

Hawton 2007

Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, et
al. Self-harm in England: a tale of three cities. Multicentre study
of self-harm. Social Psychiatry and Psychiatric Epidemiology
2007;42:513-21.

Hawton 2008

Hawton K, Harriss L. The changing gender ratio in occurrence of
deliberate self-harm across the lifecycle. Crisis 2008;29:4-10.

Högberg G, Hällström T. Active multimodal psychotherapy
in children and adolescents with suicidality: description,
evaluation and clinical profile. Clinical Child Psychology and
Psychiatry 2008;13:435-48.

Hopewell 2009

Hopewell S, Loudon K, Clarke MJ, Oxman A, Dickersin K.
Publication bias in clinical trials due to statistical significance
or direction of trial results. Cochrane Database of
Systematic Reviews 2009, Issue 1. Art. No: MR000006. [DOI:
10.1002/14651858.MR000006.pub3]

Hsu 1997

Hsu WY, Chung JM. Constructing a scale of suicide risk and
testing its reliability and validity. Formosa Journal of Mental
Health 1997;10:1-17.

Hunt 2013

Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M.
Psychosocial interventions for people with both severe
mental illness and substance misuse. Cochrane Database of
Systematic Reviews 2013, Issue 10. Art. No: CD001088. [DOI:
10.1002/14651858.CD001088.pub3]

Hawton 2013

Inagaki 2019

Hawton K, Saunders KEA, Topiwala A, Haw C. Psychiatric
disorders in patients presenting to hospital following self-
harm: a systematic review. Journal of Affective Disorders
2013;151:821-30.

Hetrick 2016

Hetrick SE, Robinson J, Spittal MJ, Carter G. Effective
psychological and psychosocial approaches to reduce
repetition of self-harm: a systematic review, meta-analysis and
meta-regression. British Medical Journal Open 2016;6:e011024.

Higgins 2011

Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and
collecting data. In: Higgins JP, Green S, editor(s). Cochrane
Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
Available from training.cochrane.org/handbook/archive/v5.1.

Higgins 2019a

Higgins JPT, Eldridge S, Li T, editor(s). Chapter 23: Including
variants on randomized trials. In: Higgins JPT, Thomas J,
Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane
Handbook for Systematic Reviews of Interventions version
6.0 (updated July 2019). Cochrane, 2019. Available from
www.training.cochrane.org/handbook.

Higgins 2019b

Higgins JPT, Li T, Deeks JJ, editor(s). Chapter 6: Choosing
effect measures and computing estimates of effect. In: Higgins
JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch
VA (editors). Cochrane Handbook for Systematic Reviews of

Inagaki M, Kawashima Y, Yonemoto N, Yamada M. Active
contact and follow-up interventions to prevent repeat suicide
attempts during high-risk periods among patients admitted
to emergency departments for suicidal behavior: a systematic
review and meta-analysis. BMC Psychiatry 2019;19:44.

Jobes 2012

Jobes DA. The Collaborative Assessment and Management
of Suicidality (CAMS): an evolving evidence-based clinical
approach to suicidal risk. Suicide and Life Threatening Behavior
2012;42:640-53.

Jones 2012

Jones C, Hacker D, Cormac I, Meaden A, Irving CB.
Cognitive behavioural therapy versus other psychological
treatments for schizophrenia. Cochrane Database of
Systematic Reviews 2012, Issue 4. Art. No: CD008712. [DOI:
10.1002/14651858.CD008712.pub2]

Kerry 1998

Kerry SM, Bland JM. Analysis of a trial randomised in clusters.
BMJ 1998;316:54.

Klonsky 2011

Klonsky ED. Non-suicidal self-injury in United States adults:
prevalence, socio-demographics, topography and functions.
Psychological Medicine 2011;41:1981-6.

Knipe 2019

Knipe D, Metcalfe C, Hawton K, Pearson M, Dawson A,
Jayamanne S, et al. Risk of suicide and repeat self-harm after

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

92

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

hospital attendance for non-fatal self-harm in Sri Lanka: a
cohort study. Lancet Psychiatry 2019;6:659-66.

Krysinska 2016

Krysinska K, Batterham PJ, Christensen H. Differences in the
effectiveness of psychosocial interventions for suicidal ideation
and behaviour in women and men: a systematic review of
randomised controlled trials. Archives of Suicide Research
2016;21:12-32.

Krysinska 2017

Krysinska K, Batterham PJ, Christensen H. Differences in the
effectiveness of psychosocial interventions for suicidal ideation
and behaviour in women and men: a systematic review of
randomised controlled trials. Archives of Suicide Research
2017;21:12-32.

Larkin 2014

Larkin C, Di Blasi Z, Arensman E. Risk factors for repetition of
self-harm: a systematic review of prospective hospital-based
studies. PLOS One 2014;9:e84282.

Liberati 2009

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC,
Ioannidis JP, et al. The PRISMA statement for reporting
systematic reviews and meta-analyses of studies that evaluate
health care interventions: explanation and elaboration. PLOS
Medicine 2009;6(7):e1000100.

Lilley 2008

Lilley R, Owens D, Horrocks J, House A, Noble R, Bergen H, et al.
Hospital care and repetition following self-harm: multicentre
comparison of self-poisoning and self-injury. British Journal of
Psychiatry 2008;192:440-5.

Linehan 1981

Linehan MM, Nielsen SL. Assessment of suicide ideation and
parasuicide: hopelessness and social desirability. Journal of
Consulting and Clinical Psychology 1981;49:773-5.

Linehan 1993

Linehan MM. Skills Training Manual for Treating Borderline
Personality Disorder. New York, NY: Guilford Press, 1993.

Liu 2020

Liu B-P, Lunde KB, Jia C-X, Qin P. The short-term rate of non-
fatal and fatal repetition of deliberate self-harm: A systematic
review and meta-analysis of longitudinal studies. J Affective
Disord 2020;273:597-603.

Lizardi 2010

Lizardi D, Stanley B. Treatment engagement: a neglected aspect
in the psychiatric care of suicidal patients. Psychiatric Services
2010;61:1183-91.

Lovibond 1995

Lovibond PF, Lovibond SH. The structure of negative emotional
states: comparison of the Depression Anxiety Stress Scales
(DASS) with the Beck Depression and Anxiety Inventories.
Behaviour Research and Therapy 1995;33:335-42.

Cochrane Database of Systematic Reviews

Lynch 2006

Lynch TR, Chapman Al, Rosenthal MZ, Kuo JR, Linehan MM.
Mechanisms of change in dialectical behavior therapy:
theoretical and empirical observations. Journal of Clinical
Psychology 2006;62:459-80.

Marshall 2000a

Marshall M, Gray A, Lockwood A, Green R. Case management
for people with severe mental disorders. Cochrane Database
of Systematic Reviews 2000, Issue 2. Art. No: CD000050. [DOI:
10.1002/14651858.CD000050.pub2]

Marshall 2000b

Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M.
Unpublished rating scales: a major source of bias in randomised
controlled trials of treatments for schizophrenia. British Journal
of Psychiatry 2000;176:249-52.

Masiran 2017

Masiran R, Haniff J, Ali NH, Amid AMA. Rates and profiles of self-
harm presenting to Malaysian general hospitals: data from the
Ministry of Health in 2011. Malaysian Journal of Medicine and
Health Sciences 2017;13:39-45.

McNair 1964

McNair DM, Lorr M. An analysis of mood in neurotics. Journal of
Abnormal and Social Psychology 1964;69:620-7.

Meares 2004

Meares R. The conversational model: an outline. American
Journal of Psychotherapy 2004;58:51-66.

Meerwijk 2016

Meerwijk EL, Parekh A, Oquendo MA, Allen IE, Franck LS,
Lee KA. Direct versus indirect psychosocial and behavioural
interventions to prevent suicide and suicide attempts: a
systematic review and meta-analysis. Lancet Psychiatry
2016;3:544-54.

Microsoft Excel RoB2 Macro [Computer program]

RoB2 Macro. Risk of Bias 2 Development Group, Version
accessed prior to 24 March 2021. Microsoft, 2019.
sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/
current-version-of-rob-2.

Miller 1993

Miller WR, Sanchez VC. Motivating young adults for treatment
and lifestyle change. In: Howard G, editors(s). Issues in Alcohol
Use and Misuse in Young Adults. South Bend, IN, USA: University
of Notre Dame Press, 1993:55-82.

Milner 2015

Milner AJ, Carter G, Pirkis J, Robinson J, Spittal MJ. Letters,
green cards, telephone calls and postcards: systematic and
meta-analytic review of brief contact interventions for reducing
self-harm, suicide attempts and suicide. British Journal of
Psychiatry 2015;206:184-90.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

93

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Milner 2016

Milner A, Spittal MJ, Kapur N, Witt K, Pirkis J, Carter G.
Mechanisms of brief contact interventions in clinical
populations: a systematic review. BMC Psychiatry 2016;16:194.

Mitchell 2016

Mitchell AJ, Hussain S, Leaver J, Rajan C, Jones A, Malcolm N,
et al. Is there a difference between hospital-verified and self-
reported self-harm? Implications for repetition. General Hospital
Psychiatry 2016;43:12-6.

Moher 1998

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.
Does quality of reports of randomised trials affect estimates
of intervention efficacy reported in meta-analyses? Lancet
1998;352:609-13.

Number 133]. London, UK: National Institute for Health and
Clinical Excellence, 2011.

O'Connor 2011

O'Connor RC. The integrated motivational-volitional model of
suicidal behavior. Crisis 2011;32:295-8.

Oliver 2010

Oliver C, Richards C. Self-injurious behavior in people
with intellectual disability. Current Opinion in Psychiatry
2010;23:412-6.

Osman 1992

Osman A, Gregg CL, Osman JR, Jones K. Factor structure and
reliability of the Reasons for Living Inventory. Psychological
Reports 1992;70:107-12.

Montgomery 1979

Owens 2002

Montgomery SA, Åsberg M. A new depression scale designed
to be sensitive to change. British Journal of Psychiatry
1979;134:382-9.

Owens D, Horrocks J, House A. Fatal and non-fatal repetition
of self-harm: systematic review. British Journal of Psychiatry
2002;181:193-9.

Morthorst 2016

Owens 2020b

Morthorst BT, Soegaard B, Nordentoft M, Erlangsen A. Incidence
rates of deliberate self-harm in Denmark, 1994-2011: a
nationwide register study. Crisis 2016;37:256-64.

Müller 2016

Müller A, Claes L, Brähler E, De Zwann M. Prevalence and
correlates of self-harm in the German general population. PLOS
One 2016;11:e0157928.

Murphy 2012

Murphy E, Kapur N, Webb R, Purandare N, Hawton K, Bergen H,
et al. Risk factors for repetition and suicide following self-harm
in older adults: multicentre cohort study. British Journal of
Psychiatry 2012;200:399-404.

NCCMH 2004

National Collaborating Centre for Mental Health. Clinical
Guideline 16. Self-Harm: The Short-Term Physical and
Psychological Management and Secondary Prevention of Self-
Harm in Primary and Secondary Care. London, UK: National
Institute for Clinical Excellence, 2004.

Owens C, Fox F, Redwood S, Davies R, Foote L, Salisbury N, et
al. Measuring outcomes in trials of interventions for people
who self-harm: qualitative study of service users' views. British
Journal of Psychiatry Open 2020;6:e22.

Padmanathan 2020

Padmanathan P, Hall K, Moran P, Jones HE, Gunnell D, Carlisle V,
et al. Prevention of suicide and reduction of self-harm among
people with substance use disorder: a systematic review and
meta-analysis of randomised controlled trials. Comprehensive
Psychiatry 2020;96:152135.

Perry 2012

Perry IJ, Corcoran P, Fitzgerald AP, Keeley HS, Reulback U,
Arensman E. The incidence and repetition of hospital-treated
deliberate self-harm: findings from the world's first national
registry. PLOS One 2012;7:e31663.

Pirkis 2020

Pirkis J, Amadeo S, Beautrais A, Phillips M, Yip PSF. Suicide
prevention in the Western Pacific region. Crisis 2020;41:s80-98.

Newcomb 2020

Platt 1983

Newcomb ME, Hill R, Buehler K,  Ryan DT , Whitton SW,
Mustanski B. High burden of mental health problems, substance
use, violence, and related psychosocial factors in transgender,
non‑binary, and gender diverse youth and young adults.
Archives of Sexual Behavior 2020;49:645-659.

Nezu 2010

Nezu AM, Nezu CM, D'Zurilla TJ. Problem-solving therapy. In:
Kazantzis N, Reinecke MA, Freeman A, editors(s). Cognitive and
Behavioral Theories in Clinical Practice. New York, NY: Guilford
Press, 2010.

NICE 2011

National Institute for Health and Clinical Excellence. Self-harm:
Longer-Term Management [National Clincial Practice Guideline

Platt S, Weyman A, Hirsch S. Social Behaviour Assessment
Schedule. 3rd edition. Windsor, UK: NFER-Nelson, 1983.

Plener 2016

Plener PL, Brunner R, Fegert JM, Groschwitz RC, In-Albon T,
Kaess M, et al. Treating nonsuicidal self-injury in adolescents:
consensus based German guidelines. Child and Adolescent
Psychiatry and Mental Health 2016;10:46.

Pridemore 2005

Pridemore WA, Damphousse KR, Moore RK. Obtaining sensitive
information from a wary population: a comparison of telephone
and face-to-face surveys of welfare recipients in the United
States. Social Science and Medicine 2005;61:976-84.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

94

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Review Manager 2020 [Computer program]

Tighe 2018

Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic
Cochrane Centre, The Cochrane Collaboration, 2020.

Reynolds 1998

Tighe J, Nicholas J, Shand F, Christensen H. Efficacy of
acceptance and commitment therapy in reducing suicidal
ideation and deliberate self-harm: systematic review. Journal of
Medical Internet Research Mental Health 2018;5:e10732.

Reynolds W. Suicidal Ideation Questionnaire: Professional
Manual. Odessa, FL: Psychological Assessment Resources, 1998.

Ting 2012

Riblet 2017

Riblet NBV, Shiner B, Young-Xu Y, Watts BV. Strategies to prevent
death by suicide: meta-analysis of randomised controlled trials.
British Journal of Psychiatry 2017;210:396-402.

Royal College of Psychiatrists 2014

Royal College of Psychiatrists. Managing Self-Harm in Young
People (Guideline number CR192). London, UK: Royal College of
Psychiatrists, 2014.

Schotte 1982

Schotte DE, Clum GA. Suicide ideation in a college population.
Journal of Consulting and Clinical Psychology 1982;50:690-6.

Ting SA, Sulivan AF, Boudreaux ED, Miller I, Camargo CA. Trends
in US emergency department visits for attempted suicide and
self-inflicted injury, 1993-2008. General Hospital Psychiatry
2012;34:557-65.

Torgerson 2004

Torgerson D. The use of Zelen's design in randomised trials.
British Journal of Obstetrics and Gynaecology 2004;111:2.

Tsiachristas 2017

Tsiachristas A, McDaid D, Casey D, Brand F, Lead J, Park A-L, et
al. General hospital costs in England of medical and psychiatric
care for patients who self-harm: a retrospective analysis. Lancet
2017;4:759-67.

Schünemann 2019

Tyrer 1990

Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA,
Skoetz N, et al. Chapter 14: Completing ‘Summary of findings’
tables and grading the certainty of the evidence. In: Higgins
JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et
al, editor(s). Cochrane Handbook for Systematic Reviews of
Interventions version 6.0 (updated July 2019). Cochrane, 2019.
Available from www.training.cochrane.org/handbook.

Tyrer P. Personality disorder and social functioning. In: Peck DF,
Shapiro CM, editors(s). Measuring Human Problems: A Practical
Guide. Chichester, UK: John Wiley & Sons, 1990:119–42.

Van Heeringen 2014

Van Heeringen K, Mann JJ. The neurobiology of suicide. Lancet
2014;1:63-72.

Selph 2014

Viechtbauer 2020

Selph SS, Ginsburg AD, Chou R. Impact of contacting study
authors to obtain additional data for systematic reviews:
diagnostic accuracy studies for hepatic fibrosis. Systematic
Reviews 2014;3:107.

Sinclair 2011

Sinclair JMA, Gray A, Rivero-Arias O, Saunders KEA, Hawton K.
Healthcare and social services resource use and costs of self-
harm patients. Social Psychiatry and Psychiatric Epidemiology
2011;46:263-71.

Sniehotta 2005

Sniehotta FF, Scholz U, Schwarzer R. Bridging the intention–
behaviour gap: planning, self-efficacy, and action control in the
adoption and maintenance of physical exercise. Psychology and
Health 2005;20:143-60.

Spitzer 1970

Spitzer R, Endicott J, Fleiss JL, Cohen J. The Psychiatric Status
Schedule: a technique for evaluating psychopathology and
impairment in role functioning. Archives of General Psychiatry
1970;23:41-55.

Sterne 2019

Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS,
Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in
randomised trials. BMJ 2019;366:I4898.

Viechtbauer W, Cheung MW-L. Outlier and influence diagnostics
for meta-analysis. Research Synthesis Methods 2020;1:112-25.

Vijayakumar 2011

Vijayakumar L, Umamaheswari C, Shujaath Ali ZS, Devaraj P,
Kesavan K. Intervention for suicide attempters: a randomized
controlled study. Indian Journal of Psychiatry 2011;53:244-8.

Weissman 1999

Weissman MM, Staff MHS. Social Adjustment Scale - Self-Report
(SAS-SR) User's Manual. North Tonawanda, NY: Multi-Health
Systems, 1999.

Westbrook 2008

Westbrook D, Kennerley H, Kirk J. An introduction to cognitive
behaviour therapy: skills and applications. In: An Introduction
to Cognitive Behaviour Therapy: Skills and Applications.
London, UK: SAGE Publications, 2008.

WHO 2014

World Health Organization. Preventing Suicide: A Global
Imperative. Geneva, Switzerland: World Health Organization,
2014.

WHO 2019

WHO. Psychiatrists and nurses working in the mental
health sector (per 100,000 population), 2014-2016.
gamapserver.who.int/gho/interactive_ charts/mental_ health/
psychiatrists_ nurses/atlas.html (accessed 19 November 2020).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

95

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Wilkinson 2002

Xu 2012

Wilkinson S, Taylor G, Templeton L, Mistral W, Salter E,
Bennett P. Admissions to hospital for deliberate self-harm in
England 1995-2000: an analysis of Hospital Episode Statistics.
Journal of Public Health 2002;24:179-83.

Xu D, Zhang X-L, Li X-Y, Niu Y-J, Zhang Y-P, Wang SL.
Effectiveness of 18-month psychosocial intervention for suicide
attempters. Zhongguo Xinli Weisheng Zazhi [Chinese Mental
Health Journal] 2012;26:24-9.

Witt 2018

Yakeley 2018

Witt K, Pache de Moraes D, Taylor Salisbury T, Arensman E,
Gunnell D, Hazell P, et al. Treatment as usual (TAU) as a
control condition in trials of cognitive behavioural-based
psychotherapy for self-harm: impact of content and quality on
outcomes in a systematic review. Journal of Affective Disorders
2018;235:434-47.

Witt 2019

Witt K, Daly C, Arensman E, Pirkis J, Lubman D. Patterns
of self-harm methods over time and the association with
methods used a repeat episodes of non-fatal self-harm and
suicide: a systematic review. Journal of Affective Disorders
2019;245:250-64.

Witt 2020a

Witt K, Townsend E, Arensman E, Gunnell D, Hazell P, Taylor
Salisbury T, et al. Psychosocial interventions for people
who self-harm: methodological issues involved in trials
to evaluate effectiveness. Archives of Suicide Research
2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]

Yakeley J, Burbridge-James W. Psychodynamic approaches to
suicide and self-harm. B J Psych Advances 2018;24:37-45.

Zahl 2004

Zahl DL, Hawton K. Repetition of deliberate self-harm and
subsequent suicide risk: long-term follow-up study of 11 583
patients. British Journal of Psychiatry 2004;185:70-5.

Zelen 1979

Zelen M. A new design for randomized clinical trial. New
England Journal of Medicine 1979;300:1242-5.

Zigmond 1983

Zigmond AS, Snaith RP. The Hospital Anxiety and Depression
Scale. Acta Psychiatrica Scandinavica 1983;67:361-70.

Zung 1965

Zung WWK. A self-rating depression scale. Archives of General
Psychiatry 1965;12:63-70.

Witt 2021a

References to other published versions of this review

Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL,
Townsend E, et al. Pharmacological interventions for self-harm
in adults. Cochrane Database of Systematic Reviews 2021, Issue
1. Art. No: CD013669. [DOI: 10.1002/14651858.CD013669.pub2]

Witt 2021b

Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor
Salisbury TL, Townsend E, et al. Interventions for self-
harm in children and adolescents. Cochrane Database of
Systematic Reviews 2021, Issue 3. Art. No: CD013667. [DOI:
10.1002/14651858.CD013667.pub2]

Hawton 2016

Hawton K, Witt KG, Taylor Salisbury Tl, Arensman E, Gunnell D,
Hazell P, et al. Psychosocial interventions for self-harm in
adults. Cochrane Database of Systematic Reviews 2016, Issue 5.
Art. No: CD012189. [DOI: 10.1002/14651858.CD012189]

Witt 2020b

Witt KG, Hawton K, Hetrick SE, Taylor Salisbury TL, Townsend E,
Hazell P. Psychosocial interventions for self-harm in adults.
Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No:
CD013668. [DOI: 10.1002/14651858.CD013668]

* Indicates the major publication for the study

C H A R A C T E R I S T I C S   O F   S T U D I E S

Characteristics of included studies [ordered by study ID]

Allard 1992 

Study characteristics

Methods

Participants were individually randomised using sealed and numbered envelopes to intensive outpa-
tient treatment or TAU.

N lost to follow-up: 24/150 (16.0%) for repetition of SH by the 24-month assessment.

Location: Montreal, Canada.

Participants

Number of total participants: 150 participants were randomised, 76 were allocated to intensive outpa-
tient treatment and 74 were allocated to TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

96

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Allard 1992  (Continued)

Cochrane Database of Systematic Reviews

Profile of participants: mean (SD) age not reported. Just over half (n = 83; 55.3%) were female. Half (n =
75; 50.0%) had a history of SH (i.e. multiple episodes of SH). The majority were diagnosed with MDD (n =
131; 87.3%), followed by SUD (n = 80; 53.3%), and any personality disorder (n = 68; 45.3%).

Source of participants: patients presenting to hospital following a suicide attempt (i.e. SH with suicidal
intent).

Inclusion criteria: i) resident in the catchment area; ii) sufficient language ability (French or English); iii)
no physical handicap preventing attendance; iv) not already in institutional care; v) able to provide in-
formed consent; vi) not sociopathic; vii) suicide attempt within one week prior to trial entry.
Exclusion criteria: i) no fixed address; ii) moving out of the catchment area; iii) in the care of an insti-
tution that ensures follow-up after all suicide attempts; iv) diagnosed with a physical disability that
would prevent attendance at follow-up sessions; v) unable to provide informed consent; vi) diagnosed
with sociopathy and presents a physical threat to hospital personnel; vii) suicide attempt occurred over
one week preceding trial entry.

Intervention: intensive outpatient treatment consisting of 18 sessions (duration not reported), includ-
ing one delivered in the participants' home (delivered by a social worker). Sessions were weekly for the
first month, fortnightly for the next three months, and monthly for the remaining eight months. Thera-
peutic content included: developing a collaborative treatment plan and other various therapeutic ap-
proaches including psychoanalytically oriented psychotherapy, psychosocial therapy, AOD treatment,
or behavioural therapy as needed. At the conclusion of the 12-month treatment period, participants
were referred to usual psychiatric care. Sessions were delivered by a social worker (information on ex-
perience not reported).

Comparator: TAU consisting of treatment by the regular personnel within the same hospital (number
and duration of sessions not reported). Further information on therapeutic content not reported.

Length of treatment: 12 months.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH according to hospital records, Coroner's records, and/or collat-
eral informant report.

Secondary outcome(s): i) treatment adherence as measured by the number of sessions attended; ii) sui-
cide as ascertained from Coroner's records and collateral informant report.

Notes

Source(s) of funding: no information on funding reported.

Conflict(s) of interest: no information on conflicts of interest reported.

Amadéo 2015 

Study characteristics

Methods

Participants were individually randomised using a block randomisation procedure.

N lost to follow-up: 10/200 (5.0%) by the post-intervention assessment.

Location: Papeete, Tahiti, French Polynesia.

Participants

Number of total participants: 200 participants were randomised, 100 were allocated to provision of in-
formation and support and 100 were allocated to TAU.

Profile of participants: mean age 32.2 years (SD not reported, range not reported). Over half (n = 122;
64.2%) were female. Just over half (n = 97; 51.0%) were diagnosed with any mood disorder, followed by
any anxiety/adjustment disorder (n = 33; 17.4%), psychosis (n = 10; 5.3%), alcohol use disorder (n = 5;
2.6%), any personality disorder (n = 4; 2.1%), and cannabis use disorder (n = 2; 1.0%).

Source of participants: patients presenting to the ED following an episode of SH.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

97

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Amadéo 2015  (Continued)

Interventions

Inclusion criteria: i) presenting to ED following an episode of SH.

Exclusion criteria: none reported.

Intervention: based on the SUPRE-MISS model (Fleischmann 2008), the intervention consisted of a brief
inpatient psychiatric admission (≥ 24 hours), a brief (one-hour) information session, and nine follow-up
telephone contacts (duration not reported) at weeks one, two, four, seven, 11, and months four, six, 12,
and 18 months post-discharge. No information on who delivered the intervention, their expertise, or
their experience was reported.

Comparator: TAU consisting of a brief inpatient psychiatric admission (≥ 24 hours), a single psychiatric
assessment (duration not reported), and then either hospitalisation, outpatient follow-up, or no care at
all.

Length of treatment: 18 months.

Outcomes

Notes

Primary outcome(s): i) repetition of SH as ascertained from self-report using the European Parasuicide
Study Interview Schedule (EPSIS); ii) suicide (as determined from Coroner's records).

Source(s) of funding: "[T]he study was funded by the French Polynesia Ministry of Health and the Centre
Hospitalier de Polynésie Française" (Amadéo 2015, p.48).
Conflict(s) of interest: "[T]he authors declare no potential conflict of interest" (Amadéo 2015, p.48).

Andreoli 2015 

Study characteristics

Methods

Participants were individually randomised using a pre-generated block randomisation procedure via
envelopes to either three months of abandonment psychotherapy delivered by certified psychothera-
pists, abandonment psychotherapy delivered by trained nurses, or TAU.

N lost to follow-up: 0/170 (0%) for repetition of SH at post-intervention.

Location: Geneva, Switzerland.

Participants

Number of total participants: 170 participants were randomised, 70 were allocated to abandonment
psychotherapy delivered by certified psychotherapists, 70 were allocated to abandonment psychother-
apy delivered by trained nurses, and 30 were allocated to TAU.

Profile of participants: mean age 31.9 ± 10.1 years (range: 18 to 60 years). The majority (n = 143; 84.1%)
were female. All (n = 170; 100%) were diagnosed with BPD. The majority (n = 138; 81.2%) were also diag-
nosed with comorbid MDD, followed by SUD (n = 62; 36.5%).

Source of participants: patients presenting to the ED following an episode of SH requiring immediate
medical/surgical treatment.

Inclusion criteria: i) 18-60 years of age; ii) diagnosed with comorbid MDD and BPD according to DSM-IV
criteria.

Exclusion criteria: i) diagnosed with psychosis, bipolar I disorder, or severe SUD according to DSM-IV cri-
teria; ii) diagnosed with an intellectual disability; iii) diagnosed with an medical condition contraindi-
cated for antidepressant medication or likely to significantly alter clinical outcome(s); iv) insufficient
language ability.

Interventions

Intervention 1: manualised abandonment psychotherapy delivered by certified psychotherapists. Aban-
donment psychotherapy consists of twice weekly sessions (duration not reported) incorporating princi-
ples from cognitive/psychodynamic therapy (e.g. cognitive restructuring), DBT (e.g. distress tolerance),
MBT (e.g. identification and labelling of different affective states), and family therapy. Sessions focus
on difficulties in romantic relationships. Participants also had access to a 24-hour crisis hotline as re-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

98

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Andreoli 2015  (Continued)

Cochrane Database of Systematic Reviews

quired. Sessions were delivered by certified psychotherapists (information on experience was not re-
ported).

Intervention 2: manualised abandonment psychotherapy (as above) delivered by trained nurses with
experience in the management of patients diagnosed with BPD. Sessions were delivered by nurses with
considerable experience in managing patient with BPD.

Comparator: TAU. Consisting of as many nurse visits (duration not reported) as needed over a two-week
period, followed by biweekly nurse visits (duration not reported), weekly clinical and medication re-
view sessions (duration not reported), weekly group-therapy sessions (duration not reported), and as
many partial hospitalisations and family therapy sessions (duration not reported) as required for the
remainder of the treatment period.

Concomitant medications: were permitted. The majority (n = 125, 89.3%) were prescribed venlafaxine.
However, the proportion of participants prescribed an any antidepressant medication was lower in the
comparator arm (76.7%) compared with either of the intervention arms (97.1% and 97.1%, respective-
ly).

Length of treatment: three months.

Outcomes

Primary outcome(s): i) clinical remission as measured by a Global Assessment Scale (GAS; Endicott
1976) score of > 60.

Secondary outcome(s): i) repetition of SH as ascertained from medical records; ii) symptom severity
as measured by a scores on the severity subscale of the Clinical Global Impression (CGI; Guy 1976); iii)
depression as measured by the HDRS; iv) remission from depression as ascertained from whether the
participant still meets DSM-IV criteria; iv) psychosocial outcome as measured by the HSRS; v) treat-
ment adherence as measured by the number of days retained in treatment and dropouts; vi) suicidal
ideation (unclear how ascertained); vii) all-cause hospitalisations as ascertained from medical records;
viii) suicide (unclear how ascertained).

Notes

Source(s) of funding: no details on funding reported.

Conflict(s) of interest: no details on conflicts of interest reported.

Armitage 2016 

Study characteristics

Methods

Participants were individually randomised using web-based software to either a guided implementa-
tion-focused intervention based on the volitional help-sheet model (Armitage 2016a), a self-directed
implementation intention-focused intervention (Armitage 2016b), or TAU.

N lost to follow-up: 0/226 (0%) for repetition of SH by the three-month assessment.

Location: Kuala Lumpur, Malaysia.

Participants

Number of total participants: 226 participants were randomised, 78 were allocated to a brief, self-direct-
ed implementation intention intervention, 75 were allocated to a brief volitional help sheet interven-
tion, and 73 were allocated to TAU.

Profile of participants: mean age 30.0 ± 13.4 years (range: 15 to 65 years). The majority (n = 158; 69.9%)
were female.

Source of participants: admitted to a general hospital following an episode of SH.

Inclusion criteria: i) admitted to a general hospital following an episode of SH.

Exclusion criteria: none reported.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

99

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Armitage 2016  (Continued)

Interventions

See Armitage 2016a and Armitage 2016b for a detailed description.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report using the Suicidal Behaviours Ques-
tionnaire; ii) suicidal ideation ascertained from self-report using the Suicidal Behaviours Questionnaire.

Secondary outcome(s): i) depression measured using the BDI; ii) motivation to avoid SH measured using
an idiosyncratic scale.

Notes

Source(s) of funding: no information on sources of funding reported.

Conflict(s) of interest: none reported.

Armitage 2016a 

Study characteristics

Methods

See Armitage 2016 for a detailed description.

Participants

See Armitage 2016 for a detailed description.

Interventions

Intervention (guided volitional help-sheet): one-off (duration not reported) session. Participants are pro-
vided with a list of common situations in which they may be tempted to engage in SH together with
a list of potential alternative behaviours. Participants then draw links between any situation that ap-
plies to them and any one of the listed alterative behaviours. Participants can make as many links as
desired. No information on who delivered the intervention, their expertise, or their experience was re-
ported.

Comparator: TAU. No further information reported.

Length of treatment: one-off session (duration not reported).

Outcomes

See Armitage 2016 for a detailed description.

Notes

See Armitage 2016 for a detailed description.

Armitage 2016b 

Study characteristics

Methods

See Armitage 2016 for a detailed description.

Participants

See Armitage 2016 for a detailed description.

Interventions

Intervention (self-directed implementation intention): one-off (duration not reported) session in which
participants were free to formulate their own safety plan. Sessions were self-delivered.

Comparator: TAU. No further information reported.

Length of treatment: one-off session (duration not reported).

Outcomes

See Armitage 2016 for a detailed description.

Notes

See Armitage 2016 for a detailed description.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

100

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Bateman 2009 

Study characteristics

Methods

Participants were individually randomised using a stochastic minimisation programme
(MINIM) balanced for age (18-25, 26-30, and > 30 years), sex, and diagnosis of ASPD to MBT or structured
case management.

N lost to follow-up: 2/136 (1.5%) for repetition data at post-intervention.

Location: London, UK.

Participants

Number of total participants: 134 participants were randomised, 71 were allocated to MBT and 63 were
allocated to structured case management.

Interventions

Profile of participants: mean age 31.1 ± 7.7 years (range: 18-65 years). The majority (n = 107; 79.9%) were
female. All (n = 134; 100%) had a history of SH (i.e. multiple episodes of SH). Just over three-quarters
(n = 103; 76.9%) were diagnosed with a milder depressive disorder such as dysthymia, followed by any
anxiety disorder (n = 82; 61.2%), SUD (n = 72; 53.7%), any eating disorder (n = 37; 27.6%), PTSD (n = 19;
14.2%), and somatoform disorder (n = 17; 12.7%). Just over one-quarter (n = 37; 27.6%) were diagnosed
with comorbid ASPD.

Source of participants: consecutive referrals to one of two community outpatient psychiatric facilities,
one of which provides specialist treatment for PD.

Inclusion criteria: i) 18-65 years of age; ii) diagnosed with BPD; iii) engaged in SH within six months prior
to trial entry.

Exclusion criteria: i) currently in long-term psychotherapeutic treatment; ii) diagnosed with any psy-
chosis or bipolar I disorder according to DSM-IV criteria; iii) dependent on any opiate to such a degree
that specialist AOD treatment is indicated; iv) diagnosed with a mental impairment or evidence of an
organic brain disorder.

Intervention: manualised MBT consisting of up to 140 sessions (duration not reported) of weekly indi-
vidual and group therapy. Therapeutic content also included: collaborative crisis planning, a general
psychiatric review every three months, case management, advocacy support, and problem-oriented
psychotherapy. Sessions were delivered by therapists (no further information on expertise or experi-
ence was reported). 

Comparator: structured case management designed to analogue TAU consisting of three-monthly in-
dividual and group therapy (duration not reported). Therapeutic content was based on a counselling
model resembling a supportive approach and included: counselling, case management, and prob-
lem-oriented psychotherapy.

Concomitant medication(s): participants were prescribed medication (e.g. antidepressants,
antipsychotics, mood stabilisers, minor tranquillisers), as needed. As baseline, just under three-quar-
ters (n = 98; 73.1%) were prescribed concomitant medications (mean number of medications pre-
scribed at baseline: 1.1 ± 0.9).

Length of treatment: 18 months.

Outcomes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) repetition of suicide attempts (un-
clear how ascertained); iii) hospital readmission (unclear how ascertained).

Secondary outcome(s): i) general functioning as measured by the GAF; ii) distress as measured by the
Global Severity Index (GSI); iii) depression as measured by the BDI; iv) social functioning as measured
by the Social Adjustment Scale (SAS); v) interpersonal functioning as measured by the Inventory of In-
terpersonal Problems (IIP); vi) medication use (unclear how ascertained).

Notes

Source(s) of funding: “Supported by a grant from the Borderline Personality Disorder Research Founda-
tion” (Bateman 2009, p. 1363).
Conflict(s) of interest: none reported.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

101

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Bateman 2009  (Continued)

Cochrane Database of Systematic Reviews

Other: data on repetition of SH, suicide attempts, and suicides were obtained via correspondence with
trial authors.

Beautrais 2010 

Study characteristics

Methods

Participants were individually randomised using a predetermined computer-generated random num-
ber procedure to a remote contact intervention (postcards) or TAU.

N lost to follow-up: 0/327 (0) for repetition of SH data.

Location: Christchurch, New Zealand.

Participants

Number of total participants: 327 participants were randomised, 153 were allocated to the remote con-
tact intervention and 174 were allocated to TAU.

Profile of participants: mean age 33.8 (SD: not reported; range: 18-65 years). Two thirds (n = 216; 66.0%)
were female. Fifty-eight (17.7%) had a history of SH (i.e. multiple episodes of SH). No information on
psychiatric diagnoses was reported.

Source of participants: patients admitted to a psychiatric emergency service following an episode of SH
or attempted suicide.

Inclusion criteria: i) 16 years of age or older; ii) admitted to a psychiatric emergency service following an
episode of SH or attempted suicide; iii) resident in New Zealand; iv) sufficient language ability.

Exclusion criteria: none reported.

Length of treatment: 12 months.

Interventions

Intervention: remote contact intervention consisting of postcards mailed at two and six weeks and
three, six, nine, and 12 months post-discharge in addition to TAU. Postcards encouraged participants to
make contact with the service if required. No information on who delivered the intervention, their ex-
pertise, or their experience was reported.

Comparator: TAU consisting of crisis assessment and referral to inpatient community-based
mental health services as required.

Primary outcome(s): i) repetition of SH as ascertained from emergency service records and medical
records; ii) representation to psychiatric emergency services as ascertained from emergency service
records and medical records.

Secondary outcome(s): i) suicide (unclear how ascertained).

Source(s) of funding: "This study was supported by grants from the Canterbury District Health Board
and the Accident Compensation Corporation (ACC). S.J.G. was supported by a University of Otago Post-
graduate Publishing Bursary" (Beautrais 2010, p. 59).

Conflict(s) of interest: none reported.
Other: data on suicides were obtained via correspondence with trial authors.

Outcomes

Notes

Bennewith 2002 

Study characteristics

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

102

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Bennewith 2002  (Continued)

Methods

cRCT. GP practices were randomised, stratified by rate of SH, via a random numbers trial to either a GP
letter or TAU.

N lost to follow-up: 0/1932 (0%) for repetition of SH data.

Location: Avon, Wiltshire, and Somerset, UK.

Participants

Number of total participants: 1932 participants were allocated, 964 were allocated to GP management
and 968 were allocated to TAU.

Profile of participants: mean age 32.5 ± 13.2 years (range: 16-95 years). Just over half (n = 1140; 59.0%)
were female. A minority (n = 244; 12.6%) had a history of SH (i.e. multiple episodes of SH) according to
case register information. No information on psychiatric diagnoses was reported.

Source of participants: patients presenting to hospital following an episode of SH and who were also
registered with one of the participating primary care practices.

Inclusion criteria (for GP practices): i) located in catchment area (i.e. within catchment area of the four
recruitment general hospitals).

Inclusion criteria (for participants): i) aged 16 years and older; ii) data able to be found in general hospi-
tal case register; iii) recruitment data able to be collected weekly from hospitals’ A&E sites; iv) fixed res-
idence.

Exclusion criteria: i) engaged in an alcohol only or illicit drug overdose (except where casualty offi-
cer felt purpose was SH or suicide); ii) imprisoned; iii) made a request that no one be informed of SH
episode; iv) SH occurred in direct response to a hallucination or delusion; v) SH episode managed en-
tirely in primary care.

Interventions

Intervention: letter from GP inviting patient to a consultation with GP (provided with management
guideline). Sessions were delivered by GPs (no information on experience was reported).

Comparator: TAU consisting of GP management, psychiatric, or other referral, as required.

Length of treatment: one-off consultation.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from hospital case registers.

Secondary outcome(s): i) frequency of SH repetition ascertained from hospital case registers; ii) time to
first repeat SH episode ascertained from hospital case registers; iii) contact with services (unclear how
ascertained).

Notes

Source(s) of funding: "National Health Service South West Research and Development Direc-
torate" (Bennewith 2002, p. 1260).
Conflict(s) of interests: none reported.

Brown 2005 

Study characteristics

Methods

Participants were individually randomised using a computer-generated sequence (designed to prohibit
more than seven consecutive assignments to the same treatment group) to either CBT or EUC.

N lost to follow-up: 18/120 (15.0%) for repetition by the six-month follow-up assessment.

Location: Pennsylvania, USA.

Participants

Number of total participants: 120 participants were allocated, 60 were allocated to CBT and 60 were al-
located to TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

103

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Brown 2005  (Continued)

Cochrane Database of Systematic Reviews

Profile of participants: mean age 35.0 ± 10.2 years (range: 18-66 years). Over half (n = 73; 60.8%) were
female. The majority (n = 87; 72.5%) had a history of SH (i.e. multiple episodes of SH). Just over three-
quarters were diagnosed with MDD (n = 92; 76.7%), followed by SUD (n = 82; 68.3%).

Source of participants: patients presenting to hospital following a suicide attempt.

Inclusion criteria: i) 16 years of age or older; ii) engaged in a suicide attempt and received medical/psy-
chiatric evaluation within 48 hours of the attempt; iii) able to provide at least two verifiable contacts;
iv) sufficient language ability; v) able to complete baseline assessment; vi) able to provide informed
consent.

Exclusion criteria: i) diagnosed with any medical condition that would prevent participation in an out-
patient clinical trial.

Interventions

Intervention: CBT-based psychotherapy consisting of 10 weekly/biweekly sessions (duration not report-
ed) in addition to TAU. Therapeutic content included: identification of proximal thoughts, core beliefs,
development of alternative coping strategies, and relapse prevention. Therapy focused on hopeless-
ness, deficits in problem-solving, treatment noncompliance, and social isolation. Sessions were deliv-
ered by trial therapists (no further information on expertise or experience was reported).

Outcomes

Notes

Carter 2005 

Study characteristics

Methods

Comparator: TAU, including referral to other services, as required.

Length of treatment: 10-20 weeks (exact duration not clearly reported).

Primary outcome(s): i) repetition of SH as ascertained from self-report; ii) depression as measured using
the HDRS and BDI; iii) hopelessness as measured by the BHS; iv) suicidal ideation as measured by the
BSSI.

Secondary outcome(s): i) treatment adherence (this outcome had to be excluded from the review due to
the nature of the data reported).

Source(s) of funding: "This research was supported by grants R01 MH60915 and P20 MH71905 from the
National Institute of Mental Health and grant R37 CCR316866 from the Centers for Disease Control and
prevention" (Brown 2005, p. 570).
Conflict(s) of interest: none reported.

Participants were individually randomised using Zelen's post-consent design to a remote contact inter-
vention in addition to TAU or TAU alone.

N lost to follow-up: 0/772 (0%) for repetition of SH data.

Location: Hunter Valley, NSW, Australia.

Participants

Number of total participants: 772 participants were allocated, 378 were allocated to a remote contact
intervention (postcards) in addition to TAU and 394 were allocated to TAU alone.

Profile of participants: median age 33.0 years (IQR: 24.0 to 44.0 years; range: not reported). Over two-
thirds (n = 525; 68.0%) were female. A minority (n = 131; 17.0%) had a history of SH (i.e. multiple
episodes of SH). Just under half (n = 333; 43.1%) were diagnosed with any mood disorder, followed by
SUD (n = 311; 40.3%), and any PD (n = 169; 21.9%).

Source of participants: patients presenting to hospital toxicology service following an episode of self-
poisoning.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

104

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Carter 2005  (Continued)

Cochrane Database of Systematic Reviews

Inclusion criteria: i) 16 years of age or older; ii) presented to a toxicology service following an episode of
deliberate self-poisoning; iii) able to provide informed consent; iv) fixed address; v) sufficient language
ability; vi) did not pose a potential threat to the interviewer.

Exclusion criteria: none reported.

Interventions

Intervention: remote contact intervention consisting of a series of postcards mailed at one, two, three,
four, six, eight, 10 and 12 months' post-discharge in addition to TAU. Postcards encouraged partici-
pants to make contact with the service if required. No information on who delivered the intervention,
their expertise, or their experience was reported.

Comparator: TAU.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from electronic hospital records.

Secondary outcome(s): i) suicide (unclear how ascertained).

Notes

Source(s) of funding: “KC is funded by the NSW Health, Burdekin Mental Health Enhancement Strate-
gy” (Carter 2005, p. 4).
Conflict(s) of interest: none reported.
Other: data on suicides obtained following correspondence with the trial authors. Additionally, 20 con-
trol group participants received intervention due to clerical errors but were included by the authors in
the control group for all intention-to-treat analyses.

Cedereke 2002 

Study characteristics

Methods

Participants were individually randomised using sealed envelopes to a remote contact intervention
(telephone contact) in addition to TAU or TAU alone.

N lost to follow-up: 44/216 (20.4%) for repetition of SH by the 12-month follow-up assessment.

Location: Lund, Sweden.

Participants

Number of total participants: 216 participants were allocated, 107 were allocated to a remote contact
intervention (telephone contact) in addition to TAU and 109 were allocated to TAU alone.

Profile of participants: mean age 41.0 ± 18.0 years (range: not reported). Almost two-thirds (n = 143;
66.2%) were female. Just over half (n = 112; 51.8%) had a history of SH (i.e. multiple episodes of SH).
The majority (n = 197; 91.2%) were diagnosed with a mood disorder.

Source of participants: patients treated in hospital following a suicide attempt (i.e. with evidence of sui-
cidal intent).

Inclusion criteria: i) received treatment in a general hospital following a suicide attempt.

Exclusion criteria: none reported.

Interventions

Intervention: remote contact intervention consisting of a two telephone contacts (20-45 minutes) at
four and eight months' post-discharge in addition to TAU. Telephone calls were designed to offer moti-
vational therapy and to encourage participants to remain adherent to TAU. Sessions were delivered by
therapists (no information on expertise reported) with a minimum of 10 years' experience working with
suicidal persons.

Comparator: TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

105

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Cedereke 2002  (Continued)

Length of treatment: eight months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report and medical records; ii) suicide
as ascertained from mortality registers.

Secondary outcomes: i) general functioning as measured by the GAF; ii) distress as measured by the
Symptom Check List-90 (SCL-90) and the GSI; iii) suicidal ideation as measured by the BSSI; iv) treat-
ment adherence as measured by the number of telephone contacts made.

Notes

Source(s) of funding: “This study was supported by grants from The Axson Johnsons foundation and
from the Vardal Foundation (V97 341)” (Cedereke 2002, p. 90).
Conflict(s) of interest: no information reported.

Clarke 2002 

Study characteristics

Methods

Participants were individually randomised using a random numbers list, stratified by sex and admitting
hospital, to case management in addition to TAU or TAU alone.

N lost to follow-up: 0/467 (0%) for repetition of SH at post-intervention.

Location: East London and Essex, UK.

Participants

Number of total participants: 467 participants were allocated, 220 were allocated to case management
in addition to TAU and 247 were allocated to TAU alone.

Profile of participants: mean age 33.0 (SD not reported; range: not reported). Over half (n = 263; 56.3%)
were female. One in five (n = 104; 22.3%) had a history of SH (i.e. multiple episodes of SH). A minority
were diagnosed with any psychiatric disorder (n = 80; 17.1%); most commonly AUD (n = 60; 75.0%) fol-
lowed by schizoaffective disorder (n = 12; 2.5%).

Source of participants: patients presenting to hospital following SH.

Inclusion criteria: i) aged 16 years or older; ii) resident in the catchment area; iii) overdose attributable
to recreational or problematic substance use.

Exclusion criteria: i) aged less than 16 years; ii) between 16 and 19 years and still in full-time secondary
education; overdose attributable to recreational or problematic substance use.

Intervention: case management comprising a comprehensive assessment of individual needs, develop-
ment of an individualised package of care, arrangement of access to services, monitoring of quality of
services provided, and long-term, flexible support. Number of sessions and their duration not reported.
Participants also received TAU. Sessions were delivered by a case manager (no further information on
expertise or experience was reported).

Comparator: TAU comprising triage, and medical and psychosocial treatment, as required.

Length of treatment: up to six months.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH according to hospital admission records; ii) suicide (unclear how
ascertained).

Notes

Source(s) of funding: "Funded by the participating health authority” (Clarke 2002, p. 167).

Conflict(s) of interest: none reported.
Other: data on suicides obtained following correspondence with trial authors.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

106

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Crawford 2010 

Study characteristics

Methods

Participants were individually randomised using a random numbers table to a brief, alcohol-focused in-
tervention or TAU.

N lost to follow-up: 0/103 (0%) for repetition of SH by the six-month assessment; 65/103 (63.1%) for sec-
ondary outcomes not included in this review (e.g. alcohol consumption, mental health problems, and
satisfaction with treatment).

Location: London, UK.

Participants

Number of total participants: 103 participants were allocated, 51 were allocated to the brief alcohol-fo-
cused intervention and 52 were allocated to TAU alone.

Interventions

Profile of participants: mean age 37.2 ± 12.0 years (range: 18-65 years). Almost half (n = 50; 48.5%) were
female. All (n = 103; 100%) were diagnosed with AUD.

Source of participants: consecutive admissions to an ED following an episode of SH and who were diag-
nosed with alcohol misuse according to scores on the Paddington Alcohol Test.

Inclusion criteria: i) aged 18 years or older; ii) admitted to an ED following an episode of SH; iii) diag-
nosed with alcohol misuse according to scores on the Paddington Alcohol Test.

Exclusion criteria: i) unwilling to provide informed consent; ii) unable to provide informed consent
(e.g. due to insufficient language ability or impaired consciousness); iii) no fixed address in the greater
London area; iv) already receiving treatment from AOD services; v) made a specific request to receive
treatment from AOD services at the index presentation.

Intervention: one-off appointment (~30 minutes) with an alcohol nurse specialist involving assessment
and discussion of both current and previous drinking behaviours delivered according to the FRAMES
approach in addition to a health information leaflet advising on the damaging effects of excessive al-
cohol consumption, recommended limits of alcohol consumption, and the contact details of nation-
ally-based alcohol misuse help lines (Miller 1993). Participants could also be referred by the alcohol
nurse specialist to individual alcohol counselling or detoxification services as required. Sessions were
delivered by an alcohol nurse specialist (no further information on experience was reported).

Comparator: TAU comprising a health information leaflet advising on the damaging effects of excessive
alcohol consumption, recommended limits of alcohol consumption, and the contact details of nation-
ally-based alcohol misuse help lines.

Length of treatment: 30 minutes.

Outcomes

Primary outcome(s): i) repetition of SH according to hospital records.

Secondary outcome(s): i) levels of alcohol consumption as measured by the Alcohol Use Disorders Iden-
tification Test (AUDIT); ii) diagnosis of probable personality disorder as ascertained by a score of ≥ 3 on
the Standardised Assessment of Personality - Abbreviated Scale (SAPAS); iii) general mental health as
measured by the General Health Questionnaire-12 (GHQ-12); iv) satisfaction with treatment as mea-
sured by the Client Satisfaction Questionnaire; v) suicide (unclear how ascertained).

Notes

Source(s) of funding: “This study was funded by St Mary’s Paddington Charitable Trust” (Crawford 2010,
p. 1827).
Conflict(s) of interest: none stated.
Other: data on suicides were obtained following correspondence with trial authors.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

107

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Davidson 2014 

Study characteristics

Methods

Participants were individually randomised (2:1 ratio) using a random numbers table to manualised
CBT-based psychotherapy or TAU.

N lost to follow-up: 6/20 (30.0%) for repetition of SH by the three-month assessment.

Location: Glasgow, UK.

Participants

Number of total participants: 20 participants were allocated, 14 were allocated to CBT-based psy-
chotherapy and 6 were allocated to TAU.

Profile of participants: mean (SD) age not reported (range: 18-65 years). Proportion female not report-
ed. All (n = 20; 100%) were diagnosed with a personality disorder; most commonly BPD (n = 17; 85.0%),
followed by avoidant PD (n = 13; 65.0%), and paranoid PD (n = 8; 40.0%). Almost half (n = 9; 45.0%) were
diagnosed with a comorbid SUD.

Source of participants: patients admitted to the medical receiving ward of the A&E department follow-
ing an episode of SH.

Inclusion criteria: i) aged 18-65 years; ii) diagnosed with any PD according to the SCID-II; iii) score of ≥ 3
on the Standardised Assessment of Personality Abbreviated Scale.

Exclusion criteria: i) unwilling or unable to provide informed consent.

Intervention: brief, manualised CBT-based psychotherapy consisting of six sessions (duration not re-
ported). Therapeutic content included: psychoeducation, development of alternatives to resolving
problems, and referral to appropriate mental health services, where required. Sessions were delivered
either by a doctoral-level clinical psychologist or a psychiatrist who received training (duration not re-
ported) in manualised CBT-based psychotherapy and ongoing weekly supervision.

Comparator: TAU consisting of referral to community mental health teams, appointments with psychia-
trists and a community psychiatric nurse, and inpatient psychiatric treatment, as required. Information
on both the number and duration of sessions was not reported.

Length of treatment: not reported.

Primary outcome(s): i) repetition of SH according to self-report using the Acts of Deliberate Self-Harm
Inventory (DSHI); ii) suicidal ideation as measured by the BSS; iii) depression as measured by the HADS;
iv) alcohol consumption as measured by the AUDIT; v) psychiatric treatment as ascertained from elec-
tronic medical records.

Secondary outcome(s): i) suicide (unclear how ascertained).

Source(s) of funding: "This work was supported by NHS Greater Glasgow and the Scottish Mental Health
Research Network” (Davidson 2014, p. 4).
Conflict(s) of interests: none reported.

Interventions

Outcomes

Notes

Dubois 1999 

Study characteristics

Methods

Participants were individually randomised; however, the method used was not reported.

N lost to follow-up: 18/102 (17.6%) for repetition of SH by the 12-month assessment.

Location: Bohars, France.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

108

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Dubois 1999  (Continued)

Participants

Number of total participants: 102 participants were allocated, 51 were allocated to CBT-based psy-
chotherapy and 51 were allocated to TAU.

Profile of participants: mean age 22.4 ± 5.8 years (range: not reported). The majority (n = 82; 80.4%) were
female. Over half (n = 57; 55.9%) were diagnosed with any mood disorder, followed by any anxiety dis-
order (n = 44; 43.1%), psychosis (n = 43; 42.1%), and SUD (n = 14; 13.7%). A minority were not diagnosed
with any psychiatric disorder (n = 13; 12.7).

Source of participants: patients attending the ED following a suicide attempt.

Inclusion criteria: i) aged 15-34 years; ii) presented to the ED following a suicide attempt.

Exclusion criteria: i) hospitalised for more than 24 hours; ii) currently being treated by a psychiatrist.

Interventions

Intervention: brief CBT-based psychotherapy consisting of five sessions (duration not reported). Whilst
these sessions followed a specific therapeutic model, the therapeutic content was not reported. Ses-
sions were delivered by the same therapist who initially saw them in the hospital (no further informa-
tion on who delivered the intervention, their expertise, or their experience was reported).

Comparator: TAU involving an assessment and follow-up by a clinical psychiatrist.

Length of treatment: one month.

Outcomes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) suicide (unclear how ascertained);
iii) treatment adherence as measured by the number of sessions attended.

Notes

Source(s) of funding: no information reported.

Conflict(s) of interest: no information reported.

Other: As data on treatment adherence were not reported for the control group, this outcome had to be
excluded from subsequent analyses.

Evans 1999a 

Study characteristics

Methods

Participants were individually randomised using sealed envelopes to either a remote contact interven-
tion (emergency card) or TAU.

N lost to follow-up: 0/827 (0%) for repetition of SH at post-intervention.

Location: Bristol, UK.

Participants

Number of total participants: 827 participants were allocated, 417 were allocated to a remote contact
intervention and 410 were allocated to TAU.

Profile of participants: mean age 33.3 ± 13.0 years (range: not reported). Just over half (n = 458; 55.4%)
were female. Just under half (n = 349; 42.2%) had a history of SH (i.e. multiple episodes of SH). The ma-
jority (n = 707; 85.5%) were diagnosed with a psychiatric disorder; however, no specific information on
these diagnoses was reported. One hundred and twenty (14.5%) did not have a psychiatric diagnosis.

Source of participants: patients admitted to general hospital following an episode of SH.

Inclusion criteria: i) admitted to the ED following an episode of SH; ii) referred for routine psychiatric
evaluation; iii) resident in catchment area; iv) judged likely to use intervention appropriately; v) made
contact with and used mental health services; vi) acceptable level of aggressive behaviour.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

109

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Evans 1999a  (Continued)

Interventions

Exclusion criteria: i) inappropriate substance abuse leading to repetitive presentation in which the par-
ticipant was aggressive; ii) unable to engage in treatment.

Intervention: remote contact intervention (emergency card) in addition to TAU. Participants were pro-
vided with an emergency card offering 24-hour service for crisis telephone consultation with an on-call
psychiatrist. Sessions were delivered by the duty trainee psychiatrist (no further information on experi-
ence was reported).

Comparator: TAU.

Length of treatment: six months.

Outcomes

Notes

Primary outcome(s): i) repetition of SH ascertained from A&E and hospital records; ii) suicide (unclear
how ascertained).

Source(s) of funding: “Funding was provided by a grant from the Department of Health” (Evans 1999a, p.
23).
Conflict(s) of interest: none stated.

Evans 1999b 

Study characteristics

Methods

Participants were individually randomised using sealed envelopes opened sequentially to either CBT-
based psychotherapy or TAU.

N lost to follow-up: 2/34 (5.9%) for repetition of SH by the six-month assessment.

Location: London, UK.

Participants

Number of total participants: 34 participants were allocated, 18 were allocated to CBT-based psy-
chotherapy and 16 were allocated to TAU.

Interventions

Profile of participants: mean (SD) not reported (range: 16 to 50 years). Over half (n = 21; 61.8%) were fe-
male. All (n = 34; 100%) had a history of SH (i.e. multiple episodes of SH). All (n = 34; 100%) were diag-
nosed with a PD.

Source of participants: patients admitted to 1 of 2 hospitals in the London area (Paddington and
Chelsea, Westminster) following an episode of SH.

Inclusion criteria: i) diagnosed with any PD (ASPD, dissocial, impulsive or BPD); ii) ≥ 1 episode of SH in
12 months preceding trial entry.

Exclusion criteria: i) diagnosed with alcohol or drug dependence, schizophrenia, or organic psychiatric
disorder.

Intervention: two to six sessions (duration not reported) of manual-assisted CBT. Therapeutic content
included: basic cognitive techniques (e.g. cognitive restructuring), problem-solving, distress tolerance,
identification and management of emotions and thoughts, identification of alternative coping strate-
gies, and relapse prevention. Sessions were delivered by a psychiatrist, community mental health team
member, or social workers with experience (duration not reported) working with persons who engage
in SH.

Comparator: TAU. Five participants had contact with a psychiatrist, three saw a community mental
health team, four saw a specialist social worker, and two saw no mental health professional.

Length of treatment: varied.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report and hospital records.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

110

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Evans 1999b  (Continued)

Cochrane Database of Systematic Reviews

Secondary outcome(s): i) time to repetition of SH as ascertained from self-report and hospital records;
ii) social functioning as measured by the Social Functioning Questionnaire; iii) depression as measured
by the depression subscale of the HADS; iv) anxiety as measured by the anxiety subscale of the HADS;
v) treatment adherence as measured by the number of sessions attended; vi) health economics evalua-
tion.

Notes

Source(s) of funding: “This work was supported by a grant from the North Thames Regional Health Au-
thority” (Evans 1999b, p. 24).
Conflict(s) of interest: no information on author interests reported.
Other: five participants in the intervention arm did not see a therapist and instead received therapy
from the booklets. One participant in the intervention arm did not receive any intervention.

Fleischmann 2008 

Study characteristics

Methods

Participants were individually randomised using a random numbers table to either provision of infor-
mation and support or TAU.

N lost to follow-up: 204/1867 (10.9%) for repetition of SH by the post-intervention assessment.

Locations: Campinas, Brazil; Chennai, India; Colombo, Sri Lanka; Karaj, Iran; Yuncheng, China.

Participants

Number of total participants: 1867 participants were allocated, 922 were allocated to information and
support and 945 were allocated to TAU.

Profile of participants: median 23.0 years (IQR not reported; range: not reported). Over half (n = 1086;
58.2%) were female. Around one in five (n = 394; 21.1%) had a history of SH (i.e. multiple episodes of
SH). No information reported on psychiatric diagnoses.

Source of participants: patients presenting to emergency care settings following an episode of SH/self-
poisoning within a defined catchment area with a population of at least 250,000 persons.

Inclusion criteria: i) presenting to services following an episode of SH/self-poisoning as determined by
medical staff.

Exclusion criteria: i) died on the ward; ii) presence of a clinical condition that would preclude interview;
iii) left hospital against medical advice; iv) resident in a different catchment area; v) insufficient lan-
guage ability.

Intervention: brief, one-off intervention involving “information about suicidal behaviour as a sign of
psychological and/or social distress, risk and protective factors, basic epidemiology, repetition, alter-
natives to suicidal behaviours, and referral options” (Fleischmann 2008, p. 705) (duration: one hour)
and contact via telephone or home visits to provide referral support in addition to TAU for up to 18
months. The number and duration of these telephone contacts was not reported. Sessions were deliv-
ered by trained psychiatrists, medical doctors, psychologists, or psychiatric nurses (no information on
experience was reported).

Comparator: TAU “according to the norms prevailing in the respective emergency departments” (Fleis-
chmann 2008, p. 704). This typically involved only acute treatment for somatic problems only.
Length of treatment: 18 months.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report using the European Parasuicide
Study Interview Schedule (EPSIS); ii) suicide (unclear how ascertained).

Secondary outcome(s): i) anger as measured by the Spielberger Trait-Anger Scale; ii) depression as
measured by the BDI; iii) hopelessness as measured by the BHS; iv) impulsiveness as measured by the
Eysenck Impulsiveness Scale; v) social support as measured by the Bille-Brahe Measurement of Social
Support; vi) suicidal intent as measured by the Beck Suicide Intent Scale; vii) treatment adherence as

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

111

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Fleischmann 2008  (Continued)

Notes

measured by the number of sessions attended; viii) well-being as measured by the WHO Well-Being In-
dex.

Source(s) of funding: “The study was funded by the Department of Mental Health and Substance Abuse,
WHO. Some field research sites obtained additional funding from the following agencies: Campinas:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), grant no 02/08288-9, São Paulo,
Brazil; Durban: Medical Research Council (MRC), Tygerberg, Cape Town, South Africa; Karaj: Tehran
Psychiatric Institute, Mental Health Research Centre (IUMS), Tehran, Iran; Tallinn: Estonian Health In-
surance Fund, Tallinn, Estonia; the Swedish National and Stockholm County Centre for Suicide Re-
search and Prevention of Mental Ill-Health (NASP), WHO Collaborating Centre for Research and Train-
ing in Suicide Prevention, Department of Public Health Sciences, Karolinska Institute, Stockholm, Swe-
den” (Fleischmann 2008, p. 708).
Conflict(s) of interest: none reported.

Gibbons 1978 

Study characteristics

Methods

Correspondence with trial authors confirmed participants were individually randomised using sequen-
tially numbered envelopes to either CBT-based psychotherapy or TAU.

N lost to follow-up: 0/400 (0%) for repetition of SH by the 12-month follow-up assessment.

Location: Southampton, UK.

Participants

Number of total participants: 400 participants were allocated, 200 were allocated to CBT-based psy-
chotherapy and 200 were allocated to TAU.

Profile of participants: mean (SD) age not reported (range: not reported). The majority (n = 284; 71.0%)
were female. A mix of both first-time and those with a history of multiple episodes of SH were included,
however, information on the proportion of each was not reported. Under half (n = 176; 44.0%) were di-
agnosed with a depressive disorder, followed by an anxiety disorder (n = 8; 2.0%), affective psychosis (n
= 8; 2.0%), and schizophrenia (n = 4; 1.0%). Diagnoses for the remaining four (1.0%) participants not re-
ported.

Source of participants: patients presenting to A&E following an episode of self-poisoning,

Inclusion criteria: i) 17 years of age or older; ii) presented to A&E following an episode of self-poisoning.

Exclusion criteria: i) at immediate suicide risk; ii) not formally diagnosed with a psychiatric disorder.

Intervention: CBT-based psychotherapy consisting of sessions (both the number and duration not re-
ported) of a time-limited, crisis-oriented, task-entered programme delivered by social workers. Thera-
peutic content involved problem-solving focused on personal and social relationships, identifying al-
ternative coping strategies, and distress tolerance. Sessions were delivered by qualified and experi-
enced (duration not reported) social workers.

Comparator: TAU. Just over half (n = 108; 54.0%) were referred to their GP, one-third (n = 66; 33.0%)
were referred to psychiatric services, and 26 (13.0%) received an unspecified referral.

Length of treatment: three months.

Primary outcome(s): i) repetition of SH as according to hospital records; ii) depression as measured by
the BDI; iii) social functioning as measured by an idiosyncratic scale; iv) treatment satisfaction accord-
ing to self-report.

Source(s) of funding: “The study was supported by the Department of Health and Social Security, and
the Wessex Regional Health Authority” (Gibbons 1978, p. 117).
Conflict(s) of interests: no information reported.

Interventions

Outcomes

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

112

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Gratz 2006 

Study characteristics

Methods

Participants were individually randomised using an unspecified method to either group-based emotion
regulation therapy or TAU.

N lost to follow-up: 2/24 (8.3%) for repetition of SH data by the post-intervention assessment.

Location: Boston, MA, USA.

Participants

Number of total participants: 24 participants were allocated, 13 were allocated to group-based emotion
regulation therapy and 11 were allocated to TAU.

Profile of participants: mean age 33.3 ± 12.2 (range: 18 to 60 years). All (n = 24; 100%) were female, had a
history of SH (i.e. multiple episodes of SH), and were diagnosed with BPD.

Source of participants: clinician referrals and self referrals from advertisements posted at a hospital
and on two websites. All had engaged in an episode of SH presenting to clinical services within the six
months preceding trial entry.

Inclusion criteria: i) diagnosed with BPD; ii) history of SH resulting in presentation to clinical services,
with ≥ 1 episode in the six months preceding trial entry; iii) have an individual therapist; iv) aged 18 to
60 years; v) female.

Exclusion criteria: i) diagnosed with psychosis, bipolar I disorder, or SUD; ii) at immediate suicide risk
(i.e. made a suicide attempt rated as having a ’high’ risk of death or greater within the six months pre-
ceding trial entry); iii) at risk of attempting suicide within the next year; iv) received DBT in the six
months preceding trial entry.

Intervention: group-based emotion regulation psychotherapy consisting of weekly (duration not report-
ed) sessions. Therapeutic content is drawn from Acceptance and Commitment Therapy (ACT), DBT, and
emotion-focused therapy and includes: psychoeducation, identification of emotions, distress toler-
ance, emotional acceptance, behavioural activation, developing alternative coping strategies, impulse
control, and identifying and clarifying valued directions. Participants also received weekly (one hour)
sessions of individual therapy and TAU. The average number of hours spent in TAU per week was 2.1 ±
1.6. Sessions were delivered by therapists (no further information on expertise or experience was re-
ported).

Comparator: TAU consisting of weekly (more than one hour) sessions of individual therapy. In addition
to individual therapy almost two-thirds (32%) attended group-based psychotherapy, and 9% attended
self-help groups (e.g. AA, NA). The average number of hours spent in TAU per week was 2.9 ± 2.8.

Length of treatment: 14 weeks.

Primary outcome(s): i) repetition of SH according to self-report using the DSHI; ii) anxiety as measured
by the anxiety subscale of the DASS; iii) BPD symptomatology as measured by the Borderline Evalua-
tion of Severity over Time (BEST); iv) depression as measured by the depression subscale of the DASS;
v) emotion regulation as measured by the DERS; vi) emotional avoidance as measured by the Accep-
tance and Action Questionnaire (AAQ); vii) stress as measured by the stress subscale of the DASS.

Source(s) of funding: ”This research was supported by the Psychosocial Fellowship of McLean Hospital,
awarded to the first author“ (Gratz 2006, p. 25).
Conflict(s) of interests: Although no author interests were reported, Prof Gratz developed emotion regu-
lation group therapy.

Interventions

Outcomes

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

113

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Gratz 2014 

Study characteristics

Methods

Participants were individually randomised, stratified by age, emotion dysregulation, number of lifetime
episodes of SH, and GAF scores to either group-based emotion regulation therapy or TAU.

N lost to follow-up: 0/61 (23.5%) for repetition of SH data by the post-intervention assessment.

Location: Jackson, MS, USA.

Participants

Number of total participants: 61 participants were allocated, 31 were allocated to group-based emotion
regulation therapy and 30 were allocated to TAU.

Profile of participants: mean age 33.2 ± 10.9 (range: 18 to 60 years). All (n = 61; 100%) were female, and
had a history of SH. Over half (n = 38; 62.3%) were diagnosed with any anxiety disorder, half (n = 31;
50.0%) were diagnosed with any mood disorder, followed by PTSD (n = 22; 36.0%), any eating disorder
(n = 8; 13.3%), and SUD (n = 1; 1.6%).

Source of participants: referrals from clinicians to the emotion regulation group therapy and from self
referrals in response to an advertisement posed both online and in the community. All had engaged in
an episode of SH presenting to clinical services within the six months preceding trial entry.

Inclusion criteria: i) aged 18-60 years; ii) females; iii) diagnosed with threshold or subthreshold BPD; iv)
history of repeated SH with ≥ 1 episode in the six months prior to trial entry; v) have one or more of the
following: individual therapist, psychiatrist, case manager.

Exclusion criteria: i) diagnosed with psychosis or bipolar I disorder; ii) current (past month) substance
use.

Intervention: manualised group-based (maximum of six participants per group) emotion regulation
psychotherapy consisting of weekly (90 minutes) sessions. Therapeutic content is drawn from Accep-
tance and Commitment Therapy (ACT), DBT, and emotion-focused therapy and includes: psychoedu-
cation, identification of emotions, distress tolerance, emotional acceptance, behavioural activation,
developing alternative coping strategies, impulse control, and identifying and clarifying valued direc-
tions. Participants also received weekly (one hour) sessions of individual therapy and TAU. The average
number of hours spent in TAU per week was 2.1 ± 1.6. Sessions were delivered by doctoral-level thera-
pists who received a minimum of four months training in delivering group-based emotion regulation
psychotherapy.

Comparator: TAU consisting of weekly (more than one hour) sessions of individual or group-based ther-
apy. Few participants (18%) received group-based therapy, however. Most (> 70%) were receiving sup-
portive or dynamic individual therapy, 19% were receiving CBT, none were receiving DBT.

Length of treatment: 14 weeks.

Primary outcome(s): i) repetition of SH according to self-report using the DSHI and the Self-Harm Inven-
tory (SHI); ii) BPD symptomatology as measured by the Zanarini Rating Scale for Borderline Personality
Disorder (ZAN-BPD) and the BEST; iii) depression as measured by the BDI and the depression subscale
of the DASS.

Secondary outcome(s): i) emotion regulation as measured by the DERS; ii) emotional avoidance as mea-
sured by the AAQ; iii) interpersonal problems as measured by the BPD-related composite of the Inven-
tory of Interpersonal Problems (IIP-BPD); iv) quality of life as measured by the Quality of Life Inventory;
v) social functioning as measured by the Sheehan Disability Scale (SDS).

Source(s) of funding: “This research was supported by National Institute of Mental Health Grant R34
MH079248, awarded to Dr. Gratz” (Gratz 2014, p. 2110).
Conflict(s) of interests: Although no author interests were reported, Prof Gratz developed emotion regu-
lation group therapy.

Interventions

Outcomes

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

114

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Grimholt 2015 

Study characteristics

Methods

Participants were individually randomised to either structured GP management or TAU.

N lost to follow-up: 6/149 (4.0%) for repetition of SH at the post-intervention assessment according to
hospital records, or 26/149 (17.5%) according to emergency department records.

Location: Oslo and Akershus County, Norway.

Participants

Number of total participants: 202 participants were randomised, 101 were allocated to structured GP
follow-up and 101 were allocated to TAU. However, data on repetition of SH were only available for
analysis for up to 59.4% of those allocated to the intervention arm and 82.2% of those allocated to TAU.

Profile of participants: mean age 38.2 (SD not reported; range: 18 to 75 years). Just under three-quarters
(n = 111; 74.5%) were female. Over one-third (n = 58; 38.9%) had a history of SH (i.e. multiple episodes
of SH). Information on psychiatric diagnoses were not reported.

Source of participants: patients admitted to the acute medical wards of any of five hospitals following
an episode of self-poisoning.

Inclusion criteria: i) 18-75 years of age; ii) admitted to the acute medical ward following an episode of
self-poisoning.

Exclusion criteria: i) diagnosed with psychosis, an intellectual disability, or organic cognitive impair-
ment; ii) insufficient language ability; iii) not registered with a GP (includes non-native citizens); iv) re-
ferred for inpatient psychiatric or other (e.g. AOD) treatment.

Intervention: structured GP follow-up consisting of one follow-up GP appointment within one-
week post-discharge, one GP consultation per month for the first three months of the intervention
(i.e. months one to three), and two further GP consultations in the final three months of the interven-
tion (i.e. months four to six). Sessions were delivered by GPs (no further information on experience re-
ported).

Comparator: referral to outpatient psychiatric, AOD, and/or family counselling, as needed. TAU did not
preclude GP management.

Length of treatment: six months.

Interventions

Outcomes

Primary outcome(s): i) suicidal ideation as measured by the BSSI.

Secondary outcome(s): i) depression as measured by the BDI; ii) hopelessness as measured by the BHS;
iii) repetition of SH as ascertained from self-report supplemented by medical records.

Notes

Source(s) of funding: "The trial was funded by the Norwegian Southern Eastern Health Authority and the
Regional Centre of Traumatic Stress and Suicide Prevention, Eastern Norway" (Grimholt 2015, pp.1-2).

Conflict(s) of interest: "The authors have declared that no competing interests exist" (Grimholt 2015,
p.2).

Guthrie 2001 

Study characteristics

Methods

Participants were individually randomised using a computer-generated list to either CBT-based psy-
chotherapy or TAU.

N lost to follow-up: 0/119 (0%) for repetition of SH by the six-month assessment.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

115

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Guthrie 2001  (Continued)

Location: Manchester, UK.

Cochrane Database of Systematic Reviews

Participants

Number of total participants: 119 participants were allocated, 58 were allocated to CBT-based psy-
chotherapy and 61 were allocated to TAU.

Interventions

Profile of participants: mean age 31.2 ± 1.5 (range: not reported). Just over half (n = 66; 55.5%) were fe-
male, had a history of SH (i.e. multiple episodes of SH) (n = 71; 59.7%), and a history of previous psychi-
atric treatment (n = 65; 54.6%); however, information on psychiatric diagnoses was not reported.

Source of participants: patients presenting to hospital after an episode of self-poisoning most common-
ly involving acetaminophen/paracetamol (n = 43; 36.1%).

Inclusion criteria: i) aged 18-65 years; ii) presenting with episode of self-poisoning; iii) sufficient lan-
guage ability; iv) living in the catchment area; v) registered with a GP.

Exclusion criteria: i) requiring immediate psychiatric treatment.

Intervention: individual CBT-based psychotherapy consisting of weekly (50 minute) sessions of home-
based psychodynamic interpersonal therapy. Therapeutic content included: resolving interpersonal
difficulties causing distress through a conversational approach, identification of feelings and relating
these to problems and relationships, and developing shared understanding and approaches to resolv-
ing family problems. Sessions were delivered by nurse therapists (no further information on experience
was reported).

Comparator: TAU. In most cases, this involved assessment by doctor in the ED and referral to psychiatry
outpatient treatment, addiction services, or GP, where required.

Length of treatment: 4 weeks.

Outcomes

Primary outcome(s): i) suicidal ideation as measured using the BSSI.

Secondary outcome(s): i) repetition of SH as ascertained by self-report supplemented by hospital
records; ii) depression as measured using the BDI; iii) service use as ascertained from records; iv) treat-
ment satisfaction as measured by an idiosyncratic scale; v) suicide (unclear how ascertained).

Notes

Source(s) of funding: “North West Regional Health Authority and the NHS Research and Development
Levy” (Guthrie 2001, p. 4).
Conflict(s) of interest: none reported.

Gysin-Maillart 2016 

Study characteristics

Methods

Participants were individually randomised using Zelen's post-consent method to either 24 months of a
CBT-based program (ASSIP) in addition to a remote contact intervention or TAU.

N lost to follow-up: 0/120 (0%) for repetition of SH at post-intervention.

Location: Bern, Switzerland.

Participants

Number of total participants: 120 participants were randomised, 60 were allocated to the multi-compo-
nent ASSIP program and 60 were allocated to TAU.

Profile of participants: mean age 38.2 ± 14.0 years; range: 18 to 75 years). Over half (n = 66; 55.0%) were
female. Half (n = 60; 50.0%) had a history of SH (i.e. multiple episodes of SH). Most (n = 76; 63.3%) were
diagnosed with any mood disorder, followed by SUD (n = 30; 25.0%), and any PD (n = 20; 16.7%).

Source of participants: patients admitted to the ED for an episode of SH.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

116

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Gysin-Maillart 2016  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Inclusion criteria: i) referred for in- or outpatient treatment; ii) sufficient language ability; iii) able to pro-
vide written informed consent.

Exclusion criteria: i) diagnosed with psychosis; ii) in custody or imprisoned; iii) insufficient language
ability.

Intervention: mixed multimodal intervention (CBT-based program together with a remote contact). The
Attempted Suicide Short Intervention Program (ASSIP) comprises three weekly sessions (60-90 min-
utes) comprising cognitive case conceptualisation based on a vulnerability-trigger model, psychoed-
ucation, collaborative safety planning, and relapse prevention. A fourth session (60-90 mins) can be
added as necessary. Participants also receive personalised letters at 1, 3, 6, 9, 12, 18, and 24 months'
post-discharge. Sessions were delivered by psychiatrists, psychologists, and other therapists with an
average of two years experience working with suicidal persons and who received training (one week) in
delivering ASSIP.

Comparator: TAU comprising a one-off structured risk assessment, a summary of which was sent to the
participant's usual care coordinator.

Concomitant medications: were permitted. Around half were prescribed antidepressants (n = 56;
46.7%), followed by antipsychotics (n = 21; 17.5%), tranquillisers (both major and minor; n = 15; 12.5%),
and other medications (not specified; n = 13; 10.8%).

Length of treatment: 24 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report supplemented by collateral infor-
mants (e.g. GPs) and medical records.

Secondary outcome(s): i) suicidal ideation as measured by the BSSI; ii) healthcare utilisation (unclear
how measured); iii) depression as measured by the BDI; iv) therapeutic alliance as measured by the
Penn Helping Alliance Questionnaire; v) suicide as ascertained from collateral informants (e.g. GPs) and
medical records.

Notes

Source(s) of funding: "The authors received no specific funding for this work (Gysin-Maillart 2016, p.1).

Conflict(s) of interest: "KM and AGM received royalties from Hogrefe Publishing for "ASSIP—At-
tempted Suicide Short Intervention Program: A Manual for Clinicians. K. Michel & A. Gysin-Maillart
(2015)" (Gysin-Maillart 2016, p.1).

Harned 2014 

Study characteristics

Methods

Participants were individually randomised using a minimisation procedure stratified for number of sui-
cide attempts/episodes of NSSI (past year), PTSD symptom severity, dissociative symptom severity,
and current use of any SSRI to either DBT (prolonged-exposure protocol) or DBT (standard protocol).

N lost to follow-up: 8/26 (30.8%) for repetition of SH data at the post-intervention assessment.

Location: Seattle, WA, USA.

Participants

Number of total participants: 26 participants were allocated, 19 were allocated to DBT (prolonged pro-
tocol) and 7 were allocated to DBT (standard protocol).

Profile of participants: mean age 32.6 ± 12.0 (range: 19-55 years). All (n = 26; 100%) were female, and
were diagnosed with comorbid PTSD and BPD.

Source of participants: patients seeking treatment from a specialist treatment service for suicidal indi-
viduals with comorbid BPD and PTSD.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

117

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Harned 2014  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Inclusion criteria: i) female; ii) aged 18-60 years; iii) diagnosed with BPD; iv) diagnosed with PTSD; v) has
satisfactory recall of at least part of the index trauma; vi) recent and recurrent SH (i.e. ≥ 2 suicide at-
tempts or episodes of NSSI in the previous five years, with ≥ 1 within the eight weeks preceding trial en-
try); vii) lives within commuting distance.

Exclusion criteria: i) diagnosed with psychosis, bipolar disorder, or mental retardation; ii) receiving
treatment under legal mandate; iii) require treatment for another life-threatening condition (e.g.
anorexia nervosa).

Intervention: DBT (prolonged-exposure protocol) consisting of either one combined individual therapy
session per week (90 minutes) or two individual therapy sessions per week delivered by the same ther-
apist (90 min), one group-based skills session (60 minutes), and telephone consultation, as required.
Therapeutic content was the same as standard DBT and included: identification of emotions, targeting
problems that may occur during or as a result of exposure to trauma, targeting trauma-related shame,
dialectics, irreverence, self-disclosure, and validation. Sessions were delivered by masters-level clini-
cians (doctoral-level students in training, licensed professionals, or postdoctoral fellows) with an aver-
age of two years of clinical experience and who received training (one day) in delivering DBT.

Comparator: standard DBT consisting of either one combined individual therapy session per week (30
minutes) or two individual therapy sessions per week delivered by the same therapist (60 minutes), one
group-based skills session (60 minutes), and telephone consultation, as required. Therapeutic content
was the same as above.

Concomitant medication(s): were permitted, however, "...patients on SSRIs were asked to either taper
off the medication before starting...or remain at a constant dose..." (Harned 2014, p.10).

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report using the SASII; ii) PTSD symp-
toms as measured by the PSS-I.

Secondary outcome(s): i) anxiety as measured by the Hamilton Rating Scale for Anxiety (HRSA); ii) de-
pression as measured by the HDRS; iii) dissociative experiences as measured by the Dissociative Expe-
riences Scale-Taxon (DES-T); iv) general psychological well-being as measured by the GSI; v) shame as
measured by the Experience of Shame Scale (ESS); vi) trauma-related guilt cognitions as measured by
the Trauma- Related Guilt Inventory (TRGI).

Notes

Source(s) of funding: “This work was supported by grant R34MH082143 from the National Institute of
Mental Health” (Harned 2014, p. 16).
Conflict(s) of interest: “Drs. Harned, Korslund, and Linehan are trainers and consultants for Behavioral
Tech, LLC” (Harned 2014, p. 16).

Hassanian-Moghaddam 2011 

Study characteristics

Methods

Participants were individually randomised using a blocking procedure and a random numbers table to
either a remote contact intervention (postcards) in addition to TAU or TAU alone.

N lost to follow-up: 187/2300 (8.1%) for repetition of SH at post-intervention.

Location: Tehran, Iran.

Participants

Number of total participants: 2300 participants were allocated, 1150 were allocated to the remote con-
tact intervention (postcards) and 1150 were allocated to TAU.

Profile of participants: mean age 24.1 ± 8.1 years (range: not reported). Over half (n = 1402; 66.4%) were
female. Just under one-third (n = 723; 31.4%) had a history of SH (i.e. multiple episodes of SH). No infor-
mation was reported on psychiatric diagnoses.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

118

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Hassanian-Moghaddam 2011  (Continued)

Cochrane Database of Systematic Reviews

Source of participants: patients admitted or transferred to a specialist hospital for the treatment of poi-
soning following an episode of self-poisoning.

Inclusion criteria: i) aged 12 years or older; ii) admitted or transferred to a specialist hospital for the
treatment of poisoning following an episode of self-poisoning.

Exclusion criteria: i) treated in the ED of a general hospital; ii) diagnosed with psychosis; iii) unable to
provide informed consent (e.g. due to insufficient language ability); iv) no fixed address; v) posed a po-
tential threat to interviewers; vi) episode of self-poisoning was classified by the attending toxicologist
as recreational, habitual, accidental, or iatrogenic.

Interventions

Intervention: remote contact intervention consisting of a series of postcards mailed at one, two, three,
four, six, eight, 10 and 12 months' post-discharge in addition to TAU. Postcards encouraged partici-
pants to make contact with the service, if required. No information on who delivered the intervention,
their expertise, or their experience was reported.

Comparator: TAU. Although no specific details were provided, the authors noted that “[f ]ollow-up care
for self-poisoning in Tehran is generally poor...Contact is mainly hospital- or office-based, and commu-
nity-based programs are almost non-existent. Psychiatric beds are often at 100% occupancy, with short
admissions and frequent readmissions.” (Hassanian-Moghaddam 2011, pp. 310-311).

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH according to self-report supplemented by hospital records; ii)
suicidal ideation (according to self-report).

Secondary outcome(s): i) suicide (unclear how ascertained); ii) treatment adherence as ascertained
by the number receiving the postcard; iii) satisfaction with treatment as ascertained by the number
reporting the postcard was useful in the prevention of SH; iv) all-cause mortality (unclear how ascer-
tained).

Notes

Source(s) of funding: “This study was supported by a grant from the Legal Medicine Organization of Iran
and the Loghman-Hakim Research Development Unit, Shahid Beheshti Medical University” (Hassan-
ian-Moghaddam 2011, p. 315).
Conflict(s) of interest: none reported.

Hatcher 2011 

Study characteristics

Methods

Participants were individually randomised using a computer-generated numbers list and Zelen's
method to either CBT-based psychotherapy in addition to TAU or TAU alone.

N lost to follow-up: 0/552 (0%) (of those consenting) by for repetition of SH by the 12-month assess-
ment.

Location: Auckland and Wellington, New Zealand.

Participants

Number of total participants: 552 participants were allocated, 253 were allocated to CBT-based psy-
chotherapy and 299 were allocated to TAU.

Profile of participants: mean age 33.7 ± 12.9 years (range: not reported). Over two-thirds (n = 380; 68.8%)
were female. Just under half (n = 247; 44.7%) had a history of SH (i.e. multiple episodes of SH).

Source of participants: patients admitted to hospital following an episode of SH.

Inclusion criteria: i) aged 16 years or older; ii) admitted to hospital following an episode of SH.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

119

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Hatcher 2011  (Continued)

Interventions

Exclusion criteria: i) enrolled full time in school; ii) receiving DBT for the treatment of BPD; iii) have a
treatment management plan which precludes short-term therapy; iv) cognitively impaired; v) admitted
to a psychiatric care unit following the index episode of SH for a minimum period of 48 hours.

Intervention: manualised CBT-based psychotherapy based on D'Zurilla 1971 consisting of up to nine (60
minutes) sessions of PST. Therapeutic content included: problem orientation, problem listing and defi-
nition, brainstorming, devising an action plan, and reviewing the plan. Sessions were delivered by clini-
cians (social workers, psychotherapists, counselling and health psychologists) who did not have exten-
sive experience working in mental health settings and who received training (one week) in delivering
problem-solving psychotherapy.

Comparator: TAU involving a one-off psychosocial assessment by a mental health professional, as well
as referral to multidisciplinary teams for psychiatric or psychological intervention, referral to men-
tal health crisis teams, recommendations for engagement with AOD centres or other health and non-
health services, as required.

Length of treatment: three months.

Outcomes

Primary outcome(s): i) repetition of SH according to hospital records; ii) time to repetition of SH accord-
ing to hospital records.

Secondary outcome(s): i) anxiety as measured by the anxiety subscale of the HADS; ii) depression as
measured by the depression subscale of the HADS; iii) hopelessness as measured by the BHS; iv) social
functioning as measured by the Social Problem-Solving Inventory Scale (SPSI); v) suicidal ideation as
measured by the BSS: vi) suicide (ascertained from Coroner's records).

Notes

Source(s) of funding: “This study was funded by the Accident Compensation Corporation of New
Zealand” (Hatcher 2011, p. 316).
Conflict(s) of interest: none reported.

Hatcher 2015 

Study characteristics

Methods

Participants were individually randomised using a computer-generated sequence, stratified by history
of SH and method of SH, using Zelen's method, to either a multimodal intervention or TAU.

N lost to follow-up: 0/1474 (0%) (of those consenting) for repetition of SH by the post-intervention as-
sessment.

Location: Waitemata, Manukau, Northland, and Waikato regions, New Zealand.

Participants

Number of total participants: 684 participants were allocated, 327 were allocated to the multimodal in-
tervention and 357 were allocated to TAU.

Profile of participants: mean age 36.8 ± 14.4 (range: not reported). Over half (n = 464; 67.8%) were fe-
male and had a history of SH (i.e. multiple episodes of SH) (n = 370; 54.1%). Information on psychiatric
diagnoses not reported.

Source of participants: patients admitted to hospital following an episode of SH.

Inclusion criteria: i) presented to the ED following an episode of SH.

Exclusion criteria: i) aged less than 17 years; ii) enrolled full time in school; iii) unable to provide in-
formed consent; iv) self-identifies as Māori (these participants were instead invited to participate in the
Hatcher 2016 trial).

Interventions

Intervention: multimodel intervention consisting of one to two face-to-face or telephone patient sup-
port sessions (duration not reported) over the fortnight following discharge from hospital to ensure pa-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

120

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Hatcher 2015  (Continued)

Cochrane Database of Systematic Reviews

tients were adhering to their agreed discharge plan; four to six sessions (duration not reported) of PST
(based on D'Zurilla 1971) in the four weeks following the index SH episode; postcards mailed at one,
two, three, four, six, eight, 10 and 12 months following the index SH episode; improved access to prima-
ry care via the provision of a voucher that could be used to access one free GP consultation (duration
not reported); development of a risk management strategy; and a cultural assessment focused on iden-
tifying patients’ sense of belonging and identification with their ethnic group. Sessions were delivered
by research clinicians (no further information on their expertise or experience was reported).

Comparator: TAU consisting of referral to multidisciplinary teams for psychiatric/psychological assess-
ment, intervention, or both; referral to crisis teams; or referral to community-based AOD treatment
teams, as required.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from electronic medical records.

Secondary outcome(s): i) repetition of SH as ascertained from self-report; ii) anxiety as measured by the
anxiety subscale of the HADS; ii) belonging as measured by the Sense of Belonging Instrument; iii) de-
pression as measured by the depression subscale of the HADS; iv) hopelessness as measured by the
BHS; v) quality of life as measured by the EQ-5D; vi) service use as measured by self-report supplement-
ed by electronic medical records; vii) suicide (unclear how ascertained).

Notes

Source(s) of funding: none reported.
Conflict(s) of interests: none reported.

Hatcher 2016 

Study characteristics

Methods

Participants were individually randomised using a computer-generated sequence, stratified by history
of SH and method of SH, using Zelen's method, to either a multimodal intervention or TAU.

N lost to follow-up: 0/365 (0%) for repetition of SH by the post-intervention assessment.

Location: Waitemata, Manukau, and Northland regions, New Zealand.

Participants

Number of total participants: 365 participants were allocated, 182 were allocated to the multimodal in-
tervention and 183 were allocated to TAU.

Profile of participants: mean age 32.3 ± 10.7 (range: not reported). Over two-thirds (n = 109; 65.3%) were
female, and over half (n = 100; 59.9%) had a history of SH (i.e. multiple episodes of SH). Information on
psychiatric diagnoses not reported.

Source of participants: patients admitted to hospital following an episode of SH.

Inclusion criteria: i) presented to the ED following an episode of SH; ii) self-identifies as Māori; iii) suffi-
cient language ability to communicate in te reo Maori (Māori language).

Exclusion criteria: i) aged less than 17 years; ii) enrolled full time in school; iii) unable to provide in-
formed consent.

Intervention: culturally-adapted multimodel intervention consisting of one to two face-to-face or tele-
phone patient support sessions (duration not reported) over the fortnight following discharge from
hospital to ensure patients were adhering to their agreed discharge plan; four to six sessions (duration
not reported) of PST (based on D'Zurilla 1971) in the four weeks following the index SH episode; post-
cards mailed at one, two, three, four, six, eight, 10 and 12 months following the index SH episode; im-
proved access to primary care via the provision of a voucher that could be used to access one free GP
consultation (duration not reported); development of a risk management strategy; and a cultural as-
sessment focused on identifying patients’ sense of belonging and identification with Māori culture. Ses-

Interventions

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

121

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Hatcher 2016  (Continued)

Cochrane Database of Systematic Reviews

sions were delivered by research clinicians (no further information on their expertise or experience was
reported).

Comparator: TAU consisting of referral to multidisciplinary teams for psychiatric/psychological assess-
ment, intervention, or both; referral to crisis teams; or referral to community-based AOD treatment
teams, as required.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from electronic medical records.

Secondary outcome(s): i) repetition of SH as ascertained from self-report; ii) anxiety as measured by the
anxiety subscale of the HADS; ii) belonging as measured by the Sense of Belonging Instrument; iii) de-
pression as measured by the depression subscale of the HADS; iv) cultural identity as measured by the
Cultural Impact Profile (CIP) which is a Maori-specific measure of cultural knowledge and practice; v)
hopelessness as measured by the BHS; vi) quality of life as measured by the EQ-5D and the Social Func-
tioning-36 item (SF-36); vii) service use as measured by self-report supplemented by electronic medical
records; viii) suicide (unclear how ascertained).

Notes

Source(s) of funding: none reported.
Conflict(s) of interests: none reported.

Hawton 1981 

Study characteristics

Methods

Participants were individually randomised using sealed, opaque envelopes to either home-based psy-
chotherapy and telephone contact or an alternative form of psychotherapy.

N lost to follow-up: 0/96 (0%) for repetition of SH by the 12-month assessment.

Location: Oxford, UK.

Participants

Number of total participants: 96 participants were allocated, 48 were allocated to home-based psy-
chotherapy and telephone contact and 48 were allocated to alternative psychotherapy.

Interventions

Profile of participants: mean age 25.2 ± 8.2 (range: not reported). The majority (n = 67; 69.8%) were fe-
male, and just under one-third (n = 31; 32.3%).and had a history of SH (i.e. multiple episodes of SH). In-
formation on psychiatric diagnoses not reported.

Source of participants: patients admitted to a general hospital following an episode of self-poisoning.

Inclusion criteria: i) aged over 16 years; ii) suitable for randomisation (e.g. fixed address).

Exclusion criteria: i) in psychiatric care; ii) residing outside the catchment area; iii) requiring treatment
for AOD addiction; iv) referred for inpatient psychiatric care.

Intervention: mixed domiciliary (home-based) therapy where the frequency of treatment sessions was
flexible (i.e. according to therapists’ ’assessment of needs’). Mean number of sessions was 4.3 (range:
one to eight). Mean duration of sessions was 45.0 ± 7.8 minutes. Open telephone access to the general
hospital service was also available, as required. Therapeutic content included: brief problem-oriented
counselling, problem-solving, and family involvement (as appropriate). Sessions were delivered by ju-
nior psychiatrists, psychiatric nurses, or social workers (no further information on experience was re-
ported).

Comparator: alternative psychotherapy consisting of weekly sessions (mean 4.9, range: one to ten) of
outpatient therapy. Mean duration of sessions was 47.0 ± 8.3 minutes.

Concomitant medication(s): were permitted "...although this was rarely necessary" (Hawton 1981,
p.170). Specific information on the medication(s) prescribed was not reported.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

122

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Hawton 1981  (Continued)

Length of treatment: up to three months.

Outcomes

Primary outcome(s): i) repetition of SH according to hospital records, self-report, and from a GP ques-
tionnaire.

Secondary outcome(s): i) depression as measured using a modification of the Lorr and McNair Mood
Scale; ii) improvement in problems as measured by an idiosyncratic scale; iii) social functioning as
measured using a modification of the Social Adjustment Scale; iv) treatment adherence as measured
by the number that completed treatment; v) suicidal ideation as measured by the BSSI.

Tertiary outcome(s): i) number of GP visits as ascertained from a questionnaire sent to GPs.

Notes

Source(s) of funding: “The project was supported by a grant from the Department of Health and Social
Security” (Hawton 1981, p. 177).
Conflict(s) of interest: none reported.

Hawton 1987 

Study characteristics

Methods

Participants were individually randomised using a random numbers table to either CBT-based psy-
chotherapy or TAU.

N lost to follow-up: 0/80 (0%) for repetition of SH by the 12-month assessment.

Location: Oxford, UK.

Participants

Number of total participants: 80 participants were allocated, 41 were allocated to CBT-based psy-
chotherapy and 39 were allocated to TAU.

Profile of participants: mean age 29.3 years (SD not reported; range: not reported). Almost two thirds (n
= 53; 66.3%) were female, and just under one-third (n = 25; 31.3%).and had a history of SH (i.e. multiple
episodes of SH). Information on psychiatric diagnoses not reported.

Source of participants: patients admitted to a general hospital following an episode of self-poisoning.

Inclusion criteria: i) aged 16 years or older; ii) registered with a GP; iii) living up to 15 miles away from
hospital; iv) suitable for outpatient counselling; iv) willing to accept aftercare offered.

Exclusion criteria: i) in need of psychiatric care (day-patient or inpatient); ii) currently receiving psychi-
atric care.

Intervention: outpatient CBT-based psychotherapy consisting of up to eight sessions (54 minutes) of
PST. No specific detail on therapeutic content reported. Sessions were delivered by counsellors from
the clinical team in the general hospital psychiatric service (no further information on experience was
reported).

Comparator: GP management consisting of individual support, marriage counselling, and/or psychi-
atric referral, as required. No information on the number of sessions or their duration reported.

Length of treatment: not reported.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH according to hospital records, self report, collateral informant
report, and/or from a GP questionnaire.

Secondary outcome(s): i) depression as measured by the BDI; ii) improvement in problems as measured
by an idiosyncratic scale; iii) social functioning as measured by the Social Adjustment Scale; iv) sympto-
matology as measured by the GHQ; v) treatment adherence as measured by the number that complet-
ed treatment; vi) treatment attitudes as measured by self-report; vii) suicide (unclear how ascertained).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

123

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Hawton 1987  (Continued)

Notes

Husain 2014 

Study characteristics

Methods

Tertiary outcome(s): i) number of GP visits as ascertained from a questionnaire sent to GPs.

Sources of funding: “This study was supported by a grant from the Medical Research Council” (Hawton
1987, p. 760).
Conflict(s) of interest: none reported.
Other: As compliance data were not reported for the comparator arm, this outcome had to be excluded
from subsequent analyses.

Participants were individually randomised using a computer-generated list to either culturally adapted
CBT-based psychotherapy or TAU.

N lost to follow-up: 8/221 (3.6%) for repetition of SH by the six-month assessment.

Location: Karachi, Sindh province, Pakistan.

Participants

Number of total participants: 221 participants were allocated, 108 were allocated to CBT-based psy-
chotherapy and 113 were allocated to TAU.

Interventions

Profile of participants: mean age 23.1 ± 5.5 (range: 16-64 years). Over two-thirds (n = 53; 66.3%) were fe-
male. A minority (n = 9; 4.1%) had a history of SH (i.e. multiple episodes of SH). Information on psychi-
atric diagnoses not reported.

Source of participants: patients admitted to the medical unit at university hospitals following an
episode of SH.

Inclusion criteria: i) aged 16-64 years; ii) living within the catchment area.

Exclusion criteria: i) referred for inpatient psychiatric treatment; ii) temporarily resident in the catch-
ment area; iii) diagnosed with a psychiatric disorder due to a general medical condition, substance mis-
use, dementia, delirium, substance dependence, schizophrenia, bipolar disorder, or an intellectual dis-
ability according to DSM-IV criteria.

Intervention: manualised, culturally-adapted CBT-based psychotherapy consisting of six sessions (50
minutes). The first two sessions were held weekly, followed by fortnightly. Therapeutic content includ-
ed: an evaluation of the SH episode, development of crisis management skills, use of problem-solv-
ing and cognitive-behavioural techniques to improve emotion regulation skills, negative thinking, in-
terpersonal relationships, and relapse prevention. Sessions were delivered by qualified, masters-level
psychologists with a minimum of three years post-qualifying clinical experience and who also received
training (duration not reported) in delivering the intervention.

Comparator: TAU. The authors further clarified that “[p]atients are not routinely referred to psychiatric
or psychological services” (Husain 2014, p. 464).

Length of treatment: three months.

Outcomes

Primary outcome(s): i) suicidal ideation as measured by the BSSI.

Secondary outcome(s): i) repetition of SH as ascertained from self-report using the SASII; ii) coping as
measured by the Coping Resource Inventory; iii) depression as measured by the BDI; iv) hopelessness
as measured by the BHS; v) quality of life as measured by the EQ-5D; vi) service use as measured by the
Client Service Receipt Inventory; vii) treatment adherence as measured by the number of sessions at-
tended; viii) days spent in inpatient treatment; ix) attendances at outpatient clinics; x) GP consulta-
tions; xi) consultations with any other doctors; xii) consultations with non-medical religious healers; xi-
ii) consultations with non-medical homeopathic healers.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

124

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Husain 2014  (Continued)

Notes

Hvid 2011 

Study characteristics

Methods

Source(s) of funding: “This study was jointly funded by the University of Manchester and Pakistan Insti-
tute of Learning and Living” (Husain 2014, p. 469).
Conflict(s) of interest: none reported.

Participants were individually randomised, stratified by sex, history of SH, history of previous psychi-
atric treatment, and use of alcohol during the index SH to either case management or TAU.

N lost to follow-up: 0/133 (0.0%) for repetition of SH by the post-intervention assessment.

Location: Amager, Denmark.

Participants

Number of total participants: 133 participants were allocated, 69 were allocated to assertive outreach
and 64 were allocated to TAU.

Profile of participants: mean age 37.5 ± 18.2 (range: not reported). Almost three-quarters (n = 95; 71.4%)
were female. Over one-third (n = 51; 38.3%) had a history of SH (i.e. multiple episodes of SH) and a his-
tory of previous psychiatric treatment (n = 49; 36.8%); however, information on psychiatric diagnoses
was not reported.

Source of participants: patients admitted to an emergency or clinical department following an episode
of SH.

Inclusion criteria: i) admitted to an emergency department or clinical department following an episode
of SH.

Exclusion criteria: i) less than 12 years old; ii) diagnosed with any major psychiatric illness, including:
schizophrenia, other psychoses, bipolar disorder, major depression, psychotic depression, mental re-
tardation, and severe dementia; iii) insufficient language ability.

Intervention: case management consisting of assertive outreach delivered according to the Baerum
model, involving: assertive outreach via home visits (mean number of home visits was eight, range
three to 22), telephone calls, email messages, and text messages (range five to 36), sessions (number
and duration not reported) of solution-focused PST, adherence therapy, and treatment continuity as
participants were contacted by the same psychiatric nurse (as far as practical) throughout the course of
treatment. Sessions were delivered by consultant-level psychiatrists or psychiatric nurses (no further
information on experience was reported).

Comparator: TAU involving encouraging participants to contact their GP who could, where required, re-
fer the participant on to further psychiatric or psychological treatment.

Length of treatment: maximum period of six months.

Interventions

Outcomes

Notes

Primary outcome(s): i) repetition of SH according to clinical records; ii) suicide according to Coroner's
records.

Source(s) of funding: “The trial has been funded by a grant from the Danish Ministry of Social Affairs, the
Lundbeck Foundation and the Health Insurance Foundation” (Hvid 2011, p. 297).
Conflict(s) of interests: none reported.

Kapur 2013 

Study characteristics

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

125

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Kapur 2013  (Continued)

Methods

Participants were individually randomised using web-based software to a remote contact intervention
(postcards) or TAU.

N lost to follow-up: 1/66 (1.5%) at post-intervention.

Location: Manchester, UK.

Participants

Number of total participants: 66 participants were allocated, 33 were allocated to the remote contact
intervention (postcards) and 33 were allocated to TAU.

Interventions

Profile of participants: not reported, although the authors noted “[i]ntervention and usual treatment
groups were similar in terms of age, gender” (Kapur 2013, p. 73). Just over half (n = 39; 59.1%) had a his-
tory of SH (i.e. multiple episodes of SH prior to trial entry).

Source of participants: patients presenting to ED following an episode of SH.

Inclusion criteria: i) i) aged 18 or older; ii) resident in the catchment area; iii) presenting to ED following
an episode of SH.

Exclusion criteria: i) referred for admission to a psychiatric unit; ii) without a telephone; iii) admitted to
a general hospital for a period of greater than seven days; iv) living outside of the catchment area; v)
deterioration in psychosis symptoms; vi) denies SH; vii) declined to participate.

Intervention: remote contact intervention consisting of a series of postcards mailed at one, two, four,
six, eight, and 12 months post-discharge, an information leaflet listing both local and national sources
of support, and two semi-structured telephone calls to facilitate referral to appropriate specialist treat-
ment, as required, in addition to TAU. Postcards encouraged participants to make contact with the ser-
vice, if required. Sessions were delivered by clinical researchers (no further information on expertise or
experience was reported).

Comparator: TAU consisting of referral to mental health services, social services, or voluntary sector
services, as required.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from hospital records; ii) frequency of SH as as-
certained from hospital records.

Notes

Kawanishi 2014 

Study characteristics

Methods

Secondary outcome(s): i) number of ED attendances; ii) number of days on a medical inpatient ward; iii)
number of face-to-face contacts with mental health services; iv) number of admissions to psychiatric
inpatient services; v) suicide (unclear how ascertained).

Source(s) of funding: “commissioned by the National Institute for Health Research (NIHR) under its Pro-
gram Grants for Applied Research scheme (RP-PG-0606-1247)” (Kapur 2013, p. 74)
Conflict(s) of interest: “N.K. chaired the National Institute for Health and Clinical Excellence (NICE)
guideline development group and evidence for the longer-term management of self-harm. N.K., D.G.,
K.H. are members of the National Suicide Prevention Strategy Advisory Group” (Kapur 2013, p. 73).

Participants were individually randomised using web-based software using minimisation stratified by
site, age, and history of SH to either assertive outreach and case management or EUC.

N lost to follow-up: 0/914 (0%) for repetition of SH by the 18-month assessment.

Location: various sites, Japan.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

126

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Kawanishi 2014  (Continued)

Participants

Interventions

Number of total participants: 914 participants were allocated, 460 were allocated to case management
and assertive outreach and 454 were allocated to EUC.

Profile of participants: mean age 42.3 ± 14.9 years (range: not reported). Over half (n = 514; 56.2%) were
female, and just under half (n = 450; 49.2%) had a history of SH (i.e. multiple episodes of SH). Informa-
tion on psychiatric diagnoses reported in a separate publication (Furuno 2018); under half (n = 426;
46.6%) were diagnosed with any mood disorder, adjustment disorder (n = 191; 20.9%), psychosis (n =
179; 19.6%), SUD (n = 45; 4.9%), and other disorders (unspecified) (n = 73; 8.0%).

Source of participants: patients admitted to EDs following a suicide attempt.

Inclusion criteria: i) aged 20 years or older; ii) admitted to EDs following a suicide attempt; iii) ≥ 2 previ-
ous suicide attempts rated as having definite suicidal intent as determined by scores on the Suicide In-
tent Scale; iv) diagnosed with any Axis I psychiatric disorder according to DSM-IV-TR criteria; v) able to
understand the trial procedure; vi) able to provide informed consent; vii) able to attend a face-to-face
interview; viii) able attend a psychoeducation session during the hospital admission.

Exclusion criteria: i) diagnosed with any psychiatric disorder which did not meet DSM-IV-TR criteria.

Intervention: assertive outreach and case management involving contact with patients at week one and
one, two, three, six, 12, and 18 months after the index suicide attempt with a view to collecting infor-
mation about the participant’s treatment status and any problems that could interfere with treatment
adherence. Therapeutic content included: providing encouragement to remain adherent with treat-
ment, coordination and referral to appointments with psychiatrists and any other primary care physi-
cians, outreach for those who had dropped out of treatment, referral to social services and other sup-
port organisations, as needed, psychoeducation, and access to a dedicated website designed to pro-
vide participants with information and resources. Sessions were delivered by psychiatrists, clinical psy-
chologists, nurses, and social workers (no further information on experience was reported).

Comparator: EUC. No further details on treatment content provided.

Length of treatment: 18 months.

Outcomes

Primary outcome(s): i) time to SH repetition (unclear how ascertained); ii) repetition of SH (unclear how
ascertained); iii) suicide as ascertained from a mortality register; iv) all-cause morality as ascertained
from a mortality register.

Secondary outcome(s): i) hopelessness as measured by the BHS; ii) quality of life as measured by the
SF-36; iii) service contacts as ascertained from records; iv) physical functioning (unclear how ascer-
tained).

Notes

Source(s) of funding: “This study was funded by the Ministry of Health, Labour, and Welfare of
Japan” (Kawanishi 2014, p. 200).
Conflict(s) of interest: none reported.

Other: The authors stated that for "[o]ther protocol-specified secondary outcomes...We plan to publish
results for all these outcomes in a separate report" (Kawanishi 2014, p. 196).

Liberman 1981 

Study characteristics

Methods

Participants were individually randomised (method not reported) to either a mixed intervention or al-
ternative psychotherapy.

N lost to follow-up: 0/24 (0%) for repetition of SH at post-intervention (including up to the 24-month as-
sessment).

Location: Los Angeles, CA, USA.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

127

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Liberman 1981  (Continued)

Participants

Interventions

Number of total participants: 24 participants were allocated, 12 were allocated to a mixed intervention
and 12 were allocated to alternative psychotherapy.

Profile of participants: mean age 29.7 ± 8.8 years (range: 18-47 years). Two thirds (n = 16; 66.6%) were fe-
male. All (n = 24; 100%) had a history of SH (i.e. multiple episodes of SH). Whilst all (n = 24; 100%) had
previously received psychiatric treatment, information on psychiatric diagnoses was not reported.

Source of participants: patients referred by psychiatric emergency services or hospital A&E following an
episode of SH.

Inclusion criteria: i) ≥ 1 suicide attempt preceding trial entry.

Exclusion criteria: i) diagnosed with psychosis; ii) addicted to drugs and alcohol; ii) diagnosed with or-
ganic brain syndrome.

Intervention: inpatient treatment consisting of daily sessions (duration not reported). Therapeutic con-
tent included: behaviour therapy, social skills training, anxiety management, and family therapy. A
therapeutic milieu with a token economy was also established. Aftercare at a community mental health
centre or with a private therapist was also used, as required. Sessions were delivered by psychologists
assisted by bachelors-level technicians (no further information on experience was reported).

Comparator: alternative psychotherapy (inpatient treatment involving insight-oriented therapy) con-
sisting of daily sessions (duration not reported). Therapeutic content included: individual therapy,
group therapy and psychodrama, and family therapy. A therapeutic milieu with a token economy was
also established. Aftercare at a community mental health centre or with a private therapist was also
used, as required.

Length of treatment: 10 days.

Outcomes

Primary outcome(s): i) repetition of SH ascertained by self-report; ii) depression as measured by the
Zung Self-rating Depression Scale, the BDI, and the depression subscale of the Minnesota Multiphasic
Personality Inventory (MMPI); iii) suicidal ideation as ascertained by self-report.

Secondary outcome(s): i) assertiveness as measured by the Assertiveness Questionnaire; ii) fear as mea-
sured by the Fear Survey Schedule; iii) reinforcement as measured by the Reinforcement Survey Sched-
ule.

Notes

Source(s) of funding: “The project was made possible by grant MH 22804 from the Clinical Research
Branch of the National Institute of Mental Health to Michael Serber, MD, and R.P.L., the co-principal in-
vestigators” (Liberman 1981, p. 1130).
Conflict(s) of interests: no information on interests reported.

Lin 2020 

Study characteristics

Methods

Participants were individually randomised using a computerised blocking procedure to either CBT-
based psychotherapy and standard case management or TAU.

N lost to follow-up: 3/150 (2.0%) for repetition of SH by the six- and 12-month assessment.

Location: Taipei and New Taipei City, Taiwan.

Participants

Number of total participants: 147 participants were randomised, 75 were allocated to brief CBT-based
psychotherapy and standard case management, and 75 were allocated to TAU.

Profile of participants: mean age 33.0 ± NR years (range: 18-81 years). The majority (n = 106; 72.1%) were
female. Over half had a history of SH (i.e. multiple episodes of SH) (n = 88; 59.9%). Most were diagnosed

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

128

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Lin 2020  (Continued)

Cochrane Database of Systematic Reviews

Interventions

with an alcohol use disorder (n = 52; 38.2%), followed by major depression (n = 54; 36.7%), and bipolar
disorder (n = 20; 14.0%).

Source of participants: patients presenting to EDs following a suicide attempt.

Inclusion criteria: i) 18 years of age or older; ii) reporting current suicidal ideation; iii) sufficient language
ability; iv) able to provide informed consent; v) able to be contacted via mail or telephone.

Exclusion criteria: i) medically or cognitively incapable of participating in the study procedure; ii) insuffi-
cient language ability; iii) receiving other research or psychotherapy.

Intervention: brief CBT-based psychotherapy in addition to standard case management, consisting
of up to six sessions (in person or via telephone) at weeks' one, two, four, seven, 11, and 15 post-dis-
charge. Session frequency could be increased to up to one per week, depending on risk. Mean dura-
tion of face-to-face sessions was 45.6 ± 14.9 minutes (range: 15-70 minutes), whilst the mean duration
of telephone sessions was 26.2 ± 10.5 minutes (range 13-55 minutes). Therapeutic content included: a
suicide risk assessment, safety planning, chain analysis, problem-solving skills training, distress toler-
ance, and seeking resources. Sessions were delivered by case managers (no further information on ex-
pertise or experience was reported).

Comparator: TAU consisting of admission to a general medical/surgical ward or a psychiatric ward (as
needed), followed by referral to a specialist suicide prevention centre for ongoing outpatient psychi-
atric treatment (as required). Participants were not routinely referred for psychotherapy from this cen-
tre.

Length of treatment: four months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report supplemented by information
from medical records.

Secondary outcome(s): i) psychiatric service use, as measured by the number of service contacts; ii) de-
pression, as measured by the HAMD-24; iii) hopelessness, as measured by the BHS; iv) suicidal ideation,
as measured by the BSSI.

Notes

Source(s) of funding: "This study was funded by the National Science Council of the Republic of China,
Taiwan" (Lin 2020, pp. 693-4).

Conflict(s) of interest: none reported.

Linehan 1991 

Study characteristics

Methods

Participants were individually randomised using a computerised procedure to either manualised DBT
or TAU.

N lost to follow-up: 19/63 (30.2%) for repetition of SH by the post-intervention assessment. Additional-
ly, data for 24/63 (38.1%) participants were deliberately not included in the 24-month follow-up assess-
ment.

Location: Seattle, WA, USA.

Participants

Number of total participants: 63 participants were randomised, 31 were allocated to DBT and 31 were
allocated to TAU.

Profile of participants: mean age not reported (range: 18-45 years). All (n = 63; 100%) were female and
had a history of SH (i.e. multiple episodes of SH).

Source of participants: referred patients with ≥ 1 episode of SH in the 8 weeks preceding trial entry.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

129

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Linehan 1991  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Inclusion criteria: i) female; ii) aged 18-45 years; iii) diagnosed with BPD; iv) ≥ 2 suicide attempts in the
five years preceding trial entry with ≥ 1 in the eight weeks preceding trial entry; v) agree to trial condi-
tions.

Exclusion criteria: none reported.

Intervention: manualised DBT consisting of weekly (60 minutes) sessions of individual psychotherapy,
and weekly (2.5 hours) sessions of group skills training, as well as telephone consultation, as required
(within each therapists’ limitations), and weekly therapist team meetings. Therapeutic content includ-
ed: DBT developed specifically for the treatment of suicidal patients with BPD, which targeted increas-
ing behavioural capabilities and motivation for treatment whilst also reinforcing functional behaviour.
Sessions were delivered by psychiatrists, psychologists, or clinical psychology graduates (no further in-
formation on experience was reported). 

Comparator: TAU consisting of referral to alternative therapy.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH according to self-report using the Parasuicide History Interview.

Notes

Linehan 2006 

Study characteristics

Methods

Secondary outcome(s): i) coping as measured by the Survival and Coping Scale; ii) depression as mea-
sured by the BDI; iii) hopelessness as measured by the BHS and the Reasons for Living Inventory; iv)
service usage as ascertained from self-report using the Treatment History Interview; v) suicidal ideation
as measured by the BSSI; vi) suicide (unclear how ascertained).

Source(s) of funding: ”This research was supported by grant MH34486 from the National Institute of
Mental Health, Bethesda, Md (Dr Linehan)" (Linehan 1991, p.1064).
Conflict(s) of interests: Although no information on conflicts of interests were reported, Dr. Linehan has
developed dialectical behaviour therapy.
Other: Half (50%) of the self-reported episodes of SH were checked against medical records, therapist
records, and observer/nurse/physician ratings.

Participants were individually randomised using a computerised adaptive minimisation procedure to
either manualised DBT or alternative psychotherapy (treatment by experts).

N lost to follow-up: 4/101 (4.0%) for repetition of SH by the post-intervention assessment.

Location: Seattle, WA, USA.

Participants

Number of total participants: 101 participants were randomised, 52 were allocated to DBT and 49 were
allocated to alternative psychotherapy (treatment by experts).

Profile of participants: mean age 29.3 ± 7.5 years (range: 18-45 years). All (n = 101; 100%) were female
and were diagnosed with BPD. Almost all (n = 97; 96.0%) were also diagnosed with MDD, followed by
SUD (n = 88; 87.1%), any anxiety disorder (n = 54; 55.4%), any eating disorder (n = 40; 39.6%), avoidant
PD (n = 21; 20.8%), and ASPD (n = 11; 10.9%).

Source of participants: clinical referrals and individuals attending inpatient units, emergency rooms
and outpatient clinics.

Inclusion criteria: i) 18-45 years; ii) female; iii) meets criteria for BPD; iv) ≥ 2 suicide attempts or episodes
of SH in the five years preceding trial entry, with ≥ 1 in the eight weeks preceding trial entry.

Exclusion criteria: i) lifetime diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, psy-
chotic disorder not otherwise specified, or mental retardation; ii) seizure disorder requiring medica-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

130

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Linehan 2006  (Continued)

Interventions

tion; iii) legally mandated to treatment; iv) requiring primary treatment for another debilitating condi-
tion.

Intervention: manualised DBT consisting of weekly (60 minutes) sessions of individual psychotherapy,
and weekly (2.5 hours) sessions of group skills training, as well as telephone consultation, as required
(within each therapists’ limitations), and weekly therapist team meetings. Therapeutic content includ-
ed: CBT developed specifically for the treatment of for suicidal patients with BPD which targeted in-
creasing behavioural capabilities and motivation for treatment whilst also reinforcing functional be-
haviour. Sessions were delivered by trained doctoral-level therapists (one-quarter had over 10 years ex-
perience working with suicidal persons).

Comparator: TAU consisting of community treatment by experts specifically designed for the trial to
control for factors previously uncontrolled in DBT trials. Whilst similar to TAU, as therapists were free
to decide on type and dose of therapy they believed was most suited to the patient (minimum of one
scheduled individual session per week; duration not reported), the characteristics of therapists were
controlled via selection of therapists and supervisory arrangements.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH according to self-report using the SASII.

Secondary outcome(s): i) medical severity of SH according to self-report using the SASII; iii) hopeless-
ness as measured by the Reasons for Living Inventory; iv) service usage as ascertained from self-report.

Notes

Source(s) of funding: “This study was supported by grants MH34486 and MH01593 from the National In-
stitute of Mental Health” (Linehan 2006; p. 765).
Conflict(s) of interests: although no information on conflicts of interests were reported, Dr Linehan de-
veloped dialectical behaviour therapy.

Linehan 2015 

Study characteristics

Methods

Participants were individually randomised using a computerised adaptive procedure stratified by
age, number of previous suicide attempts, number of previous episodes of NSSI, psychiatric hospital-
isations (past year), and depression severity to either DBT plus group-based skills training (Linehan
2015a), individual-based DBT (Linehan 2015b), or standard manualised DBT.

N lost to follow-up: 0/99 (0%) for repetition of SH by the 12-month assessment.

Location: Seattle, WA, USA.

Participants

Number of total participants: 99 participants were randomised, 33 were allocated to DBT plus group-
based skills therapy, 33 were allocated to individual-based DBT, and 33 were allocated to standard DBT.

Profile of participants: mean age 30.3 ± 8.9 years (range: 18-60 years). All (n = 99; 100%) were female.
The majority were diagnosed with any anxiety disorder (n = 81; 96.4%), followed by MDD (n = 70;
70.7%), any SUD (n = 37; 37.4%), and any eating disorder (n = 15; 15.1%). Almost three-quarters (n = 73;
73.7%) were also diagnosed with a personality disorder; commonly avoidant personality disorder (n =
26; 26.3%).

Source of participants: patients currently receiving treatment from outpatient mental health services.

Inclusion criteria: i) 18 to 60 years of age; ii) diagnosed with BPD according to DSM-IV criteria; iii) ≥ 2
episodes of suicide attempt/NSSI in the five years preceding trial entry with ≥ 1 of these episodes in the
year preceding trial entry and ≥ 1 of these episodes in the eight weeks preceding trial entry.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

131

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Linehan 2015  (Continued)

Cochrane Database of Systematic Reviews

Exclusion criteria: i) IQ score < 70 on the Peabody Picture Vocabulary Test-Revised; ii) diagnosed with
psychosis or bipolar disorder; iii) diagnosed with a seizure disorder requiring medication; iv) requiring
treatment for another life-threatening condition (e.g. severe anorexia nervosa).

Interventions

See Linehan 2015a and Linehan 2015b for a detailed description.

Outcomes

Primary outcome(s): i) repetition of SH according to self-report using the SASII; ii) frequency of SH ac-
cording to self-report using the SASII.

Secondary outcome(s): i) hopelessness as measured using the Reasons for Living Inventory (reverse
scored); ii) depression as measured using the HRSD; iii) anxiety as measured using the Hamilton Rating
Scale for Anxiety.

Notes

Source(s) of funding: "This study was supported by grant R01MH034486 from the National Institute of
Mental Health for the design and conduct of the study and for collection, management, analysis, and
interpretation of the data" (Linehan 2015, p.8).

Conflict(s) of interest: "Dr Linehan receives royalties from Guilford Press for books she has written on Di-
alectical Behavior Therapy (DBT) and from Behavioral Tech, LLC, for DBT training materials she has de-
veloped; she owns Behavioral Tech Research, Inc, a company that develops online learning and clinical
applications that include products for DBT. Drs Linehan, Korslund, Harned, Neacsiu, and Comtois are
compensated for providing DBT training and consultation. No other disclosures were reported" (Line-
han 2015, p.8).

Linehan 2015a 

Study characteristics

Methods

See Linehan 2015 for a detailed description.

Participants

See Linehan 2015 for a detailed description.

Interventions

Intervention (DBT plus group skills training): comprising manualised case management (duration not
reported), weekly group skills training (2.5 hours), DBT consultation team meeting (1 hour), and tele-
phone coaching, as needed. Participants did not receive individual therapy. Sessions were delivered by
therapists (one-third were doctoral-level therapists), the majority of whom had over 10 years clinical
experience working with suicidal persons and who received training (duration not reported) in deliver-
ing the intervention and ongoing supervision.

Comparator: comprising weekly sessions of individual therapy (1 hour), group skills training (2.5 hours),
DBT consultation team meeting (1 hour), and telephone coaching, as needed.

Concomitant medications: were permitted. The average number of psychotropic medications pre-
scribed at baseline was 3.1 ± 2.7.

Length of treatment: 12 months.

Outcomes

See Linehan 2015 for a detailed description.

Notes

See Linehan 2015 for a detailed description.

Linehan 2015b 

Study characteristics

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

132

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Linehan 2015b  (Continued)

Methods

See Linehan 2015 for a detailed description.

Participants

See Linehan 2015 for a detailed description.

Interventions

Intervention (individual-based DBT): comprising weekly sessions of individual therapy (1 hour), DBT
consultation team meeting (1 hour), and telephone coaching, as needed. Participants did not receive
group skills training. Sessions were delivered by therapists (93% were doctoral-level therapists), the
majority of whom had over 10 years clinical experience working with suicidal persons and who received
training (duration not reported) in delivering the intervention and ongoing supervision.

Comparator: comprising weekly sessions of individual therapy (1 hour), group skills training (2.5 hours),
DBT consultation team meeting (1 hour), and telephone coaching, as needed.

Concomitant medications: were permitted. The average number of psychotropic medications pre-
scribed at baseline was 3.1 ± 2.7.

Length of treatment: 12 months.

Outcomes

See Linehan 2015 for a detailed description.

Notes

See Linehan 2015 for a detailed description.

Marasinghe 2012 

Study characteristics

Methods

Participants were individually randomised using an unknown method to either a remote contact inter-
vention (brief psychotherapy delivered by mobile phone) or waiting list.

N lost to follow-up: 0/68 (0%) for repetition of SH at post-intervention.

Location: Colombo, Sri Lanka.

Participants

Number of total participants: 68 participants were randomised; 34 were allocated to the mobile phone
based psychotherapy, and 34 were allocated to waiting list.

Profile of participants: mean age 31.0 ± 14.8 years (range: 15-74 years). Half (n = 34; 50.0%) were female.
No information on psychiatric diagnoses reported.

Source of participants: patients admitted to hospital following an episode of SH.

Inclusion criteria: i) aged 15-74 years; ii) admitted to hospital following an episode of SH; iii) episode of
SH was associated with significant suicidal intent as reported either at the intake interview or accord-
ing to scores on BSS; iv) considered likely to be discharged from hospital within 2 days or able to be re-
approached if admitted for longer than 2 days; v) able to provide informed consent.

Exclusion criteria: i) currently receiving ongoing psychiatric treatment; ii) diagnosed with psychosis; iii)
diagnosed with dementia.

Intervention: brief mobile intervention consisting of an assessment of mental health, meditation, PST,
interventions to increase social support, interventions to address alcohol or other substance misuse
problems, a series of 10 telephone calls to reaffirm techniques learnt during treatment, the ability to
access telephone messages to reaffirm techniques learnt during treatment, and a series of up to 26 text
messages to encourage the participant to practice meditation techniques, problem-solving skills, to
seek social support, to avoid alcohol and other drugs, and to use the telephone helpline to get individ-
ual support in times of crisis. No information on who delivered the intervention, their expertise, or their
experience was reported.

Comparator: waiting list.

Interventions

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

133

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Marasinghe 2012  (Continued)

Length of treatment: up to 26 weeks.

Outcomes

Notes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) AOD use as measured by the AU-
DIT and the Drug Check Problem List; iii) depression as measured by the BDI; iv) social support as mea-
sured by the Medical Outcomes Study; v) suicidal ideation as measured by the BSSI; v) suicide (unclear
how ascertained).

Source(s) of funding: “We are grateful for funding from the Improving Relevance and Quality of Under-
graduate Education (IRQUE) project of the University of Jeyewardenepura, Sri Lanka” (Marasinghe
2012, p. 155).
Conflict(s) of author interests: no information on author interests reported.

McAuliffe 2014 

Study characteristics

Methods

Participants were individually randomised using a computer-generated sequence of numbers stratified
by sex, SH repeater status, and trial site to either manualised, group-based CBT-based psychotherapy
or TAU.

N lost to follow-up: 313/433 (27.7%) for repetition of SH at post-intervention.

Location: Cork and Limerick, Republic of Ireland.

Participants

Number of total participants: 433 participants were randomised; 222 were allocated to the group-based
CBT-based psychotherapy, and 211 were allocated to TAU.

Profile of participants: mean age 33.5 ± 11.8 years (range: 18-64 years). Almost two-thirds (n = 279;
64.4%) were female. Just under one-third (n = 127; 29.3%) had a history of SH (i.e. multiple episodes of
SH). No information on psychiatric diagnoses reported.

Source of participants: patients presenting to the ED following an episode of SH, or patients engaging in
SH in acute psychiatric facilities even if this did not necessitate admission to the ED.

Inclusion criteria: i) aged 18-64 years; ii) engaged in SH in the three days preceding trial entry.

Exclusion criteria: i) diagnosed with psychosis, intellectual disability, sensory disability, or an organic
cognitive impairment; ii) currently substance dependent according to scores on the Short Alcohol De-
pendent Data questionnaire; iii) imprisoned; iv) no fixed address.

Intervention: manualised problem-solving skills training consisting of six (two hour) sessions facilitat-
ed by a trained therapist and a co-therapist. Therapeutic content involved problem-solving skills train-
ing. Sessions were delivered by therapists (expertise and experience not reported) who received train-
ing (duration not reported) in delivering the intervention.

Comparator: TAU consisting of an assessment by mental health professional staff and by crisis staff, and
referral to acute mental health or community-based services, psychotherapy, and pharmacotherapy,
as necessary.

Length of treatment: six weeks.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH (as ascertained from self-report for the 6-week and 6-month fol-
low-up assessment and from hospital records for the 12-month assessment); ii) suicide as ascertained
from hospital records.

Secondary outcome(s): i) anxiety as measured by the Beck Anxiety Inventory (BAI); ii) depression as
measured by the BDI; iii) hopelessness as measured by the BHS; iv) impulsivity as measured by BIS;
v) problem-solving skills as measured by the Means-Ends Problem-Solving Procedure (MEPS) and the
Self-Rating Problem-Solving Scale; vi) self-efficacy as measured by the Generalised Self-efficacy Scale;

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

134

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

McAuliffe 2014  (Continued)

Notes

McLeavey 1994 

Study characteristics

Methods

vii) social functioning as measured by the Social Life Scale; vii) suicidal ideation as measured by the
BSSI.

Source(s) of funding: “This work was supported by funding from the Health Service Executive (HSE)
South, HSE Mid-West, the HSE National Office for Suicide Prevention, the Health Research Board and
Pobal-Dormant Accounts Fund in Ireland” (McAuliffe 2014, p. 389).
Conflict(s) of interests: none reported.

Participants were individually randomised using an open numbers table to either interpersonal prob-
lem-solving skills training or alternative psychotherapy (brief PST).

N lost to follow-up: 6/39 (15.4%) for repetition of SH by the 12-month assessment.

Location: Cork, Republic of Ireland.

Participants

Number of total participants: 39 participants were randomised, 19 were allocated to interpersonal
problem-solving skills, and 20 were allocated to alternative psychotherapy.

Interventions

Profile of participants: mean age 23.9 ± 7.2 years (range: 15-45 years). Just under three-quarters (n = 29;
74.3%) were female. Over one-third (n = 14; 35.9%) had a history of SH (i.e. multiple episodes of SH).
Almost one-quarter (n = 9; 23.1%) were diagnosed with dysthymia, followed by dependent PD (n = 6;
15.4%), and AUD (n = 5; 12.8%).

Source of participants: patients admitted to an A&E department following an episode of self-poisoning.

Inclusion criteria: i) aged 15-45 years; ii) score ≥ 80 on the Mill Hill Vocabulary Scale.

Exclusion criteria: i) history of psychosis, mental retardation, or organic cognitive impairment; ii) re-
ferred for psychiatric treatment (day care or inpatient).

Intervention: manualised interpersonal problem-solving skills training (number and duration of ses-
sions not reported). Therapeutic content involved instruction, active discussion, reflective listening,
modelling, coping strategy, role playing, sentence completion, and prompting. Sessions were delivered
by psychiatry registrars and clinical psychologists (no further information on experience was reported).

Comparator: alternative psychotherapy (brief problem-solving therapy) (number and duration of ses-
sions not reported). Therapeutic content involved focusing on patients’ current problems and preven-
tion by helping patients gain insight into problems. No specific skills training was provided, however.

Length of treatment: five weeks.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from hospital records and a GP questionnaire.

Secondary outcome(s): i) hopelessness as measured by the BHS; ii) problem-solving as measured by the
MEPS, the Optional Thinking Test, the Awareness of Consequences Test, the Self-Rating Problem-Solv-
ing Scale, and the Problems Questionnaire; iii) self-concept as measured by the Self-Perception Scale;
iv) suicide (unclear how ascertained).

Notes

Source(s) of funding: no information on funding sources reported.
Conflict(s) of interest: Although no conflicts of interest were reported, Dr McLeavey was the developer of
interpersonal problem-solving skills training.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

135

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

McMain 2009 

Study characteristics

Methods

Participants were individually randomised using a pre-generated blocking procedure to either interper-
sonal DBT or TAU.

N lost to follow-up: 32/180 (17.8%) for repetition of SH by the post-intervention assessment.

Location: Toronto, ON, Canada.

Participants

Number of total participants: 180 participants were randomised, 90 were allocated to DBT, and 90 were
allocated to TAU.

Profile of participants: mean age 30.4 ± 9.9 years (range: 18-60 years). The majority (n = 155; 86.1%) were
female. All (n = 180; 100%) had a history of SH (i.e. multiple episodes of SH), and were diagnosed with
BPD. Three-quarters (n = 135; 75.0%) were diagnosed with any anxiety disorder, just under half (n = 88;
48.9%) were diagnosed with MDD, followed by PTSD (n = 71; 37.4%), panic disorder (n = 39; 21.7%), and
SUD (n = 17; 9.4%).

Source of participants: patients attending a specialised Centre for Addiction and Mental Health, hospital
or both.

Inclusion criteria: i) aged 18-60 years; ii) met DSM-IV criteria for BPD; iii) ≥ 2 episodes of suicide attempts
and/or NSSI in the past five years with ≥ 1 in the three months preceding trial entry.

Exclusion criteria: i) met DSM-IV criteria for a psychotic disorder, bipolar I disorder, delirium, dementia,
or mental retardation; ii) diagnosed with substance dependence in the 30 days preceding trial entry; iii)
did not live within communing distance; iv) diagnosed with a serious medical condition likely to require
hospitalisation within one year (e.g. cancer); v) planning to move out of the catchment area within two
years.

Intervention: manualised DBT consisting of weekly (60 minutes) sessions of individual therapy, group-
based skills training (two hours), and telephone-based coaching (2 hours). Number of sessions not re-
ported. Therapeutic content involved: psychoeducation, validation and empathy, mindfulness, expo-
sure, contingency management, and behavioural analysis with an explicit focus on SH and suicidal be-
haviour. Additionally, therapists attended weekly therapist team meetings. Sessions were delivered by
board-certified psychiatrists and doctoral-level clinicians (no further information on experience was re-
ported).

Comparator: TAU (general psychiatric management) consisting of weekly (60 minutes) sessions of indi-
vidual therapy focused on improving medication management through the use of a structured drug al-
gorithm. Participants also received psychoeducation, providing validation and empathy within a ’here
and now’ focus. Additionally, therapists attended weekly therapist team meetings. Number of sessions
not reported.

Length of treatment: 12 months.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report using the SASII; ii) frequency of
SH as ascertained from self-report using the SASII; iii) severity of SH as ascertained from self-report us-
ing the SASII.

Secondary outcome(s): i) anger as measured by the STAXI; ii) BPD symptomatology as measured by the
Zanarini Rating Scale for Borderline Personality Disorder; iii) depression as measured by the BDI; iv)
general symptomatology as measured by the SCL-90; v) interpersonal problems as measured by the In-
ventory of Interpersonal Problems, 64-item version; vi) quality of life as measured by the EQ-5D; vii) ser-
vice use as ascertained from self-report; viii) reasons for dropout as measured by the Reasons for Ear-
ly Termination From Treatment Questionnaire; ix) treatment adherence as measured by the number of
sessions attended; x) suicide (unclear how ascertained).

Notes

Source(s) of funding: “Supported by grant 200204MCT-101123 from the Canadian Institutes for Health
Research” (McMain 2009, p. 1373)

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

136

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

McMain 2009  (Continued)

Cochrane Database of Systematic Reviews

Conflict(s) of interest: “Dr. Links has received an unrestricted educational grant from Eli Lilly Canada Inc.
All other authors report no competing interests” (McMain 2009, p. 1373).
Other: data on hospital admissions for self-harm obtained from self-report following clinician interview.

McMain 2017 

Study characteristics

Methods

Participants were individually randomised via a blocking procedure either to 20 weeks of a DBT skills
training program or active waiting list.

N lost to follow-up: 0/84 (0%) for repetition of SH at post-intervention.

Location: Toronto, Canada.

Participants

Number of total participants: 84 participants were randomised, 42 were allocated DBT plus group skills
therapy and 42 were allocated to waiting-list control.

Profile of participants: mean age 29.7 ± 8.6 years (range: 18-60 years). Over three-quarters (n = 66;
78.6%) were female. The majority (n = 51; 60.7%) were diagnosed with any anxiety disorder, followed
by SUD (n = 47 56.0%), MDD (n = 43; 51.2%), PTSD (n = 19; 22.6%), any eating disorder (n = 13; 15.5%),
and panic disorder (n = 12; 14.3%).

Source of participants: patients currently receiving treatment from outpatient mental health services.

Inclusion criteria: i) 18-60 years of age; ii) diagnosed with BPD according to DSM-IV criteria; iii) ≥ 2
episodes of SH in the five years preceding trial entry with ≥ 1 episode in the 10 weeks preceding trial en-
try; iv) sufficient language ability.

Exclusion criteria: i) diagnosed with psychosis, bipolar disorder, or dementia according to DSM-IV crite-
ria; ii) diagnosed with an organic disorder or intellectual disability; iii) received DBT within the year pre-
ceding trial entry.

Interventions

Intervention: manualised DBT plus group skills therapy consisting of a single (90 minute) individual ori-
entation session followed by weekly sessions (two hours) of group skills training comprising mindful-
ness, emotion regulation, distress tolerance, interpersonal effectiveness, and dialectics. Participants
were also provided with the numbers for 24-hour crisis lines.

Comparator: waiting-list control.

Concomitant medications: 71 participants (84.5%) were prescribed psychotropic medications (mean 1.8
± 1.4 medications per participant).

Length of treatment: 20 weeks.

Outcomes

Primary outcome(s): i) frequency of SH as ascertained from the clinician-report using the Lifetime Sui-
cide Attempt Self-Injury Interview (LSASI) together with self-report using the Deliberate Self-Harm In-
ventory (DSHI).

Secondary outcome(s): i) healthcare utilisation as measured using the Treatment History Interview-2
(THI-2); ii) number of ED visits as measured using the THI-2; iii) number of psychiatric hospital admis-
sions as measured using the THI-2; iv) use of medications as measured using the THI-2; v) borderline
personality symptoms as measured using the Borderline Symptoms List-23; vi) anger as measured by
the State-Trait Anger Expression Inventory; vii) general symptoms as measured by the Symptom Check-
list-90-Revised; viii) impulsiveness as measured by the Barrett Impulsiveness Scale-11; ix) depression
as measured by the BDI; x) social functioning as measured by the Social Adjustment Scale-Self-Report;
xi) emotion regulation as measured by the Difficulties in Emotion Regulation Scale; xii) distress as mea-
sured by the Distress Tolerance Scale; xiii) mindfulness skills as measured by the Kentucky Inventory of

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

137

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

McMain 2017  (Continued)

Cochrane Database of Systematic Reviews

Mindfulness Scale; xiv) treatment adherence as measured by the Reasons for Early Termination from
Treatment Questionnaire (for dropouts).

Notes

Source(s) of funding: "The study was funded by the Ontario Mental Health Foundation (McMain 2017, p.
147).

Conflict(s) of interest: "The authors report no conflict of interests in relationship to this study" (McMain
2017, p. 147).

Morgan 1993 

Study characteristics

Methods

Participants were individually randomised using sealed envelopes to a remote contact intervention
(emergency card) or TAU.

N lost to follow-up: 0/212 (0%) for repetition of SH at post-intervention.

Location: Bristol, UK.

Participants

Number of total participants: 212 participants were randomised, 101 were allocated to the remote con-
tact intervention (emergency card), and 111 were allocated to TAU.

Interventions

Profile of participants: mean age 30.1 years (SD: not reported; range: not reported). Proportion female
not reported. All (n = 212; 100%) had engaged in SH for the first time. One-quarter (n = 53; 25.0%) were
diagnosed with a depressive disorder.

Source of participants: patients admitted to hospital following first episode of SH.

Inclusion criteria: i) no previous episode of SH; ii) resident within the catchment area.

Exclusion criteria: none reported.

Intervention: remote contact intervention (emergency card) in addition to TAU. The green card outlined
that a doctor was available by telephone and provided their contact information and enabled partici-
pants to on-demand admission to hospital. Sessions were delivered by duty doctors (no further infor-
mation on expertise or experience was reported).

Comparator: TAU consisting of referral to the primary healthcare team, and psychiatric or inpatient ad-
missions, if required. No information on the number or duration of sessions was reported.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from hospital, psychiatric, and GP records.

Secondary outcome(s): i) use of the emergency card ascertained from hospital, psychiatric, and GP
records; ii) admission to psychiatric hospital ascertained from records ascertained from hospital, psy-
chiatric, and GP records; iii) service use ascertained from hospital, psychiatric, and GP records.

Notes

Source(s) of funding: no sources of funding were reported.
Conflict(s) of interest: no conflicts of interest were reported.

Morthorst 2012 

Study characteristics

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

138

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Morthorst 2012  (Continued)

Methods

Participants were individually randomised using a computer-based software stratified by history of sui-
cide attempts, history of psychiatric treatment or hospitalisation, and alcohol consumption at the in-
dex attempt to either case management or EUC.

N lost to follow-up: 0/243 for repetition of SH at post-intervention.

Location: Copenhagen, Denmark.

Participants

Number of total participants: 243 participants were randomised, 123 were allocated to case manage-
ment and assertive outreach, and 120 were allocated to TAU.

Profile of participants: mean age 31.0 ± 13.3 years (range: 11-69 years). Three-quarters (n = 184; 75.7%)
were female. Over half (n = 130; 53.5%) had a history of SH (i.e. multiple episodes of SH). Whilst just un-
der half (n = 109; 44.8%) had a history of psychiatric treatment prior to the index attempt, no informa-
tion on psychiatric diagnoses was reported.

Source of participants: patients admitted to acute emergency units, intensive care units, paediatric
units, or psychiatric emergency room units following a suicide attempt.

Inclusion criteria: i) aged 12 years or older; ii) admitted to acute emergency units, intensive care units,
paediatric units, or psychiatric emergency room units following a suicide attempt.

Exclusion criteria: i) living in an institution; ii) admitted to a psychiatric unit for > 14 days; iii) diagnosed
with a schizophrenia-spectrum disorder; iv) diagnosed with severe depression, bipolar disorder, or de-
mentia; v) currently receiving outreach services from social service agencies.

Intervention: between eight to 20 sessions (duration not reported) of an assertive intervention involving
case management, crisis intervention, as required, problem-solving therapy, and assertive outreach
based on motivational support to encourage patients to attend treatment sessions, assist patients to
attend these sessions, and to improve adherence to after-treatment in addition to TAU. Sessions were
delivered by psychiatric nurses (experience not reported) who received further training (duration not
reported) in suicidology.

Comparator: EUC consisting of six to eight sessions (duration not reported), including a psychiatric as-
sessment and referral to AOD treatment, psychological therapy, and GP treatment, as required. Phar-
macological treatment was also provided, where necessary, through the Centre for Excellence.

Length of treatment: six months.

Primary outcome(s): i) repetition of SH ascertained from self-report in addition to medical and hospital
records; ii) suicide ascertained from self-report in addition to medical and hospital records.

Source(s) of funding: “This study received funding from the Ministry of Health and Internal Affairs, Den-
mark, the National Board of Social Services, and independent subdivision of The Ministry of Social Af-
fairs and Integration, TrygFoden, and Aase og Ejnar Danielsens Foundation” (Morthorst 2012, p. 6).
Conflict(s) of interests: none reported.

Participants were individually randomised (procedure not reported) stratified by history of suicide at-
tempts to either a remote contact intervention (telephone contact combined with emergency cards
and letters) or TAU.

N lost to follow-up: 0/303 (0.0%) for repetition of SH at post-intervention.

Location: Bicêtre, France.

Interventions

Outcomes

Notes

Mouaffak 2015 

Study characteristics

Methods

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

139

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Mouaffak 2015  (Continued)

Participants

Interventions

Number of total participants: 303 participants were randomised, 152 were allocated to a remote contact
intervention (letters and telephone contact), and 151 were allocated to TAU.

Profile of participants: mean age 38.8 ± 13.1 years (range: not reported). Almost three-quarters (n = 224;
73.9%) were female. Just under half (n = 151; 49.8%) had a history of SH (i.e. multiple episodes of SH).
Almost one-third were diagnosed with a depressive disorder (n = 87; 28.7%) or PTSD (n = 87; 28.7%), fol-
lowed by AUD (n = 18; 5.9%). A minority were diagnosed with a comorbid PD (n = 50; 16.5%).

Source of participants: patients admitted to a psychiatric ED following a suicide attempt.

Inclusion criteria: i) aged 18 years or older; ii) discharged from the ED within 72 hours with a referral to
an outpatient follow-up programme; iii) able to provide consent; iv) able to be contacted by telephone;
v) sufficient language ability.

Exclusion criteria: i) unable to be contacted by telephone (e.g. homeless, incarcerated); ii) insufficient
language ability.

Intervention: remote contact intervention (letters and telephone contact) consisting of a letter sent
within days post-discharge providing information on scheduled interventions, and a resource card pro-
viding the contact information of a senior psychiatrist available 24 hours. Participants received further
letters one, six, and 11 months' post-discharge. Participants also received telephone contact (duration
not reported) at two weeks, and months one and three post-discharge. The purpose of these calls was
to facilitate collaborative management and foster treatment engagement. PST, crisis management, and
hospital treatment were also provided, if required. Sessions were delivered by psychiatrists (no further
information on experience was reported).

Comparator: TAU (no further details reported) as well as reminder letters one, six, and 11 months' post-
discharge.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report, collateral informant report, and/
or hospital reports; ii) time to repetition of SH ascertained from self-report, collateral informant report,
and/or hospital reports.

Secondary outcome(s): i) service use ascertained from self-report, collateral informant report, and/
or hospital reports; ii) suicide as ascertained from mortality registers; iii) all-cause mortality as ascer-
tained from mortality registers.

Notes

Source(s) of funding: none reported.

Conflict(s) of interest: none reported.

Mousavi 2015 

Study characteristics

Methods

Participants were individually randomised (procedure not reported) to either a remote contact inter-
vention (telephone contact) or alternative psychotherapy.

N lost to follow-up: 8/55 (14.5%) for repetition of SH at post-intervention.

Location: Isfahan, Iran.

Participants

Number of total participants: 55 participants were randomised, 29 were allocated to a remote contact
intervention (telephone contact), and 26 were allocated to TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

140

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Mousavi 2015  (Continued)

Cochrane Database of Systematic Reviews

Profile of participants: mean age 28.3 ± 7.8 years (range: not reported). The majority (n = 48; 87.3%) were
female. All (n = 55; 100%) had a history of SH (i.e. multiple episodes of SH). No information on psychi-
atric diagnoses was reported.

Source of participants: patients admitted to the ED of a general hospital following a suicide attempt.

Inclusion criteria: i) aged 20 years or older; ii) ≥ 2 previous suicide attempts (time-frame not reported);
iii) able to understand the trial procedure; iv) able to provide informed consent; v) sufficient language
ability.

Exclusion criteria: i) diagnosed with dementia or other cognitive impairment according to DSM-IV-TR
criteria; ii) required immediate medical intervention (e.g. emergency surgery); iii) no known contact in-
formation; iv) those unable to be contacted post-intervention; v) those who die during the follow-up
period (other than by suicide).

Intervention: remote contact intervention (telephone contact) consisting of up to eight telephone calls
(20 minutes) at weeks two and four, and at months two, three, four, five, six, and eight post-discharge.
Therapeutic content included psychoeducation, identification of problems, problem appraisal, stress
management, and referral to a psychiatrist, psychologist, or social worker, as required. Sessions were
delivered by assistant psychiatrists (no further information on experience was reported).

Comparator: face-to-face contact consisting of up to eight sessions (20 minutes) at weeks two and four,
and at months two, three, four, five, six, and eight post-discharge. Therapeutic content included psy-
choeducation, identification of problems, problem appraisal, stress management, and referral to a psy-
chiatrist, psychologist, or social worker, as required.

Length of treatment: eight months.

Interventions

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report; ii) hopefulness as ascertained from
self-report (reverse coded); iii) interest as ascertained from self-report; iv) problem resolution as ascer-
tained from self-report; v) suicidal ideation as ascertained from self-report; vi) suicide (unclear how as-
certained).

Notes

Source(s) of funding: none reported.

Conflict(s) of interest: none reported.

Mousavi 2017 

Study characteristics

Methods

Participants were individually randomised (procedure not reported) to either CBT-based psychothera-
py in addition to TAU or TAU alone.

N lost to follow-up: 0/60 (0%) for repetition of SH at post-intervention.

Location: Isfahan, Iran.

Participants

Number of total participants: 60 participants were randomised, 30 were allocated to brief CBT-based
psychotherapy in addition to TAU, and 30 were allocated to TAU alone.

Profile of participants: mean age not reported (range: not reported). The majority (n = 42; 70.0%) were
female. All (n = 60; 100%) had a history of SH (i.e. multiple episodes of SH). No information on psychi-
atric diagnoses was reported.

Source of participants: patients hospitalised following a suicide attempt.

Inclusion criteria: i) sufficient language ability; ii) able to provide informed consent.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

141

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Mousavi 2017  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Exclusion criteria: i) diagnosed with dementia or other cognitive impairment according to DSM-IV-TR
criteria; ii) required immediate medical intervention (e.g. emergency surgery); iii) no known contact in-
formation; iv) those unable to be contacted post-intervention; v) those who died during the follow-up
period (other than by suicide).

Intervention: brief psychotherapy based on principles of ACT and CBT in addition to TAU. Therapy con-
sisted of 10 face-to-face visits in weeks one and two and months two, three, four, five, six, seven, eight,
10, and 12 post-discharge. Therapeutic content included identifying and recognising thoughts that in-
terfered with problem-solving (e.g. all-or-nothing thinking), cognitive restructuring, coping with prob-
lems, acceptance of problems, and cognitive diffusion. Participants were also referred to treatment by
a psychologist, psychiatrist, or social worker, as required. No information on who delivered the inter-
vention, their expertise, or their experience was reported.

Comparator: TAU consisting of referral to the psychiatric emergency unit for review, further referral
to treatment by a psychologist, psychiatrist, or social worker, as required, and telephone contact at
months two, four, six, five, six, seven, eight, 10 and 12 post-discharge.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report; ii) hopelessness as ascertained
from self-report; iii) satisfaction with life as ascertained from self-report; iv) suicidal ideation as ascer-
tained from self-report.

Notes

Source(s) of funding: none reported.

Conflict(s) of interest: none reported.

Naidoo 2014 

Study characteristics

Methods

Participants were individually randomised using a computer generated process to either provision of
information and support or TAU.

N lost to follow-up: unclear.

Location: Durban, South Africa.

Participants

Number of total participants: 688 participants were randomised, 344 were allocated to provision of in-
formation and support and 344 were allocated to TAU.

Profile of participants: mean age 35.0 years (SD not reported, range: 20-29 years). Three-quarters (n =
516; 75.0%) were female. Information on psychiatric diagnoses was not reported.

Source of participants: patients presenting to the ED and/or admitted to the short- or long-stay wards of
one of two general hospitals following an episode of SH.

Inclusion criteria: i) aged 18 years and older; ii) presenting to the ED and/or admitted to the short- or
long-stay wards of one of two general hospitals following an episode of SH.

Exclusion criteria: none reported.

Intervention: based on the SUPRE-MISS model (Fleischmann 2008) consisting of a brief (one hour) infor-
mation and psychoeducation session, and nine follow-up contacts (duration not reported, also modal-
ity not reported) at weeks one, two, four, seven, 11, and months four, six, 12, and 18 months post-dis-
charge. Participants were also paired with a nominated support person who received training (three
sessions of four hours' duration each) in basic counselling and gate-keeping skills. No further informa-
tion on who delivered the intervention, their expertise, or their experience was reported.

Interventions

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

142

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Naidoo 2014  (Continued)

Cochrane Database of Systematic Reviews

Comparator: SUPRE-MISS intervention without support persons. Based on the SUPRE-MISS model
(Fleischmann 2008), this consisted of a brief (one hour) information ad psychoeducation session, and
nine follow-up contacts (duration not reported, also modality not reported) at weeks one, two, four,
seven, 11, and months four, six, 12, and 18 months post-discharge.

Length of treatment: 18 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report using a tool developed for the
SUPRE-MISS trial; ii) suicide (unclear how determined); iii) all-cause mortality (unclear how deter-
mined).

Notes

Source(s) of funding: no source(s) of funding reported.

Conflict(s) of interest: no conflict(s) of interest reported.

O'Connor 2015 

Study characteristics

Methods

Participants were individually randomised (method not reported) to either a brief ED-based Collabora-
tive Assessment and Management of Suicidality (CAMS)-based intervention or TAU.

N lost to follow-up: data on repetition of SH not reported. However the authors reported "[w]e complet-
ed 80% of the 1-month follow-up interviews. The 20% who were lost to follow-up did not respond to
our efforts at contacting them through telephone, mail, or email contacts" (O'Connor 2015, p.430).

Location: unclear (USA).

Participants

Number of total participants: 30 participants were randomised, 15 were allocated to a brief intervention
(based on principles of CAMS and DBT), and 15 were allocated to TAU.

Profile of participants: mean age 41.3 ± 13.8 years (range: not reported). Just over one-quarter (n = 8;
26.7%) were female. No information on psychiatric diagnoses was reported.

Source of participants: patients medically admitted to a medical or surgical ward of a trauma hospital
following a suicide attempt.

Inclusion criteria: i) 15 years of age or older; ii) medically admitted to a medical or surgical ward of a
trauma hospital following a suicide attempt; iii) sufficient language ability; iv) able to provide informed
consent.

Exclusion criteria: i) denied making an index attempt; ii) insufficient language ability; iii) imprisoned; iv)
assessed as either too cognitively impaired, delirious, or psychotic to respond to a psychosocial inter-
vention by clinical personnel.

Interventions

Intervention: brief, one-off intervention (average duration 43.98 ± 12.87 minutes) based on principles
from CAMS. Therapeutic content involved collaborative assessment and planning, rapport building,
guided discovery, functional analysis, crisis planning, and linkage to outpatient mental health services,
as required. No information on who delivered the intervention, their expertise, or their experience was
reported.

Comparator: TAU. No specific information on TAU content was reported.

Length of treatment: one-off consultation.

Outcomes

Primary outcome(s): i) satisfaction with treatment as measured by the Patient Satisfaction Question-
naire.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

143

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

O'Connor 2015  (Continued)

Cochrane Database of Systematic Reviews

Secondary outcome(s): i) suicidal ideation as measured by the BSS; ii) motivation to change as mea-
sured by the Stages of Change Questionnaire; iii) hopelessness as measured by the Reasons for Living
Inventory (reverse scored).

Notes

Source(s) of funding: "The current study was supported by grants T32HD057822 (PI: Rivara) from the Eu-
nice Kennedy Shriver National Institute of Child Health & Human Development and K24MH086814 (PI:
Zatzick) from the National Institutes of Mental Health" (O'Connor 2015, p.432).

Conflict(s) of interest: none reported.

O'Connor 2017 

Study characteristics

Methods

Participants were individually randomised (1:1) using a web-based, minimisation procedure to either a
brief ED-based guided integrated motivational-volitional-focused intervention or TAU.

N lost to follow-up: 6/518 (1.2%) for repetition of SH by the six-month follow-up assessment.

Location: Edinburgh, UK.

Participants

Number of total participants: 518 participants were randomised, 259 were allocated to a brief interven-
tion (volitional help sheet), and 259 were allocated to TAU.

Interventions

Profile of participants: mean age 36.3 ± 13.7 years (range: not reported). Over half (n = 324; 62.5%) were
female and had a history of SH (i.e. multiple episodes of SH (n = 329; 63.5%). No information on psychi-
atric diagnoses was reported.

Source of participants: patients admitted overnight to an acute medical unit of a general hospital fol-
lowing a suicide attempt.

Inclusion criteria: i) 16 years of age or older; ii) ≥ 1 self-reported episode of SH.

Exclusion criteria: i) assessed as medically unfit for interview; ii) insufficient language ability; iii) already
participating in other trials being conducted within the hospital; iv) were treated within the ED without
an admission.

Intervention: brief, volitional help-sheet (VHS) intervention consisting of a one-off assessment (dura-
tion not reported) in addition to TAU. Participants were provided with a list of common situations in
which they may be tempted to engage in SH together with a list of potential alternative behaviours.
Participants then drew links between any situation that applied to them and any one of the listed alter-
native behaviours. Participants could make as many links as desired. At the conclusion of the assess-
ment, participants took a copy of the VHS home. At approximately two months' post-discharge, partic-
ipants received a booster VHS by mail. Sessions were delivered by clinical staff (no further information
on their expertise or experience was reported).

Comparator: TAU consisting of a one-off psychosocial assessment (duration not reported) undertaken
by the liaison psychiatry service. Following this, participants were either transferred to inpatient psy-
chiatric care, or referred for outpatient psychiatric treatment, voluntary sector follow-up, or primary
care follow-up, as required.

Length of treatment: one-off consultation.

Outcomes

Notes

Primary outcome(s): i) repetition of SH ascertained from medical records; ii) number of repeat SH
episodes ascertained from medical records; iii) incremental cost per SH event averted.

Secondary outcome(s): i) time to SH repetition ascertained from medical records.

Source(s) of funding: "The trial was funded by a grant from the Chief Scientist Office, Scotland
(CZH/4/704)" (O'Connor 2017, p.459).

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

144

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

O'Connor 2017  (Continued)

Conflict(s) of interest: "We declare no competing interests" (O'Connor 2017, p.459).

O'Connor 2020 

Study characteristics

Methods

Participants were individually randomised using a minimisation procedure, stratified by sex and histo-
ry of SH to either a brief ED-based intervention (teachable moment brief intervention) or TAU.

N lost to follow-up: 25/48 (52.1%) for repetition of SH by the 12-month assessment.

Location: Nashville, TN, USA.

Participants

Number of total participants: 48 participants were randomised, 23 were allocated to a brief intervention
(teachable moment brief intervention), and 25 were allocated to TAU.

Profile of participants: mean age 42.6 ± 2.6 years (range: not reported). Over half (n = 26; 54.2%) were fe-
male. No information on psychiatric diagnoses was reported.

Source of participants: patients admitted to an acute medical unit of a general hospital following a sui-
cide attempt.

Inclusion criteria: i) aged 18 years or older; ii) admitted to an acute medical unit of a general hospital
following a suicide attempt; iii) sufficient language ability; iv) able to provide informed consent.

Exclusion criteria: i) insufficient language ability; ii) imprisoned; iii) assessed as either too cognitively
impaired, delirious, or psychotic to respond to a psychosocial intervention by clinical personnel.

Interventions

Intervention: brief intervention based on principles of CAMS, consisting of nine components (30 min-
utes' duration in total). Therapeutic content involved collaborative assessment and planning, rapport
building, guided discovery, functional analysis, crisis planning, and linkage to outpatient mental health
services, as required. Sessions were delivered by clinicians (no further information on expertise or ex-
perience was reported).

Comparator: TAU. No specific information on TAU content was reported.

Length of treatment: 30 minutes.

Outcomes

Primary outcome(s): i) satisfaction with treatment as measured by the Client Satisfaction Question-
naire.

Secondary outcome(s): i) repetition of SH according to self-report using the SASII; ii) interpersonal func-
tioning as measured by the Interpersonal Needs Questionnaire; iii) motivation to change as measured
by the Stages of Change Questionnaire; iv) hopelessness as measured by the Reasons for Living Inven-
tory (reverse scored); v) services use ascertained from the Health Services and Medication Use mea-
sure; vi) suicidal ideation as measured by the BSSI.

Notes

Source(s) of funding: "This work was supported by the American Foundation for Suicide Prevention
[grant number YIG-0-098-13]" (O'Connor 2020, p.117).

Conflict(s) of interest: none reported.

Owens 2020 

Study characteristics

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

145

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Owens 2020  (Continued)

Methods

Participants were individually randomised (1:1) using a computer adaptive minimisation procedure
balanced for: i) number of previous episode of SH leading to hospital treatment prior to study entry
(i.e. one vs. > 1); ii) method of SH at the index episode (i.e. self-poisoning vs. self-injury vs. both com-
bined); iii) sex (i.e. male vs. female); iv) age (i.e. < 30 years vs. 30–59 years vs. ≥ 60 years) to either CBT-
based psychotherapy or TAU.

N lost to follow-up: 0/62 (0%) for repetition of SH at six months (as ascertained from hospital records).

Location: Leeds and York, UK.

Participants

Number of total participants: 62 participants were randomised, 30 were allocated to PST, and 32 were
allocated to TAU.

Interventions

Profile of participants: mean age 35.2 ± 13.8 years (range: 18 to 65 years). Over half (n = 40; 64.5%) were
female. Over three-quarters (n = 48; 77.4%) and had a history of SH (i.e. multiple episodes of SH). Whilst
the majority (n = 52; 83.9%) had received mental health treatment, no specific information on psychi-
atric diagnoses was reported.

Source of participants: patients presenting to EDs following an episode of self-harm.

Inclusion criteria: i) 18 years of age or older; ii) living within the catchment area; iii) presented to one of
two EDs following an episode of SH within six weeks prior to trial entry.

Exclusion criteria: i) currently receiving treatment that may interfere with PST; ii) insufficient cognitive
capacity; iii) insufficient language ability; iv) known risk of violence to others; v) unable to be contacted
within eight weeks of the index episode of SH.

Intervention: manualised PST adapted from Hatcher 2015 and Hatcher 2016, comprising six weekly to
fortnightly sessions (1 hour). Participants could also receive a single booster session (1 hour) between
six to eight weeks following the acute phase. Therapeutic content involved problem orientation, recog-
nising and identifying problems, selecting and defining a problem, generating alternative solutions, de-
cision-making, implementing a SMART (Specific, Measurable, Achievable, Relevant, and Time-bound)
plan, and reviewing progress. Sessions were delivered by mental health nurses or occupational thera-
pists who received training (two days) in delivering the intervention together with ongoing fortnightly
supervision.

Comparator: TAU. This could vary widely, from telephone contact to remind participants of appoint-
ments, to follow-up psychosocial assessments, referral to other services (e.g. AOD), as required, and
participation in group-based therapy. Any form of TAU was received by 69%, most commonly, commu-
nity mental health contacts.

Concomitant medications: no information on concomitant medications reported.

Length of treatment: up to 12 weeks (for the acute phase), up to 20 weeks (including ‘booster’ phase).

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report and hospital records.

Notes

Secondary outcome(s): i) repetition of SH ascertained from self-report; ii) other serious adverse events
ascertained from hospital records; iii) treatment adherence as measured by the number of sessions at-
tended; iv) health-related quality of life as measured by the SF-36; v) health economics data.

Source(s) of funding: "This work represents independent research funded by the UK National Insti-
tute for Health Research in the form of a Research for Patient Benefit grant (NIHR Project Number PB-
PG-0610-22267). The treatment costs of the PST were funded by the Leeds and York Partnership NHS
Foundation Trust" (Owens 2020, p.13).

Conflict(s) of interest: "The authors declare that they have no competing interests" (Owens 2020, p.13).

Other: It should be noted that one of the authors (SH) wrote the therapeutic manual, and has been in-
volved in two further trials of this therapeutic approach.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

146

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Patsiokas 1985 

Study characteristics

Methods

Participants were individually randomised (method not reported) to either cognitive restructuring, PST,
or TAU.

N lost to follow-up: not reported.

Location: Charleston, SC, USA.

Participants

Number of total participants: 15 participants were randomised, 5 were allocated to cognitive restructur-
ing, 5 were allocated to PST, and 5 were allocated to TAU.

Interventions

Profile of participants: not reported.

Source of participants: patients admitted to a psychiatric ward following a suicide attempt.

Inclusion criteria: i) admitted to a psychiatric ward following a suicide attempt.

Exclusion criteria: i) diagnosed with psychosis; ii) diagnosed with substance abuse.

Intervention (cognitive restructuring): up to 10 sessions (60 minutes) of cognitive restructuring delivered
according to the model by Beck 1976. Therapeutic content included identifying automatic thoughts,
cognitive distortions, and discussing the validity of assumptions, beliefs, and attitudes that led to their
suicide attempt. Sessions were delivered by the same therapist for all three conditions (no further in-
formation on expertise or experience was reported).

Intervention (PST): up to 10 sessions (60 minutes) of PST according to D'Zurilla 1971. Therapeutic
content included orientation, problem definition and formulation, generation of alternatives, deci-
sion-making, and verification. Sessions were delivered by the same therapist for all three conditions
(no further information on expertise or experience was reported).

Comparator: TAU (number and duration of sessions not reported) involving open discussions about sui-
cidal behaviour, problems, and daily life.

Length of treatment: 3 weeks.

Outcomes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) cognitive flexibility as measured by
the Alternative Uses Test; iii) hopelessness as measured by the BHS; iv) problem-solving as measured
by the MEPS; v) suicidal ideation as measured from self-report using the Self-Monitoring of Suicidal
Ideation and the BSSI.

Notes

Source(s) of funding: no sources of funding reported.

Conflict(s) of interest: no conflicts of interest reported.

Priebe 2012 

Study characteristics

Methods

Participants were individually randomised using a computer-generated algorithm to either DBT or TAU.

N lost to follow-up: 5/80 (6.3%) for repetition of SH by the post-intervention assessment.

Location: London, UK.

Participants

Number of total participants: 80 participants were randomised, 40 were allocated to DBT, and 40 were
allocated to TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

147

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Priebe 2012  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Profile of participants: mean age 32.2 ± 10.8 years (range: not reported). The majority (n = 70; 87.5%)
were female.

Source of participants: referrals to a specialist DBT service.

Inclusion criteria: i) aged 16 years or older; ii) engaged in SH on ≥ 5 days in the year prior to trial entry;
iii) diagnosed with ≥ 1 PD.

Exclusion criteria: i) diagnosed with a severe learning disability that would interfere with the ability to
benefit from DBT; ii) insufficient language ability.

Intervention: DBT delivered according to Linehan 1993, involving weekly individual (60 minutes) and
group-based skills training (2 hours). Out-of-hours telephone skills training was also available, as re-
quired. Therapeutic content involved CBT, mindfulness, validation, supportive therapeutic techniques,
and skills training. No information on who delivered the intervention, their expertise, or their experi-
ence was reported.

Comparator: TAU involving referral back to the referee agency where the participant was encouraged to
engage with any treatment other than DBT, including psychotherapy, referral to psychiatrists, mental
health teams, counsellors, GPs, or other user-run support services, as required.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report.

Notes

Sahin 2018 

Study characteristics

Methods

Secondary outcome(s): i) BPD symptoms as measured by the Zanarini Rating Scale for Borderline Per-
sonality Disorder; ii) quality of life as measured by the Manchester Short Assessment of Quality of Life;
iii) symptoms as measured by the Brief Psychiatric Rating Scale and the BSI; iv) services use as mea-
sured by the Client Service Receipt Inventory; v) treatment adherence as measured by the number of
sessions attended.

Source(s) of funding: “This paper... [was] funded by the National Institute for Health Research (NIHR)
under its Research for Patient Benefit Programme (grant reference No. PB-PG-0906-10540). All authors
were funded by this grant with the exception of K.B. whose contribution was funded by the NIHR Doc-
toral Research Fellowship Scheme” (Priebe 2012, p. 364).
Conflict(s) of interests: no conflicts of interests reported.

Participants were individually randomised (method not reported) to either DBT, psychodynamic psy-
chotherapy, or TAU.

N lost to follow-up: data on repetition of SH not reported.

Location: Stockholm, Sweden.

Participants

Number of total participants: 106 participants were randomised, 35 were allocated to DBT, 36 were al-
located to object-relational psychotherapy (psychodynamic psychotherapy), and 35 were allocated to
TAU.

Profile of participants: mean age 29.5 ± 7.7 years (range: 19-50 years). All (n = 106; 100%) were female,
had a history of SH (i.e. multiple episodes of SH), and were diagnosed with BPD. A minority were also
diagnosed with the following comorbid psychiatric disorders: major depression (n = 40; 37.7%), panic
disorder (n = 40; 37.7%), PTSD (n = 28; 26.4%), avoidant PD (n = 20; 18.9%), paranoid PD (n = 13; 12.3%),
dependent PD (n = 9; 8.5%), and obsessive-compulsive PD (n = 9; 8.5%).

Source of participants: patients receiving outpatient psychiatric treatment who self-reported a history
of engaging in multiple episodes of SH.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

148

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Sahin 2018  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Inclusion criteria: i) female; ii) aged 19-50 years; iii) diagnosed with BPD according to DSM-IV criteria; iv)
≥ 2 suicide attempts with ≥ 1 of these within the six months preceding trial entry.

Exclusion criteria: i) diagnosed with SUD, psychosis, major depression with melancholic features, a life-
threatening eating disorder, dementia, or other neurological disorder.

Intervention (DBT): DBT delivered according to Linehan 1993, comprising sessions of both individual
therapy and group-based therapy. Mean number of sessions 44.5 ± 33.4 (range: 0-155). No specific in-
formation on therapeutic content reported. Sessions were delivered by masters-level psychiatrists,
psychologists, psychiatric social workers, psychiatric nurses, psychiatric nurse assistants, nurses, or oc-
cupational therapists who received training (duration not reported) in delivering DBT, who reached a
minimum score of 3.7 or higher on the DBT Global Rating Scale, who had an average of 22 years clinical
experience, and who received ongoing supervision (duration not reported).

Intervention (object-relational psychotherapy): consisting of psychodynamic psychotherapy. Mean num-
ber of sessions 58.0 ± 65.1 (range: 0-236). Therapeutic content included: structural interview according
to Clarkin 1999, comprising establishing the therapeutic contract, setting the framework of treatment,
techniques to explore mental imagery, and interpersonal relationship therapy. Sessions were delivered
by masters-level psychiatrists, psychologists, psychiatric social workers, psychiatric nurses, psychiatric
nurse assistants, nurses, or occupational therapists who received training (duration not reported) in
delivering the intervention, who had an average of 22 years clinical experience, and who received on-
going supervision (duration not reported).

Comparator: TAU. Consisted of maintenance therapy. No specific detail was reported.

Length of treatment: 12 months.

Outcomes

Primary outcome(s): i) repetition of SH as ascertained from self-report using the PHI; ii) BPD symptoms
as measured by the DSM-IV and ICD-10 Personality Disorders Interview; iii) general functioning as mea-
sured by the GAF; iv) general psychiatric symptoms as measured by the SCL-90.

Notes

Source(s) of funding: no sources of funding reported.

Conflict(s) of interest: no conflicts of interest reported.

Salkovskis 1990 

Study characteristics

Methods

Participants were individually randomised using a predetermined method of sampling without re-
placement and sealed envelopes to either CBT-based psychotherapy or TAU.

N lost to follow-up: 0/20 (0%) for repetition of SH by the six-month assessment.

Location: Leeds, UK.

Participants

Number of total participants: 20 participants were randomised, 12 were allocated to CBT-based psy-
chotherapy, and 8 were allocated to TAU.

Profile of participants: mean age 27.2 ± 6.7 years (range: 16-65 years). Half (n = 10; 50.0%) were female.
All (n = 20; 100%) had a history of SH (i.e. multiple episodes of SH). Whilst the majority (n = 19; 95.0%)
had previous psychiatric treatment (inpatient: n = 7, 35.0%; outpatient: n = 12, 60.0%), no information
on psychiatric diagnoses was reported.

Source of participants: patients referred by the duty psychiatrist following an episode of self-poisoning
using antidepressants, and who were assessed in an A&E department following this episode.

Inclusion criteria: i) aged 16-65 years; ii) of fixed abode and living within the catchment area; iii) antide-
pressants were taken as part of the self-poisoning episode; iv) ≥ 2 or more suicide attempts preceding

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

149

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Salkovskis 1990  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Outcomes

Notes

Slee 2008 

Study characteristics

Methods

trial entry; v) Buglass and Horton Risk of Repetition Scale score ≥ 4. Participants had to fulfil at least 2
criteria to be included.

Exclusion criteria: i) not requiring immediate psychiatric treatment; ii) diagnosed with psychosis; iii) di-
agnosed with a serious organic illness.

Intervention: domiciliary (home-based) CBT-based problem-solving psychotherapy consisting of five
(60 minutes) sessions. Therapeutic content involved identifying problems, priority setting, generating
alternative solutions, and goal-setting. Sessions were delivered by community psychiatric nurses (no
further information on experience was reported).

Comparator: TAU. No further information on number, duration, or therapeutic content reported.

Length of treatment: one month.

Primary outcome(s): i) repetition of SH ascertained from hospital records; ii) anxiety, tension, and fa-
tigue measured by the Profile of Mood State; iii) depression measured by the BDI; iv) hopelessness
measured by the BHS; v) problem-solving measured by the Personal Questionnaire Rapid Scaling Tech-
nique; vi) suicidal ideation measured by the BSSI; vii) suicide (unclear how ascertained).

Source(s) of funding: no sources of funding reported.
Conflict(s) of interests: no conflicts of interest reported.

Participants were individually randomised using a computer-based random number generator to ei-
ther CBT-based psychotherapy in addition to TAU or TAU alone.

N lost to follow-up: 8/90 (8.9%) for repetition of SH data by the six-month assessment.

Location: Leiden, the Netherlands.

Participants

Number of total participants: 90 participants were randomised, 48 were allocated to CBT-based psy-
chotherapy in addition to TAU, and 42 were allocated to TAU.

Profile of participants: mean age 24.6 ± 5.6 years (range: 15-35 years). The majority (n = 77; 93.9%) were
female, and were diagnosed with any mood disorder (n = 73; 89.0%), followed by any anxiety disorder
(n = 45; 54.9%), any eating disorder (n = 14; 17.1%), alcohol/drug misuse (n = 14; 17.1%), and somato-
form disorder (n = 3; 3.7%). Three-quarters (n = 62; 75.6%) had a history of SH (i.e. multiple episodes of
SH prior to trial entry).

Source of participants: patients presenting to hospital/mental health centre following an episode of SH.

Inclusion criteria: i) recently engaged in SH; ii) aged 15-35; iii) sufficient language ability; iv) residing
within the catchment area.

Exclusion criteria: i) diagnosed with a psychiatric disorder requiring intensive inpatient treatment; ii) di-
agnosed with a cognitive impairment.

Interventions

Intervention: CBT-based psychotherapy consisting of 12 sessions (duration not reported) in addition to
TAU. Therapeutic content included cognitive restructuring, problem-solving skills, and behavioural ac-
tivation. Sessions were delivered by experienced CBT practitioners (no further information on expertise
was reported).

Comparator: TAU consisting of medication, psychotherapy, or hospitalisation, as required.

Length of treatment: 5.5 months.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

150

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Slee 2008  (Continued)

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report.

Notes

Sreedaran 2020 

Study characteristics

Methods

Secondary outcome(s): i) anxiety as measured by the anxiety subscale of the SCL-90; ii) depression as
measured by the BDI; iii) problem-solving as measured by the Coping Inventory for Stressful Situations;
iv) self-esteem as measured by the Robson Self-Concept Questionnaire, Short version; v) suicidal cogni-
tions as measured by the Suicide Cognition Scale; vi) treatment adherence as measured by the number
of sessions attended; vii) suicide (unclear how ascertained).

Source(s) of funding: “Support for the study was provided by The Netherlands Organisation for Health
Research and Development (AonMw) (contract grant number: 2100.0068)" (Slee 2008, p. 210).
Conflict(s) of interests: none reported.
Other: Repetition of SH data provided by participants was subjected to reliability analysis by comparing
self reports to hospital records and information from treatment sessions.

Participants were individually randomised (1:1) using a computer-based procedure in blocks of ten to
either telephone-based psychotherapy or a remote contact intervention (telephone contact).

N lost to follow-up: 13/28 (46.4%) for repetition of SH at post-intervention.

Location: Bangalore and New Delhi, India.

Participants

Number of total participants: 28 participants were randomised, 15 were allocated to telephone-based
psychotherapy in addition to TAU, and 13 were allocated to a remote contact intervention (telephone
contact).

Profile of participants: median age 33.7 years (range: 18-55 years). Three-quarters (n = 21; 75.0%)
were female. Just under one-third (n = 9; 32.1%) were diagnosed with a common psychiatric disorder
(e.g. MDD, any anxiety disorder, adjustment disorder). A minority (n = 1; 3.6%) were diagnosed with a
personality disorder. Just under one-third (n = 9; 32.1%) were not diagnosed with a psychiatric disor-
der.

Source of participants: patients presenting to a general hospital and who had made a recent (within one
month) suicide attempt.

Inclusion criteria: i) aged 18-55 years; ii) those with a history of SH (i.e. multiple episodes of attempted
suicide); iii) sufficient language ability (English, Hindi, Kannada, Telugu, or Tamil); iv) recent (within one
month preceding trial entry) suicide attempt.

Exclusion criteria: i) diagnosed with psychosis or SUD according to the MINI, version 6, criteria; ii) diag-
nosed with an unstable medical illness; iii) diagnosed with a cognitive impairment.

Intervention: manualised telephone-based psychosocial intervention consisting of three telephone
calls (12-15 minutes) incorporating principles from supportive therapy, CBT-based psychotherapy, and
DBT. Therapeutic content involved mental status examination, reflective listening, problem-solving,
counselling, and treatment adherence. Sessions were delivered by postgraduate psychologists who re-
ceived training (duration not reported) in delivering the intervention and ongoing supervision.

Comparator: remote contact intervention consisting of three telephone calls (two to five minutes) de-
signed to encourage follow-up with mental health and other services, as required.

Length of treatment: 24 days.

Interventions

Outcomes

Primary outcome(s): i) treatment adherence as measured by dropout rates; ii) satisfaction with treat-
ment as measured by an idiosyncratic scale.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

151

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Sreedaran 2020  (Continued)

Cochrane Database of Systematic Reviews

Secondary outcome(s): i) repetition of SH (unclear how ascertained); ii) suicide (unclear how ascer-
tained).

Notes

Source(s) of funding: "This study was funded by the Indian Council of Medical Research (ICMR), with re-
search oversight by a National Coordination Unit, under Capacity Building Projects of National Mental
Health Program, ICMR-NMHP" (Sreedaran 2020, p.5).

Conflict(s) of interest: "The authors declared no potential conflicts of interest with respect to the re-
search, authorship, and/or publication of this article" (Sreedaran 2020, p.5).

Stewart 2009 

Study characteristics

Methods

Participants were individually randomised by drawing names from a hat to either CBT- or PST-based
psychotherapy or TAU.

N lost to follow-up: 0/32 (0%) for repetition of SH at post-intervention.

Location: Brisbane, QLD, Australia.

Participants

Number of total participants: 32 participants were randomised, 11 were allocated to CBT-based psy-
chotherapy, 12 were allocated to PST, and 9 were allocated to TAU.

Profile of participants: mean (SD) age not reported (range: 20-58 years). Just over half (n = 17; 53.1%)
were female. No information on psychiatric diagnoses were reported.

Source of participants: patients admitted a general hospital following a suicide attempt.

Inclusion criteria: i) suicide attempt with self-reported suicide intent; ii) admitted to hospital.

Exclusion criteria: i) diagnosed with an intellectual disability; ii) current diagnosis of mania, psychosis,
or both; iii) under 18 years. Correspondence with authors further clarified that one participant was sub-
sequently excluded after randomisation due to being a frequent repeater of SH, possibly in the context
of BPD.

Intervention (CBT- or PST-based psychotherapy): consisting of four weekly individual sessions of cogni-
tive-behavioural therapy (60 minutes) or seven weekly sessions of PST (60 minutes). CBT-based psy-
chotherapy was manualised and based on elements of both Beck’s CBT (Beck 1976) and Ellis’ theory of
rational emotive therapy (Ellis 1986). PST was also manualised and was based on the 6-step model of
D'Zurilla 1971. Specific information on therapeutic content was not reported, however. Sessions were
delivered by "the researcher" (Stewart 2009, p.542) (no further information on expertise or experience
was reported).

Comparator: TAU consisting of treatment by the hospitals' acute care teams.

Length of treatment: two months.

Primary outcome(s): i) hopelessness as measured by the BHS; ii) problem-solving as measured by the
Social Problem-Solving Inventory Revised; iii) treatment adherence as measured by the number of ses-
sions attended; iv) satisfaction with treatment as measured by the CSQ-8; v) suicidal ideation as mea-
sured by the BSSI; vi) suicide (unclear how ascertained).

Source(s) of funding: no sources of funding reported.
Conflict(s) of interests: no conflicts of interest reported.

Interventions

Outcomes

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

152

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Tapolaa 2010 

Study characteristics

Cochrane Database of Systematic Reviews

Methods

Participants were individually randomised using a coin toss to either CBT-based psychotherapy or TAU.

N lost to follow-up: 0/16 (0%) for repetition of SH by the six-month follow-up assessment (following cor-
respondence).

Location: Jyväskylä, Finland.

Participants

Number of total participants: 16 participants were randomised, 9 were allocated to CBT-based psy-
chotherapy, and 7 were allocated to TAU.

Interventions

Profile of participants: average age 33.2 years (unclear if mean or median) (range: 18-65 years). All (n =
16; 100%) were female. Although no information on psychiatric diagnoses were reported, all (n = 16;
100%) were prescribed medication.

Source of participants: admissions to an ED following an episode of SH.

Inclusion criteria: i) aged 18-65 years; ii) sufficient language ability; iii) living within the catchment area.

Exclusion criteria: none reported.

Intervention: ACT solution-focused brief therapy consisting of four weekly sessions (duration not re-
ported) in addition to TAU. Therapeutic content involved meditation, identification of problems, strate-
gies to solve these problems, reflection on alternative methods of problem-solving, providing motiva-
tion to solve these problems, frustration tolerance exercises, and identity assimilation exercises. Ses-
sions were delivered by advanced level psychology students who received 36 hours of training in deliv-
ering ACT.

Comparator: TAU consisting of four weekly sessions (duration not reported). Correspondence with trial
authors clarified that TAU involved psychiatric outpatient treatment in the form of supportive sessions
with a mental health nurse in addition to pharmacological treatment, as required.

Length of treatment: four weeks.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report using the SASII.

Secondary outcome(s): i) anxiety measured by the BAI; ii) depression measured by the BDI; iii) emotion-
al avoidance measured by the AAQ; iv) emotional regulation measured by the DERS; v) health-related
quality of life measured by the 15D; vi) suicide (unclear how ascertained).

Notes

Source(s) of funding: no information on sources of funding reported.
Conflict(s) of interests: no information on conflicts of interest reported.

Torhorst 1987 

Study characteristics

Methods

Participants were individually randomised (method not reported) to either continuity of care by the
same therapist or alternative psychotherapy (treatment by a different therapist).

N lost to follow-up: 5/141 (3.5%) for repetition of SH data by the 12 month follow-up assessment.

Location: Munich, Germany.

Participants

Number of total participants: 141 participants were randomised, 68 were allocated to crisis intervention
followed by outpatient follow-up by the same therapist, and 73 were allocated to crisis intervention fol-
lowed by outpatient follow-up by a different therapist.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

153

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Torhorst 1987  (Continued)

Cochrane Database of Systematic Reviews

Profile of participants: average age not reported, range: 18-65 years. Over half (n = 98; 63.1%) were fe-
male. Just under half (n = 68; 48.2%) had a history of SH (i.e. multiple episodes of SH).

Source of participants: patients hospitalised following a suicide attempt by self-poisoning.

Inclusion criteria: i) admitted to the toxicology department of a hospital following a suicide attempt by
acute intoxication.

Exclusion criteria: i) diagnosed with psychosis.

Intervention: short crisis intervention during hospital stay followed by 12 weekly outpatient appoint-
ments with the same therapist (duration not reported). Therapeutic content involved a motivational in-
terview, as well as a letter and assessment of motivation towards therapy delivered by the same thera-
pist. Sessions were delivered by therapists trained (duration not reported) in psychotherapy or behav-
iour therapy (further information on expertise not reported).

Comparator: short crisis intervention during hospital stay followed by outpatient appointments with
a different therapist (both the number and duration of these appointments were not reported). Thera-
peutic content involved a motivational interview, as well as a letter and assessment of motivation to-
wards therapy delivered by different therapists.

Length of treatment: three months.

Primary outcome(s): i) repetition of SH ascertained from self-report; ii) depression (unclear how mea-
sured); iii) treatment adherence as measured by the number of sessions attended; iv) suicide (unclear
how ascertained).

Source(s) of funding: no information on sources of funding reported.
Conflict(s) of interests: no information on conflicts of interest reported.
Other: in the first phase of this trial, the efficacy of standard care was assessed in terms of compli-
ance. 85 participants were not randomly assigned to this group but were instead “referred routine-
ly” (Torhorst 1987, p. 53).

Participants were individually randomised (method not reported) to either long-term (over 12 months)
or short-term (over 12 weeks) psychotherapy.

N lost to follow-up: 0/80 (0%) for repetition of SH at post-intervention.

Location: Munich, Germany.

Interventions

Outcomes

Notes

Torhorst 1988 

Study characteristics

Methods

Participants

Number of total participants: 80 participants were randomised, 40 were allocated to long-term psy-
chotherapy, and 40 were allocated to short-term psychotherapy.

Profile of participants: average age not reported, range: 18-65 years. All (n = 80; 100%) had a history of
SH (i.e. multiple episodes of SH).

Source of participants: patients hospitalised following an episode of self-poisoning and who were re-
ferred to the liaison service of a toxicological ward.

Inclusion criteria: i) sufficient language ability; ii) living within commuting distance; iii) ≥ 1 suicide at-
tempt preceding trial entry.

Exclusion criteria: i) diagnosed with endogenous psychosis; ii) already receiving psychotherapeutic
treatment (in- or outpatient); iii) overdose involving use of illicit drugs.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

154

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Torhorst 1988  (Continued)

Interventions

Outcomes

Notes

Turner 2000 

Study characteristics

Methods

Intervention: long-term psychotherapy involving one session (duration not reported) per month over
a period of 12 months in addition to a brief crisis intervention (duration not reported) delivered three
days after admission. Sessions were delivered by psychiatric attendants (no further information on ex-
perience was reported).

Comparator: short-term psychotherapy involving 12 weekly sessions (duration not reported) over a pe-
riod of three months in addition to a brief crisis intervention (duration not reported) delivered three
days after admission.

Length of treatment: for the experimental arm, 12 months; for the control arm, 3 months.

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) depression (unclear how mea-
sured); iii) general symptomatology (unclear how measured); iv) treatment adherence as measured by
the number of sessions attended.

Source(s) of funding: “Supported by a grant from the FRG Ministry for Research and Technolo-
gy” (Torhorst 1988; p. 419).
Conflict(s) of interests: no information on conflicts of interest reported.

Participants were individually randomised (method not reported) to either DBT or alternative psy-
chotherapy.

N lost to follow-up: 0/24 (0%) for repetition of SH by the post-intervention assessment.

Location: Philadelphia, PA, USA.

Participants

Number of total participants: 24 participants were randomised, 12 were allocated to DBT, and 12 were
allocated to alternative psychotherapy (client-centred psychotherapy).

Profile of participants: average age 22.0 years (SD not reported) (range: 18-27 years). The majority (n =
19; 79.2%) were female. Almost all (n = 23; 95.8%) were diagnosed with an Axis I disorder, including:
dysthymia with a comorbid generalised anxiety disorder (n = 17), MDD (n = 3), and dysthymia (n = 3). Al-
most all (n = 23; 95.8%) were also diagnosed with a comorbid Axis II disorder, including: dependent PD
(n = 9), histrionic PD (n = 6), narcissistic PD (n = 6), schizotypal PD (n = 3), ASPD (n = 2), paranoid PD (n
= 2), and compulsive PD (n = 1). Three-quarters (n = 18; 75.0%) were also diagnosed with AUD misuse,
83.3% (n = 20) were diagnosed with SUD.

Source of participants: patients admitted to hospital following a suicide attempt.

Inclusion criteria: i) diagnosed with BPD according to both the Diagnostic Interview for Borderlines and
the Personality Disorders Examination criteria; ii) admitted to hospital following a suicide attempt; iii)
able to provide written informed consent; iv) consented to randomised assignment.

Exclusion criteria: i) diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, organic
mental disorder, or mental retardation.

Intervention: DBT delivered according to Linehan’s manualised protocol (Linehan 1993) modified to in-
clude psychodynamic techniques to conceptualise patients’ behavioural, emotional, and relationship
schema. Additionally, no group skills training sessions were provided. Instead, participants received six
sessions (duration not reported) of individual therapy to provide interpersonal skills training focusing
on the identification of significant persons in the participants’ environment, including problems in rela-
tionships and with family. Sessions were delivered by therapists with an average of 22 years clinical ex-
perience working in family systems, and in delivering client-centred and psychodynamic therapy. Ther-
apists also received 12 sessions of training in delivering DBT over three months.

Interventions

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

155

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Turner 2000  (Continued)

Cochrane Database of Systematic Reviews

Comparator: client-centred therapy based on Carkhuff 1969. Therapeutic content involved a SH/sui-
cide contract, emphatic understanding, provision of a supportive atmosphere to enable individuation,
stress management, and relapse prevention. Participants also received six sessions (duration not re-
ported) of interpersonal skills training focusing on the identification of significant persons in the partic-
ipants’ environment, including problems in relationships and with family.

Concomitant medications: were permitted. The majority (n = 19, 71.2%) were prescribed some form of
psychiatric medication. A slightly greater proportion of those allocated to TAU were prescribed medica-
tion (91.7% and 66.7%, respectively).

Length of treatment: 12 months.

Primary outcome(s): i) repetition of SH ascertained from self-report; ii) anger measured by the Target
Behavior Ratings; iii) anxiety measured by the Beck Anxiety Inventory; iv) depression as measured by
the BDI; v) general symptomatology measured by the Brief Psychiatric Rating Scale; vi) impulsiveness
measured by the Target Behavior Ratings; vii) suicidal ideation measured by the BSSI.

Source(s) of funding: no information on sources of funding reported.
Conflict(s) of interests: no information on conflicts of interest reported.

Participants were individually randomised using a computer-based allocation sequence with a random
blocking procedure stratified by hospital and parasuicide risk to either CBT-based psychotherapy or
TAU.

N lost to follow-up: 50/480 (10.4%) for repetition of SH data at post-intervention.

Location: Glasgow, Edinburgh, Nottingham, West London, and South London, UK.

Outcomes

Notes

Tyrer 2003 

Study characteristics

Methods

Participants

Number of total participants: 480 participants were randomised, 239 were allocated to manual-assisted
CBT-based psychotherapy, and 241 were allocated to TAU.

Interventions

Profile of participants: average age 32.0 ± 11.0 years (range: 16-65 years). The majority (n = 326; 67.9%)
were female. Just under half (n = 202; 42.1%) were diagnosed with any PD.

Source of participants: patients presenting to hospital following an episode of SH.

Inclusion criteria: i) aged 16-65 years; ii) history of SH prior to trial entry; iii) able to provide informed
consent; iv) sufficient language ability; v) lives in the catchment area; vi) available for follow-up.

Exclusion criteria: i) diagnosed with an organic disorder, AOD dependence, schizophrenia or bipolar af-
fective disorder group of according to ICD-10 diagnostic codes; ii) required psychiatric hospitalisation.

Intervention: manual-assisted CBT-based psychotherapy consisting of up to seven sessions (five ses-
sions during the acute phase, and two further 'booster' sessions; duration not reported). Therapeu-
tic content involved an evaluation of the most recent suicide attempt, crisis skills, PST, cognitive tech-
niques for emotional, and negative thinking management, and the development of relapse prevention
strategies. Sessions were delivered by duty therapists (no further information on expertise or experi-
ence was reported).

Comparator: TAU involving psychiatric assessment, outpatient care, occasional day-patient care, refer-
ral to GP, or a combination of these.

Length of treatment: up to 3 months (for the acute phase); up to 6 months (including ‘booster’ phase).

Outcomes

Primary outcome(s): i) repetition of SH according to SH and as supplemented by GP notes, hospital
records or both; ii) anxiety as measured by the HADS; iii) depression as measured by the HADS; iv)

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

156

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Tyrer 2003  (Continued)

Cochrane Database of Systematic Reviews

hopelessness as measured by the BHS; v) general functioning as measured by the GAS; vi) social func-
tioning as measured by the SFQ; vii) quality of life as measured by the EuroQoL; viii) symptomatology,
including personality disorder symptomatology, as measured by the CSRI; ix) suicide (unclear how as-
certained).

Notes

Source(s) of funding: “The POPMACT study is funded by the Medical Research Council of the United
Kingdom” (Tyrer 2003, p. 67).
Conflict(s) of interests: no conflicts of interest reported.

Vaiva 2006 

Study characteristics

Methods

Participants were individually randomised using a computer-based pseudo-random numbers list in
opaque sealed envelopes to either a remote contact intervention (telephone contact) or TAU.

N lost to follow-up: 0/605 (0%) for repetition of SH by the 24-month assessment.

Location: Lille, France.

Participants

Number of total participants: 605 participants were randomised, 293 were allocated to a remote contact
intervention (telephone contact) in addition to TAU, and 312 were allocated to TAU.

Profile of participants: mean age 35.7 ± 11.3 years (range: 18-65 years). The majority (n = 441; 72.9%)
were female. A minority (n = 54; 9.0%) had a history of SH (i.e. multiple episodes of SH). No information
on psychiatric diagnoses reported.

Source of participants: patients presenting to hospital following a drug overdose.

Inclusion criteria: i) aged 18-65 years; ii) hospitalised following a suicide attempt by drug overdose; iii)
examined by a psychiatrist who agreed to patients’ discharge; iv) able to provide name of GP; v) able to
be contacted by phone; vi) able to provide written consent.

Exclusion criteria: i) homeless; ii) addicted to illicit drugs.

Intervention: remote contact intervention (telephone contact) consisting of a single telephone call (ei-
ther at one or three months' post-discharge; duration not reported) to review the ED-recommended
treatment in addition to TAU. Where participants found the treatment recommended during their hos-
pitalisation too difficult to follow, a new regimen was suggested. For those at high risk of suicide, an ur-
gent appointment was made at the emergency department where the patient initially received treat-
ment. No therapy other than support was provided. Sessions were delivered by psychiatrists with a
minimum of 5 years experience working with suicidal persons.

Comparator: TAU typically involving referral to the participants’ GP.

Length of treatment: single telephone call at one or three months.

Primary outcome(s): i) repetition of SH ascertained from self-report and hospital records; ii) suicide (un-
clear how ascertained).

Source(s) of funding: “This study was funded by a hospital clinical research grant (PHRC98), a state re-
gion contract plan, a subsidy from the regional hospitalization agency” (Vaiva 2006, p. 1245).

Conflict(s) of interests: no conflicts of interest reported.

Interventions

Outcomes

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

157

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Vaiva 2018 

Study characteristics

Methods

Participants were individually randomised using a computer-based pseudo-random numbers list using
a blocking procedure to either a remote contact intervention (telephone contact combined with emer-
gency cards and letters) or TAU.

N lost to follow-up: data on repetition of SH not reported.

Location: various locations, France.

Participants

Number of total participants: 987 participants were randomised, 493 were allocated to a remote contact
intervention (crisis card, postcards and/or telephone contact) in addition to TAU, and 943 were allocat-
ed to TAU.

Interventions

Profile of participants: mean age 38.3 ± 13.3 years (range not reported). Almost two-thirds (n = 361;
63.4%) were female. Just under half (n = 452; 45.8%) had a history of SH (i.e. multiple episodes of SH).
Almost half (n = 481; 48.7%) were diagnosed with MDD, followed by GAD (n = 136; 13.8%), panic disor-
der (n = 110; 11.1%), dysthymia (n = 103; 10.4%), PTSD (n = 75; 7.6%), any eating disorder (n = 47; 4.8%),
social phobia (n = 44; 4.5%), and mania (n = 36; 3.6%).

Source of participants: patients presenting to the ED following a suicide attempt.

Inclusion criteria: i) presenting to the ED following a suicide attempt.

Exclusion criteria: i) admitted to hospital for ≥ 7 days following the index suicide attempt; ii) unable to
be contacted by telephone; iii) homeless; iv) under guardianship; v) engaged in ≥ 4 suicide attempts
within the three years preceding trial entry.

Intervention: remote contact intervention consisting of either a crisis card delivered within 24 hours'
post-discharge (for those whose index attempt represented their first episode), telephone contact at
days 10 and 21 post-discharge, or for those who were unable to be contacted by telephone, a series of
postcards mailed at two, three, four, and five months post-discharge (for those who had engaged in
multiple episodes of SH). Participants in addition received TAU. Crisis, telephone contacts, and post-
cards encouraged participants to make contact with the service, if required. No information on who de-
livered the intervention, their expertise, or their experience was reported.

Comparator: TAU consisting of a follow-up appointment within 24-48 hours' post-discharge, and refer-
ral to a psychiatrist or physician, as required.

Length of treatment: six months.

Outcomes

Primary outcome(s): i) repetition of SH (at post-intervention) ascertained from self-report and electron-
ic medical records.

Secondary outcome(s): i) repetition of SH (at 13 months follow-up) ascertained from self-report and
electronic medical records; ; ii) frequency of repeated SH ascertained from self-report and electronic
medical records; iii) time to SH repetition ascertained from self-report and electronic medical records;
iv) adverse events (i.e. repetition of SH, suicide, and/or loss to follow-up).

Notes

Source(s) of funding: "This study received a Hospital Clinical Research Grant (PHRC 2009) from the
French Health Ministry" (Vaiva 2018, p.7).

Conflict(s) of interest: "The authors have no conflict of interest to disclose" (Vaiva 2018, p.7).

Van der Sande 1997 

Study characteristics

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

158

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Van der Sande 1997  (Continued)

Methods

Participants were individually randomised using a computer-generated series of random numbers to
either intensive in- and outpatient treatment or TAU.

N lost to follow-up: 0/274 (0%) for repetition of SH data by the 12-month assessment.

Location: Utrecht, the Netherlands.

Participants

Number of total participants: 274 participants were randomised, 140 were allocated to brief CBT-based
psychotherapy, and 134 were allocated to TAU.

Interventions

Profile of participants: mean age 36.3 ± 15.1 years (range not reported). Just over half (n = 158; 57.7%)
were female. Over half (n = 175; 63.9%) also had a history of SH (i.e. multiple episodes of SH). Just over
one quarter (n = 77; 28.1%) were diagnosed with a mood disorder.

Source of participants: patients admitted to hospital following a suicide attempt.

Inclusion criteria :i) admitted to hospital following a suicide attempt; ii) sufficient language ability; iii)
lived in catchment area.

Exclusion criteria: i) engaged in habitual wrist cutting of minor severity; ii) referred for psychiatric inpa-
tient treatment; iii) imprisoned; iv) diagnosed with a substance addiction; v) required recurrent consul-
tations with a liaison psychiatrist during a stay > 2 days on a somatic ward.

Intervention: brief psychiatric unit admission to a specialist unit for the treatment of suicide attempters
for a period of one to four days. Participants were then offered outpatient treatment based on Haw-
ton and Catalan’s problem-solving approach (Hawton 1987b) (number and duration of sessions not re-
ported). Therapeutic content involved discussing the reasons behind the current suicide attempt, dis-
cussing these reasons with family, partner or both, if required, and changing the ability to cope with
future problems. 24-hour emergency access to the unit was offered throughout the duration of outpa-
tient treatment. Sessions were delivered by psychiatrists, community psychiatric nurses, and psychi-
atric nurses (no further information on experience was reported).

Comparator: TAU. For around one quarter (n = 34) this involved admission to an inpatient unit, whilst
for the remaining three-quarters (n = 100), this involved referral to outpatient services.

Length of treatment: unclear.

Outcomes

Primary outcome(s): i) repetition of SH ascertained from self-report, hospital records, or both.

Secondary outcome(s): i) hopelessness measured by the BHS; ii) general symptoms measured by the
SCL-90; iii) service use ascertained from self-report; iv) suicide (unclear how ascertained).

Notes

Source(s) of funding: “This study was supported by grant OG 92-023 of the National Health Insurance
Council (Ziekenfonds-Raad)” (Van der Sande 1997, p. 40).
Conflict(s) of interests: none reported.

Van Heeringen 1995 

Study characteristics

Methods

Participants were individually randomised using an open randomisation list to either case manage-
ment or TAU.

N lost to follow-up: 125/516 (24%) for repetition of SH data by the 12-month assessment.

Location: Ghent, Belgium.

Participants

Number of total participants: 516 participants were randomised, 258 were allocated to a compliance
enhancement intervention, and 258 were allocated to TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

159

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Van Heeringen 1995  (Continued)

Cochrane Database of Systematic Reviews

Profile of participants: mean (SD) age not reported (range not reported). Just under half (n = 222; 43.0%)
were female. Just under one third (n = 155; 30.0%) had a history of SH (i.e. multiple episodes of SH). A
minority (n = 77; 14.9%) were diagnosed with any mood disorder, followed by any anxiety disorder (n =
14; 2.7%).

Source of participants: patients treated in an A&E department following a suicide attempt.

Inclusion criteria: i) aged 15 years of age or older; ii) lived in the catchment area.

Exclusion criteria: i) currently receiving inpatient medical treatment.

Intervention: case management and compliance enhancement involving home visits (number and du-
ration not reported) to those participants who did not keep to scheduled outpatient appointments in
addition to TAU. Therapeutic content involved discussing reasons for not attending appointments and
the patient was encouraged to attend future treatment sessions. Sessions were delivered by communi-
ty nurses (no further information on experience was reported).

Comparator: TAU consisting of outpatient appointments only (number and duration not reported).
Non-compliant participants did not receive home visits.

Length of treatment: not reported.

Primary outcome(s): i) repetition of SH ascertained from self-report supplemented by collateral report
from GPs, relatives, or both; ii) treatment adherence measured by the number of sessions attended; iii)
suicide (unclear how ascertained).

Source(s) of funding: “This study was supported by a grant from the National Fund for Scientific Re-
search (NFWO, grant no. 3.0061.86)” (Van Heeringen 1995, p. 969).
Conflict(s) of interests: no information on conflicts of interest reported.

Participants were individually randomised using a computer-generated sequence and a blocking pro-
cedure stratified by sex and antidepressant use at baseline, to either DBT or alternative psychotherapy.

N lost to follow-up: 48/162 (25.3%) for repetition of SH by the post-intervention assessment (data ob-
tained by correspondence).

Location: Newcastle, NSW, Australia.

Interventions

Outcomes

Notes

Walton 2020 

Study characteristics

Methods

Participants

Number of total participants: 162 participants were randomised, 81 were allocated to DBT, and 81 were
allocated to alternative psychotherapy (conversational model).

Profile of participants: mean age 22.6 ± 7.8 years (range: 18-65 years). Just over three-quarters (n = 125;
77.2%) were female. All (n = 162; 100%) were diagnosed with BPD. Just over half (n = 89; 54.9%) were di-
agnosed with any anxiety disorder, followed by MDD (n = 84; 51.8%), and SUD (n = 45; 27.8%).

Source of participants: patients referred to a specialist DBT service. Correspondence with trial authors
also revealed that all had engaged in SH resulting in presentation to clinical services within six months
preceding trial entry.

Inclusion criteria: i) aged 18-65 years of age; ii) diagnosed with BPD according to DSM-IV criteria; iii) ≥ 3
episodes of suicide attempts and/or NSSI in the 12 months preceding trial entry.

Exclusion criteria: i) diagnosed with an organic disorder, psychosis, or a developmental disability; ii) en-
gaging in antisocial behaviour that posed a significant threat to staff and fellow patients; iii) lived out-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

160

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Walton 2020  (Continued)

Interventions

side the catchment area; iv) insufficient language ability; v) substance dependant (other than nicotine);
vi) previously treatment with BDT or conversational psychotherapy.

Intervention: DBT consisting of 52 weekly individual therapy sessions (60 minutes) and 52 weekly
group-based skills sessions (2.5 hours). Participants also had access to telephone coaching, as re-
quired. DBT therapists also participated in weekly consultation team meetings (duration not reported).
Therapeutic content involved directive, problem-oriented techniques (including behavioural skill train-
ing, contingency management and cognitive modification) alongside supportive techniques. Sessions
were delivered by psychiatrists, psychologists, psychiatric trainees, mental health nurses, social work-
ers, or occupational therapists with a minimum of two years clinical experience and who had received
training (duration not reported) in delivering the intervention. Over one-third (37.5%) delivered both
the intervention and comparator conditions.

Comparator: manualised conversational model psychotherapy consisting of twice weekly sessions (60
minutes) based on Meares 2004. Therapeutic content was nondirective and included a focus on emo-
tional misunderstanding, mutual self-reflection, repair of the moment of disconnection in the thera-
peutic relationship, and the development of an authentic personal narrative.

Length of treatment: 14 months.

Outcomes

Primary outcome(s): i) frequency of SH ascertained from self-report using the SASII; ii) depression as
measured by the BDI.

Notes

Wang 2016 

Study characteristics

Methods

Secondary outcome(s): i) BPD symptoms as measured by the Borderline Personality Disorder Severity
Index (BPDSI-IV); ii) dissociation as measured by the DES; iii) emotion regulation as measured by the
DERS; iv) interpersonal problems as measured by the IIP; v) mindfulness skills as measured by the Ken-
tucky Inventory of Mindfulness Skills (KIMS); vi) sense of self as measured by the Sense of Self Inventory
(SSI).

Source(s) of funding: "No external research funding was obtained for this project. We acknowledge
the support of Hunter New England Mental Health Service and thank the Centre for Brain and Mental
Health Research (University of Newcastle) for providing a small grant specifically to cover the cost of
adherence coding" (Walton 2020, p.13).

Conflict(s) of interest: "The author(s) declared no potential conflicts of interest with respect to the re-
search, authorship and/or publication of this article" (Walton 2020, p.13).

Participants were individually randomised "according to the order of their documented suicide report
number received...Report numbers with an odd number were grouped into the TAU group, while even
numbered reports were grouped into the coping card group" (Wang 2016, p.108).

N lost to follow-up: 0/64 (0.0%) for repetition of SH by the post-intervention assessment.

Location: Chia-Yi City, Taiwan.

Participants

Number of total participants: 64 participants were randomised, 32 were allocated to a remote contact
intervention (emergency card), and 32 were allocated to TAU.

Profile of participants: mean age 37.9 ± 11.1 years (range: not reported). Almost three-quarters (n = 47;
73.4%) were female. Just over one third (n = 23; 35.9%) had a history of SH (i.e. multiple episodes of
SH). Although over half (n = 39; 60.9%) had previously received psychiatric treatment, no information
on psychiatric diagnoses was reported.

Source of participants: patients referred by gatekeepers for case management provided by a suicide
prevention service following a suicide attempt.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

161

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Wang 2016  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Inclusion criteria: i) referred by gatekeepers for case management provided by a suicide prevention ser-
vice following a suicide attempt; ii) sufficient language ability.

Exclusion criteria: i) moved outside of the catchment area; ii) refused a follow-up visit on ≥ 3 separate
occasions; iii) admitted to hospital, another institution, and/or imprisoned for ≥ 1 month; iv) pregnant.

Intervention: remote contact intervention (crisis card). Participants received a 180 x 108 mm paper fold-
ed into a business card size small enough to fit into a wallet. The card provided contact details for a 24-
hour crisis hotline telephone number and local contact details for local medical services. Additionally,
participants received a series of six weekly "training sessions" (duration not reported) provided during
home visits. Sessions were delivered by clinical psychologists, graduate psychologists, or social work-
ers who received training (30 minutes) in delivering the intervention.

Comparator: TAU consisting of a crisis assessment, emotional support, psychological support, and re-
ferral for other resources (i.e. community-based mental health services, social welfare, and vocational
training).

Length of treatment: 14 months.

Outcomes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) time to SH repetition (unclear how
ascertained).

Secondary outcome(s): i) suicide risk measured by the Suicide Risk Inventory (SRI); ii) suicidal ideation
measured by the suicidal ideation subscale of the SRI; iii) hopelessness measured by the BHS; iv) gener-
al symptoms measured by the BSRS.

Notes

Source(s) of funding: no information on sources of funding reported.
Conflict(s) of interests: no information on conflicts of interest reported.

Waterhouse 1990 

Study characteristics

Methods

Participants were individually randomised using sequentially numbered sealed envelopes to either
general hospital admission or discharge.

N lost to follow-up: 0/77 (0%) for repetition of SH data at post-intervention.

Location: York, UK.

Participants

Number of total participants: 77 participants were randomised, 38 were allocated to a short-stay hospi-
tal admission, and 39 were allocated to alternative psychotherapy (discharge from hospital).

Profile of participants: mean age 30.0 years (SD not reported; range: not reported). Over half (n = 48;
62.3%) were female. Over one third (n = 28; 36.4%) had a history of SH (i.e. multiple episodes of SH).

Source of participants: patients admitted to an A&E department following an episode of SH.

Inclusion criteria: i) aged 16 years or older.

Exclusion criteria: i) had immediate medical and/or psychiatric treatment needs.

Interventions

Intervention: general hospital admission excluding additional treatment or counselling. “Hospital ad-
mission consisted of little more than a bed, without further referral to other helping agencies” (Water-
house 1990, p. 238). No information on who delivered the intervention, their expertise, or their experi-
ence was reported.

Comparator: discharge from hospital.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

162

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Waterhouse 1990  (Continued)

Length of treatment: median length of admission was 17 hours.

Outcomes

Notes

Primary outcome(s): i) repetition of SH ascertained from collateral informant report (GPs), hospital
records, or both; ii) social functioning as measured by the Social Behaviour Assessment Schedule; iii)
depression and anxiety (unclear how ascertained); iv) hopelessness measured by the BHS; iv) social
isolation (unclear how ascertained); v) suicidal ideation as measured by the BSSI.

Source(s) of funding: no specific sources of funding were reported.
Conflict(s) of interests: “John Waterhouse was in receipt of a research grant from the Yorkshire Regional
Health Authority” (Waterhouse 1990, pg. 241).
Other: As depression data had been combined with anxiety data in this trial, this outcome could not be
included in the present review.

Wei 2013 

Study characteristics

Methods

Participants were individually randomised using a computer-generated sequence to either a CBT-
based psychotherapy, a telephone intervention, or TAU.

N lost to follow-up: 67/239 (28.0%) for repetition of SH at post-intervention; 123/239 (51.5%) at the six-
month follow-up; 151/239 (63.2%) at the 12-month follow-up.

Location: Shenyang, Liaoning Province, China.

Participants

Number of total participants: 239 participants were randomised, 82 were allocated to CBT-based psy-
chotherapy, 80 were allocated to a telephone intervention, and 77 were allocated to TAU.

Profile of participants: mean age 32.7 ± 14.0 (range: not reported). Just over three-quarters (n = 182;
76.1%) were female. Just under half (n = 108; 45.2%) were diagnosed with any psychiatric disorder.

Source of participants: patients admitted to ED following a suicide attempt.

Inclusion criteria: i) older than 15 years; ii) admitted to ED following a suicide attempt; iii) ≥ 1 contact
person to provide collateral reports on suicidal behaviour; iv) able to understand the trial procedures;
v) able to provide written informed consent.

Exclusion criteria: none reported.

Intervention: there were two experimental arms in this trial: i) CBT-based psychotherapy, and ii) tele-
phone intervention. CBT-based psychotherapy consisted of 10 weekly/biweekly/monthly sessions
(45-60 minutes). The telephone intervention involved 12 psychological support calls (20-40 minutes).
Therapeutic content involved reassurance, emphatic reasoning, collaborative PST, stress management,
and encouraging participants to increase contact with existing social supports (e.g. family, friends).
Sessions were delivered by therapists (no further information on expertise) with a minimum of five
years clinical work experience.

Comparator: "[P]atients in the control group did not receive any interventions” (Wei 2013, p. 109).

Length of treatment: three months.

Primary outcome(s): i) repetition of SH ascertained from self-report and/or collateral informant report;
ii) depression measured by the HDRS; iii) quality of life measured by an idiosyncratic scale; iv) suicidal
ideation measured by the BSSI; v) suicide (unclear how ascertained).

Source(s) of funding: “This project was part of the Small Grants Program to Improve the Quality and Im-
plementation of Suicide Research in China’ which was supported by the China Medical Board of New
York (grant number 05-813)” (Wei 2013, p. 113).

Interventions

Outcomes

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

163

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Wei 2013  (Continued)

Conflict(s) of interests: no conflicts of interest reported.

Weinberg 2006 

Study characteristics

Methods

Participants were individually randomised by asking participants to choose between two similar en-
velopes to either CBT-based psychotherapy or TAU.

N lost to follow-up: 0/30 (0%) for repetition of SH data by the six-month assessment.

Location: Boston, MA, USA.

Participants

Number of total participants: 30 participants were randomised, 15 were allocated to manual assisted
CBT-based psychotherapy, and 15 were allocated to TAU.

Profile of participants: mean age 28.2 ± 8.2 (range: 18-40 years). All (n = 30; 100%) were female.

Source of participants: recruited from the community via advertisements in local newspapers, clinical
services at a hospital, and from individuals participating in a longitudinal study.

Inclusion criteria: i) female; ii) aged 18-40 years; iii) diagnosed with BPD; iv) history of repetitive SH with
at ≥ 1 episode during the month prior to trial entry.

Exclusion criteria: i) diagnosed with comorbid psychosis; ii) judged to be at an elevated risk of suicide;
iii) diagnosed with substance abuse; iv) history of attempted suicide (only those engaging in repetitive
SH were eligible for inclusion in this trial).

Interventions

Intervention: manual assisted CBT-based psychotherapy consisting of six sessions (duration not report-
ed). Therapeutic content included evaluation of the attempt, developing crisis skills problem-solving
skills, developing cognitive techniques for emotional and negative thinking management, and relapse
prevention. The primary investigator acted as the therapist (no further information on expertise or ex-
perience was reported).

Comparator: TAU.

Length of treatment: two months.

Outcomes

Notes

Primary outcome(s): i) repetition of SH ascertained from self-report using the PHI; ii) borderline symp-
toms measured by the Revised Diagnostic Interview for Borderlines; iii) suicidal ideation measured by
the Suicide Behaviors Questionnaire; iv) service use measured by the Treatment Utilization Interview;
v) suicide (unclear how ascertained).

Source(s) of funding: ”This study was supported by a Young Investigator Award from the Borderline Per-
sonality Disorder Research Foundation (I.W.)“ (Weinberg 2006, p. 482).
Conflict(s) of interests: no conflict of interest reported.
Other: All participants were also simultaneously participating in additional treatment throughout the
duration of this trial.

Welu 1977 

Study characteristics

Methods

Participants were individually randomised using a random numbers table to either intensive outpa-
tient treatment or TAU.

N lost to follow-up: 1/120 (0.8%) for repetition of SH data by the four-month assessment.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

164

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Welu 1977  (Continued)

Location: Pittsburgh, PA, USA.

Cochrane Database of Systematic Reviews

Participants

Number of total participants: 120 participants were randomised, 63 were allocated to intensive outpa-
tient treatment, and 57 were allocated to TAU.

Profile of participants: average age 29.0 years (IQR/SD not reported; range: not reported). Information
on sex not reported. Over half (n = 72; 60.0%) had a history of SH (i.e. multiple episodes of SH).

Source of participants: patients admitted to an A&E department following an episode of SH.

Inclusion criteria: i) over 16 years of age.

Exclusion criteria: i) student living in university accommodation; ii) resident in a care-giving institution
or institutionalised at the time of the index episode of SH.

Interventions

Intervention: outreach programme involving a community mental health team contacting participants
immediately after discharge to arrange weekly/biweekly home visits. Sessions were delivered by nurs-
es, social workers, and community workers (further information on experience was not reported).

Comparator: TAU involving a psychiatric consultation at request of the treating physician. Participants
were also given a next day appointment for evaluation at the community mental health team centre.
Any further contact after discharge was at the participant’s request.

Length of treatment: unclear.

Primary outcome(s): i) repetition of SH ascertained from self-report, hospital records, and/or collateral
informant report; ii) AOD use ascertained from self-report, hospital records, and/or collateral informant
report; iii) adverse events (purposive accidents) ascertained from self-report, hospital records, and/or
collateral informant report; iv) service use ascertained from records.

Source(s) of funding: “This investigation was supported by Research Grant MH19491 from the National
Institute of Mental Health” (Welu 1977, p. 17).
Conflict(s) of interests: no conflicts of interest reported.

Outcomes

Notes

AA: alcoholics anonymous
AAQ: Acceptance and Action Questionnaire
ACT: Acceptance and Commitment Therapy
A&E: Accident and Emergency
AOD: alcohol and other drug
ASPD: antisocial personality disorder
ASSIP: Attempted Suicide Short Intervention Program
AUD: Alcohol use disorder
AUDIT: Alcohol Use Disorders Identification Test
BAI: Beck Anxiety Inventory
BDI: Beck Depression Inventory
BEST: Brief Education Supported Treatment
BHS: Beck Hopelessness Scale
BIS: Barratt Impulsiveness Scale
BPD: borderline personality disorder
BPDSI-IV: Borderline Personality Disorder Severity Index, 4th revision
BSRS: Brief Symptom Rating Scale
BSSI: Beck Scale for Suicidal Ideation
CAMS: Collaborative Assessment and Management of Suicidality
CBT: Cognitive Behavioural Therapy
CGI: Clinical Global Impression
CIP: Cultural Impact Profile
cRCT: cluster randomised controlled trial
CSQ-8: Client Satisfaction Questionnaire (8 item)
CSRI: Client Services Receipt Inventory
DASS: Depression Anxiety Stress Scale
DBT: Dialectical Behaviour Therapy

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

165

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

DERS: Difficulties in Emotion Regulation Scale
DES(-T): Dissociative Experiences Scale (-Taxon)
DSHI: Deliberate Self-Harm Inventory
DSM-IV(-TR): Diagnostic and Statistical Manual for mental disorders, version IV (Text Revision)
ED: emergency department
EPSIS: European Parasuicide Study Interview Schedule
EQ-5D: European Quality of Life-5 Dimension
ESS: Experience of Shame Scale
EUC: enhanced usual care
EuroQoL: European Quality of Life
FRAMES: Feedback, Responsibility, Advice, Menu, Empathic, and Self-efficacy
GAD: Generalized Anxiety Disorder
GAF: General Assessment of Functioning
GAS: Global Assessment Scale
GHQ(-12): General Health Questionnaire (12 item)
GP: general practitioner
GSI: Global Severity Index
HADS: Hospital Anxiety and Depression Scale
HAMD-24: Hamilton Rating Scale, 24-item
HDRS: Hamilton Depression Rating Scale
HRSA: Health Resources and Services
HRSD: Hamilton Rating Scale for Depression
HSRS: Health Sickness Rating Scale
ICD-10: International Classification of Diseases, 10th Revision
IIP: Inventory of Interpersonal Problems
IQ: intelligence quotient
IQR: interquartile range
KIMS: Kentucky Inventory of Mindfulness Skills
LSASI: Lifetime Suicide Attempt Self-Injury Interview
MBT: Mentalisation-Based Therapy
MDD: Major Depressive Disorder
MEPS: Means-Ends Problem-Solving procedure
MINIM: minimisation programme
MMPI: Minnesota Multiphasic Personality Inventory
NA: narcotics anonymous
NR: not reported
NSSI: non-suicidal self-injury
PD: personality disorder
p.: page
PHI: Parasuicide History Inventory
PSS-I: PTSD Symptom Scale - Interview
PST: problem-solving therapy
PTSD: Post-traumatic stress disorder
SAPAS: Standardised Assessment of Personality - Abbreviated Scale
SAS: Social Assessment Scale
SASII: Suicide Attempt-Self-Injury Interview
SCID-II: Structured Clinical Interview for DSM-IV Axis II Personality Disorders
SCL-90: Symptom Check List-90
SD: standard deviation
SF-36: Social Functioning - 36 item
SFQ: Social Functioning Questionnaire
SH: self-harm
SHI: Self-Harm Inventory
SMART: Specific, Measurable, Achievable, Relevant, and Time-bound
SPSI: Social Problem-Solving Inventory
SRI: Suicide-Resilience Inventory
SSRI: Selective Serotonin Reuptake Inhibitor
STAXI: State-Trait Anxiety Inventory
SUD: substance use disorder
SUPRE-MISS: SUicide-PREvention Multisite Intervention Study on Suicidal behaviours
TAU: Treatment-as-usual
THI-2: Treatment History Interview-2

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

166

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

TRGI: Trauma-Related Guilt Interview
VHS: Volitional Help Sheet
vs.: versus
WHO: World Health Organization
ZAN-BPD: Zanarini Rating Scale for Borderline Personality Disorder
15D: 15D measure of health-related quality of life

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Agyapong 2016

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Ahmed 2016

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Albuixech-García 2020

Non-RCT

Andover 2015

Non-RCT

Andover 2017

At baseline, 78.8% of the sample had engaged in SH.

Andreasson 2016

Due to difficulties in recruitment, inclusion criteria for recency of SH was changed from within one
month of trial entry to within five years of trial entry. At baseline, 96% of the sample had engaged in
SH.

Andreoli 2019

Reported on outcomes ≥ 3 years post-intervention. Data for earlier follow-up assessments were in-
cluded in this review, however.

Barnes 2018

At baseline, 25.0% of the sample had engaged in SH.

Barnhofer 2015

Participants engaging in regular SH were excluded.

Bateman 2020

Bentley 2017

Reported on outcomes ≥ 8 years post-intervention. Data for earlier follow-up assessments were in-
cluded in this review, however.

At baseline, mean number of SH episodes per participant was < 1, suggesting that not all some par-
ticipants had engaged in SH.

Berrouiguet 2019

Study protocol. However, non-RCT

Betz 2020

Bryan 2017a

Bryan 2017b

Cebria 2015

Celano 2017

Currier 2015

Dassa 2018

Correspondence with trial authors indicated information on SH within six months of trial entry was
not recorded. However, at baseline, 6.1% of the sample had presented to the ED with SH.

At baseline, 56.0% of the sample had engaged in SH.

At baseline, 44.0% of the sample had engaged in SH.

Non-RCT

Correspondence with trial authors indicated information on SH within six months of trial entry was
not recorded. However, at baseline, 41.5% had engaged in SH.

Study protocol. However, non-RCT

We were unable to locate full text despite correspondence.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

167

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Reason for exclusion

Davidson 2006

Information on SH within six months of trial entry was not recorded. However, at baseline, 70.7%
had engaged SH.

Dimeff 2020

Non-RCT

Di Simplicio 2020

Participants were recruited from non-clinical settings.

Dixon-Gordon 2015

Participants were recruited from non-clinical settings.

Doering 2010

At baseline, 61.5% of the sample had engaged in SH.

Ducasse 2018

We were unable to obtain data on the proportion of participants with an episode of SH within six
months of trial entry from trial authors. However, at baseline, 27.5% had engaged in SH within one
month of trial entry.

Exbrayat 2017

Non-RCT

Franklin 2016

Participants were recruited from non-clinical settings.

Gabilondo 2020

Non-RCT

Galfalvy 2017

We were unable to locate full text despite correspondence.

Gooding 2020

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Goodman 2016

We were unable to obtain data on the proportion of participants with an episode of SH within six
months of trial entry from trial authors.

Goodman 2020

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Haddock 2019

We were unable to obtain data on the proportion of participants with an episode of SH within six
months of trial entry from trial authors.

Hashemi-Aliabadi 2020

Non-RCT

Hooley 2014

Hooley 2018

At baseline, 74.6% of the sample had engaged in SH.

Participants were recruited from non-clinical settings.

Hurtado-Santiago 2018

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Inder 2015

At baseline, 50.0% of the sample had engaged in SH.

ISRCTN10115835

Recruitment into this trial has suspended.

ISRCTN16003313

Trial paused. Recruitment into this trial has suspended due to COVID-19 restrictions.

ISRCTN16049211

Trial paused. Recruitment into this trial has suspended due to COVID-19 restrictions.

ISRCTN16862589

Trial paused. Recruitment into this trial has suspended due to COVID-19 restrictions.

ISRCTN18761534

Trial registration record last updated 12 December 2017. Current status therefore unknown

Jardon 2019

Non-RCT

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

168

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Jobes 2017

Reason for exclusion

At baseline, 50.0% of the sample had engaged in SH.

Johnson 2018

SH did not occur within six months of trial entry.

Kawanishi 2018

Study protocol for a cohort follow-up study of an RCT. Data from the RCT were included in this re-
view, however.

Kennedy 2018

Participants were recruited from non-clinical settings.

Kholodkov 2015

Participants were recruited from non-clinical settings.

Kim 2020

Kline 2016

Non-RCT

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Korczak 2020

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

LaCroix 2018

Lahoz 2016

Lin 2019

Luxton 2014

Mackie 2017

Correspondence with trial authors indicated that, at baseline, 86.1% of the sample had engaged in
SH.

Reported on outcomes ≥ 5 years post-intervention.

Participants were recruited from non-clinical settings.

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Non-RCT (qualitative investigation)

Marriott 2016

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Matsubara 2019

Non-RCT

McCall 2019

At baseline, 30.1% of the sample had engaged in SH.

McManama O'Brien 2018

Correspondence with trial authors indicated information on SH within six months of trial entry not
recorded. However, at baseline, 80.4% had a lifetime history of SH.

Miller 2016

Morley 2014

Navarro-Haro 2018

NCT00218725

At baseline, 74.5% had engaged in SH.

At baseline, 55.1% had engaged in SH within six months of trial entry.

Correspondence with trial authors indicated that, at baseline, 38.9% had engaged in NSSI and
38.9% had made a suicide attempt.

Correspondence with trial authors indicated the trial was terminated early due to feasibility prob-
lems in identifying and recruiting participants.

NCT00601939

Trial paused. Recruitment into this trial has suspended due to COVID-19 restrictions.

NCT00603421

We were unable to locate full text despite correspondence.

NCT00641498

We were unable to locate full text despite correspondence.

NCT00980824

Trial registration record last updated 28 June 2010. Current trial status therefore unknown

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

169

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Reason for exclusion

NCT01359761

Sample overlapped with LaCroix 2018.

NCT01823120

Correspondence with trial authors indicated the trial was terminated early due to a lack of funding
and resignation of critical trial staff.

NCT01952405

We were unable to locate full text despite correspondence.

NCT02227160

Trial was withdrawn due to a lack of funding.

NCT02299440

We were unable to obtain data on the proportion of participants with an episode of SH within six
months of trial entry from trial authors.

NCT02522143

Trial was withdrawn due to a lack of funding.

NCT02742922

Trial registration record last updated 1 February 2018. Current trial status therefore unknown

NCT03300596

We were unable to locate full text despite correspondence.

NCT03376113

Trial registration record last updated 1 December 2018. Current trial status therefore unknown

NCT03489382

Trial registration record last updated 1 June 2018. Current trial status therefore unknown

NCT03533075

Trial registration record last updated 1 August 2019. Current trial status therefore unknown

NCT03600532

Trial terminated early due to feasibility problems in identifying and recruiting participants

NCT03943862

Trial terminated early due to feasibility problems in identifying and recruiting participants

O'Toole 2019

At baseline, 16.3% of the sample had engaged in SH.

Pearce 2017

Pfeiffer 2019

Philips 2018

At baseline, 66.7% of the sample had engaged in SH.

At baseline, 77.1% of the same had engaged in SH.

Participants were recruited from non-clinical settings.

Pistorello 2020

At baseline, 30.6% of the sample had engaged in SH.

Pratt 2015

Rees 2015

At baseline, 85.5% of the sample had engaged in SH.

Trial terminated early due to feasibility problems in identifying and recruiting participants

Rompogren 2018

Participants were recruited from non-clinical settings.

Rudd 2015

Ryberg 2019

Sáiz 2014

Santel 2020

Sayal 2019

At baseline, 59.3% of the sample had engaged in SH.

At baseline, 69.2% of the sample had engaged in SH.

Correspondence with trial authors indicated that not all participants were randomised to the inter-
vention or control arms; some could choose to receive the intervention (i.e. non-RCT).

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Trial terminated early due to to feasibility problems in identifying and recruiting participants. Addi-
tionally, at baseline, 81.8% of the sample had engaged in SH.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

170

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Reason for exclusion

Sequeira 2016

At baseline, 15.4% of the sample had engaged in SH.

Simon 2016

Study protocol. However, unlikely that all participants would have engaged in SH at baseline

Sinnaeve 2018

Correspondence with trial authors indicated information on SH within six months of trial entry was
not recorded. However, at baseline, 91.7% of the sample had engaged in SH.

Slesnick 2020

At baseline, 80.0% of the sample had engaged in SH.

Smits 2020

Taha 2015

Tejedor 2011

At baseline, 42.1% had engaged in NSSI and 16.7% had made a suicide attempt.

SH did not occur within six months of trial entry.

Correspondence with trial authors indicated information in SH within six months of trial entry was
not recorded. However, at baseline, 39.0% had engaged in SH.

Vaiva 2016

Book chapter

Van Spijker 2018

At baseline, 54.3% of the sample had engaged in SH.

Ward-Ciesielski 2016

Participants were recruited from non-clinical settings.

Westling 2019

At baseline, 80.0% of the sample had engaged in SH.

Wilks 2018

Participants were recruited from non-clinical settings.

Wittouck 2014

Participants were those bereaved by suicide.

Yang 2020

Participants were recruited from non-clinical settings.

ED: emergency department; NSSI: non-suicidal self-injury; RCT: randomised controlled trial; SH: self-harm.

Characteristics of studies awaiting classification [ordered by study ID]

NCT00533117 

Methods

Participants

Triple (participant, investigator, outcome assessor)-blind RCT

Assignment: parallel-group, individual-level

Inclusion criteria: i) aged between 18 and 55 years; ii) diagnosed with borderline personality disor-
der; iii) at least one suicide attempt in the two months preceding trial entry; iv) at least one further
suicide attempt in the year preceding trial entry; v) experiences continued SH urges; vi) stable liv-
ing situation; vii) clinically stable enough to undergo a wash-out of all psychotropic medications;
viii) not participating in other forms of treatment; ix) women of child-bearing age must also be us-
ing effective birth control

Exclusion criteria: i) diagnosed with any organic mental disorder (current); ii) lifetime diagnosis of
schizophrenia, another psychosis, bipolar disorder, or mental retardation; iii) unable and/or unwill-
ing to complete a psychiatric interview; iv) unable to tolerate DBT or fluoxetine; v) currently receiv-
ing treatment for an acute medical illness, including substance abuse or anorexia nervosa; vi) his-
tory of major depression lasting longer than three months; vii) Hamilton Depression Score > 22; viii)
pregnant or breastfeeding

Interventions

Intervention 1 (DBT plus fluoxetine): DBT consisting of twice weekly individual therapy sessions (60
minutes' duration) and once weekly group therapy sessions (90 minutes' duration) for 12 months

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

171

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT00533117  (Continued)

Cochrane Database of Systematic Reviews

Outcomes

Notes

NCT00834834 

Methods

Participants

in addition to fluoxetine administered with a starting dose of 20 mg/day increasing by 20 mg/day in
monthly increments to one month, depending on tolerability, to up to 80 mg/day

Intervention 2 (Supportive psychotherapy plus fluoxetine): Supportive psychotherapy consisting of
weekly individual therapy sessions (50 minutes' duration) for 12 months in addition to fluoxetine
administered with a starting dose of 20 mg/day increasing by 20 mg/day in monthly increments to
one month, depending on tolerability, to up to 80 mg/day

Comparator 1 (DBT plus placebo): DBT consisting of twice weekly individual therapy sessions (60
minutes' duration) and once weekly group therapy sessions (90 minutes' duration) for 12 months in
addition to placebo

Comparator 2 (Supportive psychotherapy plus placebo): Supportive psychotherapy consisting of
weekly individual therapy sessions (50 minutes' duration) for 12 months in addition to placebo

Primary outcome(s): i) repetition of SH as ascertained from self-report

Single-blind RCT

Assignment: parallel-group, individual-level

Inclusion criteria: i) meets DSM-IV criteria for borderline personality disorder; ii) at least one sui-
cide attempt in the two months preceding trial entry; iii) at least one further suicide attempt in the
year preceding trial entry; iv) current suicidal ideation; v) not currently receiving optimum psychi-
atric treatment; vi) has a stable living arrangement; v) sufficient language ability; vi) clinically sta-
ble enough to undergo a washout of all psychotropic medications with the exception of benzodi-
azepines; viii) women of child-bearing age must also be using effective birth control

Exclusion criteria: i) diagnosed with an intellectual disability, bipolar disorder, schizophrenia, delu-
sional disorder; schizophreniform disorder, schizoaffective disorder, or a psychotic disorder not
otherwise specified; ii) severe psychiatric disorder or medical condition requiring acute treatment;
iii) clinically too unstable to be treated as an outpatient; iv) failed two adequate trials of fluoxetine
and citalopram within the two years preceding trial entry; v) history of severe allergies, adverse
drug reactions, or known allergy to fluoxetine or citalopram; vi) has a heart pacemaker body im-
plant, other metal implants, shrapnel or surgical prostheses that may present a risk to the partici-
pant or interfere with the fMRI scan; vii) diagnosed with Raynaud's disorder; viii) history of hyper-
tension, cardiovascular disease, or abnormal electrocardiograms; ix) claustrophobia or significant
discomfort in enclosed space; x) pregnant

Interventions

Psychosocial: DBT consisting of weekly individual therapy sessions (60 minutes' duration) and
group therapy sessions (90 minutes' duration) for six months

Pharmacological: fluoxetine. Starting dose of 20 mg/day increasing to over four weeks, depending
on tolerability, to up to 40 mg/day. Treatment will last six months.

Outcomes

Primary outcome(s): i) SH, as measured by the Columbia Suicide History Interview (CSHI)

Secondary outcome(s): i) number of participants with SH, as measured by the CSHI

Notes

CSHI:  Columbia  Suicide  History  Interview;  DBT:  dialectical  behaviour  therapy;  DSM-IV:  Diagnostic  and  Statistical  Manual  of  Mental
Disorders, fourth revision; fMRI: functional magnetic resonance imaging; mg: milligram; RCT: randomised controlled trial; SH: self-harm.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

172

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Characteristics of ongoing studies [ordered by study ID]

ACTRN12617000529347 

Study name

Will prisoners who self-harm reduce their frequency of self-harming after going through the dialec-
tical behaviour therapy intervention?

Methods

Open-label RCT

Allocation: parallel-group, blocked, individual-level

Participants

Inclusion criteria: i) males; ii) between 14 and 21 years of age; iii) convicted of any offence and cur-
rently serving a term of imprisonment; iv) remaining length of sentence of six months or greater; v)
able to understand trial procedures (but not necessarily how to read or write)

Exclusion criteria: i) females; ii) insufficient language ability; iii) foreign nationality; iv) diagnosed
with a psychiatric disorder, alcohol, drug, or other physical health condition that would interfere
with participation

Interventions

Intervention: group-based DBT. Twice weekly sessions (two hours' duration) of manualised, group-
based DBT for 12 weeks

Comparator. TAU, consisting of psychoeducation and ongoing monitoring by prison medical staff

Outcomes

Primary outcome(s): i) SH, as measured by the Inventory of Statements about Self-Injury (ISAS); ii)
borderline personality disorder symptoms, as measured by the Structured Clinical Interview for
Borderline Personality Disorder (SCID-BPD)

Secondary outcome(s): i) well-being, as measured by the Well-being Survey; ii) emotion regulation,
as measured by the Difficulties in Emotion Regulation Scale (DERS)

Starting date

26 April, 2017

Contact information

Principal investigator:

Prof. Brin Grenyer, University of Wollongong, Wollongong, New South Wales, Australia (greny-
er@uow.edu.au)

Notes

We were unable to confirm the above details were correct despite correspondence.

Berrouiguet 2014 

Study name

SIAM (Suicide Intervention Assisted by Messages): The development of a post-acute crisis text mes-
saging outreach for suicide prevention

Methods

Open-label RCT

Assignment: parallel-group, blocked, individual-level

Participants

Interventions

Inclusion criteria: i) aged 18 years and older; ii) discharged from the emergency department and/or
psychiatric unit following a presentation for attempted suicide; iii) hospitalised for < 7 days; iv) able
to provide informed consent; v) able to be contacted by telephone

Exclusion criteria: i) unwilling or unable to provide informed consent; ii) under guardianship; iii) in-
carcerated; iv) enrolled in other trials; v) not in possession of a mobile (cell) telephone

Intervention: a series of nine text messages sent within 48 hours post-discharge, at days 8, 15,
and at months 1, 2, 3, 4, 5, and 6. Message content will provide validation, reminders of discharge
agreements, and will also include information on how to access support from the participants’

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

173

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Berrouiguet 2014  (Continued)

Cochrane Database of Systematic Reviews

managing doctor (i.e. psychiatrist or general practitioner, as appropriate), as well as appointment
reminders.

Comparator: TAU

Outcomes

Primary outcome(s): i) repetition of SH as measured by the Columbia Scale

Secondary outcome(s): i) suicidal ideation as measured by the Columbia Scale; ii) satisfaction with
treatment as measured using a study-specific scale

Starting date

8 April, 2014

Contact information

Principal investigator:

Dr. Sofian Berrouiguet, Brest Medical University Hospital, Brest, France

(sofian.berrouiguet@gmail.com)

Notes

Chaïb 2020 

Study name

Group post-admission cognitive therapy for suicidality vs individual support therapy for the pre-
vention of repeat suicide attempts: a randomized controlled trial

Methods

Single (assessor)-blind RCT

Allocation: parallel-group, blocked, individual-level

Participants

Interventions

Inclusion criteria: i) aged 18 years and older; ii) hospitalised for the prevention of suicide; iii) high
suicide risk score, as measured by the MINI; iv) suicide attempt within the month prior to trial entry;
v) available to attend mid-week appointments; vi) insured or beneficiary of a health insurance plan;
vii) sufficient language ability; viii) able to provide informed consent

Exclusion criteria: i) participated in another interventional trial within the three months prior to trial
entry; ii) under an exclusion period as a consequence of participating in another trial; iii) under ju-
dicial protection or is an adult under legal guardianship; vi) unable and/or unwilling to provide in-
formed consent; v) diagnosed with schizophrenia or another psychotic disorder according to the
MINI; vi) diagnosed with a severe cognitive impairment on clinical observation; vii) diagnosed with
a severe AOD dependence

Intervention: group-based CBT consisting of six weekly sessions (90-120 minutes' duration) over six
weeks. Therapeutic content is based on the Post-Admission Cognitive Therapy model (Ghahraman-
lou-Holloway 2012). Therapeutic content includes: i) psychoeducation; ii) problem identification;
iii) cognitive restructuring; iv) behavioural activation; v) identification of reasons for living; vi) hope
box; vii) emotion regulation; viii) development of coping strategies; ix) problem-solving; x) relapse
prevention; xi) safety planning.

Comparator: individual supportive therapy consisting of six weekly sessions (60-90 minutes' dura-
tion) over six weeks. Therapeutic content includes: i) providing a supportive, non-judgemental and
empathetic environment in which the participant can explore reasons for SH. Therapists are specif-
ically told to avoid applying any principles of CBT-based psychotherapy.

Length of treatment: six weeks

Outcomes

Primary outcome(s): i) time to SH repetition (unclear how ascertained)

Secondary outcome(s): i) suicidal ideation, as measured by the C-SSRS and the BSSI; ii) depres-
sion, as measured by the BDI; iii) hopelessness, as measured by the BHS; iv) general symptoms, as

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

174

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Chaïb 2020  (Continued)

Cochrane Database of Systematic Reviews

measured by the MINI-7; v) suicide attempt lethality, as measured by the Risk Rescue Rating Scale
(RRRS)

Starting date

1 November, 2017

Contact information

Pincipal investigator:

Dr. Laurent Chaïb, Centre Hospitalier Université de Nîmes, Nîmes, France (lauren-
t.chaib@chu-nimes.fr)

Notes

McMain 2018 

Study name

The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality
disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol

Methods

Multisite, single (assessor)-blind RCT

Allocation: parallel-group, blocked, individual-level

Participants

Interventions

Inclusion criteria: i) aged between 18 and 65 years; ii) diagnosed with BPD according to DSM-IV cri-
teria and the International Personality Disorders Examination; iii) ≥ 2 episodes of SH in the five
years prior to trial entry, including ≥ 1 episode in the eight weeks prior to trial entry; iv) sufficient
language ability; v) able to provide informed consent; vi) have either Ontario Health Insurance Plan
(OHIP) coverage or BC Medical Services Plan (MSP) health insurance for ≥ 1 year

Exclusion criteria: i) received > 8 weeks of DBT in the 12 months prior to trial entry; ii) diagnosed
with psychosis, bipolar disorder, or dementia according to DSM-IV criteria; iii) estimated IQ ≤ 70; iv)
diagnosed with a chronic physical health condition expected to require periods of hospitalisation
within the next 12 months (e.g. cancer); v) plan to move outside of the catchment area within the
next two years

Intervention 1: manualised DBT (12-month protocol) consisting of weekly sessions (one hour) of in-
dividual therapy, weekly sessions (2 hours) of group skills training, access to 24/7 telephone con-
sultation, as needed, and weekly (duration not reported) therapist consultation meetings. Thera-
peutic content involves: i) acceptance-based techniques; ii) problem-solving; iii) behavioural analy-
sis; iv) contingency management; v) skills training.

Intervention 2: manualised DBT (six-month protocol) consisting of weekly sessions (one hour) of in-
dividual therapy, weekly sessions (2 hours) of group skills training, access to 24/7 telephone con-
sultation as needed, and weekly (duration not reported) therapist consultation meetings. Thera-
peutic content involves: i) acceptance-based techniques; ii) problem-solving; iii) behavioural analy-
sis; iv) contingency management; v) skills training.

Outcomes

Primary outcome(s): i) frequency of SH, as measured by the SASII; ii) severity of SH, as measured by
the SASII

Secondary outcome(s): i) characteristics of SH, as measured by the L-SASI; ii) service use, as mea-
sured by the Treatment History Interview, version 2; iii) borderline symptoms, as measured by the
Borderline Symptom List-23; iv) impulsivity, as measured by the Barratt Impulsiveness Scale-11; v)
depression, as measured by the BDI; anger, as measured by the State-Trait Anger Expression Inven-
tory-2; vi) general symptomatology, as measured by the Symptom Checklist-90 Revised; vii) inter-
personal functioning, as measured by the Inventory of Interpersonal Problems-64; viii) social func-
tioning, as measured by the Social Adjustment Scale Self-Report; ix) health-related quality of life,
as measured by the EQ-5D-5L and the SF-36; x) alcohol use, as measured by the AUDIT; xi) drug use,
as measured by the Drug Abuse Screening Test; xii) NSSI, as measured by the Inventory of State-
ments About Self-Injury; xiii) suicidal ideation, as measured by the BSSI; xiv) post-traumatic symp-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

175

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

McMain 2018  (Continued)

Cochrane Database of Systematic Reviews

toms, as measured by the PTSD Checklist for DSM-5; xv) emotion regulation, as measured by the
DERS; xvi) mindfulness, as measured by the Kentucky Inventory of Mindfulness; xvii) coping during
stressful situations, as measured by the Dialectical Behavior Therapy-Ways of Coping Checklist

Tertiary outcome(s): i) personality, as measured by the NEO-Five Factor Inventory; ii) experiences of
trauma, as measured by the Childhood Trauma Questionnaire-Short Form and the Credibility/Ex-
pectancy Questionnaire; iii) therapeutic alliance, as measured by the Working Alliance Invento-
ry-Short Form (therapist and client versions); iv) reasons for treatment discontinuation, as mea-
sured by the Reasons for Early Termination from Treatment Questionnaire

Starting date

1 February 2015

Contact information

Principal investigator:

Dr. Shelley McMain, Centre for Addiction and Mental Health, Department of Psychiatry, University
of Toronto, Toronto, Canada (shelley.mcmain@camh.ca)

Notes

NCT02060448 

Study name

Methods

Participants

Exploring two emotion-focused treatment modules in non-suicidal self-injury

Single-case experimental design. Participants are randomly allocated to receive either mindful
emotion awareness training or cognitive reappraisal and then, depending on improvement, are
permitted to cross over to receive the alternate module.

Assignment: parallel-group, individual-level

Inclusion criteria: i) aged 18 years and older; ii) current NSSI; iii) meets DSM-5 criteria for NSSI; iv) ei-
ther not taking psychotropic medications, or taking stable doses likely to be maintained through-
out the duration of the trial

Exclusion criteria: i) current suicidal ideation with a plan; ii) currently receiving CBT or any other
psychotherapy to reduce NSSI, anxiety, depression, or other Axis I disorder; iii) unwilling to refrain
from initiating additional treatment throughout the duration of the trial; iv) current or recent (with-
in three months) history of a substance use disorder; v) experiencing emotional symptoms due to a
medical/physical condition

Interventions

Intervention (mindful emotion awareness training): consisting of four 50-minute weekly sessions of
mindful emotion awareness training

Intervention (cognitive reappraisal): consisting of four 50-minute weekly sessions of cognitive reap-
praisal

Outcomes

Primary outcome(s): i) frequency of urges and acts of NSSI, as ascertained from self-report

Secondary outcome(s): i) anxiety, as measured by the OASIS and BAI; ii) depression as measured
by the ODSIS and BDI; iii) emotion regulation, as measured by the Deficits in Emotion Regulation
Scale (DERS) and the Emotion Regulation Questionnaire (ERQ); iv) mindfulness, as measured by
the Southampton Mindfulness Questionnaire (SMQ); v) experiential avoidance, as measured by the
Multi-dimensional Experiential Avoidance Questionnaire (MEAQ); vi) sleep problems, as measured
by the Insomnia Severity Index (ISI); vii) subjective symptomatology, as measured by the Subjec-
tive Symptoms Scale (SSS)

Tertiary outcome(s): i) self-injury implicit associations, as measured by the Self-Injury Implicit Asso-
ciation Test (SI-IAT)

Starting date

1 November, 2013

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

176

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT02060448  (Continued)

End date: 31 December, 2015

Contact information

Principal investigators:

Prof. David Barlow, Boston University, Boston, MA, USA (dhbarlow@bu.edu)

Assistant Prof. Kate Bentley, Harvard Medical School, Harvard University, Cambridge, MA, USA
(KBENTLEY@mgh.harvard.edu)

Notes

We are grateful to Assistant Prof. Kate Bentley for confirming the above details were correct, 21 Oc-
tober, 2020.

NCT02354183 

Study name

Commitment and motivation in a brief DBT intervention for self harm

Methods

Single-blind RCT

Assignment: parallel-group, individual-level

Participants

Interventions

Inclusion criteria: i) aged between 18 and 80 years; ii) ≥ 3 episodes of SH in the five year preceding
trial entry, including ≥ 1 in the preceding eight weeks; iii) received no more than four weeks of DBT
in the one year preceding trial entry; iv) self-reports no knowledge of core DBT skills; v) has a valid
Canadian healthcare card; vi) sufficient language ability

Exclusion criteria: i) diagnosed with an organic brain disorder and/or intellectual disability

Intervention: DBT. Single one-hour session of DBT core skills, including wise mind, distraction,
mindfulness of the current emotion, and opposite to emotion action skills, in addition to psychoed-
ucation

Comparator: Psychoeducation. Single one-hour session of psychoeducation

Outcomes

Primary outcome(s): i) motivation, as measured by the Autonomous and Controlled Motivation for
Treatment Questionnaire

Secondary outcome(s): i) frequency of SH, as measured by the DSHI; ii) severity of SH, as measured
by the DSHI

Starting date

1 April, 2015

Contact information

Principal investigator:

Dr Michelle Leybman, McGill University, Montreal, Quebec, Canada (Michelle.leybman@mail.m-
cgill.ca)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT03081078 

Study name

Effects of community-based caring contact on post-discharge young adults with self-harm - a mul-
ti-center randomized controlled trial

Methods

Open-label RCT

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

177

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT03081078  (Continued)

Participants

Interventions

Outcomes

Assignment: parallel-group, individual-level

Inclusion criteria: i) aged between 18 and 45 years; ii) ≥ 1 episode of SH, ascertained from ICD-10 as-
signed codes, leading to admission to the ED; iii) received mental health assessment by a psychia-
trist or consultation liaison nurse; iv) able to provide written informed consent

Exclusion criteria: i) diagnosis of any DSM-IV-TR axis II personality disorder; iii) diagnosed with psy-
chosis or bipolar disorder

Intervention 1: Mobile (cell) telephone app with remote contact intervention in addition to TAU.
Participants receive access to the app (no further details on content or therapeutic focus provided)
and remote contact (≥ 2 telephone contacts and/or text messages) by volunteers over a two-month
period in addition to TAU.

Intervention 2: Mobile (cell) telephone app in addition to TAU. Participants receive access to the app
(no further details on content or therapeutic focus provided) in addition to TAU.

Control: TAU

Primary outcome(s): i) suicidal ideation, as measured by the Chinese language translation of the
ASIQ; ii) hopelessness, as measured by the Chinese language translation of the BHS-4; iii) thwarted
belongingness, as measured by the Thwarted Belongingness subscale of the Interpersonal Needs
Questionnaire (INQ-15); iv) perceived burdensomeness as measured by the Perceived Burden-
someness subscale of the INQ-15; v) service use, as measured by the self-reported compliance with
any prescribed treatment(s); vi) SH, as measured by a four-item scale for levels of suicidality devel-
oped by the authors

Secondary outcome(s): i) depression, as measured by the Center for Epidemiologic Studies Depres-
sion Scale (CES-D); ii) frequency of SH, according to self-report and medical records; iii) suicide, as
verified by records retrieved from the Hong Kong Special Administrative Region (HKSAR) Coroner's
Court; iv) time spent engaging with the mobile app, as measured by time-stamp logs; v) time spent
engaging with remote contacts, as measured by time-stamp logs and volunteer service records

Starting date

1 June 2017

Contact information

Principal investigator:

Associate Prof. Yik-Wa Law, The Univesrity of Hong Kong, Hong Kong (flawhk@hku.hk)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT03185026 

Study name

Effectiveness of the first French psychoeducational program for suicidal behavior: a randomized
controlled trial

Methods

Single-blind RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged between 18 and 65 years; ii) diagnosed with suicidal behaviour disorder
(DSM-5) (i.e. ≥ 1 suicide attempt in 12 months preceding trial entry); iii) sufficient language ability;
iv) able to provide written informed consent; iv) belongs to a social safety system

Exclusion criteria: i) current or past diagnosis of an organic mental disorder; ii) lifetime history of
schizophrenia; iii) diagnosed with an intellectual disability; iv) unable to comply with the study visit
procedures

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

178

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT03185026  (Continued)

Interventions

Intervention: relaxation training consisting of 10 weekly sessions (two hours' duration) of a stan-
dardised relaxation programme

Comparator: psychoeducation consisting of 10 weekly sessions (two hours' duration) of a psychoe-
ducation programme focused on providing education on suicidal behaviour, identification of pat-
terns, and self-assessment of suicidal ideation, and presentation of a stress-diathesis model of sui-
cidal behaviour

Outcomes

Primary outcome(s): i) SH, as measured by the C-SSRS

Secondary outcomes(s): i) suicide attempt (both interrupted and aborted) rate reduction, as mea-
sured by the C-SSRS; ii) suicidal ideation, as measured by the C-SSRS; iii) intensity of suicidal
ideation, as measured by the C-SSRS; iv) treatment adherence, as measured by the Medication Ad-
herence Rating Scale; v) service use, as measured by an idiosyncratic scale; vi) depression, as mea-
sured by the Inventory of Depressive Symptomatology; vii) anxiety, as measured using the State-
Trait Anxiety Inventory; viii) psychological pain, as measured by an idiosyncratic scale; ix) hopeless-
ness, as measured by the BHS; x) general functioning, as measured by the Functioning Assessment
Short Test; xi) quality of life, as measured by the World Health Organization Quality Of Life measure
(WHOQOL-BREF); xii) social support, as measured by an idiosyncratic scale; xiii) emergency service
use; xiv) acceptance, as measured by the Acceptance and Action questionnaire; xv) mindfulness, as
measured by the Mindful Attention Awareness Scale; xvi) meaning in life, as measured by the Life
Regard Index; xvii) treatment adherence, as measured by the number of sessions attended

Starting date

6 September, 2017

Contact information

Principal investigator:

Dr. Deborah Ducasse, University Hospital, Montpellier, France (d-ducasse@chu-montpellier.fr)

Notes

We are grateful to Dr. Deborah Ducasse for confirming the above details were correct, 28 October,
2020.

NCT03427190 

Study name

Suicide prevention algorithm in the French Overseas Territories (APSOM)

Methods

Open-label, RCT

Assignment: parallel-group, individual-level

Participants

Interventions

Inclusion criteria: i) aged 16 years and older; ii) discharged from hospital within 15 days of an index
suicide attempt; iii) has healthcare insurance; iv) able to be contacted via telephone and mail; v)
resident of one of the French overseas territories participating in the trial (i.e. Guadeloupe, French
Guyana, Martinique, or Reunion Island); vi) sufficient language ability; vii) willing and able to pro-
vide oral informed consent

Exclusion criteria: i) homeless; ii) disabled, under judicial/court protection, and/or legally incompe-
tent; iii) unable to understand the study protocol

Intervention: remote contact intervention (telephone contact and/or postcards), in addition to GP
management. Participants will receive telephone contact within 21 days' post-discharge. If par-
ticipants are unable to be contacted via telephone, postcards will be sent at months' 2, 3, 4, and
5 post-discharge. Participants will also be contacted by their GP within 21 days' post-discharge to
organise a consultation within 21 to 45 days' post-discharge. Two additional GP contacts will be
made at months 6 and 13 post-discharge.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

179

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT03427190  (Continued)

Cochrane Database of Systematic Reviews

Comparator: remote contact intervention (telephone contact and/or postcards) consisting of tele-
phone contact within 21 days' post-discharge. If participants are unable to be contacted via tele-
phone, postcards will be sent at months' 2, 3, 4, and 5 post-discharge.

Outcomes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) suicide (unclear how ascer-
tained)

Secondary outcome(s): i) frequency of SH repetition (unclear how ascertained); ii) anxiety and de-
pression as measured by the HADS; iii) suicide risk as measured by the C-SSRS

Starting date

9 February, 2018

Contact information

Principal investigator:

Dr. Louis Jehel, University Hospital Martinique, Fort-de-France, Martinique (louis.jehel@chu-mar-
tinique.fr)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT03463980 

Study name

Compassion meditation and ReliefLink app for suicidal, low-income, African-Americans

Methods

Open-label, RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged between 18 and 64 years; ii) self-identifies as black or African-American;
iii) presents to the medical or psychiatric department of a general hospital following a suicide at-
tempt; iv) at least moderate suicidal intent, as defined by a BSSI score of ≥ 8; v) Mini Mental Status
Examination (MMSE) score ≥ 22

Exclusion criteria: i) significant cognitive impairment, as defined by a MMSE score < 22; ii) psychosis
symptoms; iii) diagnosed with an imminently life-threatening medical condition

Interventions

Intervention: compassion meditation consisting of six weekly sessions (120 minutes' duration) of
compassion meditation. Participants will also be encouraged to meditate at least 30 minutes a day
and will be asked to track their daily meditation time.

Comparator: supportive group therapy consisting of six weekly sessions (90 minutes' duration) of
supportive group therapy

Outcomes

Primary outcome(s): i) suicidal ideation, as measured by the BSSI

Secondary outcome(s): i) depression, as measured by the BDI; ii) shame, as measured by the Expe-
rience of Shame Scale (ESS); iii) self-criticism, as measured by the Self-Criticism Scale; iv) interper-
sonal connectedness, as measured by the Social Support Behaviors Scale (SSB); v) self-compas-
sion, as measured by the Self-Compassion Scale (SCS); vi) mindfulness, as measured by the Five
Facet Mindfulness Questionnaire (FFMQ); vii) behavioural monitoring, as measured by the Behavior
Monitoring Form (BMF)

Starting date

13 May, 2010

Contact information

Principal investigator:

Prof. Nadine Kaslow, Emory University, Atlanta, GA, USA (nkaslow@emory.edu)

Notes

We were unable to confirm the above details were correct despite correspondence.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

180

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT03541824 

Study name

Reducing suicide risk associated with weight loss

Methods

Single-blind RCT

Allocation: cross-over, individual-level

Participants

Inclusion criteria: i) aged between 18 and 65 years; ii) males and females; iii) ≥ 1 episode of NSSI
within the one month prior to trial entry; iv) > 5 pounds weight suppression

Exclusion criteria: i) indicating being "sure" of suicide attempt on a trial-specific screening ques-
tionnaire; ii) lives outside of the USA; iii) pregnant

Interventions

Intervention: Body Acceptance Program (BAP), an internet-based intervention designed to chal-
lenge the appearance-ideal

Comparator: waiting-list control

Outcomes

Primary outcome(s): i) frequency of SH, as measured by the Self-Injurious Thoughts and Behaviors
Interview-Short Form

Secondary outcome(s): i) body self-esteem, as measured by the appearance subscale of the Body
Esteem Scale; iii) body weight esteem, as measured by the weight subscale of the Body Esteem
Scale; iv) body attribution, as measured by the attribution subscale of the Body Esteem Scale; v)
body shape, as measured by the Body Shape Questionnaire-8; vi) depression, as measured by the
BDI; vii) positive and negative affect, as measured by the Positive and Negative Affect Schedule

Starting date

1 July 2016

Contact information

Principal investigator:

Prof. Pamela Keel, Florida State University, Tallahassee, FL, USA (keel@psy.fsu.edu)

Notes

We are grateful to Prof. Pamela Keel for confirming the above details were correct, 29 October,
2020.

NCT03732300 

Study name

Evaluation of ASSIP - Attempted Suicide Short Intervention Program: a randomized controlled trial

Methods

Single-blind RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged 18 years and older; ii) suicide attempt in the six months preceding trial en-
try; iii) able and willing to provide written informed consent; iv) received treatment in an in/outpa-
tient psychiatric facility; v) able and willing to comply with the trial procedures

Exclusion criteria: i) acute psychosis; ii) insufficient language ability; iii) diagnosed with dementia;
iv) engaging in chronic SH without suicidal intent; v) receiving current ECT; vi) previously enrolled
in the trial; vii) study investigators, their family members and other dependants, and employees
are also excluded from participation

Interventions

Intervention: Attempted Suicide Short Intervention Program (ASSIP) in addition to TAU. Three ses-
sions (duration not reported) of ASSIP, in addition to up to 12 remote contact interventions (letters)

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

181

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT03732300  (Continued)

Comparator: TAU

Cochrane Database of Systematic Reviews

Outcomes

Primary outcome(s): i) suicide deaths (unclear how ascertained); ii) repetition of SH (unclear how
ascertained); iii) duration of hospital admissions (days) ascertained from records; iv) costs of hos-
pital admissions ascertained from records; v) electrophysiological wakefulness regulation, as mea-
sured by a standardised algorithm; vi) electrophysiological heart rate variability, as measured by a
standardised algorithm

Starting date

1 December 2018

Contact information

Principal investigator:

Prof. Sebastian Olbrich, University of Zurich, Zurich, Switzerland (sebastian.olbrich@puk.zh.ch)

Notes

We are grateful to Prof. Sebastian Olbrich for confirming the above details were correct, 8 October,
2020.

NCT03853382 

Study name

Cognitive Analytic Therapy-informed Containment for self-Harm (CATCH)

Methods

RCT (feasibility)

Assignment: parallel-group, individual-level

Participants

Interventions

Outcomes

Inclusion criteria: i) aged 16 years and older; ii) access to email and Internet (necessary for complet-
ing study measures); iii) currently in receipt of clinical support from National Health Service (NHS)
or private health services; iv) ≥ 5 or more episodes of NSSI in the year preceding trial entry; v) able
to provide written informed consent in English; vi) capable of providing written informed consent
Exclusion criteria: i) currently receiving any form of psychological therapy; ii) received any form of
psychological therapy in the month preceding trial entry; iii) previously received Cognitive Analytic
Therapy; iv) diagnosed with a learning disability and/or autistic spectrum disorder; v) currently at
high risk of suicidal behaviour; vi) hospitalised for SH in the one month preceding trial entry

Intervention: brief Cognitive Analytic Therapy-informed Containment for self-Harm (CATCH) con-
sisting of two sessions, each lasting approximately 90 minutes
Comparator: TAU. No further details provided

Primary outcome(s): i) acceptability, as measured by the proportion of participants who complete
both sessions and from qualitative interviews with participants; ii) safety, as measured by the Ad-
verse Effects in Psychotherapy; iii) feasibility, as measured by the proportion of participants at-
tending a post-therapy follow-up assessment

Secondary outcome(s): i) NSSI, as measured by the Self-Injurious Thoughts and Behaviors Invento-
ry Short-Form; ii) self-compassion, as measured by the Self-Compassion Scale; iii) depression, as
measured by the PHQ-9; iv) self-injury urges, as measured by the Alexian Brothers Urges to Self-In-
jury Scale. Assessments for secondary outcomes were not completed at comparable time points
for the two arms.

Starting date

1 April, 2019

Contact information

Prinicpal investigator:

Dr Peter Taylor, University of Manchester, Manchester, UK (peter.taylor-2@manchester.ac.uk)

Notes

We are grateful to Dr. Peter Taylor for confirming the above details were correct, 9 October, 2020.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

182

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT03894462 

Study name

Effectiveness of a targeted brief intervention for recent suicide attempt survivors

Methods

Single-blind RCT

Assignment: parallel-group, individual-level (N = 400)

Participants

Interventions

Inclusion criteria: i) aged 18 years and older; ii) attempted suicide in the 60 days preceding trial en-
try; iii) able and willing to provide written informed consent; iv) have at least one contact person
who can promote participant’s safety and who can be contacted in the event of missed follow-up
appointments

Exclusion criteria: i) acute psychosis; ii) insufficient language ability

Intervention: Attempted Suicide Short Intervention Program (ASSIP) in addition to TAU. Three out-
patient sessions (approximately one hours' duration each) of ASSIP. All three ASSIP sessions will be
completed within six weeks. Participants have the choice to receive the intervention in person or
via telehealth.

Comparator: TAU from providers that have adopted the Zero Suicide model, incorporating en-
hanced clinical care protocols, improved clinical coding for suicidal behaviour, and the adoption of
common protocols

Outcomes

Primary outcome(s): i) time to SH, as ascertained from the C-SSRS and electronic medical records

Starting date

1 October 2020

Contact information

Principal investigator:

A/Prof. Anthony R. Pisani, PhD, University of Rochester Medical Center, Rochester, NY, USA (antho-
ny_pisani@urmc.rochester.edu)

Notes

We are grateful to Caroline Kelberman for confirming the above details were correct, 8 October,
2020.

NCT04072666 

Study name

Investigations of psychological interventions in suicide prevention: a comparison of brief cognitive
behavioural therapy and the attempted suicide short intervention program

Methods

Double-blind RCT

Assignment: parallel=group, block randomisation, individual-level

Participants

Inclusion criteria: i) aged 16 years and older; ii) presenting to a general hospital following a recent
(duration not reported) suicide attempt; iii) referred to the Suicide Prevention Pathway

Exclusion criteria: i) unable or unwilling to provide consent; ii) receiving any other psychosocial in-
tervention. Those taking stable doses of any psychotropic medications will not be excluded.

Interventions

Intervention 1: Attempted Suicide Short Intervention Program (ASSIP) plus Suicide Prevention
Pathway (SPP) consisting of three sessions (60 minutes' duration each) manualised ASSIP along
with a remote contact intervention over a 24-month period plus SPP

Intervention 2: CBT plus SPP. Five sessions (60 minutes' duration each) of manualised individ-
ual-level CBT plus SPP

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

183

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT04072666  (Continued)

Cochrane Database of Systematic Reviews

Comparator: SPP. Seven sessions (duration not reported) of a blended face-to-face and online pro-
gramme incorporating a psychosocial assessment, formulation of suicide risk, collaborative safe-
ty planning, counselling on access to lethal means, development of a transition care plan, and a re-
mote contact intervention (letters and/or text messages) for a 24-month period

Outcomes

Primary outcome(s): i) SH, as ascertained from representations to hospital; ii) suicide, as ascer-
tained from official records

Secondary outcome(s): i) coping, as measured by the Coping Inventory for Stressful Situations
(CISS); ii) resilience, as measured by the Resilience Scale for Adults (RSA) or the Resilience Scale for
Adolescents (READ) (as appropriate for age); iii) therapeutic alliance, as measured by the revised
Helping Alliance Questionnaire – II; iv) interpersonal problem-solving, as measured by the Indepen-
dent-Interdependent Problem Solving Scale (IIPSS)

Starting date

1 October 2019

Contact information

Principal investigator:

Prof. Chris Stapelberg, Bond University, Gold Coast, Queensland, Australia (chris.stapel-
berg@health.qld.gov.au)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT04168645 

Study name

Inpatient cognitive-behavioral therapy to reduce suicide risk post-discharge

Methods

Single-blind RCT

Assignment: parallel=group, stratified block randomisation, individual-level

Participants

Inclusion criteria: i) aged between 18 and 65 years; ii) at least one suicide attempt in the week pre-
ceding trial entry; iii) admitted to either a medical or psychiatric inpatient ward

Exclusion criteria: i) diagnosed with a schizophrenia spectrum disorder; ii) diagnosed with an or-
ganic brain disorder and/or intellectual disability; iii) acute mania; iv) diagnosed with any other
psychiatric and/or medical condition that would preclude the participant being able to provide in-
formed consent; v) referred for ECT

Interventions

Intervention: CBT. Up to four sessions of CBT (between 1 to 1.5 hours' duration)

Comparator: TAU

Outcomes

Primary outcome(s): i) SH, as measured by the C-SSRS; ii) suicidal ideation, as measured by the C-
SSRS; iii) number of readmissions, as ascertained from electronic medical records

Starting date

15 October 2019

Contact information

Principal investigator:

Prof. David Tolin, Yale University, New Haven, CT, USA (David.Tolin@hhchealth.org)

Notes

We are grateful to Prof. David Tolin for confirming the above details were correct, 7 October, 2020.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

184

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT04191122 

Study name

Community Outpatient Psychotherapy Engagement Service for Self-harm (COPESS): a feasibility
study

Methods

Double-blind RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged 16 years and older; ii) ≥ 1 episode of SH in the six months preceding trial
entry; iii) presented to GPs

Exclusion criteria: i) diagnosed with an intellectual disability; ii) alcohol and/or drug dependant; iii)
severe suicidal ideation; iv) currently experiencing symptoms of psychosis or treatment-resistant
depression; iv) unwilling or unable to provide written informed consent; v) insufficient language
ability

Interventions

Intervention: Psychodynamic psychotherapy consisting of five sessions (50 minutes' duration each)
of psychotherapy based on a psychodynamic and cognitive analytic approach in addition to TAU

Comparator: TAU based on NICE 2011 principles

Outcomes

Primary outcome(s): i) treatment acceptability, as measured by the proportion of participants com-
pleting treatment; ii) adverse events, as measured by the AEP; iii) feasibility, as measured by the
number of assessments completed by participants

Secondary outcome(s): i) depression, as measured by the BDI; ii) frequency of NSSI, as measured
by the Self-Injurious Thoughts and Behaviors Interview (SITBI); iii) severity of NSSI, as measured by
the SITBI; iv) intensity of SH urges, as measured by the SITBI; v) emotion regulation, as measured
by the Emotion Regulation Questionnaire (ERQ); vi) clinical outcomes, as measured by the Clinical
Outcomes in Routine Evaluation (CORE-10); vii) help-seeking attitudes, as measured by the General
Help-Seeking Questionnaire (GHSQ) and the Actual Help Seeking Questionnaire (AHSQ); viii) thera-
peutic alliance, as measured by the Helping Relationship Questionnaire (HRQ)

Starting date

2 May 2020

Contact information

Principal investigator:

Dr Pooja Saini, Liverpool John Moores University, Liverpool, UK (poojasaini@hotmail.co.uk)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT04244786 

Study name

Treating self injurious behavior: a novel brain stimulation approach

Methods

Quadruple-blind RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged between 18 and 60 years; ii) engages in frequent NSSI (defined as ≥ 2
episodes of NSSI in the two months prior to trial entry); iii) able to provide informed consent; iv) if
diagnosed with bipolar I or II disorder, taking a stable therapeutic dose of a mood stabiliser

Exclusion criteria: i) diagnosed with an unstable medical condition; ii) diagnosed with psychosis,
mania, hypomania, or an intellectual disability; iii) current suicidal ideation with a plan that can-
not be managed safely in an outpatient setting; iv) pregnant, lactating, or planning to conceive dur-
ing the trial duration; v) diagnosed with a neurological disease or prior head trauma with evidence
of cognitive impairment (defined as scoring ≥ 1.5 standard deviations below the mean on the Trail-
making A&B Test); vi) current moderate to severe alcohol or substance use disorder; v) those whose

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

185

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT04244786  (Continued)

Cochrane Database of Systematic Reviews

dose of any current psychiatric medications (including antidepressants, anxiolytics, antipsychotic
medications, mood stabilisers, and benzodiazepines) was increased within two weeks prior to tri-
al entry; vi) received any form of psychotherapy within two weeks prior to trial entry; vii) any met-
al implants or paramagnetic objects contained within the body (including heart pacemaker, shrap-
nel, or surgical prostheses) which may present a risk to the participant and/or interfere with the
MRI scan; viii) claustrophobia significant enough to interfere with MRI scanning; ix) weight that ex-
ceeds 325 pounds or inability to fit into MRI scanner

Interventions

Intervention: Transcranial magnetic stimulation. Six 20-minute sessions of transcranial direct cur-
rent stimulation (1.5 milliamp) delivered to the right ventrolateral prefrontal cortex

Outcomes

Comparator: Sham. Six 20-minute sessions where an electrode montage is applied to the right ven-
trolateral prefrontal cortex

Primary outcome(s): i) adverse effects, as measured by the Transcranial Direct Current Stimulation
Adverse Effects Questionnaire; ii) social processing, as measured by changes in brain responses
whilst undertaking a social processing task during an fMRI scan; iii) NSSI urges and behaviours, as
measured by ecological momentary assessment (EMA)

Secondary outcome(s): i) mood state, as measured by a task during an fMRI scan and EMA

Starting date

1 October 2019

Contact information

Principal investigator:

Dr Jeffrey M. Miller, New York State Psychiatric Institute and Columbia University, NYC, NY, USA

Public contact:

Young Cho, New York State Psychiatric Institute and Columbia University, NYC, NY, USA (mailto:y-
oung.cho%40nyspi.columbia.edu?subject=NCT04244786,%20#7170, Treating Self Injurious Behav-
ior: A Novel Brain Stimulation Approach)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT04284085 

Study name

Evaluation of a psychoeducational intervention for people with suicidal behaviour in the peniten-
tiary environment: N'VIU project

Methods

Single-blind RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged 18 years and older; ii) history of attempted suicide (unclear the time frame
over which this will be assessed)

Exclusion criteria: i) diagnosis of any psychiatric disorder in an acute phase; ii) intellectual disabili-
ty; iii) cognitive impairment

Interventions

Intervention: psychoeducation consisting of 13 sessions (90 minutes' each), of a group-based psy-
choeducation programme

Comparator: fact-sheet on the risks of suicide, along with tips for reducing suicidal ideation

Outcomes

Primary outcome(s): i) frequency of SH (unclear how ascertained)

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

186

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT04284085  (Continued)

Cochrane Database of Systematic Reviews

Secondary outcome(s): i) suicidal ideation, as measured by the C-SSRS; ii) anxiety, as measured by
the HARS; iii) depression, as measured by the HDRS; iv) quality of life, as measured by the Euro-
QoL-5D Health Questionnaire

Starting date

15 October 2019

Contact information

Principal investigator:

Dr. Pere Roura-Poch, Consorci Hospitalari de Vic, Barcelona, Spain (tac.vhc@aruorp)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT04343703 

Study name

Suicide prevention and intervention (SURVIVE): cohort study and nested randomized controlled tri-
als of secondary prevention programs for suicide attempts

Methods

Single-blind RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged 12 years and older; ii) presented to an ED following a suicide attempt; iii)
willing and able to provide written informed consent, and able to comply with the trial procedures

Exclusion criteria: i) unable to provide written informed consent; ii) insufficient language ability; iii)
currently participating in another clinical trial of psychosocial therapy for SH

Interventions

Intervention 1: telephone management consisting of three telephone consultations (between 5-45
minutes' duration each). Therapeutic content includes: 1) assessment; 2) crisis management.

Intervention 2: internet-based CBT. Participants will receive access to an internet-based CBT pro-
gramme consisting of seven modules. Whilst the intervention can be self-paced, each module
should be worked through over a week-long period. Therapeutic content includes: i) behaviour-
al activation; ii) cognitive restructuring; iii) sleep regulation; iv) mood monitoring; v) establishing
healthy lifestyle habits.

Comparator: TAU, consisting of any nonspecific intervention to address suicidal behavior or to pre-
vent suicide

Outcomes

Primary outcome(s): i) SH (unclear how ascertained); ii) suicide (unclear how ascertained)

Secondary outcomes(s): i) general symptoms, as measured by the BSI; ii) depression, as measured
by the PHQ-9; iii) anxiety, as measured by the GAD-7; iv) quality of life, as measured by the EQ-5D;
v) impulsivity, as measured by the BIS; vi) acquired capability, as measured by the Acquired Capa-
bility for Suicide Scale-Fearlessness about Death (ACSS-FAD); vii) mentalising skills, as measured by
the Reflective Functioning Questionnaire-8; viii) suicidal ideation, as measured by the C-SSRS; ix)
strengths and difficulties, as measured by the SDQ

Starting date

17 June 2020

Contact information

Principal investigator:

Dr. Victor Pérez, Parc de Salut Mar, Barcelona, Spain (vperezsola@parcdesalutmar.cat)

Notes

We were unable to confirm the above details were correct despite correspondence.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

187

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

NCT04366466 

Study name

Program to promote Engagement in care for the Prevention of Suicidal recidivism (PEPS)

Methods

Open-label RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged 18 years and older; ii) admitted to a general hospital following a suicide
attempt; iii) referred for outpatient follow-up; iv) able and willing to provide written informed con-
sent

Exclusion criteria: i) not in receipt of social security and/or state medical care; ii) diagnosed with
cognitive or delusional disorders; iii) hospitalised for > 72 hours following the index suicide at-
tempt; iv) currently under psychiatric care; v) unable to be reached by telephone (e.g. without a
telephone, homeless, or incarcerated); vi) insufficient language ability

Interventions

Intervention: consisting of a series of telephone contacts (both the number and duration not re-
ported) delivered over a 12-month period. Therapeutic content not reported

Comparator: TAU

Outcomes

Primary outcome(s): i) repetition of SH (unclear how ascertained); ii) feasibility, as measured by the
percentage of participants fulfilling the inclusion and exclusion criteria and the proportion of par-
ticipants who received the treatment in full

Starting date

29 April, 2020

Contact information

Principal investigator:

Dr Fayçal Mouaffak, Centre Hospitalier de Ville-Evrard, Paris, France (mouaffakf@yahoo.fr)

Notes

We were unable to confirm the above details were correct despite correspondence.

NCT04420546 

Study name

Using implementation intentions to reduce self-harm

Methods

Double-blind, RCT

Assignment: parallel-group, individual-level

Participants

Inclusion criteria: i) aged 18 years and older; ii) have a history of SH (lifetime); iii) sufficient language
ability

Exclusion criteria: i) not currently residing in an inpatient psychiatric facility

Interventions

Intervention: electronic volitional help sheet. Participants read a brief statement designed to en-
courage them to avoid self-harming by forming implementation intentions by linking critical situa-
tions with appropriate alternative responses for each critical situation.

Comparator: analogue volitional help sheet

Outcomes

Primary outcome(s): i) NSSI, as ascertained from self-report; ii) suicidal ideation, as ascertained
from self-report; iii) suicide attempts, as ascertained from self-report

Secondary outcome(s): i) exposure to suicide and mental imagery about death, as measured by a
seven-point scale adapted from Dhingra 2015; ii) capability, opportunity, and motivation, as mea-
sured by the Capability, Opportunity, Motivation Questionnaire; iii) habit, as measured by a self-re-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

188

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

NCT04420546  (Continued)

Cochrane Database of Systematic Reviews

ported scale; iv) self-regulation, as measured by items adapted from Sniehotta 2005; v) frequency
with which critical situations were encountered and appropriate responses were used

Starting date

1 June, 2020

Contact information

Principal investigator:

Dr. Chris Keyworth, University of Manchester, Manchester, UK (chris.keyworth@manchester.ac.uk)

Notes

We are grateful to Dr. Chris Keyworth for confirming the above details were correct, 9 October,
2020.

O'Connor 2019 

Study name

SAFETEL randomised controlled feasibility trial of a safety planning intervention with follow-up
telephone contact to reduce suicidal behaviour: study protocol

Methods

Open-label, RCT

Assignment: 2:1 allocation, individual-level

Participants

Included: i) aged 18 years and older; ii) admitted to hospital following a suicide attempt; iii) as-
sessed by the Liaison Psychiatry team; iv) sufficient language ability

Interventions

Excluded: i) no suicidal intent; ii) medically unfit for interview; iii) unable to provide informed con-
sent; iv) insufficient language ability; v) participating in another psychological intervention study
within the trial hospital; vi) no access to a telephone

Intervention: SAFETEL consisting of collaborative safety planning and five structured telephone
calls (around 15 minutes' duration each) over a period of four weeks. Therapeutic content involves:
i) safety planning; ii) suicide risk assessment; iii) mood monitoring; iv) reviewing and revising the
safety plan (as needed); v) treatment engagement enhancement; vi) motivational enhancement;
vii) problem-solving.

Comparator: TAU consisting of referral to any one of the following services as needed (e.g. prima-
ry care, community psychiatric service, third sector services, specialist mental health services, in-
tensive home treatment, outpatient services, transfer to inpatient care, social work, or no further
treatment)

Outcomes

Primary outcome(s): i) repetition of SH, as measured by the C-SSRS and medical records; ii) feelings
of entrapment, as measured by the Entrapment Scale; iii) interpersonal functioning, as measured
by the Interpersonal Needs Questionnaire; iv) social functioning, as measured by the ENRICHD So-
cial Support Instrument; v) coping skills, as measured by the Suicide-Related Coping Scale

Starting date

5 May, 2017

Contact information

Principal investigator:

Prof. Rory O'Connor, University of Glasgow, Glasgow, UK (Rory.OConnor@glasgow.ac.uk)

Notes

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

189

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

SLCTR/2017/008 

Study name

A pilot randomised controlled trial to evaluate the acceptability and feasibility of a counselling in-
tervention, delivered by nurses, for those who have attempted self-poisoning in Sri Lanka

Methods

Open-label RCT

Assignment: parallel-group, blocked, individual-level

Participants

Inclusion criteria: i) aged 16 years and older; ii) admitted to hospital for medical management fol-
lowing an episode of self-poisoning

Exclusion criteria: i) diagnosed with schizophrenia, any psychosis, bipolar disorder, dementia, intel-
lectual disability, or cognitive impairment; ii) physically too unwell to comply with the study proce-
dures

Interventions

Intervention: brief Culturally-adapted Manually Assisted Problem-solving training (C-MAP) consist-
ing of one session (20-30 minutes' duration) of an adapted form of C-MAP

Outcomes

Comparator: TAU

Primary outcome(s): i) coping skills, as measured by the Brief-COPE inventory; ii) alcohol use, as
measured by the Alcohol Use Disorders Identification Test (AUDIT); iii) depression, as measured by
the Patient Health Questionnaire 9 (PHQ-9) and the Peradeniya Depression Scale; iv) anxiety, as
measured by the Generalised Anxiety Disorder 7-item scale (GAD-7); v) suicidal intent, as measured
by the Pierce Suicide Intent Scale (PSIS)

Secondary outcome(s): acceptability, feasibility, and utility, as ascertained from qualitative inter-
views with participants

Starting date

27 March, 2017

Contact information

Principal investigator:

Dr. Thillini Rajapakse, University of Peradeniya, Sri Lanka (gemba471@gmail.com)

Notes

We are grateful to Dr. Thillini Rajapakse for confirming the above details were correct, 29 October,
2020.

Stevens 2019 

Study name

SMS SOS: using SMS text messages to prevent SH

Methods

Open-label Zelen RCT

Assignment: parallel-group, individual-level, blocked randomisation stratified by multiple SH status

Participants

Inclusion criteria: i) aged 16 years of age or older; ii) assessed in participating EDs following an
episode of SH; iii) sufficient language ability; iv) owns a mobile (cell) telephone

Exclusion criteria: i) no fixed address; ii) do not own a mobile (cell) telephone; iii) unable or unwill-
ing to provide informed consent

Interventions

Intervention: series of nine SMS text messages delivered via mobile (cell) telephone at 1, 2, 3, 4, 5, 6,
8, 10, and 12 months' post-discharge. Messages are designed to express concern for participants'
well-being and to encourage them to make contact with local crisis services, if needed. Participants
will also receive TAU.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

190

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Stevens 2019  (Continued)

Cochrane Database of Systematic Reviews

Comparator: TAU consisting of in- or outpatient mental health treatment, referral to other services
(e.g. AOD services), and/or GP management (as appropriate)

Outcomes

Primary outcome(s): i) frequency of SH as ascertained from hospital records; ii) time to SH repeti-
tion as ascertained from hospital records

Secondary outcome(s): i) repetition of SH as ascertained from hospital records; ii) suicide as ascer-
tained from mortality registers; iii) all-cause mortality as ascertained from mortality registers

Starting date

8 May, 2017

Contact information

Principal investigator:

Dr. Garry Stevens, Western Sydney University, Sydney, New South Wales, Australia (g.steven-
s@westernsydney.edu.au)

Notes

ACSS-FAD: Acquired Capability for Suicide Scale-Fearlessness about Death
AEP:
AHSQ: Actual Help Seeking Questionnaire
AOD: alcohol and other drug
app: application
APSOM:
ASIQ: Adult Suicidal Ideation Questionnaire
ASSIP: Attempted Suicide Short Intervention Program
AUDIT: Alcohol Use Disorders Identification Test
BAI: Beck Anxiety Inventory
BAP:
BDI: Beck Depression Inventory
BHQ: Beck Hopelessness Scale
BHS(-4):
BIS: Barratt Impulsiveness Scale
BMF: Behavior Monitoring Form
BPD:
Brief-COPE:
BSI: Brief Symptom Inventory
BSSI:
CATCH:
CBT: cognitive behavioural therapy
CES-D: Center for Epidemiologic Studies Depression Scale
CISS: Coping Inventory for Stressful Situations
COPESS:
CORE-10: Clinical Outcomes in Routine Evaluation-10
C-MAP: Culturally-adapted Manually Assisted Problem-solving training
C-SSRS: Columbia-Suicide Severity Rating Scale
DBT: Dialectical Behaviour Therapy
DERS: Difficulties in Emotion Regulation Scale
DSH: deliberate self-harm
DSHI: Deliberate Self-Harm Interview
DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision
DSM-5: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
ECT: electroconvulsive therapy
ED: emergency department
ENRICHD:
EQ-5D: European Quality of Life-5 Dimension
EMA: ecological momentary assessment
ERQ: Emotion Regulation Questionnaire
ESS: Experience of Shame Scale
EuroQoL-5D: European Quality of Life-5 Dimension

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

191

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

FASTER:
FFMQ: Five Facet Mindfulness Questionnaire
fMRI: functional magnetic resonance imaging
GAD-7:
GHSQ: General Help-Seeking Questionnaire
GP: general practitioner
HADS:
HARS: Hamilton Anxiety Rating Scale
HDRS: Hamilton Depression Rating Scale
HKSAR: Hong Kong Special Administrative Region
HRQ: Helping Relationship Questionnaire
ICD-10: International Classification of Diseases, 10th Revision
INQ-15: Interpersonal Needs Questionnaire-15
IIPSS: Independent-Interdependent Problem Solving Scale
IQ: intelligence quotient
ISAS:
ISI: Insomnia Severity Index
L-SASI:
MEAQ: Multi-dimensional Experiential Avoidance Questionnaire
MINI(-7):
MMSE: Mini Mental Status Examination
MRI: magnetic resonance imaging
MSP:
NEO:
NHS: National Health Service
NSSI: non-suicidal self-injury
N'VIU:
OASIS: Overall Anxiety Severity and Impairment Scale
ODSIS: Overall Depression Severity and Impairment Scale
OHIP:
PEPS:
PHQ-9: Patient Health Questionnaire 9
PSIS: Pierce Suicide Intent Scale
PTSD:
RCT: randomised controlled trial
READ: Resilience Scale for Adolescents
RRRS:
RSA: Resilience Scale for Adults
SAFETEL:
SASII:
SCID-BPD: Structured Clinical Interview for Borderline Personality Disorder
SCS: Self-Compassion Scale
SDQ:
SF-36:
SH: self-harm
SIAM:
SI-IAT: Self-Injury Implicit Association Test
SITBI: Self-Injurious Thoughts and Behaviors Interview
SMQ: Southampton Mindfulness Questionnaire
SMS: short messaging service
SOS:
SPP: Suicide Prevention Pathway
SSB: Social Support Behaviours Scale
SSS: Subjective Symptoms Scale
SURVIVE:
TAU: treatment-as-usual
vs:
WHOQOL-BREF:

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

192

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

R I S K   O F   B I A S

Legend:   

  Low risk of bias    

  High risk of bias    

  Some concerns   

Risk of bias for analysis 1.1 Repetition of SH at post-intervention

Bias

Cochrane Database of Systematic Reviews

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Study

Mousavi 2017

Stewart 2009

Wei 2013

Weinberg 2006

Risk of bias for analysis 2.1 Repetition of SH by post-intervention

Bias

Study

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Subgroup 2.1.1 Comparator: TAU

Linehan 1991

McMain 2009

Priebe 2012

Subgroup 2.1.2 Comparator: Alternative psychotherapy

Linehan 2006

Turner 2000

Walton 2020

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

193

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Risk of bias for analysis 3.1 Repetition of SH at post-intervention

Bias

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Study

Gratz 2006

Gratz 2014

Risk of bias for analysis 4.1 Repetition of SH at post-intervention

Bias

Study

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Subgroup 4.1.1 TAU (whole sample)

Clarke 2002

Hvid 2011

Subgroup 4.1.2 Enhanced usual care (whole sample)

Kawanishi 2014

Morthorst 2012

Risk of bias for analysis 5.1 Repetition of SH at post-intervention

Bias

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Study

Evans 1999a

Morgan 1993

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

194

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Risk of bias for analysis 6.1 Repetition of SH at post-intervention

Bias

Study

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Subgroup 6.1.1 Postcards (whole sample)

Beautrais 2010

Carter 2005

Hassan-
ian-Moghaddam
2011

Kapur 2013

Subgroup 6.1.2 Postcards (males)

Carter 2005

Subgroup 6.1.3 Postcards (females)

Carter 2005

Risk of bias for analysis 7.1 Repetition of SH at post-intervention

Bias

Study

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Marasinghe 2012

Wei 2013

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

195

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Risk of bias for analysis 8.1 Repetition of SH at post-intervention

Bias

Study

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Amadéo 2015

Fleischmann 2008

Risk of bias for analysis 9.1 Repetition of SH at post-intervention

Bias

Study

Randomisation
process

Deviations
from intended
interventions

Missing
outcome data

Measurement
of the outcome

Selection of
the reported
results

Overall

Subgroup 9.1.1 Whole sample

Gysin-Maillart
2016

Hatcher 2015

Hatcher 2016

Subgroup 9.1.2 First SH episode

Hatcher 2015

Hatcher 2016

Subgroup 9.1.3 Repeat SH episode

Hatcher 2015

Hatcher 2016

D A T A   A N D   A N A L Y S E S

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

196

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Comparison 1.   CBT-based psychotherapy

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1.1 Repetition of SH at post-inter-
vention

4

1.2 Repetition of SH at six months

12

1.3 Repetition of SH at 12 months

1.4 Repetition of SH at 24 months

1.5 Frequency of SH at post-inter-
vention

9

2

4

1.6 Frequency of SH at six months

4

1.7 Time to SH repetition

1.8 Depression scores at post-in-
tervention

1.9 Depression scores at six
months

1.10 Depression scores at 12
months

1.11 Depression scores at 24
months

1.12 Hopelessness scores at post-
intervention

1.13 Hopelessness scores at six
months

1.14 Hopelessness scores at 12
months

1.15 Suicidal ideation scores at
post-intervention

1.16 Suicidal ideation scores at
six months

1.17 Proportion reporting suici-
dal ideation

1.17.1 Post-intervention

3

5

8

7

2

5

2

3

5

4

2

2

238

1260

2458

105

149

118

953

934

1130

225

803

315

539

718

353

219

Odds Ratio (M-H, Random, 95%
CI)

0.35 [0.12, 1.02]

Odds Ratio (M-H, Random, 95%
CI)

0.52 [0.38, 0.70]

Odds Ratio (M-H, Random, 95%
CI)

0.81 [0.66, 0.99]

Odds Ratio (M-H, Random, 95%
CI)

0.31 [0.14, 0.69]

Mean Difference (IV, Random,
95% CI)

-0.53 [-1.67, 0.61]

Mean Difference (IV, Random,
95% CI)

-0.71 [-1.32, -0.11]

Hazard Ratio (IV, Random, 95%
CI)

0.81 [0.61, 1.08]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.28 [-0.54, -0.02]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.24 [-0.50, 0.01]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.36 [-0.64, -0.07]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.22 [-0.48, 0.05]

Mean Difference (IV, Random,
95% CI)

-2.99 [-3.91, -2.07]

Mean Difference (IV, Random,
95% CI)

-3.14 [-4.78, -1.49]

Mean Difference (IV, Random,
95% CI)

-1.89 [-2.97, -0.81]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.48 [-0.68, -0.28]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.38 [-0.60, -0.17]

Odds Ratio (M-H, Random, 95%
CI)

Subtotals only

Odds Ratio (M-H, Random, 95%
CI)

0.44 [0.08, 2.26]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

197

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1.17.2 Six months

1.17.3 12 months

1.18 Suicide deaths by final fol-
low-up

1.19 Repetition of SH at 12
months (by repeater status)

1.19.1 History of prior SH

1.19.2 No history of prior SH

1

1

16

2

2

2

159

159

2130

508

733

Odds Ratio (M-H, Random, 95%
CI)

1.27 [0.66, 2.46]

Odds Ratio (M-H, Random, 95%
CI)

1.20 [0.62, 2.31]

Odds Ratio (M-H, Random, 95%
CI)

0.79 [0.34, 1.80]

Odds Ratio (M-H, Random, 95%
CI)

Subtotals only

Odds Ratio (M-H, Random, 95%
CI)

0.56 [0.36, 0.88]

Odds Ratio (M-H, Random, 95%
CI)

1.10 [0.48, 2.52]

Analysis 1.1.   Comparison 1: CBT-based psychotherapy, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Mousavi 2017
Stewart 2009
Wei 2013
Weinberg 2006

2
3
0
12

30
23
55
15

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.25, df = 3 (P = 0.97); I² = 0%
Test for overall effect: Z = 1.92 (P = 0.05)
Test for subgroup differences: Not applicable

123

17

30
9
61
15

40.0%
29.0%
11.0%
20.0%

0.29 [0.05 , 1.55]
0.53 [0.07 , 3.82]
0.36 [0.01 , 9.11]
0.29 [0.03 , 3.12]

115

100.0%

0.35 [0.12 , 1.02]

6
2
1
14

23

0.1

0.2

0.5
Favours CBT

1

2

5
Favours comparator

10

Risk of Bias
E
B

C

D

?
+
+
+

+
+
-

+

?
+
?
?

?
?
?
?

A

?
?
?
+

F

?
?
-

?

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

198

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.2.   Comparison 1: CBT-based psychotherapy, Outcome 2: Repetition of SH at six months

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Brown 2005
Davidson 2014
Evans 1999b
Guthrie 2001
Husain 2014
Lin 2020
Owens 2020
Salkovskis 1990
Tapolaa 2010
Tyrer 2003
Wei 2013
Weinberg 2006

9
4
10
5
1
11
7
0
2
64
1
12

50
10
18
58
102
72
30
12
9
213
35
15

18
4
10
17
1
24
12
3
4
77
4
14

52
4
14
61
111
75
32
8
7
217
40
15

10.6%
0.9%
4.1%
7.8%
1.2%
13.7%
7.4%
0.9%
2.0%
47.9%
1.8%
1.6%

0.41 [0.17 , 1.04]
0.08 [0.00 , 1.81]
0.50 [0.11 , 2.21]
0.24 [0.08 , 0.71]
1.09 [0.07 , 17.64]
0.38 [0.17 , 0.86]
0.51 [0.17 , 1.54]
0.06 [0.00 , 1.44]
0.21 [0.02 , 1.88]
0.78 [0.52 , 1.17]
0.26 [0.03 , 2.49]
0.29 [0.03 , 3.12]

Total (95% CI)
188
Total events:
Heterogeneity: Tau² = 0.01; Chi² = 11.26, df = 11 (P = 0.42); I² = 2%
Test for overall effect: Z = 4.22 (P < 0.0001)
Test for subgroup differences: Not applicable

126

624

636

100.0%

0.52 [0.38 , 0.70]

0.1

0.2

0.5
Favours CBT

1

2

5
Favours comparator

10

Analysis 1.3.   Comparison 1: CBT-based psychotherapy, Outcome 3: Repetition of SH at 12 months

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Brown 2005
Dubois 1999
Gibbons 1978
Hatcher 2011
Hawton 1987
Lin 2020
Slee 2008
Tyrer 2003
Wei 2013

12
8
27
70
3
15
26
84
1

49
43
200
522
41
72
40
213
25

23
10
29
81
6
18
21
99
5

49
41
200
572
39
75
33
217
27

5.6%
3.8%
13.0%
35.1%
1.9%
6.9%
4.5%
28.3%
0.8%

0.37 [0.16 , 0.87]
0.71 [0.25 , 2.02]
0.92 [0.52 , 1.62]
0.94 [0.67 , 1.32]
0.43 [0.10 , 1.87]
0.83 [0.38 , 1.81]
1.06 [0.41 , 2.78]
0.78 [0.53 , 1.14]
0.18 [0.02 , 1.69]

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 7.00, df = 8 (P = 0.54); I² = 0%
Test for overall effect: Z = 2.06 (P = 0.04)
Test for subgroup differences: Not applicable

1205

246

292

1253

100.0%

0.81 [0.66 , 0.99]

0.1 0.2

0.5
Favours CBT

1

2

5
Favours comparator

10

Analysis 1.4.   Comparison 1: CBT-based psychotherapy, Outcome 4: Repetition of SH at 24 months

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Brown 2005
Salkovskis 1990

13
3

45
12

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.01, df = 1 (P = 0.92); I² = 0%
Test for overall effect: Z = 2.85 (P = 0.004)
Test for subgroup differences: Not applicable

57

16

23
4

27

40
8

81.8%
18.2%

0.30 [0.12 , 0.74]
0.33 [0.05 , 2.24]

48

100.0%

0.31 [0.14 , 0.69]

0.1 0.2

0.5
Favours CBT

1

2

5
Favours comparator

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

199

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.5.   Comparison 1: CBT-based psychotherapy, Outcome 5: Frequency of SH at post-intervention

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Slee 2008
Stewart 2009
Tapolaa 2010
Weinberg 2006

5.3
0.33
0.17
0.6

9.44
0.63
0.41
0.91

40
23
6
15

4.04
0.22
0.86
3.63

7.16
0.5
1.46
4.8

34
9
7
15

7.6%
45.1%
32.6%
14.7%

1.26 [-2.53 , 5.05]
0.11 [-0.31 , 0.53]
-0.69 [-1.82 , 0.44]
-3.03 [-5.50 , -0.56]

Total (95% CI)
Heterogeneity: Tau² = 0.71; Chi² = 7.84, df = 3 (P = 0.05); I² = 62%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Not applicable

84

65

100.0%

-0.53 [-1.67 , 0.61]

-10

-5
Favours CBT

0

5

10

Favours comparator

Analysis 1.6.   Comparison 1: CBT-based psychotherapy, Outcome 6: Frequency of SH at six months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Davidson 2014
Owens 2020
Tapolaa 2010
Weinberg 2006

2.1
0.6
0.43
1.98

3.51
1.28
0.54
3.57

10
30
6
15

10
1.4
1
6.69

11.53
2.43
0.89
12.23

3
32
7
15

0.2%
39.9%
59.0%
0.9%

-7.90 [-21.13 , 5.33]
-0.80 [-1.76 , 0.16]
-0.57 [-1.36 , 0.22]
-4.71 [-11.16 , 1.74]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 2.77, df = 3 (P = 0.43); I² = 0%
Test for overall effect: Z = 2.31 (P = 0.02)
Test for subgroup differences: Not applicable

61

57

100.0%

-0.71 [-1.32 , -0.11]

-10

-5
Favours CBT

0

5

10

Favours comparator

Analysis 1.7.   Comparison 1: CBT-based psychotherapy, Outcome 7: Time to SH repetition

Study or Subgroup

log[Hazard Ratio]

SE

Weight

Hazard Ratio
IV, Random, 95% CI

Hazard Ratio
IV, Random, 95% CI

Brown 2005
Hatcher 2011
Tyrer 2003

-0.67
-0.02
-0.22

0.34
0.17
0.17

15.6%
42.2%
42.2%

0.51 [0.26 , 1.00]
0.98 [0.70 , 1.37]
0.80 [0.58 , 1.12]

Total (95% CI)
Heterogeneity: Tau² = 0.02; Chi² = 3.02, df = 2 (P = 0.22); I² = 34%
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Not applicable

100.0%

0.81 [0.61 , 1.08]

0.01

0.1
Favours CBT

1

10

100

Favours comparator

Analysis 1.8.   Comparison 1: CBT-based psychotherapy, Outcome 8: Depression scores at post-intervention

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Brown 2005
Hatcher 2011
Husain 2014
Slee 2008
Wei 2013

19.96
5.2
13
16.58
8.43

14.82
4.3
16.2
13.7
10.45

60
196
105
40
55

21.19
7.5
17.1
28.56
7.14

14.92
5.1
16.4
18.62
8.33

60
230
112
34
61

18.8%
25.4%
22.4%
14.8%
18.6%

-0.08 [-0.44 , 0.28]
-0.48 [-0.68 , -0.29]
-0.25 [-0.52 , 0.02]
-0.73 [-1.21 , -0.26]
0.14 [-0.23 , 0.50]

Total (95% CI)
Heterogeneity: Tau² = 0.06; Chi² = 13.66, df = 4 (P = 0.008); I² = 71%
Test for overall effect: Z = 2.12 (P = 0.03)
Test for subgroup differences: Not applicable

456

497

100.0%

-0.28 [-0.54 , -0.02]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

-1

-0.5
Favours CBT

0

0.5

1

Favours comparator

200

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.9.   Comparison 1: CBT-based psychotherapy, Outcome 9: Depression scores at six months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Brown 2005
Davidson 2014
Evans 1999b
Guthrie 2001
Husain 2014
Tapolaa 2010
Tyrer 2003
Wei 2013

13.82
9.27
5.7
18.5
14.8
25
7.9
7.82

12.34
5.73
5.5
13.5
17.3
13.57
5.3
10.38

50
11
18
47
102
6
195
35

19.33
16.75
10.1
24
19.4
24.71
7.5
5.85

15.61
1.5
4.1
12.5
16.9
11.87
5.3
8.16

Total (95% CI)
Heterogeneity: Tau² = 0.07; Chi² = 18.49, df = 7 (P = 0.010); I² = 62%
Test for overall effect: Z = 1.89 (P = 0.06)
Test for subgroup differences: Not applicable

464

52
4
14
48
111
7
194
40

15.4%
3.3%
8.0%
15.0%
19.1%
4.4%
21.2%
13.6%

-0.39 [-0.78 , 0.00]
-1.39 [-2.67 , -0.10]
-0.87 [-1.60 , -0.13]
-0.42 [-0.83 , -0.01]
-0.27 [-0.54 , 0.00]
0.02 [-1.07 , 1.11]
0.08 [-0.12 , 0.27]
0.21 [-0.24 , 0.67]

470

100.0%

-0.24 [-0.50 , 0.01]

-1

-0.5
Favours CBT

0

0.5

1

Favours comparator

Analysis 1.10.   Comparison 1: CBT-based psychotherapy, Outcome 10: Depression scores at 12 months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Brown 2005
Hatcher 2011
Hawton 1987
Salkovskis 1990
Slee 2008
Tyrer 2003
Wei 2013

13.59
5.3
6.5
15
11.58
7
7.26

13.4
4.7
8.26
6.16
12.12
5.3
10.58

49
190
30
12
40
198
25

18.73
6.2
9.6
23
29.61
7.1
5.84

13.87
4.8
10.96
6.16
17.51
5.2
8.23

49
232
35
8
33
202
27

15.4%
19.9%
13.4%
6.1%
13.1%
19.8%
12.3%

-0.37 [-0.77 , 0.03]
-0.19 [-0.38 , 0.00]
-0.31 [-0.80 , 0.18]
-1.24 [-2.24 , -0.25]
-1.21 [-1.71 , -0.70]
-0.02 [-0.22 , 0.18]
0.15 [-0.40 , 0.69]

Total (95% CI)
Heterogeneity: Tau² = 0.10; Chi² = 25.39, df = 6 (P = 0.0003); I² = 76%
Test for overall effect: Z = 2.42 (P = 0.02)
Test for subgroup differences: Not applicable

544

586

100.0%

-0.36 [-0.64 , -0.07]

-1

-0.5
Favours CBT

0

0.5

1

Favours comparator

Analysis 1.11.   Comparison 1: CBT-based psychotherapy, Outcome 11: Depression scores at 24 months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Brown 2005
Gibbons 1978

14.51
10.57

12.9
11.39

45
69

18.18
12.62

13.75
10.95

40
71

37.6%
62.4%

-0.27 [-0.70 , 0.15]
-0.18 [-0.51 , 0.15]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.11, df = 1 (P = 0.74); I² = 0%
Test for overall effect: Z = 1.62 (P = 0.11)
Test for subgroup differences: Not applicable

114

111

100.0%

-0.22 [-0.48 , 0.05]

-1

-0.5
Favours CBT

0

0.5

1

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

201

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.12.   Comparison 1: CBT-based psychotherapy, Outcome 12: Hopelessness scores at post-intervention

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Brown 2005
Hatcher 2011
Husain 2014
Patsiokas 1985
Stewart 2009

7.45
5.7
7.9
3.3
4.35

4.99
5.5
8.7
2.34
4.22

60
193
105
10
23

9.06
8.9
11.3
9
7.56

6.98
6.6
8.9
7.8
8.53

60
226
112
5
9

17.8%
62.6%
15.3%
1.7%
2.5%

-1.61 [-3.78 , 0.56]
-3.20 [-4.36 , -2.04]
-3.40 [-5.74 , -1.06]
-5.70 [-12.69 , 1.29]
-3.21 [-9.04 , 2.62]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 2.38, df = 4 (P = 0.67); I² = 0%
Test for overall effect: Z = 6.39 (P < 0.00001)
Test for subgroup differences: Not applicable

391

412

100.0%

-2.99 [-3.91 , -2.07]

-10

-5
Favours CBT

0

5

10

Favours comparator

Analysis 1.13.   Comparison 1: CBT-based psychotherapy, Outcome 13: Hopelessness scores at six months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Brown 2005
Husain 2014

5.57
7.5

4.47
8.8

50
102

8.21
11.2

6.96
9.1

52
111

53.1%
46.9%

-2.64 [-4.90 , -0.38]
-3.70 [-6.10 , -1.30]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.40, df = 1 (P = 0.53); I² = 0%
Test for overall effect: Z = 3.73 (P = 0.0002)
Test for subgroup differences: Not applicable

152

163

100.0%

-3.14 [-4.78 , -1.49]

-10

-5
Favours CBT

0

5

10

Favours comparator

Analysis 1.14.   Comparison 1: CBT-based psychotherapy, Outcome 14: Hopelessness scores at 12 months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Brown 2005
Hatcher 2011
Salkovskis 1990

6.57
5.8
6.75

5.76
5.8
2.3

49
189
12

8.22
7.2
10

6.77
6.4
2.3

52
229
8

17.6%
58.4%
24.0%

-1.65 [-4.10 , 0.80]
-1.40 [-2.57 , -0.23]
-3.25 [-5.31 , -1.19]

Total (95% CI)
Heterogeneity: Tau² = 0.16; Chi² = 2.37, df = 2 (P = 0.31); I² = 16%
Test for overall effect: Z = 3.43 (P = 0.0006)
Test for subgroup differences: Not applicable

250

289

100.0%

-1.89 [-2.97 , -0.81]

-10

-5
Favours CBT

0

5

10

Favours comparator

Analysis 1.15.   Comparison 1: CBT-based psychotherapy, Outcome 15: Suicidal ideation scores at post-intervention

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Hatcher 2011
Husain 2014
Patsiokas 1985
Stewart 2009
Weinberg 2006

3.7
7.1
5.1
1.91
24.47

6.8
9.8
5.29
4.07
16.92

194
105
10
23
15

7.1
10.5
8.6
10.11
42.69

8.6
9.6
9.2
12.67
17.67

230
112
5
9
15

50.3%
34.8%
3.2%
5.5%
6.2%

-0.43 [-0.63 , -0.24]
-0.35 [-0.62 , -0.08]
-0.49 [-1.58 , 0.60]
-1.08 [-1.90 , -0.26]
-1.02 [-1.79 , -0.26]

Total (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 4.98, df = 4 (P = 0.29); I² = 20%
Test for overall effect: Z = 4.74 (P < 0.00001)
Test for subgroup differences: Not applicable

347

371

100.0%

-0.48 [-0.68 , -0.28]

-2

-1

0

1

2

Favours CBT

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

202

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.16.   Comparison 1: CBT-based psychotherapy, Outcome 16: Suicidal ideation scores at six months

Study or Subgroup

CBT-based psychotherapy
Total
SD
Mean

Comparator
SD

Mean

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Davidson 2014
Guthrie 2001
Husain 2014
Weinberg 2006

12.36
8.3
7.8
37.96

12.48
8.6
10.7
18.68

11
47
102
15

26.5
12.1
11.3
45.69

1.92
10.4
10.4
14.38

4
48
111
15

2.9%
27.2%
61.4%
8.5%

-1.21 [-2.46 , 0.04]
-0.39 [-0.80 , 0.01]
-0.33 [-0.60 , -0.06]
-0.45 [-1.18 , 0.27]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.87, df = 3 (P = 0.60); I² = 0%
Test for overall effect: Z = 3.55 (P = 0.0004)
Test for subgroup differences: Not applicable

175

178

100.0%

-0.38 [-0.60 , -0.17]

-2

-1
Favours CBT

0

1

2

Favours comparator

Analysis 1.17.   Comparison 1: CBT-based psychotherapy, Outcome 17: Proportion reporting suicidal ideation

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

1.17.1 Post-intervention
Mousavi 2017
Wei 2013
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 1.20; Chi² = 6.52, df = 1 (P = 0.01); I² = 85%
Test for overall effect: Z = 0.99 (P = 0.32)

30
82
112

7
33

40

19
32

51

30
77
107

46.0%
54.0%
100.0%

0.18 [0.06 , 0.54]
0.95 [0.50 , 1.78]
0.44 [0.08 , 2.26]

1.17.2 Six months
Wei 2013
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.72 (P = 0.47)

30

30

1.17.3 12 months
Wei 2013
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.55 (P = 0.59)

30

30

82
82

82
82

24

24

25

25

77
77

100.0%
100.0%

1.27 [0.66 , 2.46]
1.27 [0.66 , 2.46]

77
77

100.0%
100.0%

1.20 [0.62 , 2.31]
1.20 [0.62 , 2.31]

0.01

0.1
Favours CBT

1

10

100

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

203

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.18.   Comparison 1: CBT-based psychotherapy, Outcome 18: Suicide deaths by final follow-up

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Brown 2005
Davidson 2014
Dubois 1999
Guthrie 2001
Hatcher 2011
Hawton 1987
Husain 2014
Lin 2020
Owens 2020
Salkovskis 1990
Slee 2008
Stewart 2009
Tapolaa 2010
Tyrer 2003
Wei 2013
Weinberg 2006

0
1
0
0
3
1
2
2
0
0
0
0
0
1
0
0

60
10
51
58
253
41
102
72
30
12
48
23
9
239
26
15

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 3.78, df = 7 (P = 0.80); I² = 0%
Test for overall effect: Z = 0.56 (P = 0.57)
Test for subgroup differences: Not applicable

1049

10

6.6%
6.0%

30.2%
6.6%
17.5%
11.7%

6.6%

14.8%

60
4
51
61
299
39
111
75
32
8
42
9
7
241
27
15

0.33 [0.01 , 8.21]
1.42 [0.05 , 42.22]
Not estimable
Not estimable
0.89 [0.20 , 3.99]
2.93 [0.12 , 74.00]
1.09 [0.15 , 7.88]
2.11 [0.19 , 23.84]
Not estimable
Not estimable
0.29 [0.01 , 7.19]
Not estimable
Not estimable
0.20 [0.02 , 1.71]
Not estimable
Not estimable

1081

100.0%

0.79 [0.34 , 1.80]

1
0
0
0
4
0
2
1
0
0
1
0
0
5
0
0

14

0.01

0.1
Favours CBT

1

10

100

Favours comparator

Analysis 1.19.   Comparison 1: CBT-based psychotherapy,
Outcome 19: Repetition of SH at 12 months (by repeater status)

Study or Subgroup

Events

Total

Events

Total

Weight

CBT-based psychotherapy

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

1.19.1 History of prior SH
Hatcher 2011
Lin 2020
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.06, df = 1 (P = 0.81); I² = 0%
Test for overall effect: Z = 2.52 (P = 0.01)

208
39
247

28
11

39

212
49
261

75.6%
24.4%
100.0%

0.55 [0.33 , 0.91]
0.62 [0.25 , 1.53]
0.56 [0.36 , 0.88]

47
19

66

1.19.2 No history of prior SH
Hatcher 2011
Lin 2020
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.20; Chi² = 2.03, df = 1 (P = 0.15); I² = 51%
Test for overall effect: Z = 0.23 (P = 0.82)

314
33
347

42
8

50

34
9

43

360
26
386

67.1%
32.9%
100.0%

1.48 [0.92 , 2.39]
0.60 [0.19 , 1.88]
1.10 [0.48 , 2.52]

Test for subgroup differences: Chi² = 1.97, df = 1 (P = 0.16), I² = 49.3%

0.1 0.2

0.5
Favours CBT

1

2

5
Favours comparator

10

Comparison 2.   DBT

Outcome or subgroup title

No. of studies

2.1 Repetition of SH by post-in-
tervention

6

No. of partici-
pants

502

Statistical method

Effect size

Odds Ratio (M-H, Random, 95%
CI)

0.71 [0.32, 1.55]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

204

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

2.1.1 Comparator: TAU

2.1.2 Comparator: Alternative
psychotherapy

2.2 Repetition of SH by 12
months

2.2.1 Comparator: TAU

2.2.2 Comparator: Alternative
psychotherapy

2.3 Frequency of SH by post-in-
tervention

2.3.1 Comparator: TAU

2.3.2 Comparator: Alternative
psychotherapy

2.4 Treatment adherence: Pro-
portion completing treatment

2.4.1 Comparator: TAU

2.4.2 Comparator: Alternative
psychotherapy

2.5 Depression scores by post-in-
tervention

2.5.1 Comparator: TAU

2.5.2 Comparator: Alternative
psychotherapy

2.6 Suicidal ideation scores by
post-intervention

2.6.1 Comparator: TAU

2.6.2 Comparator: Alternative
psychotherapy

2.7 Suicide deaths by post-inter-
vention

3

3

3

2

1

7

4

3

4

1

3

6

3

3

3

1

2

5

267

235

269

172

97

659

376

283

467

180

287

557

282

275

194

81

113

563

Odds Ratio (M-H, Random, 95%
CI)

0.59 [0.16, 2.15]

Odds Ratio (M-H, Random, 95%
CI)

0.67 [0.16, 2.78]

Odds Ratio (M-H, Random, 95%
CI)

0.65 [0.24, 1.72]

Odds Ratio (M-H, Random, 95%
CI)

0.36 [0.05, 2.47]

Odds Ratio (M-H, Random, 95%
CI)

1.18 [0.35, 3.95]

Mean Difference (IV, Random,
95% CI)

-5.00 [-8.92, -1.08]

Mean Difference (IV, Random,
95% CI)

-10.09 [-21.57, 1.40]

Mean Difference (IV, Random,
95% CI)

-5.00 [-7.91, -2.09]

Odds Ratio (M-H, Random, 95%
CI)

1.40 [0.73, 2.67]

Odds Ratio (M-H, Random, 95%
CI)

0.95 [0.52, 1.74]

Odds Ratio (M-H, Random, 95%
CI)

1.79 [0.65, 4.89]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.37 [-0.58, -0.17]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.27 [-0.50, -0.03]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.50 [-0.85, -0.14]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.31 [-0.64, 0.02]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.34 [-0.78, 0.10]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.40 [-1.11, 0.31]

Odds Ratio (M-H, Random, 95%
CI)

3.00 [0.12, 76.49]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

205

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

2.7.1 Comparator: TAU

2.7.2 Comparator: Alternative
psychotherapy

2.8 Suicide deaths by 12 months

2.8.1 Comparator: TAU

2.8.2 Comparator: Alternative
psychotherapy

2.9 Suicide deaths by 24 months

2.9.1 Comparator: TAU

2.9.2 Comparator: Alternative
psychotherapy

4

1

2

2

0

2

2

0

401

162

254

254

0

254

254

0

Odds Ratio (M-H, Random, 95%
CI)

3.00 [0.12, 76.49]

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Odds Ratio (M-H, Random, 95%
CI)

Not estimable

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

206

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.1.   Comparison 2: DBT, Outcome 1: Repetition of SH by post-intervention

Study or Subgroup

Events

Total

Events

Total

Weight

DBT

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

2.1.1 Comparator: TAU
Linehan 1991
McMain 2009
Priebe 2012
Subtotal (95% CI)
81
Total events:
Heterogeneity: Tau² = 0.77; Chi² = 4.86, df = 2 (P = 0.09); I² = 59%
Test for overall effect: Z = 0.80 (P = 0.43)

22
70
37
129

22
78
38
138

14
33
34

21
36
35

92

2.1.2 Comparator: Alternative psychotherapy
Linehan 2006
Turner 2000
Walton 2020
Subtotal (95% CI)
80
Total events:
Heterogeneity: Tau² = 1.09; Chi² = 7.51, df = 2 (P = 0.02); I² = 73%
Test for overall effect: Z = 0.55 (P = 0.58)

45
12
63
120

52
12
51
115

37
8
39

46
1
33

84

244

Total (95% CI)
161
Total events:
Heterogeneity: Tau² = 0.50; Chi² = 12.51, df = 5 (P = 0.03); I² = 60%
Test for overall effect: Z = 0.87 (P = 0.39)
Test for subgroup differences: Chi² = 0.02, df = 1 (P = 0.90), I² = 0%

258

176

9.1%
26.2%
13.0%
48.4%

19.0%
8.1%
24.5%
51.6%

0.08 [0.01 , 0.74]
1.04 [0.54 , 1.99]
0.97 [0.18 , 5.15]
0.59 [0.16 , 2.15]

1.66 [0.53 , 5.20]
0.05 [0.00 , 0.49]
1.13 [0.52 , 2.43]
0.67 [0.16 , 2.78]

100.0%

0.71 [0.32 , 1.55]

Risk of Bias
E
B

C

D

?
+
+

-

+
+

-

+
?

?
?
?

A

+
+
?

F

-

?
?

?
?
+

?
+
+

+
+
+

+
-

?

?
?
?

?
-

?

0.01

0.1
Favours DBT

1

10

100

Favours comparator

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH by post-intervention
(C) Bias due to missing outcome data: Repetition of SH by post-intervention
(D) Bias in measurement of the outcome: Repetition of SH by post-intervention
(E) Bias in selection of the reported result: Repetition of SH by post-intervention
(F) Overall bias: Repetition of SH by post-intervention

Analysis 2.2.   Comparison 2: DBT, Outcome 2: Repetition of SH by 12 months

Study or Subgroup

Events

Total

Events

Total

Weight

DBT

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

2.2.1 Comparator: TAU
Linehan 1991
McMain 2009
Subtotal (95% CI)
32
Total events:
Heterogeneity: Tau² = 1.35; Chi² = 2.93, df = 1 (P = 0.09); I² = 66%
Test for overall effect: Z = 1.03 (P = 0.30)

22
59
81

22
69
91

21
24

15
17

45

15.6%
50.2%
65.8%

0.10 [0.01 , 0.92]
0.76 [0.36 , 1.61]
0.36 [0.05 , 2.47]

2.2.2 Comparator: Alternative psychotherapy
Linehan 2006
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.27 (P = 0.79)

52
52

46

46

39

39

45
45

34.2%
34.2%

1.18 [0.35 , 3.95]
1.18 [0.35 , 3.95]

133

Total (95% CI)
78
Total events:
Heterogeneity: Tau² = 0.35; Chi² = 3.76, df = 2 (P = 0.15); I² = 47%
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Chi² = 1.03, df = 1 (P = 0.31), I² = 3.1%

136

84

100.0%

0.65 [0.24 , 1.72]

0.01

0.1
Favours DBT

1

10

100

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

207

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.3.   Comparison 2: DBT, Outcome 3: Frequency of SH by post-intervention

Study or Subgroup

Mean

DBT
SD

Total

Mean

Comparator
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

2.3.1 Comparator: TAU
Linehan 1991
McMain 2009
McMain 2017
Priebe 2012
Subtotal (95% CI)
Heterogeneity: Tau² = 73.05; Chi² = 8.68, df = 3 (P = 0.03); I² = 65%
Test for overall effect: Z = 1.72 (P = 0.09)

12.35
9.32
3.26
42

33.54
12.87
2.59
65.1

22
90
42
31
185

6.82
4.29
1.14
27.2

2.3.2 Comparator: Alternative psychotherapy
Linehan 2006
Turner 2000
Walton 2020
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.73, df = 2 (P = 0.69); I² = 0%
Test for overall effect: Z = 3.36 (P = 0.0008)

10.81
1.23
35.95

52
12
81
145

8.79
0.75
10.1

23.64
5.58
15

Total (95% CI)
Heterogeneity: Tau² = 9.05; Chi² = 11.85, df = 6 (P = 0.07); I² = 49%
Test for overall effect: Z = 2.50 (P = 0.01)
Test for subgroup differences: Chi² = 0.71, df = 1 (P = 0.40), I² = 0%

330

69.97
51.45
6.9
93.8

77.34
5.28
30.09

22
90
42
37
191

1.7%
10.1%
38.3%
1.3%
51.4%

-26.72 [-56.41 , 2.97]
-8.58 [-19.38 , 2.22]
-1.45 [-3.76 , 0.86]
-37.90 [-71.55 , -4.25]
-10.09 [-21.57 , 1.40]

45
12
81
138

2.8%
34.8%
11.0%
48.6%

-14.85 [-37.64 , 7.94]
-4.83 [-7.90 , -1.76]
-4.90 [-15.11 , 5.31]
-5.00 [-7.91 , -2.09]

329

100.0%

-5.00 [-8.92 , -1.08]

-20

-10
Favours DBT

0

10

20

Favours comparator

Analysis 2.4.   Comparison 2: DBT, Outcome 4: Treatment adherence: Proportion completing treatment

Study or Subgroup

Events

Total

Events

Total

Weight

DBT

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

2.4.1 Comparator: TAU
McMain 2009
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.15 (P = 0.88)

55

55

90
90

56

56

90
90

32.8%
32.8%

0.95 [0.52 , 1.74]
0.95 [0.52 , 1.74]

2.4.2 Comparator: Alternative psychotherapy
Linehan 2006
Turner 2000
Walton 2020
Subtotal (95% CI)
96
Total events:
Heterogeneity: Tau² = 0.51; Chi² = 6.28, df = 2 (P = 0.04); I² = 68%
Test for overall effect: Z = 1.13 (P = 0.26)

52
12
81
145

49
12
81
142

42
9
45

28
6
48

82

24.4%
10.7%
32.1%
67.2%

3.15 [1.29 , 7.69]
3.00 [0.53 , 16.90]
0.86 [0.46 , 1.60]
1.79 [0.65 , 4.89]

235

Total (95% CI)
151
Total events:
Heterogeneity: Tau² = 0.24; Chi² = 7.24, df = 3 (P = 0.06); I² = 59%
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Chi² = 1.10, df = 1 (P = 0.29), I² = 8.9%

138

232

100.0%

1.40 [0.73 , 2.67]

0.1

0.2

0.5
Favours DBT

1

2

5
Favours comparator

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

208

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.5.   Comparison 2: DBT, Outcome 5: Depression scores by post-intervention

Study or Subgroup

Mean

DBT
SD

Total

Mean

Comparator
SD

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

2.5.1 Comparator: TAU
Linehan 1991
McMain 2009
McMain 2017
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.99, df = 2 (P = 0.37); I² = 0%
Test for overall effect: Z = 2.24 (P = 0.03)

21
22.18
22.76

7.48
16.14
12.55

7
90
42
139

21.91
24.83
29.73

2.5.2 Comparator: Alternative psychotherapy
Linehan 2006
Turner 2000
Walton 2020
Subtotal (95% CI)
Heterogeneity: Tau² = 0.04; Chi² = 3.44, df = 2 (P = 0.18); I² = 42%
Test for overall effect: Z = 2.75 (P = 0.006)

17
24.08
22.13

14
14.92
15.94

7.3
8.26
14.52

50
12
81
143

Total (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 6.49, df = 5 (P = 0.26); I² = 23%
Test for overall effect: Z = 3.61 (P = 0.0003)
Test for subgroup differences: Chi² = 1.11, df = 1 (P = 0.29), I² = 10.2%

282

14.85
14.83
13.5

8.2
5.55
17.78

11
90
42
143

4.3%
29.2%
16.8%
50.4%

-0.07 [-1.02 , 0.88]
-0.17 [-0.46 , 0.12]
-0.53 [-0.97 , -0.09]
-0.27 [-0.50 , -0.03]

39
12
81
132

17.6%
4.9%
27.1%
49.6%

-0.39 [-0.81 , 0.04]
-1.26 [-2.15 , -0.37]
-0.38 [-0.69 , -0.07]
-0.50 [-0.85 , -0.14]

275

100.0%

-0.37 [-0.58 , -0.17]

-2

-1
Favours DBT

0

1

2

Favours comparator

Analysis 2.6.   Comparison 2: DBT, Outcome 6: Suicidal ideation scores by post-intervention

Study or Subgroup

Mean

DBT
SD

Total

Mean

Comparator
SD

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

2.6.1 Comparator: TAU
Linehan 1991
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.50 (P = 0.13)

24.01

19.8

31.92

26.8

46
46

35
35

41.3%
41.3%

-0.34 [-0.78 , 0.10]
-0.34 [-0.78 , 0.10]

2.6.2 Comparator: Alternative psychotherapy
Linehan 2006
Turner 2000
Subtotal (95% CI)
Heterogeneity: Tau² = 0.16; Chi² = 2.42, df = 1 (P = 0.12); I² = 59%
Test for overall effect: Z = 1.10 (P = 0.27)

32.8
11.58

24.5
8.03

29.8
3.83

50
12
62

Total (95% CI)
Heterogeneity: Tau² = 0.02; Chi² = 2.49, df = 2 (P = 0.29); I² = 20%
Test for overall effect: Z = 1.86 (P = 0.06)
Test for subgroup differences: Chi² = 0.02, df = 1 (P = 0.89), I² = 0%

108

26.3
9.21

39
12
51

44.8%
13.9%
58.7%

-0.12 [-0.54 , 0.30]
-0.87 [-1.71 , -0.02]
-0.40 [-1.11 , 0.31]

86

100.0%

-0.31 [-0.64 , 0.02]

-2

-1
Favours DBT

0

1

2

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

209

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.7.   Comparison 2: DBT, Outcome 7: Suicide deaths by post-intervention

Study or Subgroup

Events

Total

Events

Total

Weight

DBT

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

2.7.1 Comparator: TAU
Linehan 1991
McMain 2009
McMain 2017
Priebe 2012
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.66 (P = 0.51)

1
0
0
0

1

32
90
42
38
202

2.7.2 Comparator: Alternative psychotherapy
Walton 2020
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable

81
81

0

0

283

Total (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable

1

31
90
42
36
199

81
81

100.0%

100.0%

3.00 [0.12 , 76.49]
Not estimable
Not estimable
Not estimable
3.00 [0.12 , 76.49]

Not estimable
Not estimable

280

100.0%

3.00 [0.12 , 76.49]

0
0
0
0

0

0

0

0

0.01

0.1
Favours DBT

1

10

100

Favours comparator

Analysis 2.8.   Comparison 2: DBT, Outcome 8: Suicide deaths by 12 months

Study or Subgroup

Events

Total

Events

Total

Weight

DBT

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

2.8.1 Comparator: TAU
McMain 2009
Priebe 2012
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable

0
0

0

90
38
128

2.8.2 Comparator: Alternative psychotherapy
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable

0

0

128

Total (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Test for subgroup differences: Not applicable

0

90
36
126

Not estimable
Not estimable
Not estimable

0

Not estimable

126

Not estimable

0
0

0

0

0

0.01

0.1
Favours DBT

1

10

100

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

210

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.9.   Comparison 2: DBT, Outcome 9: Suicide deaths by 24 months

Study or Subgroup

Events

Total

Events

Total

Weight

DBT

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

2.9.1 Comparator: TAU
McMain 2009
Priebe 2012
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable

0
0

0

90
38
128

2.9.2 Comparator: Alternative psychotherapy
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable

0

0

128

Total (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Test for subgroup differences: Not applicable

0

90
36
126

Not estimable
Not estimable
Not estimable

0

Not estimable

126

Not estimable

0
0

0

0

0

0.01

0.1
Favours DBT

1

10

100

Favours comparator

Comparison 3.   Group-based emotion-regulation psychotherapy

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

3.1 Repetition of SH at post-interven-
tion

3.2 Frequency of repetition of SH at
post-intervention

3.3 Depression scores at post-interven-
tion

2

2

2

83

83

83

Odds Ratio (M-H, Random,
95% CI)

0.34 [0.13, 0.88]

Mean Difference (IV, Ran-
dom, 95% CI)

-12.76 [-34.92,
9.40]

Mean Difference (IV, Ran-
dom, 95% CI)

-9.59 [-13.43,
-5.75]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

211

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Risk of Bias
E
B

C

D

?
+

+
+

+
?

?
?

F

?
?

Analysis 3.1.   Comparison 3: Group-based emotion-regulation
psychotherapy, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Emotion-regulation
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Gratz 2006
Gratz 2014

6
17

12
31

7
24

10
30

29.5%
70.5%

0.43 [0.07 , 2.50]
0.30 [0.10 , 0.95]

A

?
?

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.10, df = 1 (P = 0.75); I² = 0%
Test for overall effect: Z = 2.23 (P = 0.03)
Test for subgroup differences: Not applicable

43

23

31

40

100.0%

0.34 [0.13 , 0.88]

0.1

0.2
0.5
Favours ER

1

2

5
Favours comparator

10

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

Analysis 3.2.   Comparison 3: Group-based emotion-regulation psychotherapy,
Outcome 2: Frequency of repetition of SH at post-intervention

Study or Subgroup

Emotion-regulation
SD

Total

Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Gratz 2006
Gratz 2014

5
16.67

4.94
39.74

12
31

30.33
19.26

35.08
24.25

10
30

44.7%
55.3%

-25.33 [-47.25 , -3.41]
-2.59 [-19.05 , 13.87]

Total (95% CI)
Heterogeneity: Tau² = 160.73; Chi² = 2.64, df = 1 (P = 0.10); I² = 62%
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Not applicable

43

40

100.0%

-12.76 [-34.92 , 9.40]

-50

-25
Favours ER

0

25

50

Favours comparator

Analysis 3.3.   Comparison 3: Group-based emotion-regulation
psychotherapy, Outcome 3: Depression scores at post-intervention

Study or Subgroup

Emotion-regulation
SD

Total

Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Gratz 2006
Gratz 2014

9
19.98

6.52
8.26

12
31

23.2
28.81

15.32
8.26

10
30

14.2%
85.8%

-14.20 [-24.39 , -4.01]
-8.83 [-12.98 , -4.68]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.92, df = 1 (P = 0.34); I² = 0%
Test for overall effect: Z = 4.90 (P < 0.00001)
Test for subgroup differences: Not applicable

43

40

100.0%

-9.59 [-13.43 , -5.75]

-50

-25
Favours ER

0

25

50

Favours comparator

Comparison 4.   Case management

Outcome or subgroup title

No. of studies

4.1 Repetition of SH at post-in-
tervention

4

No. of partici-
pants

1608

Statistical method

Effect size

Odds Ratio (M-H, Random, 95%
CI)

0.78 [0.47, 1.30]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

212

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

4.1.1 TAU (whole sample)

4.1.2 Enhanced usual care
(whole sample)

4.2 Suicide deaths at post-inter-
vention

4.2.1 TAU

4.2.2 Enhanced usual care

2

2

4

2

2

600

1008

1757

600

1157

Odds Ratio (M-H, Random, 95%
CI)

0.59 [0.25, 1.40]

Odds Ratio (M-H, Random, 95%
CI)

0.99 [0.42, 2.31]

Odds Ratio (M-H, Random, 95%
CI)

0.95 [0.57, 1.57]

Odds Ratio (M-H, Random, 95%
CI)

1.50 [0.24, 9.35]

Odds Ratio (M-H, Random, 95%
CI)

0.91 [0.54, 1.55]

Analysis 4.1.   Comparison 4: Case management, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Case management
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

A

Risk of Bias
E
B

D

C

4.1.1 TAU (whole sample)
Clarke 2002
Hvid 2011
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.22; Chi² = 2.17, df = 1 (P = 0.14); I² = 54%
Test for overall effect: Z = 1.20 (P = 0.23)

220
69
289

19
6

25
14

25

39

247
64
311

27.7%
16.2%
43.9%

0.84 [0.45 , 1.57]
0.34 [0.12 , 0.95]
0.59 [0.25 , 1.40]

+
+

+
+

+
+

+
+

?
?

F

?
?

4.1.2 Enhanced usual care (whole sample)
Kawanishi 2014
Morthorst 2012
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.28; Chi² = 3.60, df = 1 (P = 0.06); I² = 72%
Test for overall effect: Z = 0.03 (P = 0.97)

380
123
503

41
13

28
20

48

54

385
120
505

32.6%
23.5%
56.1%

0.67 [0.40 , 1.10]
1.60 [0.76 , 3.38]
0.99 [0.42 , 2.31]

+
+

+
+

+
+

+
+

?
?

?
?

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.14; Chi² = 6.46, df = 3 (P = 0.09); I² = 54%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Chi² = 0.70, df = 1 (P = 0.40), I² = 0%

792

73

93

816

100.0%

0.78 [0.47 , 1.30]

0.5
0.1 0.2
Favours case management

1

2

5
Favours comparator

10

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

213

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 4.2.   Comparison 4: Case management, Outcome 2: Suicide deaths at post-intervention

Study or Subgroup

Case management
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

4.2.1 TAU
Clarke 2002
Hvid 2011
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.08, df = 1 (P = 0.78); I² = 0%
Test for overall effect: Z = 0.44 (P = 0.66)

220
69
289

1
1

1
2

2

3

4.2.2 Enhanced usual care
Kawanishi 2014
Morthorst 2012
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.53, df = 1 (P = 0.47); I² = 0%
Test for overall effect: Z = 0.35 (P = 0.73)

460
123
583

30
0

27
1

30

28

247
64
311

3.4%
4.4%
7.8%

1.12 [0.07 , 18.07]
1.88 [0.17 , 21.25]
1.50 [0.24 , 9.35]

454
120
574

89.7%
2.5%
92.2%

0.88 [0.52 , 1.51]
2.95 [0.12 , 73.16]
0.91 [0.54 , 1.55]

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.87, df = 3 (P = 0.83); I² = 0%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi² = 0.27, df = 1 (P = 0.60), I² = 0%

872

32

31

885

100.0%

0.95 [0.57 , 1.57]

0.5
0.1 0.2
Favours case management

1

2

5
Favours comparator

10

Comparison 5.   Remote contact interventions: Emergency cards

Outcome or subgroup title

No. of studies

5.1 Repetition of SH at post-inter-
vention

5.2 Repetition of SH at 12 months

5.2.1 Emergency cards (whole sam-
ple)

5.2.2 Emergency cards (history of
prior SH)

5.2.3 Emergency cards (no history of
prior SH)

2

1

1

1

1

No. of partici-
pants

1039

827

394

427

Statistical method

Effect size

Odds Ratio (M-H, Random,
95% CI)

0.82 [0.31, 2.14]

Odds Ratio (M-H, Random,
95% CI)

Subtotals only

Odds Ratio (M-H, Random,
95% CI)

1.19 [0.85, 1.67]

Odds Ratio (M-H, Random,
95% CI)

1.85 [1.14, 3.03]

Odds Ratio (M-H, Random,
95% CI)

0.64 [0.34, 1.22]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

214

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 5.1.   Comparison 5: Remote contact interventions:
Emergency cards, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Remote contact
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Evans 1999a
Morgan 1993

90
5

417
101

77
12

410
111

63.2%
36.8%

1.19 [0.85 , 1.67]
0.43 [0.15 , 1.27]

A

+
?

518

Total (95% CI)
95
Total events:
Heterogeneity: Tau² = 0.35; Chi² = 3.11, df = 1 (P = 0.08); I² = 68%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Not applicable

89

521

100.0%

0.82 [0.31 , 2.14]

0.5
0.1 0.2
Favours remote contact

1

2

5
Favours comparator

10

Risk of Bias
E
B

D

C

+
+

+
+

+
+

?
?

F

?
?

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

Analysis 5.2.   Comparison 5: Remote contact interventions:
Emergency cards, Outcome 2: Repetition of SH at 12 months

Study or Subgroup

Remote contact
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

5.2.1 Emergency cards (whole sample)
Evans 1999a
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 1.00 (P = 0.32)

90

90

417
417

5.2.2 Emergency cards (history of prior SH)
194
Evans 1999a
194
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 2.47 (P = 0.01)

52

52

5.2.3 Emergency cards (no history of prior SH)
Evans 1999a
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 1.36 (P = 0.17)

221
221

18

18

410
410

100.0%
100.0%

1.19 [0.85 , 1.67]
1.19 [0.85 , 1.67]

200
200

100.0%
100.0%

1.85 [1.14 , 3.03]
1.85 [1.14 , 3.03]

206
206

100.0%
100.0%

0.64 [0.34 , 1.22]
0.64 [0.34 , 1.22]

77

77

33

33

25

25

Test for subgroup differences: Chi² = 6.70, df = 2 (P = 0.04), I² = 70.2%

0.1 0.2
0.5
Favours remote contact

1

2

5
Favours comparator

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

215

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 6.   Remote contact interventions: Postcards

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

6.1 Repetition of SH at post-in-
tervention

6.1.1 Postcards (whole sam-
ple)

6.1.2 Postcards (males)

6.1.3 Postcards (females)

6.2 Repetition of SH at 12
months

6.2.1 Postcards (whole sam-
ple)

6.2.2 Postcards (males)

6.2.3 Postcards (females)

6.3 Frequency of SH at post-in-
tervention

6.3.1 Postcards (whole sam-
ple)

6.3.2 Postcards (males)

6.3.3 Postcards (females)

6.3.4 Postcards (history of pri-
or SH)

6.3.5 Postcards (no history of
prior SH)

6.4 Frequency of SH at 12
months

6.4.1 Postcards (whole sam-
ple)

6.4.2 Postcards (males)

6.4.3 Postcards (females)

6.4.4 Postcards (history of pri-
or SH)

4

4

1

1

2

2

1

1

3

3

3

3

3

3

2

2

2

2

2

Odds Ratio (M-H, Random, 95% CI)

Subtotals only

3277

Odds Ratio (M-H, Random, 95% CI)

0.87 [0.62, 1.23]

247

524

Odds Ratio (M-H, Random, 95% CI)

0.86 [0.42, 1.75]

Odds Ratio (M-H, Random, 95% CI)

0.89 [0.56, 1.41]

Odds Ratio (M-H, Random, 95% CI)

Subtotals only

2885

Odds Ratio (M-H, Random, 95% CI)

0.76 [0.57, 1.02]

247

524

1097

401

695

339

758

984

336

647

296

Odds Ratio (M-H, Random, 95% CI)

0.95 [0.50, 1.84]

Odds Ratio (M-H, Random, 95% CI)

1.19 [0.78, 1.80]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.07 [-0.32, 0.18]

Mean Difference (IV, Random, 95%
CI)

-0.01 [-0.13, 0.12]

Mean Difference (IV, Random, 95%
CI)

-0.04 [-0.29, 0.20]

Mean Difference (IV, Random, 95%
CI)

-0.09 [-0.68, 0.51]

Mean Difference (IV, Random, 95%
CI)

0.23 [-0.32, 0.77]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.19 [-0.58, 0.20]

Mean Difference (IV, Random, 95%
CI)

0.03 [-0.11, 0.16]

Mean Difference (IV, Random, 95%
CI)

-0.22 [-0.62, 0.18]

Mean Difference (IV, Random, 95%
CI)

-0.64 [-2.07, 0.80]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

216

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

6.4.5 Postcards (no history of
prior SH)

6.5 Frequency of SH at 24
months

6.5.1 Postcards (whole sam-
ple)

6.5.2 Postcards (males)

6.5.3 Postcards (females)

6.5.4 Postcards (history of pri-
or SH)

6.5.5 Postcards (no history of
prior SH)

6.6 Suicide deaths at post-in-
tervention

6.6.1 Postcards (whole sam-
ple)

2

1

1

1

1

1

1

4

4

688

472

220

252

338

134

3464

3464

Mean Difference (IV, Random, 95%
CI)

-0.07 [-0.22, 0.09]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.03 [-0.16, 0.10]

Mean Difference (IV, Random, 95%
CI)

0.04 [-0.21, 0.29]

Mean Difference (IV, Random, 95%
CI)

-0.07 [-0.21, 0.07]

Mean Difference (IV, Random, 95%
CI)

-0.09 [-0.31, 0.13]

Mean Difference (IV, Random, 95%
CI)

-0.01 [-0.16, 0.14]

Odds Ratio (M-H, Random, 95% CI)

1.86 [0.61, 5.72]

Odds Ratio (M-H, Random, 95% CI)

1.86 [0.61, 5.72]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

217

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.1.   Comparison 6: Remote contact interventions:
Postcards, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Remote contact
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

6.1.1 Postcards (whole sample)
Beautrais 2010
Carter 2005
Hassanian-Moghaddam 2011
Kapur 2013
Subtotal (95% CI)
220
Total events:
Heterogeneity: Tau² = 0.06; Chi² = 6.11, df = 3 (P = 0.11); I² = 51%
Test for overall effect: Z = 0.78 (P = 0.43)

153
378
1043
33
1607

39
57
69
11

49
68
99
4

176

174
394
1070
32
1670

25.5%
31.9%
36.3%
6.4%
100.0%

0.87 [0.53 , 1.43]
0.85 [0.58 , 1.25]
0.69 [0.50 , 0.96]
3.50 [0.98 , 12.50]
0.87 [0.62 , 1.23]

A

+
?
+
?

Risk of Bias
E
B

D

C

+
-
+
+

+
+
+
+

+
+
?
+

?
?
?
?

F

?
-
?
?

6.1.2 Postcards (males)
Carter 2005
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.41 (P = 0.68)

6.1.3 Postcards (females)
Carter 2005
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.50 (P = 0.62)

20

20

37

37

145
145

233
233

16

16

51

51

102
102

100.0%
100.0%

0.86 [0.42 , 1.75]
0.86 [0.42 , 1.75]

?

-

+

+

?

-

291
291

100.0%
100.0%

0.89 [0.56 , 1.41]
0.89 [0.56 , 1.41]

?

-

+

+

?

-

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

0.5
0.1 0.2
Favours remote contact

1

2

5
Favours comparator

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

218

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.2.   Comparison 6: Remote contact interventions: Postcards, Outcome 2: Repetition of SH at 12 months

Study or Subgroup

Remote contact
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

6.2.1 Postcards (whole sample)
Carter 2005
Hassanian-Moghaddam 2011
Subtotal (95% CI)
256
Total events:
Heterogeneity: Tau² = 0.02; Chi² = 1.97, df = 1 (P = 0.16); I² = 49%
Test for overall effect: Z = 1.80 (P = 0.07)

378
1043
1421

90
166

80
114

194

6.2.2 Postcards (males)
Carter 2005
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.14 (P = 0.89)

6.2.3 Postcards (females)
Carter 2005
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.80 (P = 0.42)

26

26

54

54

145
145

233
233

19

19

59

59

394
1070
1464

42.9%
57.1%
100.0%

0.91 [0.64 , 1.28]
0.67 [0.52 , 0.86]
0.76 [0.57 , 1.02]

102
102

100.0%
100.0%

0.95 [0.50 , 1.84]
0.95 [0.50 , 1.84]

291
291

100.0%
100.0%

1.19 [0.78 , 1.80]
1.19 [0.78 , 1.80]

0.5
0.1 0.2
Favours remote contact

1

2

5
Favours comparator

10

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

219

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.3.   Comparison 6: Remote contact interventions:
Postcards, Outcome 3: Frequency of SH at post-intervention

Study or Subgroup

Remote contact
SD

Total

Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

6.3.1 Postcards (whole sample)
378
Carter 2005
119
Hassanian-Moghaddam 2011
33
Kapur 2013
530
Subtotal (95% CI)
Heterogeneity: Tau² = 0.03; Chi² = 5.35, df = 2 (P = 0.07); I² = 63%
Test for overall effect: Z = 0.54 (P = 0.59)

0.267
0.11
1.24

0.898
0.53
3.67

6.3.2 Postcards (males)
Carter 2005
Hassanian-Moghaddam 2011
Kapur 2013
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.60, df = 2 (P = 0.45); I² = 0%
Test for overall effect: Z = 0.12 (P = 0.91)

0.56
0.75
6.02

0.2
0.18
2.64

145
63
11
219

6.3.3 Postcards (females)
233
Carter 2005
56
Hassanian-Moghaddam 2011
22
Kapur 2013
311
Subtotal (95% CI)
Heterogeneity: Tau² = 0.03; Chi² = 4.34, df = 2 (P = 0.11); I² = 54%
Test for overall effect: Z = 0.35 (P = 0.73)

1.054
0.36
1.34

0.309
0.08
0.55

6.3.4 Postcards (history of prior SH)
63
Carter 2005
75
Hassanian-Moghaddam 2011
22
Kapur 2013
160
Subtotal (95% CI)
Heterogeneity: Tau² = 0.14; Chi² = 3.99, df = 2 (P = 0.14); I² = 50%
Test for overall effect: Z = 0.29 (P = 0.77)

1.748
0.68
4.41

0.571
0.2
1.82

6.3.5 Postcards (no history of prior SH)
Carter 2005
Hassanian-Moghaddam 2011
Kapur 2013
Subtotal (95% CI)
Heterogeneity: Tau² = 0.22; Chi² = 49.25, df = 2 (P < 0.00001); I² = 96%
Test for overall effect: Z = 0.82 (P = 0.41)

0.585
0.41
0.3

0.206
0.07
0.91

315
44
11
370

0.49
0.13
0.22

1.985
0.49
0.66

394
141
32
567

42.5%
53.8%
3.6%
100.0%

-0.22 [-0.44 , -0.01]
-0.02 [-0.14 , 0.10]
1.02 [-0.25 , 2.29]
-0.07 [-0.32 , 0.18]

0.21
0.19
0.33

0.569
0.64
0.89

102
68
12
182

73.6%
26.3%
0.1%
100.0%

-0.01 [-0.15 , 0.13]
-0.01 [-0.25 , 0.23]
2.31 [-1.28 , 5.90]
-0.01 [-0.13 , 0.12]

0.57
0.1
0.15

2.263
0.39
0.49

291
73
20
384

33.3%
53.4%
13.3%
100.0%

-0.26 [-0.55 , 0.03]
-0.02 [-0.15 , 0.11]
0.40 [-0.20 , 1.00]
-0.04 [-0.29 , 0.20]

1.12
0.27
0.36

2.634
0.72
0.86

66
96
17
179

31.2%
60.2%
8.6%
100.0%

-0.55 [-1.32 , 0.22]
-0.07 [-0.28 , 0.14]
1.46 [-0.43 , 3.35]
-0.09 [-0.68 , 0.51]

0.36
0.06
0.07

1.805
0.3
0.26

328
45
15
388

33.2%
33.9%
32.9%
100.0%

-0.15 [-0.36 , 0.05]
0.01 [-0.14 , 0.16]
0.84 [0.62 , 1.06]
0.23 [-0.32 , 0.77]

-1

-0.5

0

0.5

1

Favours remote contact

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

220

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.4.   Comparison 6: Remote contact interventions: Postcards, Outcome 4: Frequency of SH at 12 months

Study or Subgroup

Remote contact
SD

Total

Mean

6.4.1 Postcards (whole sample)
378
Carter 2005
98
Hassanian-Moghaddam 2011
476
Subtotal (95% CI)
Heterogeneity: Tau² = 0.07; Chi² = 6.32, df = 1 (P = 0.01); I² = 84%
Test for overall effect: Z = 0.94 (P = 0.35)

1.077
0.43

0.38
0.1

6.4.2 Postcards (males)
Carter 2005
Hassanian-Moghaddam 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.12, df = 1 (P = 0.73); I² = 0%
Test for overall effect: Z = 0.35 (P = 0.73)

0.768
0.58

0.28
0.16

145
53
198

6.4.3 Postcards (females)
233
Carter 2005
45
Hassanian-Moghaddam 2011
278
Subtotal (95% CI)
Heterogeneity: Tau² = 0.07; Chi² = 4.13, df = 1 (P = 0.04); I² = 76%
Test for overall effect: Z = 1.06 (P = 0.29)

1.228
0.32

0.45
0.07

6.4.4 Postcards (history of prior SH)
63
Carter 2005
80
Hassanian-Moghaddam 2011
143
Subtotal (95% CI)
Heterogeneity: Tau² = 0.90; Chi² = 5.25, df = 1 (P = 0.02); I² = 81%
Test for overall effect: Z = 0.87 (P = 0.38)

2.026
0.66

0.84
0.23

6.4.5 Postcards (no history of prior SH)
315
Carter 2005
18
Hassanian-Moghaddam 2011
333
Subtotal (95% CI)
Heterogeneity: Tau² = 0.01; Chi² = 1.67, df = 1 (P = 0.20); I² = 40%
Test for overall effect: Z = 0.84 (P = 0.40)

0.73
0.18

0.29
0.03

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

0.79
0.11

2.739
0.39

394
114
508

44.1%
55.9%
100.0%

-0.41 [-0.70 , -0.12]
-0.01 [-0.12 , 0.10]
-0.19 [-0.58 , 0.20]

0.28
0.11

0.788
0.37

102
36
138

50.0%
50.0%
100.0%

0.00 [-0.20 , 0.20]
0.05 [-0.15 , 0.25]
0.03 [-0.11 , 0.16]

0.92
0.12

3.054
0.39

291
78
369

40.3%
59.7%
100.0%

-0.47 [-0.85 , -0.09]
-0.05 [-0.18 , 0.08]
-0.22 [-0.62 , 0.18]

2.36
0.26

4.796
0.55

66
87
153

40.9%
59.1%
100.0%

-1.52 [-2.78 , -0.26]
-0.03 [-0.22 , 0.16]
-0.64 [-2.07 , 0.80]

0.47
0.04

1.96
0.24

328
27
355

33.6%
66.4%
100.0%

-0.18 [-0.41 , 0.05]
-0.01 [-0.13 , 0.11]
-0.07 [-0.22 , 0.09]

-1

-0.5

0

0.5

1

Favours remote contact

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

221

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.5.   Comparison 6: Remote contact interventions: Postcards, Outcome 5: Frequency of SH at 24 months

Study or Subgroup

Remote contact
SD

Total

Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

6.5.1 Postcards (whole sample)
Hassanian-Moghaddam 2011
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.45 (P = 0.65)

6.5.2 Postcards (males)
Hassanian-Moghaddam 2011
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.31 (P = 0.75)

6.5.3 Postcards (females)
Hassanian-Moghaddam 2011
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.99 (P = 0.32)

6.5.4 Postcards (history of prior SH)
Hassanian-Moghaddam 2011
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.81 (P = 0.42)

6.5.5 Postcards (no history of prior SH)
Hassanian-Moghaddam 2011
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.13 (P = 0.90)

0.21

0.75

0.33

1.07

0.14

0.52

0.42

1.06

0.09

0.47

217
217

116
116

101
101

155
155

62
62

0.24

0.68

255
255

100.0%
100.0%

-0.03 [-0.16 , 0.10]
-0.03 [-0.16 , 0.10]

0.29

0.82

104
104

100.0%
100.0%

0.04 [-0.21 , 0.29]
0.04 [-0.21 , 0.29]

0.21

0.59

151
151

100.0%
100.0%

-0.07 [-0.21 , 0.07]
-0.07 [-0.21 , 0.07]

0.51

0.96

183
183

100.0%
100.0%

-0.09 [-0.31 , 0.13]
-0.09 [-0.31 , 0.13]

0.1

0.41

72
72

100.0%
100.0%

-0.01 [-0.16 , 0.14]
-0.01 [-0.16 , 0.14]

-1

-0.5

0

0.5

1

Favours remote contact

Favours comparator

Analysis 6.6.   Comparison 6: Remote contact interventions:
Postcards, Outcome 6: Suicide deaths at post-intervention

Study or Subgroup

Remote contact
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

6.6.1 Postcards (whole sample)
Beautrais 2010
Carter 2005
Hassanian-Moghaddam 2011
Kapur 2013
Subtotal (95% CI)
6
Total events:
Heterogeneity: Tau² = 0.17; Chi² = 3.41, df = 3 (P = 0.33); I² = 12%
Test for overall effect: Z = 1.08 (P = 0.28)

153
378
1150
33
1714

0
4
2
0

2
2
7
1

12

Total (95% CI)
6
Total events:
Heterogeneity: Tau² = 0.17; Chi² = 3.41, df = 3 (P = 0.33); I² = 12%
Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable

1714

12

174
394
1150
32
1750

12.7%
35.6%
40.4%
11.3%
100.0%

5.76 [0.27 , 120.90]
0.52 [0.09 , 2.85]
3.52 [0.73 , 16.96]
3.00 [0.12 , 76.40]
1.86 [0.61 , 5.72]

1750

100.0%

1.86 [0.61 , 5.72]

0.01

0.1

1

10

100

Favours remote contact

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

222

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 7.   Remote contact interventions: Telephone-based psychotherapy

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

7.1 Repetition of SH at post-interven-
tion

7.2 Depression scores at post-inter-
vention

7.3 Suicide deaths at post-interven-
tion

2

2

3

185

185

240

Odds Ratio (M-H, Random,
95% CI)

0.36 [0.01, 8.94]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.40 [-1.39, 0.59]

Odds Ratio (M-H, Random,
95% CI)

3.09 [0.12, 78.55]

Analysis 7.1.   Comparison 7: Remote contact interventions: Telephone-
based psychotherapy, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Events

Total

Events

Total

Weight

Telephone

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Marasinghe 2012
Wei 2013

0
0

34
56

Total (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable

0

90

34
61

100.0%

Not estimable
0.36 [0.01 , 8.94]

95

100.0%

0.36 [0.01 , 8.94]

0
1

1

0.01
Favours telephone

0.1

1

10

100

Favours comparator

Risk of Bias
E
B

D

C

+
+

+
-

+
?

?
?

A

?
?

F

?
-

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

Analysis 7.2.   Comparison 7: Remote contact interventions: Telephone-
based psychotherapy, Outcome 2: Depression scores at post-intervention

Study or Subgroup

Mean

Telephone
SD

Total

Mean

Comparator
SD

Total

Weight

Std. Mean Difference
IV, Random, 95% CI

Std. Mean Difference
IV, Random, 95% CI

Marasinghe 2012
Wei 2013

7
7.92

5
9.26

34
56

14.6
7.14

10.4
8.33

34
61

48.5%
51.5%

-0.92 [-1.42 , -0.42]
0.09 [-0.27 , 0.45]

Total (95% CI)
Heterogeneity: Tau² = 0.46; Chi² = 10.21, df = 1 (P = 0.001); I² = 90%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable

90

95

100.0%

-0.40 [-1.39 , 0.59]

-2

-1

0

1

2

Favours telephone

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

223

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 7.3.   Comparison 7: Remote contact interventions: Telephone-
based psychotherapy, Outcome 3: Suicide deaths at post-intervention

Study or Subgroup

Events

Total

Events

Total

Weight

Telephone

Comparator

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Marasinghe 2012
Sreedaran 2020
Wei 2013

1
0
0

34
8
80

122

Total (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.68 (P = 0.49)
Test for subgroup differences: Not applicable

1

100.0%

34
7
77

3.09 [0.12 , 78.55]
Not estimable
Not estimable

118

100.0%

3.09 [0.12 , 78.55]

0
0
0

0

0.01
Favours telephone

0.1

1

10

100

Favours comparator

Comparison 8.   Provision of information and support

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

8.1 Repetition of SH at post-intervention

8.2 Suicide deaths at post-intervention

8.2.1 Provision of information and sup-
port

8.2.2 Provision of information and sup-
port with peer support

2

3

2

1

1853

2577

1889

688

Odds Ratio (M-H, Random,
95% CI)

1.09 [0.79, 1.50]

Odds Ratio (M-H, Random,
95% CI)

0.15 [0.05, 0.48]

Odds Ratio (M-H, Random,
95% CI)

0.12 [0.03, 0.44]

Odds Ratio (M-H, Random,
95% CI)

0.33 [0.03, 3.20]

Analysis 8.1.   Comparison 8: Provision of information and support, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Mixed intervention
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

Amadéo 2015
Fleischmann 2008

24
66

90
863

21
60

100
800

22.7%
77.3%

1.37 [0.70 , 2.68]
1.02 [0.71 , 1.47]

A

?
+

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.56, df = 1 (P = 0.45); I² = 0%
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable

953

90

81

900

100.0%

1.09 [0.79 , 1.50]

0.2

0.5

1

2

5

Favours mixed

Favours comparator

Risk of Bias
E
B

C

D

+
?

+
-

+
+

?
?

F

?
-

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

224

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 8.2.   Comparison 8: Provision of information and support, Outcome 2: Suicide deaths at post-intervention

Study or Subgroup

Mixed intervention
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

8.2.1 Provision of information and support
Amadéo 2015
Fleischmann 2008
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.19, df = 1 (P = 0.67); I² = 0%
Test for overall effect: Z = 3.16 (P = 0.002)

90
872
962

2
18

0
2

20

2

8.2.2 Provision of information and support with peer support
Naidoo 2014
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.95 (P = 0.34)

344
344

1

1

3

3

100
827
927

14.0%
60.7%
74.7%

0.22 [0.01 , 4.60]
0.10 [0.02 , 0.45]
0.12 [0.03 , 0.44]

344
344

25.3%
25.3%

0.33 [0.03 , 3.20]
0.33 [0.03 , 3.20]

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.79, df = 2 (P = 0.67); I² = 0%
Test for overall effect: Z = 3.21 (P = 0.001)
Test for subgroup differences: Chi² = 0.59, df = 1 (P = 0.44), I² = 0%

1306

23

3

1271

100.0%

0.15 [0.05 , 0.48]

0.01

0.1

1

10

100

Favours mixed

Favours comparator

Comparison 9.   Other multimodal interventions

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

9.1 Repetition of SH at post-in-
tervention

9.1.1 Whole sample

9.1.2 First SH episode

9.1.3 Repeat SH episode

9.2 Time to SH repetition

9.3 Depression scores at post-in-
tervention

9.4 Hopelessness scores at post-
intervention

9.5 Suicide deaths at post-inter-
vention

3

3

2

2

2

3

2

3

1937

901

938

651

556

971

Odds Ratio (M-H, Random, 95%
CI)

Subtotals only

Odds Ratio (M-H, Random, 95%
CI)

0.69 [0.37, 1.30]

Odds Ratio (M-H, Random, 95%
CI)

1.02 [0.70, 1.47]

Odds Ratio (M-H, Random, 95%
CI)

0.92 [0.52, 1.62]

Hazard Ratio (IV, Random, 95%
CI)

0.39 [0.09, 1.76]

Mean Difference (IV, Random,
95% CI)

-0.52 [-2.08, 1.05]

Mean Difference (IV, Random,
95% CI)

-0.29 [-1.27, 0.69]

Odds Ratio (M-H, Random, 95%
CI)

0.63 [0.13, 3.06]

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

225

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 9.1.   Comparison 9: Other multimodal interventions, Outcome 1: Repetition of SH at post-intervention

Study or Subgroup

Mixed multimodal
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

9.1.1 Whole sample
Gysin-Maillart 2016
Hatcher 2015
Hatcher 2016
Subtotal (95% CI)
232
Total events:
Heterogeneity: Tau² = 0.22; Chi² = 10.26, df = 2 (P = 0.006); I² = 81%
Test for overall effect: Z = 1.14 (P = 0.25)

55
737
182
974

16
135
92

5
142
85

43
737
183
963

243

18.9%
42.6%
38.5%
100.0%

0.17 [0.06 , 0.51]
1.06 [0.82 , 1.38]
0.87 [0.57 , 1.31]
0.69 [0.37 , 1.30]

A

+
+
?

Risk of Bias
E
B

C

D

+
+
+

+
+
+

+
+
+

+
+
+

F

+
+
?

9.1.2 First SH episode
Hatcher 2015
Hatcher 2016
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.26, df = 1 (P = 0.61); I² = 0%
Test for overall effect: Z = 0.08 (P = 0.93)

369
81
450

40
40

39
38

80

77

359
92
451

62.3%
37.7%
100.0%

0.94 [0.59 , 1.50]
1.15 [0.63 , 2.09]
1.02 [0.70 , 1.47]

9.1.3 Repeat SH episode
Hatcher 2015
Hatcher 2016
Subtotal (95% CI)
Total events:
Heterogeneity: Tau² = 0.12; Chi² = 3.07, df = 1 (P = 0.08); I² = 67%
Test for overall effect: Z = 0.29 (P = 0.77)

368
101
469

104
47

95
52

147

151

378
91
469

58.3%
41.7%
100.0%

1.17 [0.85 , 1.62]
0.65 [0.37 , 1.15]
0.92 [0.52 , 1.62]

Test for subgroup differences: Chi² = 1.05, df = 2 (P = 0.59), I² = 0%

0.5
Favours mixed multimodal

0.1 0.2

1

Risk of bias legend
(A) Bias arising from the randomization process
(B) Bias due to deviations from intended interventions: Repetition of SH at post-intervention
(C) Bias due to missing outcome data: Repetition of SH at post-intervention
(D) Bias in measurement of the outcome: Repetition of SH at post-intervention
(E) Bias in selection of the reported result: Repetition of SH at post-intervention
(F) Overall bias: Repetition of SH at post-intervention

+
?

+
+

+
+

+
+

+
+

+
?

+
?

+
+

+
+

+
+

+
+

+
?

2

5
Favours comparator

10

Analysis 9.2.   Comparison 9: Other multimodal interventions, Outcome 2: Time to SH repetition

Study or Subgroup

log[Hazard Ratio]

SE

Weight

Hazard Ratio
IV, Random, 95% CI

Hazard Ratio
IV, Random, 95% CI

Gysin-Maillart 2016
Hatcher 2016

-1.77
-0.23

0.48
0.19

45.9%
54.1%

0.17 [0.07 , 0.44]
0.79 [0.55 , 1.15]

100.0%
Total (95% CI)
Heterogeneity: Tau² = 1.05; Chi² = 8.90, df = 1 (P = 0.003); I² = 89%
Test for overall effect: Z = 1.22 (P = 0.22)
Test for subgroup differences: Not applicable

0.39 [0.09 , 1.76]

0.01

0.1

1

10

100

Favours multimodal

Favours comparator

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

226

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 9.3.   Comparison 9: Other multimodal interventions, Outcome 3: Depression scores at post-intervention

Study or Subgroup

Gysin-Maillart 2016
Hatcher 2015
Hatcher 2016

Mixed multimodal
SD

Total

Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

6.54
6.8
5.8

9.98
4.9
4.5

54
211
66

10.63
6.5
6.3

9.75
5.1
4.3

38
234
48

11.8%
51.0%
37.1%

-4.09 [-8.18 , -0.00]
0.30 [-0.63 , 1.23]
-0.50 [-2.13 , 1.13]

Total (95% CI)
Heterogeneity: Tau² = 1.02; Chi² = 4.59, df = 2 (P = 0.10); I² = 56%
Test for overall effect: Z = 0.65 (P = 0.52)
Test for subgroup differences: Not applicable

331

320

100.0%

-0.52 [-2.08 , 1.05]

-10
Favours mixed multimodal

-5

0

5

10

Favours comparator

Analysis 9.4.   Comparison 9: Other multimodal interventions, Outcome 4: Hopelessness scores at post-intervention

Study or Subgroup

Mixed multimodal
SD

Total

Mean

Comparator
SD

Mean

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

Hatcher 2015
Hatcher 2016

8.3
5

6.3
4.4

210
66

8.4
5.7

6.4
4.8

233
47

68.2%
31.8%

-0.10 [-1.28 , 1.08]
-0.70 [-2.43 , 1.03]

Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.31, df = 1 (P = 0.58); I² = 0%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable

276

280

100.0%

-0.29 [-1.27 , 0.69]

-10
Favours mixed multimodal

-5

0

5

10

Favours comparator

Analysis 9.5.   Comparison 9: Other multimodal interventions, Outcome 5: Suicide deaths at post-intervention

Study or Subgroup

Gysin-Maillart 2016
Hatcher 2015
Hatcher 2016

Mixed multimodal
Total
Events

Comparator

Events

Total

Weight

Odds Ratio
M-H, Random, 95% CI

Odds Ratio
M-H, Random, 95% CI

1
1
0

60
327
72

1
2
1

60
357
95

32.2%
43.5%
24.3%

1.00 [0.06 , 16.37]
0.54 [0.05 , 6.03]
0.43 [0.02 , 10.82]

Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.17, df = 2 (P = 0.92); I² = 0%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable

459

2

4

512

100.0%

0.63 [0.13 , 3.06]

0.01

0.1

1

10

100

Favours mixed multimodal

Favours comparator

A D D I T I O N A L   T A B L E S

Table 1.   Methods used at the index episode of self-harm 

Reference

Method

Self-poisoning

Self-injury

n (%)

n (%)

Combined self-
poisoning and
self-injury

Unspecified

n (%)

Allard 1992

Amadéo 2015

-

-

-

-

n (%)

-

-

-

-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

227

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 1.   Methods used at the index episode of self-harm  (Continued)

Andreoli 2015

Armitage 2016

Bateman 2009

Beautrais 2010 1

Bennewith 2002

Brown 2005

Carter 2005

Cedereke 2002

Clarke 2002 1

Crawford 2010

Davidson 2014

Dubois 1999

Evans 1999a

Evans 1999b

Fleischmann 2008

Gibbons 1978

Gratz 2006

Gratz 2014

Grimholt 2015

Guthrie 2001

Gysin-Maillart 2016

Harned 2014

Hatcher 2011

Hatcher 2015

Hatcher 2016

Hawton 1981

Hawton 1987

-

-

-

-

-

-

250 (76.7)

64 (19.6)

7,733 (89.7)

158 (8.2)

70 (58.3)

33 (27.5)

772 (100)

-

-

-

-

-

-

-

-

-

-

-

442 (94.6)

25 (5.3)

8 (1.70)

74 (71.8)

25 (24.3)

-

-

808 (97.7)

-

-

400 (100)

-

-

149 (100)

119 (100)

-

-

-

-

-

-

-

-

-

-

-

-

-

26 (100)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

471 (85.3)

81 (14.7)

532 (77.8)

125 (18.3)

27 (3.9)

115 (68.9)

41 (24.5)

11 (6.6)

96 (100)

80 (100)

-

-

-

-

-

-

-

15 (4.6)

41 (2.1)

17 (14.2)

-

-

-

4 (3.9)

-

-

19 (2.3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Hassanian-Moghaddam 2011

2,300 (100)

-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

228

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 1.   Methods used at the index episode of self-harm  (Continued)

Husain 2014

Hvid 2011

Kapur 2013

Kawanishi 2014 1

Liberman 1981

Lin 2020

Linehan 1991

Linehan 2006

Linehan 2015

Marasinghe 2012

McAuliffe 2014 2

McLeavey 1994

McMain 2009

McMain 2017

Morgan 1993

Morthorst 2012

Mouaffak 2015 3

Mousavi 2015

Mousavi 2017

Naidoo 2014

O'Connor 2015

O'Connor 2017

O'Connor 2020

Owens 2020

Patsiokas 1985

Priebe 2012

Sahin 2018

Salkovskis 1990

217 (98.2)

4 (1.8)

-

-

-

-

707 (77.3)

332 (36.3)

-

-

-

-

-

-

-

-

-

-

-

-

161 (37.2)

57 (13.2)

39 (100)

-

-

207 (97.6)

-

-

55 (100)

-

-

-

504 (97.3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40 (64.6)

12 (19.3)

10 (16.1)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42 (4.6)

-

-

-

-

-

-

4 (0.9)

-

-

-

5 (2.4)

-

-

-

-

-

-

14 (2.7)

-

-

-

-

-

-

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

229

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 1.   Methods used at the index episode of self-harm  (Continued)

Slee 2008

Sreedaran 2020

Stewart 2009

Tapolaa 2010

Torhorst 1987

Torhorst 1988

Turner 2000

Tyrer 2003

Vaiva 2006

Vaiva 2018

Van der Sande 1997

Van Heeringen 1995

Walton 2020

Wang 2016 4

73 (89.0)

-

-

-

141 (100)

80 (100)

-

-

605 (100)

926 (93.8)

232 (84.7)

463 (89.7)

-

-

Waterhouse 1990

77 (100)

Wei 2013

Weinberg 2006

Welu 1977

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

120 (100)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42 (15.3)

53 (10.3)

-

-

-

-

-

-

1 Percentages greater than 100% as participants could have used multiple methods.
2 Methods of self-harm for the remaining 221 (48.7%) participants were not reported.
3 The majority of participants engaged in 'non-violent' methods (n = 258; 85.2%), followed by 'violent' methods (n = 45; 14.8%). The methods
considered to be 'non-violent' or 'violent' in this trial were not reported, however.
4 The majority of participants engaged in 'low lethality' methods (n = 57; 89.1%), followed by 'high lethality' methods, including hanging,
charcoal burning, or jumping from a height (n = 7; 10.9%). The methods considered to be 'low lethality' in this trial were not reported,
however.

A P P E N D I C E S

Appendix 1. Cochrane Common Mental Disorders Specialised Register

The  Cochrane  Common  Mental  Disorders  Group  (CCMD)  maintains  an  archived  controlled  trials  register  known  as  the  CCMDCTR.  This
specialised register contains over 40,000 reference records (reports of RCTs) for anxiety disorders, depression, bipolar disorder, eating
disorders, self-harm, and other mental disorders within the scope of this Group. The CCMDCTR is a partially studies-based register with
more than 50% of reference records tagged to around 12,500 individually PICO-coded study records. Reports of studies for inclusion in
the register were collated from (weekly) generic searches of key bibliographic databases to June 2016, which included: MEDLINE (1950
onwards), Embase (1974 onwards), PsycINFO (1967 onwards), quarterly searches of the Cochrane Central Register of Controlled Trials
(CENTRAL), and review-specific searches of additional databases. Reports of studies were also sourced from international trials registries,

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

230

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

drug  companies,  the  handsearching  of  key  journals,  conference  proceedings  and  other  (non-Cochrane)  systematic  reviews  and  meta-
analyses. Details of CCMD's core search strategies (used to identify RCTs) are on the Group's website, with an example of the core MEDLINE
search displayed below.

[MeSH Headings]: eating disorders/ or anorexia nervosa/ or binge-eating disorder/ or bulimia nervosa/ or female athlete triad syndrome/
or pica/ or hyperphagia/ or bulimia/ or self-injurious behavior/ or self mutilation/ or suicide/ or suicidal ideation/ or suicide, attempted/
or mood disorders/ or affective disorders, psychotic/ or bipolar disorder/ or cyclothymic disorder/ or depressive disorder/ or depression,
postpartum/  or  depressive  disorder,  major/  or  depressive  disorder,  treatment-resistant/  or  dysthymic  disorder/  or  seasonal  affective
disorder/  or  neurotic  disorders/  or  depression/  or  adjustment  disorders/  or  exp  antidepressive  agents/  or  anxiety  disorders/  or
agoraphobia/  or  neurocirculatory  asthenia/  or  obsessive-compulsive  disorder/  or  obsessive  hoarding/  or  panic  disorder/  or  phobic
disorders/ or stress disorders, traumatic/ or combat disorders/ or stress disorders, post-traumatic/ or stress disorders, traumatic, acute/
or anxiety/ or anxiety, castration/ or koro/ or anxiety, separation/ or panic/ or exp anti-anxiety agents/ or somatoform disorders/ or body
dysmorphic disorders/ or conversion disorder/ or hypochondriasis/ or neurasthenia/ or hysteria/ or munchausen syndrome by proxy/ or
munchausen syndrome/ or fatigue syndrome, chronic/ or obsessive behavior/ or compulsive behavior/ or behavior, addictive/ or impulse
control disorders/ or firesetting behavior/ or gambling/ or trichotillomania/ or stress, psychological/ or burnout, professional/ or sexual
dysfunctions,  psychological/  or  vaginismus/  or  Anhedonia/  or  Affective  Symptoms/  or  *Mental  Disorders/  OR  [Title/  Author  Keywords]:
(eating disorder*  or anorexia nervosa or bulimi* or binge eat* or (self adj (injur* or mutilat*)) or suicide* or suicidal or parasuicid*  or
mood disorder* or affective disorder* or bipolar i or bipolar ii or (bipolar and (affective or disorder*)) or mania or manic or cyclothymic* or
depression or depressive or dysthymi* or neurotic or neurosis or adjustment disorder* or antidepress* or anxiety disorder* or agoraphobia
or obsess* or compulsi* or panic or phobi* or ptsd or posttrauma* or post trauma* or combat or somatoform or somati#ation or medical*
unexplained or body dysmorphi* or conversion disorder or hypochondria* or neurastheni* or hysteria or munchausen or chronic fatigue*
or gambling or trichotillomania or vaginismus or anhedoni* or affective symptoms or mental disorder* or mental health).tw,kf. AND [RCT
filter]: (controlled clinical trial.pt. or randomised controlled trial.pt. or (randomi#ed or randomi#ation).ab,ti. or randomly.ab. or (random*
adj3 (administ* or allocat* or assign* or class* or control* or determine* or divide* or distribut* or expose* or fashion or number* or place*
or recruit* or subsitut* or treat*)).ab. or placebo*.ab,ti. or drug therapy.fs. or trial.ab,ti. or groups.ab. or (control* adj3 (trial* or study or
studies)).ab,ti. or ((singl* or doubl* or tripl* or trebl*) adj3 (blind* or mask* or dummy*)).mp. or clinical trial, phase ii/ or clinical trial, phase
iii/ or clinical trial, phase iv/ or randomised controlled trial/ or pragmatic clinical trial/ or (quasi adj (experimental or random*)).ti,ab. or
((waitlist* or wait* list* or treatment as usual or TAU) adj3 (control or group)).ab.)

Records were screened for reports of RCTs within the scope of the Cochrane Common Mental Disorders Group. Secondary reports of RCTs
were tagged to the appropriate study record

An information specialist with CCMD will cross-search the CCMDCTR-Studies and References register using the following terms (all fields):

(suicid* or parasuicid* or "auto mutilat*" or automutilat* or "self destruct*" or selfdestruct* or self-harm* or selfharm* or "self immolat*"
or selfimmolat* or "self inflict*" or selfinflict* or "self injur*" or selfinjur* or selfmutilat* or "self mutilat*" or "self poison*" or selfpoison*
or (self adj2 (cut or cuts or cutting or cutter? or burn or burns or burning or bite or bites or biting or hit or hits or hitting)) or "head bang*"
or headbang* or "over dose*" or overdos* or NSSI* or nonsuicid* or non-suicid*) (2015-June-2016) n = 29

Appendix 2. MEDLINE, Embase, PsycINFO Ovid search strategy

An  information  specialist  with  CCMD  searched  the  main  biomedical  databases  using  the  terms  listed  below  from  January  2015  to  4-
July-2020. [N.B. CCMDCTR is current to June 2016 only]

Search summary

Date-of-search: 4-July-2020

• Cochrane Library (CDSR) Systematic Reviews, n = 38
• Cochrane Library (CDSR) Protocols, n = 12
• Cochrane Library CENTRAL, n = 2727
• Cochrane Specialised Register (CCMDCTR), n = 291
• Ovid MEDLINE, PsycINFO (cross-search), n = 2743
• Ovid Embase (precise), n = 1375

Total = 7186
Duplicates removed, n = 2483
To screen, n = 4703
[Cochrane Library CENTRAL-Trial Register Records (removed) n = 1969]
Cochrane Library (Issue 7 of 12, 2020) [Date limited, 2015 onwards]
#1 MeSH descriptor: [Self-Injurious Behavior] explode all trees
#2 (overdose* and prevent*):kw or (overdos* near/3 prevent*):ti,ab
#3 ((nonfatal or non-fatal) near/2 (overdose* or over dose*)):ti,ab,kw

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

231

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

#4 (NSSI* or ((nonsuicid* or non-suicid*) near/2 (self* or injur*))):ti,ab
#5 (suicid* or parasuicid* or (auto next mutilat*) or automutilat* or (self next destruct*) or selfdestruct* or self-harm* or selfharm* or (self
next harm*) or (self next immolat*) or selfimmolat* or (self next inflict*) or selfinflict* or (self next injur*) or selfinjur* or selfmutilat* or (self
next mutilat*) or (self next poison*) or selfpoison* or (self near/2 (cut or cuts or cutting or cutter* or burn or burns or burning or bite or
bites or biting or hit or hits or hitting)) or (head next bang*) or headbang*):ti,ab,kw
#6 (#1 or #2 or #3 or #4 or #5)
Limited 2015 to date
CDSR-reviews (38); CDSR-protocols (12); CENTRAL (2727); CENTRAL-TR (1969)
***************************
PsycINFO/MEDLINE cross-search

Ovid APA PsycInfo <1806 to June Week 5 2020>, Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and
Daily <1946 to July 02, 2020> [Date limited, 2015 onwards]
Search Strategy:
--------------------------------------------------------------------------------
1 Automutilation/ or Self-injurious Behavior/ or Self-destructive Behavior/ or Self-mutilation/ or Self-inflicted Wounds/ (19601)
2 Suicidal Behavior/ or Suicide/ or Suicidal Ideation/ or Attempted Suicide/ or Suicide, Attempted/ or Self Poisoning/ or Suicide Prevention/
or Suicide Prevention Centers/ or Suicidology/ (97875)
3 (suicid* or parasuicid* or auto mutilat* or automutilat* or self destruct* or selfdestruct* or self-harm* or selfharm* or self immolat* or
selfimmolat* or self inflict* or selfinflict* or self injur* or selfinjur* or selfmutilat* or self mutilat* or self poison* or selfpoison* or (self
adj2  (cut  or  cuts  or  cutting  or  cutter?  or  burn  or  burns  or  burning  or  bite  or  bites  or  biting  or  hit  or  hits  or  hitting))  or  head  bang*  or
headbang*).ti,ab,kf,kw,id. (164244)
4 (NSSI? or ((nonsuicid* or non-suicid*) adj2 (self* or injur*))).ti,ab,kf,kw,id. (3469)
5 (Overdose/ or Drug Overdose/ or Drug Overdoses/) and prevent*.af. (3529)
6 ((nonfatal or non-fatal) adj2 (overdose? or over dose?)).mp. (571)
7 or/1-6 (183505)
8 Randomized Controlled Trial/ (509272)
9 Randomized Controlled Trial.pt. (508805)
10 Randomization/ (103117)
11 Random Allocation/ (103117)
12 Controlled Clinical Trial/ (93744)
13 Controlled Clinical Trial.pt. (93744)
14 Double-blind Method/ or Single-blind Method/ (186347)
15 (randomi#ed or randomi#ation or randomi#ing).ti,ab,kf,kw,id. (726423)
16 (RCT or "at random" or (random* adj3 (administ* or allocat* or assign* or class* or cluster or crossover or cross-over or control* or
determine* or divide* or division or distribut* or expose* or fashion or number* or place* or pragmatic or quasi or recruit* or split or
subsitut* or treat*))).ti,ab,kf,kw,id. (667814)
17 trial.ti. (251482)
18 placebo/ or (placebo and (allocat* or assign* or control* or group*)).ti,ab,kf,kw,id. (204672)
19 (control* adj3 group*).ab. (634930)
20 (control* and (trial or study or group*) and (waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,kf,kw,id. (32182)
21 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,kf,kw,id. (200109)
22 treatment effectiveness evaluation/ (24511)
23 or/8-22 (1833008)
24 7 and 23 (9906)
25 (2015* or 2016* or 2017* or 2018* or 2019* or 2020*).yr,dc,dp,dt,ep,ez. (7909383)
26 24 and 25 (3732)
27 remove duplicates from 26 (2743)
***************************
Ovid Embase <1974 to 2020 Week 26> [Date limited, 2015 onwards]
Search Strategy:
--------------------------------------------------------------------------------
1 Automutilation/ (17795)
2 suicidal behavior/ or self immolation/ or self poisoning/ or suicidal ideation/ or suicide/ or suicide attempt/ (101066)
3 Drug Overdose/ and prevent*.af. (4897)
4 (suicid* or parasuicid* or auto mutilat* or automutilat* or self destruct* or selfdestruct* or self-harm* or selfharm* or self immolat* or
selfimmolat* or self inflict* or selfinflict* or self injur* or selfinjur* or selfmutilat* or self mutilat* or self poison* or selfpoison* or (self
adj2  (cut  or  cuts  or  cutting  or  cutter?  or  burn  or  burns  or  burning  or  bite  or  bites  or  biting  or  hit  or  hits  or  hitting))  or  head  bang*  or
headbang*).ti,kw. (62383)
5 (NSSI? or ((nonsuicid* or non-suicid*) adj2 (self* or injur*))).ti,ab,kw. (1786)
6 ((nonfatal or non-fatal) adj2 (overdose? or over dose?)).mp. (418)
7 or/1-6 (125188)

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

232

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

8 randomized controlled trial/ (608057)
9 randomization.de. (87068)
10 controlled clinical trial/ and (Disease Management or Drug Therapy or Prevention or Rehabilitation or Therapy).fs. (253859)
11 *clinical trial/ (17606)
12 placebo.de. (351476)
13 placebo.ti,ab. (307193)
14 trial.ti. (301646)
15 (randomi#ed or randomi#ation or randomi#ing).ti,ab,kw. (917476)
16 (RCT or "at random" or (random* adj3 (administ* or allocat* or assign* or class* or cluster or control* or crossover or cross-over or
determine* or divide* or division or distribut* or expose* or fashion or number* or place* or pragmatic or quasi or recruit* or split or
subsitut* or treat*))).ti,ab,kw. (769731)
17 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$ or dummy)).mp. (309225)
18 (control* and (study or group?) and (waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,kw,hw. (39665)
19 or/8-18 (1732296)
20 ((animal or nonhuman) not (human and (animal or nonhuman))).de. (5683745)
21 19 not 20 (1575127)
22 7 and 21 (8502)
23 (2015* or 2016* or 2017* or 2018* or 2019* or 2020*).yr,dc,dp. (9329153)
24 22 and 23 (3277)
25 limit 24 to exclude medline journals (353)
26 *Automutilation/ (7770)
27 *suicidal behavior/ or *self immolation/ or *self poisoning/ or *suicidal ideation/ or *suicide/ or *suicide attempt/ (49956)
28 *Drug Overdose/ and prevent*.af. (984)
29 4 or 5 or 6 or 26 or 27 or 28 (72349)
30 21 and 29 (2692)
31 23 and 30 (1132)
32 25 or 31 (1375)
***************************

W H A T ' S   N E W

Date

Event

Description

21 April 2021

New citation required and conclusions
have changed

A new protocol including updated methodology was applied
(Witt 2020b). Twenty-one new studies were included in this re-
view compared to the earlier version (Hawton 2016). 

21 April 2021

New search has been performed

This review updates and replaces the Cochrane Review 'Psy-
chosocial interventions for self-harm in adults' (Hawton 2016).

H I S T O R Y

Protocol first published: Issue 7, 2020
Review first published: Issue 4, 2021

Date

Event

Description

1 July 2020

New citation required and major
changes

We updated the protocol developed for Hawton 2016

C O N T R I B U T I O N S   O F   A U T H O R S

KH had the idea for the review. All authors screened studies for inclusion. KGW, SEH, GR, and KH extracted data and assessed risk of bias
for included studies. KGW, SEH, and TLTS conducted the statistical analyses. KGW and KH wrote the initial version of the review and all
authors contributed to the writing of drafts. All authors approved the final version of the review for publication.

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

233

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

D E C L A R A T I O N S   O F   I N T E R E S T

Cochrane Database of Systematic Reviews

KGW: is an editor for the Cochrane Common Mental Disorders Group, and senior editor for the Self-Harm and Suicide Satellite of the group.
SEH: is the joint co-ordinating editor of the Cochrane Common Mental Disorders Group. She is funded by an Auckland Medical Research
Foundation Douglas Goodfellow Repatriation Fellowship to develop and test a digital intervention for young people who engage in self-
harm. She is the Principal Clinical Advisor of the Suicide Prevention Office of the Ministry of Health for the New Zealand Government.
GR: no declarations of interest to report in relation to this review
PH: no declarations of interest to report in relation to this review
TLTS: no declarations of interest to report in relation to this review
ET: no declarations of interest to report in relation to this review
KH: no declarations of interest to report in relation to this review

S O U R C E S   O F   S U P P O R T

Internal sources

• No sources of support supplied

External sources

• National Health and Medical Research Council, Australia

KW is supported by an Emerging Leadership 1 Fellowship awarded by the NHMRC (APP1177787).

• National Institute of Health Research (NIHR), UK

KW received support from the NIHR (Award number: NIHR 131986)

D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W

Following consensus discussions with review authors, we combined one comparison with case management:

• Treatment adherence enhancement approaches.

We added three further comparisons to reflect approaches used in new trials of psychosocial interventions for SH in adults identified by
this update:

• Psychodynamic psychotherapy;
• Structured general practitioner (GP) follow-up;
• Brief emergency department-based interventions.

I N D E X   T E R M S

Medical Subject Headings (MeSH)

*Cognitive Behavioral Therapy;  Confidence Intervals;  Depression  [therapy];  *Dialectical Behavior Therapy;  Mentalization;  Problem
Solving;  Psychosocial Intervention  [*methods];  *Psychotherapy, Psychodynamic;  Randomized Controlled Trials as Topic;  Recurrence; 
Secondary Prevention  [methods];  Self-Injurious Behavior  [psychology]  [*therapy];  Suicide Prevention

MeSH check words

Adult; Female; Humans; Male

Psychosocial interventions for self-harm in adults (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

234
